FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ferreira, MLB
   de Albuquerque, MDPM
   de Brito, CAA
   Franca, RFD
   Moreira, AJP
   Machado, MID
   Melo, RP
   Medialdea-Carrera, R
   Mesquita, SD
   Santos, ML
   Mehta, R
   Silva, RRE
   Leonhard, SE
   Ellul, M
   Rosala-Hallas, A
   Burnside, G
   Turtle, L
   Griffiths, MJ
   Jacobs, BC
   Bhojak, M
   Willison, HJ
   Pena, LJ
   Pardo, CA
   Ximenes, RAA
   Martelli, CMT
   Brown, DWG
   Cordeiro, MT
   Lant, S
   Solomon, T
AF Brito Ferreira, Maria Lucia
   Pessoa Militao de Albuquerque, Maria de Fatima
   Antunes de Brito, Carlos Alexandre
   de Oliveira Franca, Rafael Freitas
   Porto Moreira, Alvaro Jose
   de Morais Machado, Maria Iris
   Melo, Roberta Paz
   Medialdea-Carrera, Raquel
   Mesquita, Solange Dornelas
   Santos, Marcela Lopes
   Mehta, Ravi
   Ramos e Silva, Rafael
   Leonhard, Sonja E.
   Ellul, Mark
   Rosala-Hallas, Anna
   Burnside, Girvan
   Turtle, Lance
   Griffiths, Michael J.
   Jacobs, Bart C.
   Bhojak, Maneesh
   Willison, Hugh J.
   Pena, Lindomar Jose
   Pardo, Carlos A.
   Ximenes, Ricardo A. A.
   Turchi Martelli, Celina Maria
   Brown, David W. G.
   Cordeiro, Marli Tenorio
   Lant, Suzannah
   Solomon, Tom
TI Neurological disease in adults with Zika and chikungunya virus infection
   in Northeast Brazil: a prospective observational study
SO LANCET NEUROLOGY
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; CASE DEFINITIONS; ENCEPHALITIS; DIAGNOSIS;
   GUIDELINES; COLLECTION; CRITERIA; DENGUE; STATE
AB Background Since 2015, the arthropod-borne viruses (arboviruses) Zika and chikungunya have spread across the Americas causing outbreaks, accompanied by increases in immune-mediated and infectious neurological disease. The spectrum of neurological manifestations linked to these viruses, and the importance of dual infection, are not known fully. We aimed to investigate whether neurological presentations differed according to the infecting arbovirus, and whether patients with dual infection had a different disease spectrum or severity.
   Methods We report a prospective observational study done during epidemics of Zika and chikungunya viruses in Recife, Pernambuco, a dengue-endemic area of Brazil. We recruited adults aged 18 years or older referred to Hospital da Restauracao, a secondary-level and tertiary-level hospital, with suspected acute neurological disease and a history of suspected arboviral infection. We looked for evidence of Zika, chikungunya, or dengue infection by viral RNA or specific IgM antibodies in serum or CSF. We grouped patients according to their arbovirus laboratory diagnosis and then compared demographic and clinical characteristics.
   Findings Between Dec 4, 2014, and Dec 4, 2016, 1410 patients were admitted to the hospital neurology service; 201 (14%) had symptoms consistent with arbovirus infection and sufficient samples for diagnostic testing and were included in the study. The median age was 48 years (IQR 34-60), and 106 (53%) were women. 148 (74%) of 201 patients had laboratory evidence of arboviral infection. 98 (49%) of them had a single viral infection (41 [20%] had Zika, 55 [27%] had chikungunya, and two [1%] had dengue infection), whereas 50 (25%) had evidence of dual infection, mostly with Zika and chikungunya viruses (46 [23%] patients). Patients positive for arbovirus infection presented with a broad range of CNS and peripheral nervous system (PNS) disease. Chikungunya infection was more often associated with CNS disease (26 [47%] of 55 patients with chikungunya infection vs six [15%] of 41 with Zika infection; p=0.0008), especially myelitis (12 [22%] patients). Zika infection was more often associated with PNS disease (26 [63%] of 41 patients with Zika infection vs nine [16%] of 55 with chikungunya infection; p=0.0001), particularly Guillain-Barre syndrome (25 [61%] patients). Patients with Guillain-Barre syndrome who had Zika and chikungunya dual infection had more aggressive disease, requiring intensive care support and longer hospital stays, than those with mono-infection (median 24 days [IQR 20-30] vs 17 days [10-20]; p=0.0028). Eight (17%) of 46 patients with Zika and chikungunya dual infection had a stroke or transient ischaemic attack, compared with five (6%) of 96 patients with Zika or chikungunya mono-infection (p=0.047).
   Interpretation There is a wide and overlapping spectrum of neurological manifestations caused by Zika or chikungunya mono-infection and by dual infections. The possible increased risk of acute cerebrovascular disease in patients with dual infection merits further investigation.
C1 [Brito Ferreira, Maria Lucia; Porto Moreira, Alvaro Jose; de Morais Machado, Maria Iris; Melo, Roberta Paz; Mesquita, Solange Dornelas; Ramos e Silva, Rafael] Hosp Restauracao, Dept Neurol, Recife, PE, Brazil.
   [Pessoa Militao de Albuquerque, Maria de Fatima; Santos, Marcela Lopes; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Collect Hlth, Recife, PE, Brazil.
   [de Oliveira Franca, Rafael Freitas; Pena, Lindomar Jose; Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Fed Univ Pemambuco, Dept Clin Med, Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.] Fed Univ Pemambuco, Dept Trop Med, Recife, PE, Brazil.
   [Medialdea-Carrera, Raquel; Mehta, Ravi; Ellul, Mark; Turtle, Lance; Griffiths, Michael J.; Lant, Suzannah; Solomon, Tom] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Inst Infect Vet & Ecol Sci, Liverpool, Merseyside, England.
   [Leonhard, Sonja E.; Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
   [Ellul, Mark; Bhojak, Maneesh; Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
   [Rosala-Hallas, Anna; Burnside, Girvan] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England.
   [Turtle, Lance; Solomon, Tom] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England.
   [Griffiths, Michael J.] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England.
   [Willison, Hugh J.] Univ Glasgow, Dept Neurol, Glasgow, Lanark, Scotland.
   [Willison, Hugh J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Neuroimmunol & Neuroinfect Disorders, Baltimore, MD 21205 USA.
   [Brown, David W. G.] Publ Hlth England, Blood Borne Virus Unit, Virus Reference Dept, London, England.
   [Brown, David W. G.] Fundacao Oswaldo Cruz, Evandro Chagas Natl Infect Dis Inst, Flavivirus Reference Lab, Rio De Janeiro, Brazil.
RP Solomon, T (corresponding author), Univ Liverpool, Inst Infect Vet & Ecol Sci, NIHR Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 7BE, Merseyside, England.
EM tsolomon@liverpool.ac.uk
FU Fundacao do Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE); EU's
   Horizon 2020 research and innovation programme; National Institute for
   Health ResearchNational Institute for Health Research (NIHR)
FX Fundacao do Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE), EU's
   Horizon 2020 research and innovation programme, National Institute for
   Health Research.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Acosta-Ampudia Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00116
   Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499
   Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cassidy H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02677
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X
   Hsu CH, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007084
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kelly MJ, 2012, J INFECT DIS, V205, P106, DOI 10.1093/infdis/jir707
   Kirkwood B. R., 2003, ESSENTIAL MED STAT
   Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lannuzel A, 2019, NEUROLOGY, V92, pE2406, DOI 10.1212/WNL.0000000000007536
   Li HM, 2018, CAN MED ASSOC J, V190, pE285, DOI 10.1503/cmaj.170994
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Mallewa M, 2013, LANCET GLOB HEALTH, V1, pE153, DOI 10.1016/S2214-109X(13)70060-3
   McGill F, 2016, J INFECTION, V72, P405, DOI 10.1016/j.jinf.2016.01.007
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Montecillo-Aguado MR, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7239347
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Nagel MA, 2017, J NEUROIMMUNOL, V308, P112, DOI 10.1016/j.jneuroim.2017.03.014
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Sejvar JJ, 2007, VACCINE, V25, P5771, DOI 10.1016/j.vaccine.2007.04.060
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Solomon T, 2009, BRAINS DIS NERVOUS S
   Stegmann-Planchard S, 2020, CLIN INFECT DIS, V70, P1233, DOI 10.1093/cid/ciz625
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
NR 42
TC 3
Z9 3
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD OCT
PY 2020
VL 19
IS 10
BP 826
EP 839
PG 14
WC Clinical Neurology
SC Neurosciences & Neurology
GA OF3NN
UT WOS:000581119100020
PM 32949543
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Cezar, RDD
   Castanha, PMD
   Freire, NM
   Mola, C
   do Carmo, RF
   Cordeiro, MT
   Baptista, P
   Vasconcelos, LRS
   Moura, P
   Teixeira, VGD
AF da Silva Cezar, Renata Duarte
   da Silva Castanha, Priscila Mayrelle
   Matos Freire, Naishe
   Mola, Carla
   Feliciano do Carmo, Rodrigo
   Tenorio Cordeiro, Marli
   Baptista, Paulo
   Silva Vasconcelos, Luydson Richardson
   Moura, Patricia
   da Silva Teixeira, Vanessa Gabryelle
TI Association between interferon lambda 3 rs12979860 polymorphism and
   clinical outcome in dengue virus-infected children
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Article
DE children; dengue; interferon; polymorphism
ID CHRONIC HEPATITIS-C; GENETIC-VARIATION; SPONTANEOUS CLEARANCE;
   HEMORRHAGIC-FEVER; IL28B; ALPHA; INFANTS; CELLS
AB Single nucleotide polymorphisms (SNPs) in immune-related genes have been shown to play a role in driving the development of the severe phenotypes of dengue virus (DENV) infection. We assessed the association between IFNL3 gene SNP (rs12979860) and dengue clinical outcomes in children. Patients with dengue-related symptoms (aged 1-15 years) admitted at a public hospital in Northeast Brazil were invited to participate. The association between rs12979860 polymorphism and dengue classification and clinical signs and symptoms were analysed. A total of 206 DENV-infected children were included: 53.4% of the infections were classified as severe dengue. The T allele carriers had higher risk of developing severe dengue when compared to CC genotype carriers (OR: 1.81; 95% CI: 0.98-3.32 p = .054). The T allele carriers also showed longer fever episodes when compared to patients with the CC genotype (OR: 1.90; 95%CI: 1.07-3.38; p = .027). On the other hand, the ones carrying the CT/TT genotype had 70% lower chance of developing thrombocytopenia when compared to those with the CC genotype (OR: 0.30; 95%CI: 0.08-0.88; p = .042). Our findings demonstrated that the T allele carriers of the IFNL3 gene had higher risk of developing severe dengue, suggesting a link between IFN-lambda expression and DENV immunopathogenesis.
C1 [da Silva Cezar, Renata Duarte; Mola, Carla; da Silva Teixeira, Vanessa Gabryelle] Univ Pernambuco, Inst Ciencias Biol, Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
   [da Silva Castanha, Priscila Mayrelle; Matos Freire, Naishe; Baptista, Paulo; Silva Vasconcelos, Luydson Richardson] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [da Silva Castanha, Priscila Mayrelle; Tenorio Cordeiro, Marli; Silva Vasconcelos, Luydson Richardson] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Feliciano do Carmo, Rodrigo] Univ Fed Vale do Sao Francisco UNIVASF, Petrolina, Brazil.
   [Silva Vasconcelos, Luydson Richardson] Inst Figado, Recife, PE, Brazil.
   [Moura, Patricia] Fac Ciencias Med, Inst Ciencias Biol, Recife, PE, Brazil.
   [Moura, Patricia] Univ Pernambuco, Campus Arcoverde, Recife, PE, Brazil.
RP Moura, P (corresponding author), Univ Pernambuco, Inst Ciencias Biol, Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
EM patricia.moura@upe.br
RI Da Silva Castanha, Priscila Mayrelle/G-1785-2012; Carmo, Rodrigo
   Feliciano do/V-9795-2017
OI Da Silva Castanha, Priscila Mayrelle/0000-0002-1220-5308; Carmo, Rodrigo
   Feliciano do/0000-0001-9601-6995; Moura, Patricia/0000-0003-4259-388X;
   Cezar, Renata/0000-0002-7278-5682
FU Brazilian Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Pernambuco Foundation for Science and Technology (FACEPE)
   [APQ-0296-4.01/08]
FX This study was supported by Brazilian Council for Scientific and
   Technological Development (CNPq) and Pernambuco Foundation for Science
   and Technology (FACEPE) [grant number APQ-0296-4.01/08].
CR Vargas-Castillo AB, 2018, VIRAL IMMUNOL, V31, P249, DOI 10.1089/vim.2017.0069
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Capeding RZ, 2010, AM J TROP MED HYG, V82, P330, DOI 10.4269/ajtmh.2010.09-0542
   Chen RF, 2009, CLIN IMMUNOL, V131, P404, DOI 10.1016/j.clim.2009.01.015
   Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   Duangkhae P, 2018, J INVEST DERMATOL, V138, P618, DOI 10.1016/j.jid.2017.10.018
   Egli A, 2014, J INFECT DIS, V210, P717, DOI 10.1093/infdis/jiu144
   Figueiredo GG, 2016, HUM IMMUNOL, V77, P571, DOI 10.1016/j.humimm.2016.05.006
   Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Han H, 2013, J HEPATOL, V59, P957, DOI 10.1016/j.jhep.2013.07.004
   Hsu YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24530
   Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x
   Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020
   Lee MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17030
   Li Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008219
   Liu MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035902
   Feitosa RNM, 2016, VIRAL IMMUNOL, V29, P379, DOI 10.1089/vim.2016.0026
   Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007
   Palma-Ocampo HK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0383-4
   Pan American Health Organization, 2015, NUMB REP CAS DENG SE
   Perez AB, 2010, HUM IMMUNOL, V71, P1135, DOI 10.1016/j.humimm.2010.08.004
   Pica F, 2010, ANTIVIR THER, V15, P737, DOI 10.3851/IMP1610
   Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056
   Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4
   Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005
   Silva LK, 2010, EUR J HUM GENET, V18, P1221, DOI 10.1038/ejhg.2010.98
   Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085
   Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447
   Syedbasha M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00119
   Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449
   Tang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012644
   Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463
   Trevino A, 2012, CLIN INFECT DIS, V55, pE1, DOI 10.1093/cid/cis343
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   World Health Organization, 2017, DENG SEV DENG FACT S
   Xavier-Carvalho C, 2017, INFECT GENET EVOL, V56, P99, DOI 10.1016/j.meegid.2017.11.009
NR 42
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-3121
EI 1744-313X
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD AUG
PY 2020
VL 47
IS 4
BP 351
EP 358
DI 10.1111/iji.12477
EA FEB 2020
PG 8
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA ML9IN
UT WOS:000513712900001
PM 32065450
DA 2020-12-08
ER

PT J
AU Simao, EP
   Silva, DBS
   Cordeiro, MT
   Gil, LHV
   Andrade, CAS
   Oliveira, MDL
AF Simao, Estefani P.
   Silva, Dammyres B. S.
   Cordeiro, Marli T.
   Gil, Laura H. V.
   Andrade, Cesar A. S.
   Oliveira, Maria D. L.
TI Nanostructured impedimetric lectin-based biosensor for arboviruses
   detection
SO TALANTA
LA English
DT Article
DE Concanavalin A; Nanoparticles; Arboviruses; Biosensor; Impedance
   spectroscopy
ID ZINC-OXIDE NANOPARTICLES; BORON-NITRIDE NANOSHEETS; GOLD NANOPARTICLES;
   SENSOR; DENGUE; CHIKUNGUNYA; DIAGNOSIS; SEROTYPE
AB Arboviruses have been emerging as a significant global health problem due to the recurrent epidemics. Arboviruses require the development of new diagnostic devices due to the nonspecific clinical manifestations. Herein, we report a biosensor based on cysteine (Cys), zinc oxide nanoparticles (ZnONp), and Concanavalin A (ConA) lectin to differentiate between arboviruses infections. ConA is capable of interacting with the saccharide components of the viral capsid. In this study, we evaluated the reproducibility, sensitivity, and specificity of the sensor for the virus of Dengue type 2 (DENV2), Zika (ZIKV), Chikungunya (CHIKV), and Yellow fever (YFV). Atomic force microscopy measurements confirmed the electrode surface modification and revealed a heterogeneous topography during the biorecognition process. Cyclic voltammetry (CV) and impedance spectroscopy (EIS) were used to characterize the biosensor. The blockage of the oxidation-reduction process is related to the formation of Cys-ZnONp-ConA system on the electroactive area and its subsequent interaction with viral glycoproteins. The sensor exhibited a linear response to different concentrations of the studied arboviruses. Our study demonstrates that ConA lectin recognizes the structural glycoproteins of the DENV2, ZIKV, CHIKV, and YFV. DENV2 is the most structurally similar to ZIKV. Our results have shown that the impedimetric response correlates with the structural glycoproteins, as follow: DENV2 (18.6 k Omega) > ZIKV (14.6 k Omega) > CHIKV (6.86 k Omega) > YFV (5.98 k Omega). The homologous structural regions contribute to ConA-arboviruses recognition. Our results demonstrate the use of the proposed system for the development of biosensors for arboviruses infections.
C1 [Simao, Estefani P.; Oliveira, Maria D. L.] Univ Fed Pernambuco, Programa Posgrad Ciencias Biol, BR-50670901 Recife, PE, Brazil.
   [Silva, Dammyres B. S.; Andrade, Cesar A. S.; Oliveira, Maria D. L.] Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
   [Cordeiro, Marli T.; Gil, Laura H. V.] Inst Aggeu Magalhaes Fiocruz, Dept Virol, BR-50670420 Recife, PE, Brazil.
RP Oliveira, MDL (corresponding author), Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
EM m_danielly@yahoo.com.br
RI Oliveira, Maria/AAM-4055-2020
OI Souza de Andrade, Cesar Augusto/0000-0002-3271-2817; Oliveira,
   Maria/0000-0002-8572-4846
FU Foundation for Science and Technology of the State of Pernambuco
   (FACEPE); FACEPE [APQ-0739-2.12/17]; CNPqNational Council for Scientific
   and Technological Development (CNPq) [314894/2018-7, 314756/2018-3]
FX E.P. Simao would like to thank Foundation for Science and Technology of
   the State of Pernambuco (FACEPE) for a Ph.D. scholarship. L.H.V. Gil
   would like to thank FACEPE (grant APQ-0739-2.12/17). M.D.L. Oliveira and
   C.A.S. Andrade would like to thank CNPq (grant 314894/2018-7 and
   314756/2018-3).
CR Akahata W, 2012, J VIROL, V86, P8879, DOI 10.1128/JVI.00370-12
   Andrade CAS, 2011, J COLLOID INTERF SCI, V362, P517, DOI 10.1016/j.jcis.2011.07.013
   Atar N, 2018, J ELECTROCHEM SOC, V165, pH255, DOI [10.1149/2.1311805jes, 10.1149/2.1311805JES]
   Bouckaert J, 1996, J BIOL CHEM, V271, P16144, DOI 10.1074/jbc.271.27.16144
   CDC (U.S. Centers for Disease Control and Prevention), 2016, TRIOPL REAL TIM RT P
   CDC (U.S. Centers for Disease Control and Prevention), 2016, TYP ZIK VIR TESTS
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   da Silva JSL, 2014, COLLOID SURFACE B, V117, P549, DOI 10.1016/j.colsurfb.2013.12.057
   Deeba F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv119
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Grasset F, 2003, J ALLOY COMPD, V360, P298, DOI 10.1016/S0925-8388(03)00371-2
   Grubhoffer L., 2009, LECTINS BIOL BIOCH C, V7, P313
   Gupta VK, 2013, SENSOR ACTUAT B-CHEM, V188, P1201, DOI 10.1016/j.snb.2013.08.034
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Khan R, 2008, ANAL CHIM ACTA, V616, P207, DOI 10.1016/j.aca.2008.04.010
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kurstack E.K.C., 1981, COMP DIAGNOSIS VIRAL
   Ma XH, 2017, SENSOR ACTUAT B-CHEM, V248, P201, DOI 10.1016/j.snb.2017.03.172
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nascimento HPO, 2011, COLLOID SURFACE B, V86, P414, DOI 10.1016/j.colsurfb.2011.04.028
   Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Oliveira MDL, 2011, J COLLOID INTERF SCI, V362, P194, DOI 10.1016/j.jcis.2011.06.042
   Oliveira MDL, 2011, SENSOR ACTUAT B-CHEM, V155, P789, DOI 10.1016/j.snb.2011.01.049
   Oliveira MDL, 2009, SYNTHETIC MET, V159, P2162, DOI 10.1016/j.synthmet.2009.09.022
   Oliveira MDL, 2009, BIOSENS BIOELECTRON, V25, P728, DOI 10.1016/j.bios.2009.08.009
   Oliveira N, 2015, SENSORS-BASEL, V15, P15562, DOI 10.3390/s150715562
   ORAM JD, 1971, NATURE-NEW BIOL, V233, P50
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Pereira EMA, 2008, COLLOID SURFACE B, V66, P45, DOI 10.1016/j.colsurfb.2008.05.013
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   Schwartz R.M., 2016, J CHROMATOGR B, V1032, P2
   Simao EP, 2016, J BRAZIL CHEM SOC, V27, P1040, DOI 10.5935/0103-5053.20150361
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Taylor P., 2008, ANAL LETT, V41, P37
   Volk DE, 2009, VIROLOGY, V394, P12, DOI 10.1016/j.virol.2009.09.001
   Yang HY, 2016, SENSOR ACTUAT B-CHEM, V229, P297, DOI 10.1016/j.snb.2015.08.034
   Yola ML, 2019, BIOSENS BIOELECTRON, V126, P418, DOI 10.1016/j.bios.2018.11.016
   Yola ML, 2018, APPL SURF SCI, V458, P648, DOI 10.1016/j.apsusc.2018.07.142
   Yola ML, 2015, SENSOR ACTUAT B-CHEM, V210, P149, DOI 10.1016/j.snb.2014.12.098
   Yola ML, 2014, ELECTROCHIM ACTA, V119, P24, DOI 10.1016/j.electacta.2013.12.028
   Yola ML, 2014, ELECTROCHIM ACTA, V125, P38, DOI 10.1016/j.electacta.2014.01.074
   Yumak T, 2011, COLLOID SURFACE B, V86, P397, DOI 10.1016/j.colsurfb.2011.04.030
   Zhao LZ, 2016, SENSOR ACTUAT B-CHEM, V235, P575, DOI 10.1016/j.snb.2016.05.136
NR 48
TC 2
Z9 2
U1 2
U2 42
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD FEB 1
PY 2020
VL 208
AR 120338
DI 10.1016/j.talanta.2019.120338
PG 7
WC Chemistry, Analytical
SC Chemistry
GA JW8RM
UT WOS:000503314200016
PM 31816752
DA 2020-12-08
ER

PT J
AU Ximenes, RAD
   Miranda, DD
   Brickley, EB
   Montarroyos, UR
   Martelli, CMT
   de Araujo, TVB
   Rodrigues, LC
   de Albuquerque, MDPM
   de Souza, WV
   Castanha, PMD
   Franca, RFO
   Dhalia, R
   Marques, ETA
   Alves, SV
   Bezerra, LCA
   Braga, MC
   Brainer, ACM
   Carvalho, MDCG
   Cordeiro, MT
   Dimech, G
   Eickmann, SH
   Brandao, SP
   Gois, ADL
   Goncalves, AV
   Gouveia, MDL
   de Melo, APL
   Muniz, LF
   Oliveira, DMD
   Pastich, F
   Pinto, MH
   Ramos, RCF
   Rocha, MAW
   Silva, PFS
   de Vasconcelos, RAL
   Ventura, CVDC
   Ventura, LMVD
AF Ximenes, Ricardo Arraes de Alencar
   Miranda-Filho, Democrito de Barros
   Brickley, Elizabeth B.
   Montarroyos, Ulisses Ramos
   Martelli, Celina Maria Turchi
   de Araujo, Thalia Velho Barreto
   Rodrigues, Laura C.
   de Albuquerque, Maria de Fatima Pessoa Militao
   de Souza, Wayner Vieira
   Castanha, Priscila Mayrelle da Silva
   Franca, Rafael F. O.
   Dhalia, Rafael
   Marques, Ernesto T. A.
   Alves, Sandra Valongueiro
   Bezerra, Luciana Caroline Albuquerque
   Braga, Maria Cynthia
   Brainer, Alessandra Cintia Mertens
   Carvalho, Maria Durce Costa Gomes
   Cordeiro, Marli Tenorio
   Dimech, Geroge
   Eickmann, Sophie Helena
   Brandao Filho, Sinval Pinto
   Gois, Adriana de Oliveira Lima
   Goncalves, Andreia Veras
   Gouveia, Mariana de Carvalho Leal
   de Melo, Ana Paula Lopes
   Muniz, Lilian Ferreira
   Oliveira, Danielle Maria da Silva
   Pastich, Fabiana
   Pinto, Maria Helena
   Ramos, Regina Coeli Ferreira
   Rocha, Maria Angela Wanderley
   Silva, Paula Fabiana Sobral
   de Vasconcelos, Romulo Augusto Lucena
   Ventura, Camila Vieira de Oliveira Carvalho
   Ventura, Liana Maria Vieira de Oliveira
CA MERG
TI Zika virus infection in pregnancy: Establishing a case definition for
   clinical research on pregnant women with rash in an active transmission
   setting
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID US TERRITORIES; ANTIBODIES; EPIDEMIC; EXPOSURE; OUTCOMES; JANUARY;
   UPDATE; BRAZIL
AB Defining cases of Zika virus (ZIKV) infection is a critical challenge for epidemiological research. Due to ZIKV's overlapping clinical features and potential immunologic cross-reactivity with other flaviviruses and the current lack of an optimal ZIKV-specific diagnostic assay, varying approaches for identifying ZIKV infections have been employed to date. This paper presents the laboratory results and diagnostic criteria developed by the Microcephaly Epidemic Research Group for defining cases of maternal ZIKV infection in a cohort of pregnant women with rash (N = 694) recruited during the declining 2015-2017 epidemic in northeast Brazil. For this investigation, we tested maternal sera for ZIKV by quantitative reverse transcription polymerase chain reaction (qRT-PCR), Immunoglobulin (Ig) M and IgG3 enzyme-linked immunosorbent assays (ELISAs), and Plaque Reduction Neutralization Test (PRNT50). Overall, 23.8% of participants tested positive by qRT-PCR during pregnancy (range of detection: 0-72 days after rash onset). However, the inter-assay concordance was lower than expected. Among women with qRT-PCR-confirmed ZIKV and further testing, only 10.1% had positive IgM tests within 90 days of rash, and only 48.5% had ZIKV-specific PRNT50 titers >= 20 within 1 year of rash. Given the complexity of these data, we convened a panel of experts to propose an algorithm for identifying ZIKV infections in pregnancy based on all available lines of evidence. When the diagnostic algorithm was applied to the cohort, 26.9% of participants were classified as having robust evidence of a ZIKV infection during pregnancy, 4.0% as having moderate evidence, 13.3% as having limited evidence of a ZIKV infection but with uncertain timing, and 19.5% as having evidence of an unspecified flavivirus infection before or during pregnancy. Our findings suggest that integrating longitudinal data from nucleic acid and serologic testing may enhance diagnostic sensitivity and underscore the need for an on-going dialogue regarding the optimization of strategies for defining cases of ZIKV in research.
C1 [Ximenes, Ricardo Arraes de Alencar] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [Ximenes, Ricardo Arraes de Alencar; Miranda-Filho, Democrito de Barros] Univ Pernambuco, Dept Med Interna, Recife, PE, Brazil.
   [Brickley, Elizabeth B.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Montarroyos, Ulisses Ramos] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Martelli, Celina Maria Turchi; de Albuquerque, Maria de Fatima Pessoa Militao; de Souza, Wayner Vieira; Castanha, Priscila Mayrelle da Silva; Franca, Rafael F. O.; Dhalia, Rafael; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [de Araujo, Thalia Velho Barreto] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil.
   [Castanha, Priscila Mayrelle da Silva; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Castanha, Priscila Mayrelle da Silva] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
RP Ximenes, RAD (corresponding author), Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.; Ximenes, RAD (corresponding author), Univ Pernambuco, Dept Med Interna, Recife, PE, Brazil.
EM raaximenes@uol.com.br
RI Marques, Ernesto T. A/L-4967-2013; Dhalia, Rafael/AAD-5432-2020; Da
   Silva Castanha, Priscila Mayrelle/G-1785-2012; Montarroyos,
   Ulisses/AAJ-7527-2020; Brickley, Elizabeth/U-3625-2017
OI Marques, Ernesto T. A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Brickley, Elizabeth/0000-0003-0280-2288
FU Wellcome TrustWellcome Trust [205377/Z/16/Z, MC_PC_15088]; UK's
   Department for International Development [205377/Z/16/Z]; Wellcome
   Trust's Enhancing Research Activity in Epidemic Situations programme
   [107779/Z/15/Z, ER1505, ER1601]; European Union's Horizon 2020 research
   and innovation program under ZikaPLAN grant [734584]; Medical Research
   Council on behalf of the Newton Fund [MC_PC_15088]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [309722/2017-9, 308590/2013-9,
   306708/2014-0, 308491/2013-0, 306222/20132]; Secretaria de Vigilancia em
   Saude/Ministerio da Saude de Brasil Resposta a Emergencia em Saude
   Publica -Zika vi'rus e Microcefalia [837058/2016]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Departamento de
   Ciencia e Tecnologia [440839/2016-5]
FX This work was supported by the: Wellcome Trust & the UK's Department for
   International Development (205377/Z/16/Z to LCR;
   https://wellcome.ac.uk/), the Wellcome Trust's Enhancing Research
   Activity in Epidemic Situations programme (107779/Z/15/Z; with ER1505 &
   ER1601 to RAAX), the European Union's Horizon 2020 research and
   innovation program (https://ec.europa.eu/programmes/horizon2020/) under
   ZikaPLAN grant agreement No. 734584 (https://zikaplan.tghn.org/), the
   Medical Research Council on behalf of the Newton Fund and the Wellcome
   Trust (MC_PC_15088 to LCR; https://mrc.ukri.org/), the Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico(309722/2017-9to RAAX,
   308590/2013-9 to DBMF, and 306708/2014-0 to CMTM, 308491/2013-0 to
   MFPMA, 306222/20132 to WVS;http://www.cnpq.br/), Secretaria de
   Vigilancia em Saude/Ministerio da Saude de Brasil Resposta a Emergencia
   em Saude Publica -Zika vi ' rus e Microcefalia (837058/2016 to RAAX),
   the Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico,
   the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (http://www.capes.gov.br/), & the Departamento de Ciencia e Tecnologia
   (http://rebrats.saude.gov.br/noticias/59DECIT)for Prevencao e Combate a
   o virus Zika I (440839/2016-5 to RAAX). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Castanha PMS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007246
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Centers for Disease Control and Prevention, 2018, ZIK MAC ELISA INSTR
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cortes F, 2018, ACTA TROP, V182, P190, DOI 10.1016/j.actatropica.2018.03.006
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Judice CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22159-2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay108
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rodriguez-Barraquer I, 2018, ZIKA EMERGENCE DENGU
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Secretaria de Vigilancia em Saude-Ministerio da Saude-Brasil. Ministerio da Saude SituacAo epidemiologica de ocorrencia de microcefalias no Brasil, 2015, B EPIDEMIOLOGICO, V46
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01972-17, 10.1128/JCM.01972-17]
   WHO, 2016, WHOZIKVSUR161
NR 30
TC 6
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2019
VL 13
IS 10
AR e0007763
DI 10.1371/journal.pntd.0007763
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JK6WK
UT WOS:000494982700021
PM 31589611
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-08
ER

PT J
AU Alves, RD
   Franco, DL
   Cordeiro, MT
   de Oliveira, EM
   Dutra, RAF
   Sotomayor, MDT
AF Alves, Rafael da Fonseca
   Franco, Diego Leoni
   Cordeiro, Marli Tenorio
   de Oliveira Junior, Ernesto Marques
   Fireman Dutra, Rosa Amalia
   Taboada Sotomayor, Maria Del Pilar
TI Novel electrochemical genosensor for Zika virus based on a
   poly-(3-amino-4-hydroxybenzoic acid)-modified pencil carbon graphite
   electrode
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Zika virus; Pencil graphite; Electrochemical genosensor;
   3-Amino-4-hydroxybenzoic acid polymer
ID ELECTROPOLYMERIZATION; TRANSMISSION; AMINOPHENOL; AMERICA; PURINES; FILM
AB The Zika virus has recently emerged as a major worldwide threat because it induces microencephaly and other brain damage in babies born to infected mothers. Epidemiological monitoring of infection has been hampered by the lack of reliable tests capable of distinguishing between Zika and other Flavivirus infections, especially the dengue virus. The present work describes the electrochemical modification of pencil carbon graphite electrodes with a material derived from 3-amino-4-hydroxybenzoic acid. Solutions were prepared in acid medium and the material formed showed insulating behavior. Optical and electrical data suggested that carboxyl groups did not participate in the reaction mechanism. FT-IR spectra indicated that these groups were retained, enabling the proposal of a mechanism based on the data obtained. The material formed was used for immobilization of the ssDNAzv aminated oligonucleotide. Detection of the hybridization was based on the Delta ip resulting from the higher electrostatic repulsion of [Fe(CN)(6)](3-), caused by the increase of phosphates by addition of the complementary target sequence. The system showed a good linear correlation coefficient (r(2) = 0.997), with satisfactory selectivity and reproducibility, a low limit of detection (25.4 pM), and precision (RSD) of 3.1%, using real samples of human serum enriched with total extract of Zika virus RNA. Tests of the system using the total RNA extracted from dengue virus types 2 and 3 cultures showed little difference in the observed current, hence confirming the specificity of the system. These findings demonstrated the potential of the proposed biosensor.
C1 [Alves, Rafael da Fonseca; Taboada Sotomayor, Maria Del Pilar] State Univ Sao Paulo UNESP, Dept Analyt Chem, Inst Chem, BR-14801970 Araraquara, SP, Brazil.
   [Franco, Diego Leoni] Univ Fed Uberlandia, Inst Quim, Grp Eletroquim Aplicada & Polimeros & Sensores, BR-38700128 Patos De Minas, MG, Brazil.
   [Cordeiro, Marli Tenorio; de Oliveira Junior, Ernesto Marques] Oswaldo Cruz Fiocruz Fdn, Aggeu Magalhaes Inst, Av Prof Moraes Rego S-N,POB 7-472, BR-50670420 Recife, PE, Brazil.
   [Fireman Dutra, Rosa Amalia] Univ Fed Pernambuco, Biomed Engn Lab, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
RP Sotomayor, MDT (corresponding author), State Univ Sao Paulo UNESP, Dept Analyt Chem, Inst Chem, BR-14801970 Araraquara, SP, Brazil.
EM m.sotomayor@unesp.br
RI Franco, Diego L/H-1660-2012; Alves, Rafael F./P-3427-2018; Sotomayor,
   Maria/M-6317-2013
OI Franco, Diego L/0000-0003-4675-971X; Sotomayor,
   Maria/0000-0002-6173-7888; da Fonseca Alves, Rafael/0000-0002-6319-9817
FU Sao Paulo State Research Foundation -Brazil (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2017/07436-0]; Coordination
   for the Improvement of Higher Education Personnel (CAPES)CAPES; National
   Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [440605/2016-4]
FX The authors are grateful for financial support provided by the Sao Paulo
   State Research Foundation -Brazil (FAPESP, grant #2017/07436-0),
   Coordination for the Improvement of Higher Education Personnel (CAPES)
   and the National Council for Scientific and Technological Development
   (CNPq, grant #440605/2016-4).
CR Alves RD, 2017, TALANTA, V165, P69, DOI 10.1016/j.talanta.2016.12.025
   BARBERO C, 1987, ELECTROCHIM ACTA, V32, P693, DOI 10.1016/0013-4686(87)87063-9
   BARBERO C, 1989, J ELECTROANAL CHEM, V263, P333, DOI 10.1016/0022-0728(89)85103-4
   Bonanni A, 2015, TALANTA, V136, P95, DOI 10.1016/j.talanta.2015.01.004
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), 2018, TYP ZIK VIR TESTS ZI
   Cha JH, 2003, BIOSENS BIOELECTRON, V18, P1241, DOI 10.1016/S0956-5663(03)00088-55
   Chen CX, 2013, ELECTROCHIM ACTA, V97, P112, DOI 10.1016/j.electacta.2013.02.138
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Cruz FS, 2017, J ELECTROANAL CHEM, V806, P172, DOI 10.1016/j.jelechem.2017.10.070
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franco DL, 2008, POLYM ENG SCI, V48, P2043, DOI 10.1002/pen.21044
   Franco DL, 2008, MATER CHEM PHYS, V107, P404, DOI 10.1016/j.matchemphys.2007.08.006
   Goncalves D, 2000, J ELECTROANAL CHEM, V487, P90, DOI 10.1016/S0022-0728(00)00151-0
   Guenbour A, 2000, PROG ORG COAT, V38, P121, DOI 10.1016/S0300-9440(00)00085-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamdan N. A., 2012, CURR RES TUBERCULOSI, V4, P1, DOI DOI 10.3923/CRT.2012.1.12
   Hofer U, 2016, NAT REV MICROBIOL, V14, P401, DOI 10.1038/nrmicro.2016.80
   Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kafka J, 2008, ELECTROCHIM ACTA, V53, P7467, DOI 10.1016/j.electacta.2008.01.031
   Kawaguchi H, 2015, BIORESOURCE TECHNOL, V198, P410, DOI 10.1016/j.biortech.2015.09.024
   KUNIMURA S, 1988, MACROMOLECULES, V21, P894, DOI 10.1021/ma00182a007
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti R. S., 2015, EMERG INFECT DIS, V22, P2015
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li LL, 2004, ELECTROANAL, V16, P81, DOI 10.1002/elan.200302921
   Li P, 2018, CELL HOST MICROBE, V24, P875, DOI 10.1016/j.chom.2018.10.011
   Marques ETA, 1998, MOL BIOCHEM PARASIT, V93, P237, DOI 10.1016/S0166-6851(98)00033-4
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miao YQ, 2004, TRENDS BIOTECHNOL, V22, P227, DOI 10.1016/j.tibtech.2004.03.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliveira RML, 2010, J MATER SCI, V45, P475, DOI 10.1007/s10853-009-3964-z
   Ortega JM, 2000, THIN SOLID FILMS, V371, P28, DOI 10.1016/S0040-6090(00)00980-9
   Pavia G. S., 2010, INTRO SPECTROSCOPY G
   Peng H, 2006, BIOSENS BIOELECTRON, V21, P1727, DOI 10.1016/j.bios.2005.08.011
   Qi H, 2007, TALANTA, V72, P1030, DOI 10.1016/j.talanta.2006.12.032
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Suzuki H, 2006, J BIOL CHEM, V281, P36944, DOI 10.1074/jbc.M608103200
   Tappe D, 2014, EURO SURVEILL, V19, P20865
   Thenmozhi G, 2014, INT J ELECTROCHEM, V2014, DOI 10.1155/2014/961617
   Vieira SN, 2006, MACROMOL SYMP, V245, P236, DOI 10.1002/masy.200651333
   VISCHER E, 1948, J BIOL CHEM, V176, P703
   Wang J, 2002, ANAL CHIM ACTA, V469, P63, DOI 10.1016/S0003-2670(01)01399-X
   Wu J, 2005, SENSOR ACTUAT B-CHEM, V104, P43, DOI 10.1016/j.snb.2004.04.097
NR 50
TC 6
Z9 6
U1 4
U2 42
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
EI 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD OCT 1
PY 2019
VL 296
AR 126681
DI 10.1016/j.snb.2019.126681
PG 10
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA II6PC
UT WOS:000475314800066
DA 2020-12-08
ER

PT J
AU Castanha, PMS
   Souza, WV
   Braga, C
   de Araujo, TVB
   Ximenes, RAA
   Albuquerque, MDPM
   Montarroyos, UR
   Miranda, DB
   Cordeiro, MT
   Dhalia, R
   Marques, ETA
   Rodrigues, LC
   Martelli, CMT
   de Brito, CAA
   Batista, JDL
   Bezerra, LCA
   Rocha, MAW
   Carvalho, MDCG
   Silva, PFS
   Pastich, F
   Valongueiro, S
   Melo, AP
   Montarroyos, U
   Ramos, RCF
   Brandao, SP
AF Castanha, Priscila M. S.
   Souza, Wayner V.
   Braga, Cynthia
   Barreto de Araujo, Thalia Velho
   Ximenes, Ricardo A. A.
   Albuquerque, Maria de Fatima P. M.
   Montarroyos, Ulisses R.
   Miranda-Filho, Democrito B.
   Cordeiro, Marli T.
   Dhalia, Rafael
   Marques, Ernesto T. A., Jr.
   Rodrigues, Laura C.
   Martelli, Celina M. T.
   Antunes de Brito, Carlos Alexandre
   Lyra Batista, Joanna d'Arc
   Albuquerque Bezerra, Luciana Caroline
   Wanderley Rocha, Maria Angela
   Costa Gomes Carvalho, Maria Durce
   Sobral Silva, Paula Fabiana
   Pastich, Fabiana
   Valongueiro, Sandra
   Melo, Ana Paula
   Montarroyos, Ulisses
   Ferreira Ramos, Regina Coeli
   Brandao Filho, Sinval Pinto
CA Microcephaly Epidemic Res Grp
TI Perinatal analyses of Zika- and dengue virus-specific neutralizing
   antibodies: A microcephaly case-control study in an area of high dengue
   endemicity in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LOAD
AB Laboratory confirmation of Zika virus (ZIKV) infection during pregnancy is challenging due to cross-reactivity with dengue virus (DENV) and limited knowledge about the kinetics of anti-Zika antibody responses during pregnancy. We described ZIKV and DENV serological markers and the maternal-fetal transfer of antibodies among mothers and neonates after the ZIKV microcephaly outbreak in Northeast Brazil (2016). We included 89 microcephaly cases and 173 neonate controls at time of birth and their mothers. Microcephaly cases were defined as newborns with a particular head circumference (2 SD below the mean). Two controls without microcephaly were matched by the expected date of delivery and area of residence. We tested maternal serum for recent (ZIKV genome, IgM and IgG3 anti-NS1) and previous (ZIKV and DENV neutralizing antibodies [NAbs]) markers of infection. Multiple markers of recent or previous ZIKV and DENV infection in mothers were analyzed using principal component analysis (PCA). At delivery, 5.6% of microcephaly case mothers and 1.7% of control mothers were positive for ZIKV IgM. Positivity for ZIKV IgG3 anti-NS1 was 8.0% for case mothers and 3.5% for control mothers. ZIKV NAbs was slightly higher among mothers of cases (69.6%) than that of mothers of controls (57.2%; p = 0.054). DENV exposure was detected in 85.8% of all mothers. PCA discriminated two distinct components related to recent or previous ZIKV infection and DENV exposure. ZIKV NAbs were higher in newborns than in their corresponding mothers (p<0.001). We detected a high frequency of ZIKV exposure among mothers after the first wave of the ZIKV outbreak in Northeast Brazil. However, we found low sensitivity of the serological markers to recent infection (IgM and IgG3 anti-NS1) in perinatal samples of mothers of microcephaly cases. Since the neutralization test cannot precisely determine the time of infection, testing for ZIKV immune status should be performed as early as possible and throughout pregnancy to monitor acute Zika infection in endemic areas.
C1 [Castanha, Priscila M. S.; Souza, Wayner V.; Braga, Cynthia; Barreto de Araujo, Thalia Velho; Albuquerque, Maria de Fatima P. M.; Cordeiro, Marli T.; Dhalia, Rafael; Marques, Ernesto T. A., Jr.; Martelli, Celina M. T.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Castanha, Priscila M. S.; Ximenes, Ricardo A. A.; Montarroyos, Ulisses R.; Miranda-Filho, Democrito B.] Univ Pernambuco, Sch Med Sci, Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho; Ximenes, Ricardo A. A.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Martelli, CMT (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
EM turchicm@gmail.com
RI Dhalia, Rafael/AAD-5432-2020; Marques, Ernesto T. A/L-4967-2013; Da
   Silva Castanha, Priscila Mayrelle/G-1785-2012; Montarroyos,
   Ulisses/AAJ-7527-2020; Braga, Maria Cynthia/A-8204-2013; Souza, Wayner
   V/H-3798-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Braga, Maria Cynthia/0000-0002-7862-6455;
   Turchi Martelli, Celina Maria/0000-0002-2491-0688
FU Brazilian Ministry of Health, Pan American Health Organization,
   Enhancing Research Activity in Epidemic Situations; National Advisory
   Board of Scientific and Technological Development (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq])National Council for
   Scientific and Technological Development (CNPq) [306708/2014-0,
   308818/2013-0, 308590/2013-9, 308491/2013-0, 304174/2014-9,
   306222/2013-2]; European Union's Horizon 2020 research and innovation
   programme under Zika-PLAN [734584]; CuraZika
FX This study was funded by the Brazilian Ministry of Health, Pan American
   Health Organization, Enhancing Research Activity in Epidemic Situations.
   Some of the investigators received partial support from the National
   Advisory Board of Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq]; scholarship
   306708/2014-0 to CMTM, 308818/2013-0 to RAAX, 308590/2013-9 to DBM-F,
   308491/2013-0 to MFPMA, 304174/2014-9 to CB, and 306222/2013-2 to WVS).
   LCR is partly funded by the European Union's Horizon 2020 research and
   innovation programme under Zika-PLAN (grant agreement no. 734584). The
   study also received parcial support from CuraZika to ETAM. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brazilian Minister of Health, 2017, MONITORAMENTO DOS CA
   Brazilian Minister of Health, 2017, 57 BRAZ MIN HLTH
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pan American Health Organization, 2019, EP UPD YELL FEV 25 J
   Pan American Health Organization, 2018, EP REP BRAZ
   Pan American Health Organization, 2018, REG ZIK EP UPD AM
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Simmons G, 2018, CLIN INFECT DIS, V66, P1181, DOI 10.1093/cid/cix972
   SMFM Consult Series #39, 2016, J INFECT DIS, V214, pB9
   World Health Organization, 2018, ZIK VIR SIT REP
   World Health Organization, 2018, ZIK VIR FACT SHEET
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 46
TC 8
Z9 8
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007246
DI 10.1371/journal.pntd.0007246
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300043
PM 30856223
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU van der Linden, V
   Petribu, NCD
   Pessoa, A
   Faquini, I
   Paciorkowski, AR
   van der Linden, H
   Silveira-Moriyama, L
   Cordeiro, MT
   Hazin, AN
   Barkovich, AJ
   Raybaud, C
   Abath, MD
   Ribeiro, E
   Juca, CEB
   Aragao, MDVV
   Travassos, PTC
   Jungmann, P
AF van der Linden, Vanessa
   de Lima Petribu, Natacha Calheiros
   Pessoa, Andre
   Faquini, Igor
   Paciorkowski, Alex R.
   van der Linden, Helio, Jr.
   Silveira-Moriyama, Laura
   Cordeiro, Marli Tenorio
   Hazin, Adriano Nassri
   Barkovich, A. James
   Raybaud, Charles
   Abath, Marilia de Brito
   Ribeiro, Erlane
   Barros Juca, Carlos Eduardo
   Viana Vasco Aragao, Maria de Fatima
   Coelho Travassos, Patricia Teresa
   Jungmann, Patricia
TI Association of Severe Hydrocephalus With Congenital Zika Syndrome
SO JAMA NEUROLOGY
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; VIRUS-INFECTION; CEREBROSPINAL-FLUID; VESSELS
   DRAIN; DENGUE VIRUS; APOPTOSIS; EPIDEMIC; STRAIN; CELLS; BIRTH
AB IMPORTANCE Hydrocephalus is a treatable but potentially fatal complication that has not been previously described in congenital Zika syndrome (CZS).
   OBJECTIVE To describe the clinical features and imaging findings in 24 patients with congenital Zika syndrome (CZS) who developed hydrocephalus.
   DESIGN, SETTING, AND PARTICIPANTS This case series included patients with hydrocephalus who were born in October and November 2015 and followed up until mid-2017 in the 2 largest national referral centers for CZS in Brazil. The participants included consecutively enrolled children with a clinical and laboratorial diagnosis of CZS who developed clinical and/or image findings suggestive of hydrocephalus and who were confirmed to experience increased intracranial hypertension during ventriculoperitoneal shunt procedures.
   MAIN OUTCOMES AND MEASURES To retrospectively describe clinical and image findings in these 24 patients.
   RESULTS This multicenter cohort included 308 patients with CZS; 24 consecutive children were enrolled in this study. These children were aged between 3 to 18 months, and 13 of 24 (54%) were female. All patients presented with at least 1 positive test result for anti-Zika antibodies in cerebrospinal fluid or serum and had classic signs of CZS. At the time of hydrocephalus diagnosis, only 14 of 24 patients (58%) had symptoms and signs suggestive of hydrocephalus (mainly worsening seizures, vomiting, irritability, and/or sudden increase of head circumference percentile). Two of 24 patients (8%) had no symptoms suggestive of hydrocephalus but were found to have reduced brain volume on repeated imaging. Cerebellar or brainstem hypoplasia on baseline imaging were found in 18 of 23 patients (78%). At the second computed tomographic scan, all patients showed a marked increase of ventricular volume, compatible with communicating hydrocephalus, and reduction of brain tissue that was visibly worse than on baseline imaging for the 23 patients with repeated scans.
   CONCLUSIONS AND RELEVANCE We present evidence that hydrocephalus is a complication of CZS in at least a proportion of patients. The clinical spectrum of this condition continues to evolve, but given that presenting signs and symptoms of hydrocephalus can be challenging to recognize in CZS, we provisionally recommend that high suspicion and appropriate monitoring for hydrocephalus should be part of the standard care of patients with CZS.
C1 [van der Linden, Vanessa] Assoc Assistance Disabled Children, Ave Advogado Jose Paulo Cavalcante, BR-50080810 Recife, PE, Brazil.
   [van der Linden, Vanessa; de Lima Petribu, Natacha Calheiros; Abath, Marilia de Brito] Barao Lucena Hosp, Recife, PE, Brazil.
   [Pessoa, Andre; Ribeiro, Erlane] Albert Sabin Children Hosp, Fortaleza, Ceara, Brazil.
   [Pessoa, Andre] Christus Univ, Fortaleza, Ceara, Brazil.
   [Faquini, Igor; Hazin, Adriano Nassri] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Neurosci, Rochester, NY 14642 USA.
   [van der Linden, Helio, Jr.] Dr Henr Santillo Rehabil Ctr, Goiania, Go, Brazil.
   [Silveira-Moriyama, Laura] Univ Nove Julho, Uninove, Postgrad Program Med, Sao Paulo, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Barkovich, A. James] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Raybaud, Charles] Univ Toronto, Toronto, AB, Canada.
   [Barros Juca, Carlos Eduardo] Univ Fortaleza, Fortaleza, Ceara, Brazil.
   [Viana Vasco Aragao, Maria de Fatima] Multimagem Diagnost Ctr, Recife, PE, Brazil.
   [Coelho Travassos, Patricia Teresa; Jungmann, Patricia] Univ Pernambuco, Recife, PE, Brazil.
RP van der Linden, V (corresponding author), Assoc Assistance Disabled Children, Ave Advogado Jose Paulo Cavalcante, BR-50080810 Recife, PE, Brazil.
EM vanessavdlinden@hotmail.com
RI Moriyama, Laura Silveira/G-4592-2014; Faquini, Igor/S-4936-2019; Juca,
   Eduardo/AAF-7029-2019
OI Moriyama, Laura Silveira/0000-0003-2184-626X; Faquini,
   Igor/0000-0002-1538-396X; Juca, Eduardo/0000-0003-3269-2577; VAN DER
   LINDEN JUNIOR, HELIO/0000-0002-3123-2264
FU Association for Assistance of Disabled Children, Barao de Lucena
   Hospital
FX We thank the Association for Assistance of Disabled Children, Barao de
   Lucena Hospital, Professor Fernando Figueira Integral Medicine
   Institute, and Health Secretaries of Pernambuco for their support. We
   thank our patients and their families for participating in this study,
   particularly the family of the patient depicted in Figure 3 for granting
   permission to publish these images.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Barkovich AJ, 2012, PEDIAT NEUROIMAGING
   Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dissing-Olesen L, 2015, EBIOMEDICINE, V2, P776, DOI 10.1016/j.ebiom.2015.08.019
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ford ML, 2016, AM J TRANSPLANT, V16, P735, DOI 10.1111/ajt.13742
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Greitz D, 2007, CHILD NERV SYST, V23, P487, DOI 10.1007/s00381-007-0303-z
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013
   Jungmann P, 2017, ACTA OBSTET GYN SCAN, V96, P1039, DOI 10.1111/aogs.13184
   Krishnamurthy S, 2014, TRANSL PEDIATR, V3, P185, DOI 10.3978/j.issn.2224-4336.2014.07.02
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal MDC, 2020, BRAZ J OTORHINOLAR, V86, P513, DOI 10.1016/j.bjorl.2016.06.001
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Raper D, 2016, TRENDS NEUROSCI, V39, P581, DOI 10.1016/j.tins.2016.07.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rekate HL, 2011, CHILD NERV SYST, V27, P1535, DOI 10.1007/s00381-011-1558-y
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Simeone RM, 2013, BIRTH DEFECTS RES A, V97, P431, DOI 10.1002/bdra.23138
   Sivagnanam M, 2012, HYDROCEPHALUS, P1, DOI [10.5772/32502, DOI 10.5772/32502]
   Svatonova J, 2006, FOLIA MICROBIOL, V51, P485, DOI 10.1007/BF02931596
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   VANDVIK B, 1982, J NEUROL, V228, P25, DOI 10.1007/BF00313407
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 40
TC 8
Z9 8
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD FEB
PY 2019
VL 76
IS 2
BP 203
EP 210
DI 10.1001/jamaneurol.2018.3553
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA HL0AX
UT WOS:000458357400013
PM 30452526
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU van der Linden, H
   Carvalho, MD
   van der Linden, V
   Lacerda, KM
   Pessoa, A
   Carneiro, ML
   Cordeiro, MT
   Valente, KD
AF van der Linden, Helio, Jr.
   Carvalho, Maria D.
   van der Linden, Vanessa
   Lacerda, Kalyne M.
   Pessoa, Andre
   Carneiro, Mara L.
   Cordeiro, Marli T.
   Valente, Kette D.
TI Epilepsy Profile in Infants with Congenital Zika Virus Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID BRAZIL
C1 [van der Linden, Helio, Jr.; Carneiro, Mara L.] Dr Henrique Santillo Rehabil & Readaptat Ctr, Goiania, Go, Brazil.
   [Carvalho, Maria D.; Lacerda, Kalyne M.] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [van der Linden, Vanessa] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [Pessoa, Andre] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Cordeiro, Marli T.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Valente, Kette D.] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil.
RP Valente, KD (corresponding author), Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil.
EM kette.valente@hc.fm.usp.br
RI Valente, Kette/AAW-4579-2020
OI Valente, Kette/0000-0002-5008-0809; VAN DER LINDEN JUNIOR,
   HELIO/0000-0002-3123-2264
CR Alves Lucas Victor, 2016, Rev. Bras. Saude Mater. Infant., V16, pS27, DOI 10.1590/1806-9304201600s100003
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 5
TC 13
Z9 13
U1 0
U2 2
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD AUG 30
PY 2018
VL 379
IS 9
BP 891
EP 892
DI 10.1056/NEJMc1716070
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GR9EA
UT WOS:000443047800017
PM 30157396
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Nascimento, EJM
   Huleatt, JW
   Cordeiro, MT
   Castanha, PMS
   George, JK
   Grebe, E
   Welte, A
   Brown, M
   Burke, DS
   Marques, ETA
AF Nascimento, Eduardo J. M.
   Huleatt, James W.
   Cordeiro, Marli T.
   Castanha, Priscila M. S.
   George, James K.
   Grebe, Eduard
   Welte, Alex
   Brown, Monique
   Burke, Donald S.
   Marques, Ernesto T. A.
TI Development of antibody biomarkers of long term and recent dengue virus
   infections
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Antibody; IgG subclasses; IgG3; Long term; Recent infection; Virus
   exposure; Biomarker
ID RESPONSES; DIAGNOSIS; RECIFE; COHORT; BRAZIL; FEVER; TESTS; PHASE;
   SERUM; IGM
AB Dengue virus (DENV) infections elicit antibody responses to the non-structural protein 1 (NS1) that are associated with protection against disease. However, the antibody isotypes and subclasses involved, and their kinetics have not been extensively studied. We characterized the antibody responses to DENV NS1 by enzyme linked immunosorbent assay (ELISA) in a longitudinal cohort of 266 confirmed dengue cases in Recife, Northeast Brazil. Samples were collected during the febrile phase and up to over 3 years after onset of symptoms. The antibodies investigated [IgA, IgM, total IgG (all subclasses measured together) and each subclass (IgG2, IgG3 and IgG4) measured separately] had distinct kinetic profiles following primary or secondary DENV infections. Of interest, most of these antibodies were consistently detected greater than 6 months after onset of symptoms, except for IgG3. Anti-dengue NS1-specific IgG was consistently detected from the acute phase to beyond 3 years after symptom onset. In contrast, anti-dengue NS1-specific IgG3 was detected within the first week, peaked at week 2-3, and disappeared within 4-6 months after onset of symptoms. The mean duration of the IgG3 positive signal was 149 days (ranging from 126 to 172 days). In conclusion, anti-dengue NS1-specific IgG and IgG3 are potential biomarkers of long-term and recent (less than 6 months) DENV infections, respectively.
C1 [Nascimento, Eduardo J. M.; Burke, Donald S.; Marques, Ernesto T. A.] Univ Pittsburgh, Grad Sch Publ Hlth, Biomed Sci Tower 3,Room 9052,3501 5th Ave, Pittsburgh, PA 15261 USA.
   [Nascimento, Eduardo J. M.; Burke, Donald S.; Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Biomed Sci Tower 3,Room 9052,3501 5th Ave, Pittsburgh, PA 15261 USA.
   [Nascimento, Eduardo J. M.; Huleatt, James W.; George, James K.; Brown, Monique] Sanofi Pasteur, One Discovery Dr, Swiftwater, PA 18370 USA.
   [Cordeiro, Marli T.; Castanha, Priscila M. S.; Marques, Ernesto T. A.] Fiocruz MS, Aggeu Magalhaes Inst, Oswaldo Cruz Fdn, Av Prof Moraes Rego S-N,Campus UFPE, BR-50740465 Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Sch Med Sci, Recife, PE, Brazil.
   [Grebe, Eduard; Welte, Alex] DST NRF Ctr Excellence Epidemiol Modelling & Anal, Stellenbosch, Western Cape, South Africa.
RP Marques, ETA (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Biomed Sci Tower 3,Room 9052,3501 5th Ave, Pittsburgh, PA 15261 USA.
EM Eduardo.Nascimento@sanofi.com; marques@pitt.edu
RI Marques, Ernesto T. A/L-4967-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Grebe, Eduard/0000-0001-7046-7245
FU Sanofi Pasteur; CuraZika Alliance
FX This study was funded by Sanofi Pasteur. The IgG3 assay development was
   also funded by CuraZika Alliance.
CR Ahmed NH, 2014, J VECTOR DIS, V51, P194
   Alagarasu K, 2016, EPIDEMIOL INFECT, V144, P876, DOI 10.1017/S0950268815001922
   Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cordeiro MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004945
   de Melo AB, 2011, AM J TROP MED HYG, V85, P739, DOI 10.4269/ajtmh.2011.10-0496
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Kaabinejadian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066298
   Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429
   Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07
   Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Plennevaux E, 2018, CLIN INFECT DIS, V66, P1164, DOI 10.1093/cid/cix966
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Seaton KE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94355
   Shu PY, 2000, J MED VIROL, V62, P224, DOI 10.1002/1096-9071(200010)62:2&lt;224::AID-JMV14&gt;3.0.CO;2-C
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Yates NL, 2011, AIDS, V25, P2089, DOI 10.1097/QAD.0b013e32834b348e
NR 26
TC 16
Z9 17
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD JUL
PY 2018
VL 257
BP 62
EP 68
DI 10.1016/j.jviromet.2018.04.009
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA GI8BA
UT WOS:000434745600011
PM 29684416
OA Other Gold
DA 2020-12-08
ER

PT J
AU de Araujo, TVB
   Ximenes, RADA
   Miranda, DD
   Souza, WV
   Montarroyos, UR
   de Melo, APL
   Valongueiro, S
   de Albuquerque, MDPM
   Braga, C
   Brandao, SP
   Cordeiro, MT
   Vazquez, E
   Cruz, DDS
   Henriques, CMP
   Bezerra, LCA
   Castanha, PMD
   Dhalia, R
   Marques, ETA
   Martelli, CMT
   Rodrigues, LC
AF Barreto de Araujo, Thalia Velho
   de Alencar Ximenes, Ricardo Arraes
   Miranda-Filho, Democrito de Barros
   Souza, Wayner Vieira
   Montarroyos, Ulisses Ramos
   Lopes de Melo, Ana Paula
   Valongueiro, Sandra
   Pessoa Militao de Albuquerque, Maria de Fatima
   Braga, Cynthia
   Brandao Filho, Sinval Pinto
   Cordeiro, Marli Tenorio
   Vazquez, Enrique
   Souza Cruz, Danielle di Cavalcanti
   Pessanha Henriques, Claudio Maierovitch
   Albuquerque Bezerra, Luciana Caroline
   da Silva Castanha, Priscila Mayrelle
   Dhalia, Rafael
   Azevedo Marques-Junior, Ernesto Torres
   Turchi Martelli, Celina Maria
   Rodrigues, Laura Cunha
CA Investigators Microcephaly Epidem
TI Association between microcephaly, Zika virus infection, and other risk
   factors in Brazil: final report of a case-control study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID BIRTH-DEFECTS; GESTATIONAL-AGE; PREGNANCY; INFANTS; FETUSES; SMOKING
AB Background A Zika virus epidemic emerged in northeast Brazil in 2015 and was followed by a striking increase in congenital microcephaly cases, triggering a declaration of an international public health emergency. This is the final report of the first case-control study evaluating the potential causes of microcephaly: congenital Zika virus infection, vaccines, and larvicides. The published preliminary report suggested a strong association between microcephaly and congenital Zika virus infection.
   Methods We did a case-control study in eight public maternity hospitals in Recife, Brazil. Cases were neonates born with microcephaly, defined as a head circumference of 2 SD below the mean. Two controls without microcephaly were matched to each case by expected date of delivery and area of residence. We tested the serum of cases and controls and the CSF of cases for detection of Zika virus genomes with quantitative RT-PCR and for detection of IgM antibodies with capture-IgM ELISA. We also tested maternal serum with plaque reduction neutralisation assays for Zika and dengue viruses. We estimated matched crude and adjusted odds ratios with exact conditional logistic regression to determine the association between microcephaly and Zika virus infection.
   Findings We screened neonates born between Jan 15 and Nov 30, 2016, and prospectively recruited 91 cases and 173 controls. In 32 (35%) cases, congenital Zika virus infection was confirmed by laboratory tests and no controls had confirmed Zika virus infections. 69 (83%) of 83 cases with known birthweight were small for gestational age, compared with eight (5%) of 173 controls. The overall matched odds ratio was 73.1 (95% CI 13.0-infinity) for microcephaly and Zika virus infection after adjustments. Neither vaccination during pregnancy or use of the larvicide pyriproxyfen was associated with microcephaly. Results of laboratory tests for Zika virus and brain imaging results were available for 79 (87%) cases; within these cases, ten were positive for Zika virus and had cerebral abnormalities, 13 were positive for Zika infection but had no cerebral abnormalities, and 11 were negative for Zika virus but had cerebral abnormalities.
   Interpretation The association between microcephaly and congenital Zika virus infection was confirmed. We provide evidence of the absence of an effect of other potential factors, such as exposure to pyriproxyfen or vaccines (tetanus, diphtheria, and acellular pertussis, measles and rubella, or measles, mumps, and rubella) during pregnancy, confirming the findings of an ecological study of pyriproxyfen in Pernambuco and previous studies on the safety of Tdap vaccine administration during pregnancy.
C1 [Barreto de Araujo, Thalia Velho; Valongueiro, Sandra] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Miranda-Filho, Democrito de Barros; Montarroyos, Ulisses Ramos] Univ Pernambuco, Recife, PE, Brazil.
   [Souza, Wayner Vieira; Pessoa Militao de Albuquerque, Maria de Fatima; Braga, Cynthia; Brandao Filho, Sinval Pinto; Cordeiro, Marli Tenorio; da Silva Castanha, Priscila Mayrelle; Dhalia, Rafael; Azevedo Marques-Junior, Ernesto Torres; Turchi Martelli, Celina Maria] Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [Lopes de Melo, Ana Paula] Univ Fed Pernambuco, Dept Community Hlth, Vitoria De Santo Antao, Brazil.
   [Vazquez, Enrique] Pan Amer Hlth Org, Brasilia, DF, Brazil.
   [Souza Cruz, Danielle di Cavalcanti] Inst Materno Infantil Fernando Figueira, Recife, PE, Brazil.
   [Pessanha Henriques, Claudio Maierovitch] Brazilian Minist Hlth, Brasilia, DF, Brazil.
   [Albuquerque Bezerra, Luciana Caroline] State Hlth Dept Pernambuco, Recife, PE, Brazil.
   [Azevedo Marques-Junior, Ernesto Torres] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP de Araujo, TVB (corresponding author), Univ Fed Pernambuco, BR-50670901 Recife, PE, Brazil.
EM thalia@ufpe.br
RI Souza, Wayner V/H-3798-2013; Dhalia, Rafael/AAD-5432-2020;
   Brandao-Filho, Sinval Pinto/AAP-4792-2020; Montarroyos,
   Ulisses/AAJ-7527-2020; Da Silva Castanha, Priscila Mayrelle/G-1785-2012;
   Braga, Maria Cynthia/A-8204-2013; Marques, Ernesto T. A/L-4967-2013
OI Brandao-Filho, Sinval Pinto/0000-0003-3768-2810; Da Silva Castanha,
   Priscila Mayrelle/0000-0002-1220-5308; Braga, Maria
   Cynthia/0000-0002-7862-6455; Marques, Ernesto T. A/0000-0003-3826-9358;
   Souza, Wayner/0000-0002-0939-9332; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU Brazilian Ministry of Health; Pan American Health Organization;
   Enhancing Research Activity in Epidemic Situations; Medical Research
   CouncilMedical Research Council UK (MRC) [MC_PC_15088] Funding Source:
   researchfish
FX Brazilian Ministry of Health, Pan American Health Organization, and
   Enhancing Research Activity in Epidemic Situations.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022
   HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Instituto de Pesquisa Economica Aplicada, 2014, SIT SOC POP NEGR EST
   Ko TJ, 2014, PEDIATR NEONATOL, V55, P20, DOI 10.1016/j.pedneo.2013.05.005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Ministerio da Saude (BR), 2014, INF TECN IMPL VAC AD
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   STATA, EX LOG REGR REF MAN, P507
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Walls T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009536
   WHO, 2016, SCREEN ASS MAN NON I
NR 33
TC 110
Z9 112
U1 5
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2018
VL 18
IS 3
BP 328
EP 336
DI 10.1016/S1473-3099(17)30727-2
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FX2ZO
UT WOS:000425938000040
PM 29242091
OA Bronze, Green Accepted
DA 2020-12-08
ER

PT J
AU Loeffler, F
   Lins, R
   Fischer, N
   Viana, I
   Cataldi, C
   Leite, B
   Magalhaes, T
   Cordeiro, MT
   Marques, ET
   Jaenisch, T
AF Loeffler, Felix
   Lins, Roberto
   Fischer, Nico
   Viana, Isabelle
   Cataldi, Catarina
   Leite, Bruno
   Magalhaes, Tereza
   Cordeiro, Marli
   Marques, Ernesto
   Jaenisch, Thomas
TI UNEXPECTED PROPERTIES OF A ZIKA NS2B EPITOPE SUGGEST ITS POTENTIAL AS A
   BIOMARKER FOR DIAGNOSIS AND PROGNOSIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Loeffler, Felix] Max Planck Inst Colloids & Interfaces, Potsdam, Germany.
   [Lins, Roberto; Viana, Isabelle; Cataldi, Catarina; Leite, Bruno; Cordeiro, Marli] Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Fischer, Nico; Jaenisch, Thomas] Heidelberg Univ Hosp, Heidelberg, Germany.
   [Magalhaes, Tereza] Colorado State Univ, Ft Collins, CO 80523 USA.
   [Marques, Ernesto] Univ Pittsburgh, Pittsburgh, PA USA.
RI Marques, Ernesto T. A/L-4967-2013; Loeffler, Felix F/K-6192-2016
OI Marques, Ernesto T. A/0000-0003-3826-9358; Loeffler, Felix
   F/0000-0002-8227-2522
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 943
BP 297
EP 297
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603279
DA 2020-12-08
ER

PT J
AU de Carvalho, OV
   Felix, DM
   de Mendonca, LR
   de Araujo, CMCS
   Franca, RFD
   Cordeiro, MT
   Silva, A
   Pena, LJ
AF de Carvalho, Otavio Valerio
   Felix, Daniele Mendes
   de Mendonca, Leila Rodrigues
   Cataldi Sabino de Araujo, Catarina Maria
   de Oliveira Franca, Rafael Freitas
   Cordeiro, Marli Tenorio
   Silva Junior, Abelardo
   Pena, Lindomar Jose
TI The thiopurine nucleoside analogue 6-methylmercaptopurine riboside
   (6MMPr) effectively blocks Zika virus replication
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Antiviral; Zika virus; Cytotoxicity; 6MMPr; Vero cells; Neuronal cells
ID INFECTION; AZATHIOPRINE; INHIBITORS; SCREEN; PREGNANCY; DISEASE;
   PROTEIN; DRUGS; WOMEN
AB Since the emergence of Zika virus (ZIKV) in Brazil in 2015, 48 countries and territories in the Americas have confirmed autochthonous cases of disease caused by the virus. ZIKV-associated neurological manifestations and congenital defects make the development of safe and effective antivirals against ZIKV of utmost importance. Here we evaluated the antiviral activity of 6-methylmercaptopurine riboside (6MMPr), a thiopurine nucleoside analogue derived fromthe prodrug azathioprine, against the epidemic ZIKV strain circulating in Brazil. In all of the assays, an epithelial (Vero) and a human neuronal (SH-SY5Y) cell line were used to evaluate the cytotoxicity and effective concentrations of 6MMPr against ZIKV. Levels of ZIKV-RNA, viral infectious titre and the percentage of infected cells in the presence or absence of 6MMPr were used to determine antiviral efficacy. 6MMPr decreased ZIKV production by >99% in both cell lines in a dose-and time-dependent manner. Interestingly, 6MMPr was 1.6 times less toxic to SH-SY5Y cells compared with Vero cells, presenting a 50% cytotoxic concentrations (CC50) of 460.3 mu M and 291 mu M, respectively. The selectivity index of 6MMPr for Vero and SH-SY5Y cells was 11.9 and 22.7, respectively, highlighting the safety profile of the drug to neuronal cells. Taken together, these results identify, for the first time, the thiopurine nucleoside analogue 6MMPr as a promising antiviral candidate against ZIKV that warrants further in vivo evaluation. (C) 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
C1 [de Carvalho, Otavio Valerio; Felix, Daniele Mendes; de Mendonca, Leila Rodrigues; Cataldi Sabino de Araujo, Catarina Maria; de Oliveira Franca, Rafael Freitas; Cordeiro, Marli Tenorio; Pena, Lindomar Jose] Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.
   [Silva Junior, Abelardo] Fed Univ Vicosa UFV, Dept Vet Med, Av PH Rolfs S-N, BR-36570900 Vicosa, MG, Brazil.
RP Pena, LJ (corresponding author), Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.; Silva, A (corresponding author), Fed Univ Vicosa UFV, Dept Vet Med, Av PH Rolfs S-N, BR-36570900 Vicosa, MG, Brazil.
EM asjvet@gmail.com; lindomar.pena@cpqam.fiocruz.br
FU CNPq (National Council for Scientific and Technological Development,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); FACEPE (Pernambuco State Foundation for Science and Technology,
   Brazil); FACEPE; CAPESCAPES; Scientific Initiation fellowship (PIBIC)
   from FACEPE
FX This work was supported in part by grants from CNPq (National Council
   for Scientific and Technological Development, Brazil) and FACEPE
   (Pernambuco State Foundation for Science and Technology, Brazil). OVC is
   the recipient of a postdoctoral fellowship from FACEPE. DMF is the
   recipient of a doctoral fellowship from CAPES. LRM is the recipient of a
   doctoral fellowship from FACEPE. CMCSA is the recipient of a Scientific
   Initiation fellowship (PIBIC) from FACEPE.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Cleary BJ, 2009, BIRTH DEFECTS RES A, V85, P647, DOI 10.1002/bdra.20583
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Crotty S, 2000, NAT MED, V6, P1375
   D'Abramo CM, 2004, J MOL BIOL, V337, P1, DOI 10.1016/j.jmb.2004.01.030
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Hoffmann HH, 2008, ANTIVIR RES, V80, P124, DOI 10.1016/j.antiviral.2008.05.008
   Hoover S, 2008, J GEN VIROL, V89, P1000, DOI 10.1099/vir.0.83381-0
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Konidari Anastasia, 2014, World J Gastrointest Pharmacol Ther, V5, P63, DOI 10.4292/wjgpt.v5.i2.63
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langagergaard V, 2007, ALIMENT PHARM THER, V25, P73, DOI 10.1111/j.1365-2036.2006.03162.x
   Lim PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026697
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Matalon ST, 2004, REPROD TOXICOL, V18, P219, DOI 10.1016/j.reprotox.2003.10.014
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mumtaz Noreen, 2016, Curr Treat Options Infect Dis, V8, P208
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Ramalho Rocha Yuri Raoni, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.e854dbf51b8075431a05b39042c00244
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sahoo Maheswata, 2016, Genomics & Informatics, V14, P104, DOI 10.5808/GI.2016.14.3.104
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Stangl JR, 2004, TRANSPLANTATION, V77, P562, DOI 10.1097/01.TP.0000114610.40412.C6
   Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726
   Wright S, 2004, GUT, V53, P1123, DOI 10.1136/gut.2003.032896
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang FB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003326
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 37
TC 15
Z9 15
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
EI 1872-7913
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD DEC
PY 2017
VL 50
IS 6
BP 718
EP 725
DI 10.1016/j.ijantimicag.2017.08.016
PG 8
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA FN2LA
UT WOS:000415822600005
PM 28803932
DA 2020-12-08
ER

PT J
AU Brasil, P
   Marques, ET
   Tami, A
   Sandoval, EP
   Caprara, A
   Magalhaes, T
   Calvet, G
   Bethencourt, S
   Guzman, MG
   Simmons, CP
   Bispo, A
   Cordeiro, MT
   Wills, B
   Rosenberger, K
   Jaenisch, T
AF Brasil, Patricia
   Marques, Ernesto T.
   Tami, Adriana
   Sandoval, Ernesto Pleitess
   Caprara, Andrea
   Magalhaes, Tereza
   Calvet, Guilherme
   Bethencourt, Sarah
   Guzman, Maria G.
   Simmons, Cameron P.
   Bispo, Ana
   Cordeiro, Marli Tenorio
   Wills, Bridget
   Rosenberger, Kerstin
   Jaenisch, Thomas
TI CLINICAL CHARACTERIZATION OF ACUTE ZIKA PATIENTS IN BRAZIL, VENEZUELA,
   AND EL SALVADOR IN 2015/16
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Brasil, Patricia; Calvet, Guilherme; Bispo, Ana] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Marques, Ernesto T.; Magalhaes, Tereza; Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Tami, Adriana] Univ Med Ctr Groningen, Groningen, Netherlands.
   [Sandoval, Ernesto Pleitess] Hosp Natl Ninos Benjamin Bloom, San Salvador, El Salvador.
   [Caprara, Andrea] Univ Estadual Ceara, Fortaleza, Ceara, Brazil.
   [Bethencourt, Sarah] Univ Carabobo, Valencia, Venezuela.
   [Guzman, Maria G.] Pedro Kouri Inst, Havana, Cuba.
   [Simmons, Cameron P.; Wills, Bridget] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.
   [Rosenberger, Kerstin; Jaenisch, Thomas] Heidelberg Univ Hosp, Heidelberg, Germany.
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Tami,
   Adriana/0000-0002-1918-9144
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 749
BP 236
EP 236
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502272
DA 2020-12-08
ER

PT J
AU Magalhaes, T
   Braga, C
   Cordeiro, MT
   Oliveira, ALS
   Castanha, PMS
   Maciel, APR
   Amancio, NML
   Gouveia, PN
   Peixoto-da-Silva, VJ
   Peixoto, TFL
   Britto, H
   Lima, PV
   Lima, ARS
   Rosenberger, KD
   Jaenisch, T
   Marques, ETA
AF Magalhaes, Tereza
   Braga, Cynthia
   Cordeiro, Marli T.
   Oliveira, Andre L. S.
   Castanha, Priscila M. S.
   Maciel, Ana Paula R.
   Amancio, Nathalia M. L.
   Gouveia, Pollyanne N.
   Peixoto-da-Silva, Valter J., Jr.
   Peixoto, Thaciana F. L.
   Britto, Helena
   Lima, Priscilla V.
   Lima, Andreza R. S.
   Rosenberger, Kerstin D.
   Jaenisch, Thomas
   Marques, Ernesto T. A.
TI Zika virus displacement by a chikungunya outbreak in Recife, Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
AB Background
   Several arboviruses, including dengue virus (DENV), Zika virus (ZIKV) and chikungunya virus (CHIKV), transmitted by Aedes mosquitoes, circulate in northeast Brazil. Diseases caused by these viruses are of great public health relevance, however, their epidemiological features in areas where the three viruses co-circulate are scarce. Here, we present analyses of molecular and serological diagnostics in a prospective study of acute febrile patients recruited from May 2015 to May 2016 in Recife, Brazil.
   Methods
   Two hundred sixty-three acute febrile patients with symptoms suggestive of an arboviral disease who attended an urgent heath care clinic in the Recife Metropolitan Region in northeast Brazil were enrolled. Acute and convalescent blood samples were collected and tested using molecular and serological assays for infection with DENV, ZIKV and CHIKV.
   Results
   Quantitative real-time reverse-transcriptase polymerase chain reactions (qRTPCR) performed on acute phase sera detected no patients positive for DENV, but 26 (9.9%) positive for ZIKV and 132 (50.2%) positive for CHIKV. There were a few suspected and only one confirmed dengue case. Specific serological assays for ZIKV and CHIKV confirmed the qRTPCR data. Analyses of DENV IgM and IgG ELISAs in the context of qRTPCR results suggested high levels of cross reactive antibodies in ZIKV-positive samples. Results from neutralization assays highly corroborated those from qRTPCR and ZIKV ELISA, indicating very few positive DENV cases. ZIKV infections were temporally clustered in the first months of the study and started to decrease concomitantly with an increase in CHIKV infections in August 2015. The proportion of CHIKV infections increased significantly in September 2015 and remained high until the end of the study period, with an average of 84.7% of recruited patients being diagnosed from August 2015 to May 2016. ZIKV infections exhibited a female bias and the cases were spread over the study site, while CHIKV cases had a male bias and were spatially clustered in each month.
   Conclusions
   In 2015 +/- 2016 in the Recife Metropolitan Region, we detected the tail end of a Zika epidemic, which was displaced by a chikungunya epidemic. Few dengue cases were identified despite a high number of official dengue notifications in the area during this period. We show here important epidemiological features of these cases.
C1 [Magalhaes, Tereza; Cordeiro, Marli T.; Castanha, Priscila M. S.; Lima, Priscilla V.; Lima, Andreza R. S.; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Lab Virol & Expt Therapeut, Recife, PE, Brazil.
   [Magalhaes, Tereza] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab AIDL, Ft Collins, CO 80523 USA.
   [Braga, Cynthia] Fiocruz MS, IAM, Dept Parasitol, Recife, PE, Brazil.
   [Braga, Cynthia; Britto, Helena] Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil.
   [Oliveira, Andre L. S.] Fiocruz MS, IAM, Stat & Geoproc Lab, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Fac Med Sci, Recife, PE, Brazil.
   [Maciel, Ana Paula R.; Amancio, Nathalia M. L.; Gouveia, Pollyanne N.; Peixoto-da-Silva, Valter J., Jr.; Peixoto, Thaciana F. L.] IMIP, Urgent Hlth Care Unit, Paulista, Brazil.
   [Rosenberger, Kerstin D.; Jaenisch, Thomas] Heidelberg Univ Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
   [Jaenisch, Thomas] German Ctr Infect Res DZIF, Partner Site Heidelberg, Heidelberg, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
RP Magalhaes, T; Marques, ETA (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Lab Virol & Expt Therapeut, Recife, PE, Brazil.; Magalhaes, T (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab AIDL, Ft Collins, CO 80523 USA.; Marques, ETA (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
EM tereza.magalhaes@colostate.edu; emarques@cpqam.fiocruz.br
RI Braga, Maria Cynthia/A-8204-2013; Magalhaes, Tereza/V-6632-2019; Da
   Silva Castanha, Priscila Mayrelle/G-1785-2012; Marques, Ernesto T.
   A/L-4967-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Marques, Ernesto T. A/0000-0003-3826-9358
FU European Union's Seventh Framework Programme for research, technological
   development and demonstrationEuropean Union (EU) [FP7-281803 IDAMS,
   IDAMS 45]; State of Pernambuco funding agency (Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco-FACEPE) [PPSUS
   APQ-0302-4.01/13]; European Union's Horizon 2020 Research and Innovation
   Programme under ZIKAlliance [734548]; National Institute of Allergy and
   Infectious Diseases of the National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129464]; ZikaCura (PITT-FIOCRUZ Alliance); Brazilian national
   funding agency (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico of Brazil-CNPq) [472360/2013-2]
FX This study was funded by the European Union's Seventh Framework
   Programme for research, technological development and demonstration
   (grant FP7-281803 IDAMS; http://www.idams.eu/), where it has been
   designated with publication reference number IDAMS 45; the State of
   Pernambuco funding agency (Fundacao de Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco-FACEPE; grant PPSUS APQ-0302-4.01/13); the European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   (grant 734548); the National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health (grant R21AI129464); the
   ZikaCura (PITT-FIOCRUZ Alliance); and the Brazilian national funding
   agency (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of
   Brazil-CNPq; grant 472360/2013-2). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the funding agencies. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P668, DOI 10.1590/0037-8682-0279-2016
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Aubry M, 2017, EMERG INFECT DIS, V23
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Governo do Estado de Pernambuco, 2015, B PLUV
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/jcm.00580-17, 10.1128/JCM.00580-17]
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Ministerio da Saude Brasil, 2017, MON CAS DENG FEBR CH, V52
   Ministerio da Saude Brasil, 2015, PROT VIG RESP PEL VI
   Ministerio da Saude Brasil, 2015, MON CAS DENG FEBR CH, V48
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Organizaco Pan-Americana da Saude, 2016, B SEM
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 42
TC 22
Z9 22
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2017
VL 11
IS 11
AR e0006055
DI 10.1371/journal.pntd.0006055
PG 25
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA VI3XC
UT WOS:000480724600001
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ayres, C
   Guedes, D
   Paiva, M
   Donato, M
   Barbosa, P
   Krokovsky, L
   Rocha, S
   Saraiva, K
   Crespo, M
   Rezende, T
   Wallau, G
   Barbosa, R
   Oliveira, C
   Melo-Santos, MA
   Pena, L
   Cordeiro, M
   Franca, R
   Oliveira, A
   Peixoto, C
   Leal, WS
AF Ayres, Constancia
   Guedes, Duschinka
   Paiva, Marcelo
   Donato, Mariana
   Barbosa, Priscilla
   Krokovsky, Larissa
   Rocha, Sura
   Saraiva, Karina
   Crespo, Monica
   Rezende, Tatiana
   Wallau, Gabriel
   Barbosa, Rosangela
   Oliveira, Claudia
   Melo-Santos, Maria Alice
   Pena, Lindomar
   Cordeiro, Marli
   Franca, Rafael
   Oliveira, Andre
   Peixoto, Christina
   Leal, Walter S.
TI Response to: 'Lack of evidence for Zika virus transmission by Culex
   mosquitoes'
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID AEDES-AEGYPTI MOSQUITOS; YELLOW-FEVER; BRAZIL; ISOLATIONS
C1 [Ayres, Constancia; Guedes, Duschinka; Paiva, Marcelo; Donato, Mariana; Barbosa, Priscilla; Krokovsky, Larissa; Rocha, Sura; Saraiva, Karina; Crespo, Monica; Rezende, Tatiana; Wallau, Gabriel; Barbosa, Rosangela; Oliveira, Claudia; Melo-Santos, Maria Alice; Pena, Lindomar; Cordeiro, Marli; Franca, Rafael; Oliveira, Andre; Peixoto, Christina] Fundacao Oswaldo Cruz, FIOCRUZ, IAM, Av Moraes Rego,S-N Campus UFPE,Cidade Univ, BR-50670420 Recife, PE, Brazil.
   [Paiva, Marcelo] Univ Fed Pernambuco, Ctr Acad Agreste, BR-55002970 Caruaru, PE, Brazil.
   [Leal, Walter S.] Univ Calif Davis, Davis, CA 95616 USA.
RP Ayres, C (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, IAM, Av Moraes Rego,S-N Campus UFPE,Cidade Univ, BR-50670420 Recife, PE, Brazil.
EM tans@cpqam.fiocruz.br
RI Wallau, Gabriel Luz/B-5911-2008; Ayres, Constancia/AAQ-3448-2020;
   PEIXOTO, CHRISTINA/AAD-9608-2019; Barbosa, Rosangela/AAC-3339-2020
OI Wallau, Gabriel Luz/0000-0002-1419-5713; Barbosa,
   Rosangela/0000-0002-1171-598X; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Donato, Mariana/0000-0002-3361-2789
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elizondo-Quiroga D, 2017, BIORXIV
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW A. J., 1964, BULL WORLD HEALTH ORGAN, V31, P57
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Tabachnick WJ, 2016, CURR OPIN VIROL, V21, P124, DOI 10.1016/j.coviro.2016.09.008
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, COMMUNICATION
NR 15
TC 4
Z9 4
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD OCT 18
PY 2017
VL 6
AR e91
DI 10.1038/emi.2017.86
PG 2
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FK4EV
UT WOS:000413443300002
PM 29044194
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Castanha, PMS
   Montarroyos, UR
   Silveira, SMM
   Albuquerque, GDM
   Mello, MJG
   Lopes, KGS
   Cordeiro, MT
   Marques, ETA
   Martelli, CMT
   Braga, C
AF Castanha, P. M. S.
   Montarroyos, U. R.
   Silveira, S. M. M.
   Albuquerque, G. D. M.
   Mello, M. J. G.
   Lopes, K. G. S.
   Cordeiro, M. T.
   Marques, E. T. A., Jr.
   Martelli, C. M. T.
   Braga, C.
TI Incidence and risk factors for Dengue virus (DENV) infection in the
   first 2 years of life in a Brazilian prospective birth cohort
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Children; cohort; dengue virus; incidence
ID HEMORRHAGIC-FEVER; ANTIBODIES; CHILDREN; TRANSMISSION; NORTHEAST;
   RESPONSES; SEVERITY; KINETICS; INFANTS
AB This study assessed the incidence and risk factors for dengue virus (DENV) infection among children in a prospective birth cohort conducted in the city of Recife, a hyperendemic dengue area in Northeast Brazil. Healthy pregnant women (n = 415) residing in Recife who agreed to have their children followed were enrolled. Children were followed during their first 24 months of age (May/2011-June/2014), before the 2015 Zika virus outbreak. DENV infection was detected by reverse-transcriptase polymerase chain reaction and/or serology (anti-DENV IgM/IgG). The incidence rates per 1000 person-years (py) and its association with risk factors by age bands (0-12, > 12-30 months) were estimated through Poisson regression models. Forty-nine dengue infections were detected; none progressed to severe forms. The incidence rates were 107.6/1000py (95% CI 76.8-150.6) and 93.3/1000py (95% CI 56.1-154.4) in the first and second years of age, respectively. Male children (risk ratios (RR) = 2.33; 95% CI 1.09-4.98) and those born to DENV-naive mothers (RR = 2.42; 95% CI 1.01-5.80) were at greater risk of infection in the first year of age. In the second year, children born to Caucasian/Asian descent skin colour mothers had a threefold higher risk of infection (RR = 3.34; 95% CI: 1.08-10.33). These data show the high exposure of children to DENV infection in our setting and highlight the role of biological factors in this population's susceptibility to infection.
C1 [Castanha, P. M. S.; Albuquerque, G. D. M.; Lopes, K. G. S.; Cordeiro, M. T.; Marques, E. T. A., Jr.; Martelli, C. M. T.; Braga, C.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Av Prof Moraes Rego S-N,Campus UFPE, Recife, PE, Brazil.
   [Castanha, P. M. S.; Montarroyos, U. R.] Univ Pernambuco, Fac Med Sci, Biol Sci Inst, Recife, PE, Brazil.
   [Silveira, S. M. M.; Mello, M. J. G.; Braga, C.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Marques, E. T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Marques, E. T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
RP Castanha, PMS (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Av Prof Moraes Rego S-N,Campus UFPE, Recife, PE, Brazil.
EM castanha.priscila@gmail.com
RI Montarroyos, Ulisses/AAJ-7527-2020; Marques, Ernesto T. A/L-4967-2013;
   Braga, Maria Cynthia/A-8204-2013; amsalu, ribka/G-8780-2019; Da Silva
   Castanha, Priscila Mayrelle/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU National Council for Scientific and Technological Development of the
   Brazilian government [482915/2010-2 MCT/CNPq-14/2010]; Strategic Program
   to Support Health Research/PAPES VI [407697/2012-8]
FX We thank the mothers and their infants, for participating in the study;
   and the nurses and clinical staff from IMIP who assisted with the study.
   This work was supported by the National Council for Scientific and
   Technological Development of the Brazilian government (C.B., grant
   482915/2010-2 MCT/CNPq-14/2010); and the Strategic Program to Support
   Health Research/PAPES VI (C.B., grant 407697/2012-8).
CR Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/wpsar.2011.2.1.002, 10.5365/WPSAR.2011.2.1.002]
   Arguello DF, 2015, AM J TROP MED HYG, V92, P486, DOI 10.4269/ajtmh.14-0231
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00095815
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117
   Clapham H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004262
   Clayton D, 1993, STAT MODELS EPIDEMIO, P3421
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Del Principe D, 2013, CURR MOL MED, V13, P499
   Endy TP, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00183
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/j.jcv.2014.02.009, 10.1016/J.JCV.2014.02.009]
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Raza FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089868
   Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Teixeira MG, 2012, TROP MED INT HEALTH, V17, P1391, DOI 10.1111/j.1365-3156.2012.03086.x
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   Verhagen LM, 2014, J INFECTION, V69, pS77, DOI 10.1016/j.jinf.2014.07.020
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
NR 38
TC 4
Z9 4
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD OCT
PY 2017
VL 145
IS 14
BP 2971
EP 2979
DI 10.1017/S095026881700214X
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FK0ZG
UT WOS:000413208700011
PM 28918772
OA Bronze
DA 2020-12-08
ER

PT J
AU Xavier-Carvalho, C
   Cezar, RDD
   Freire, NM
   de Vasconcelos, CMM
   Solorzano, VEF
   de Toledo-Pinto, TG
   Fialho, LG
   do Carmo, RF
   Vasconcelos, LRS
   Cordeiro, MT
   Baptista, P
   de Azeredo, EL
   da Cunha, RV
   de Souza, LJ
   Pacheco, AG
   Kubelka, CF
   de Moura, PMMF
   Moraes, MO
AF Xavier-Carvalho, Caroline
   da Silva Cezar, Renata Duarte
   Freire, Naishe Matos
   Mola de Vasconcelos, Carla Maria
   Fiestas Solorzano, Victor Edgar
   de Toledo-Pinto, Thiago Gomes
   Fialho, Luciana Gomes
   do Carmo, Rodrigo Feliciano
   Silva Vasconcelos, Luydson Richardson
   Cordeiro, Marli Tenorio
   Baptista, Paulo
   de Azeredo, Elzinandes Leal
   da Cunha, Rivaldo Venancio
   de Souza, Luiz Jose
   Pacheco, Antonio Guilherme
   Kubelka, Claire Fernandes
   Freire de Moura, Patricia Muniz Mendes
   Moraes, Milton Ozorio
TI Association of rs1285933 single nucleotide polymorphism in CLEC5A gene
   with dengue severity and its functional effects
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE Dengue; CLEC5A; Polymorphisms; Severe dengue; SNPs; TNF
ID DAP12-ASSOCIATING LECTIN (MDL)-1; VIRUS; ACTIVATION; RECEPTOR; BINDING;
   INFLAMMATION; DISEASE; PATTERN; SHOCK
AB Outbreaks of the Zika, dengue, and chikungunya viruses, especially in the Americas, pose a global threat due to their rapid spread and difficulty controlling the vector. Extreme phenotypes are often observed, from asymptomatic to severe clinical manifestations, which are well-studied in dengue. Host variations are also important contributors to disease outcomes, and many case-control studies have associated single nucleotide polymorphisms (SNPs) with severe dengue. Here, we found that the TC genotype and T-carriers for SNP rs1285933 in the C-type lectin superfamily member 5 (CLEC5A) gene was associated with severe dengue in a Northern Brazilian population (OR= 2.75 and p-value = 0.01, OR= 2.11 and p-value = 0.04, respectively). We also tested the functional effect of the CLEC5A protein and found that it is upregulated on the surface of human monocytes after in vitro dengue infection. CLEC5A was correlated with viral load inside the monocytes (Spearman r = 0.55, p = 0.008) and TNF production in culture supernatants (Spearman r = 0.72, p = 0.03). Analysis of mRNA in blood samples from DENV4-infected patients exhibiting mild symptoms showed that CLEC5A mRNA expression is correlated with TNF (r = 0.67, p = 0.0001) and other immune mediators. Monocytes from rs1285933 TT/TC individuals showed lower CLEC5A expression compared to CC genotypes. However, in these cells, CLEC5A was not correlated with TNF production. In summary, we confirmed that CLEC5A is genetically associated with dengue severity outcome, playing a central role during the immune response triggered by a dengue viral infection, and rs1285933 is a relevant SNP that is able to regulate signaling pathways after interactions between the dengue virus and CLEC5A receptors. (C) 2017 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Xavier-Carvalho, Caroline; de Toledo-Pinto, Thiago Gomes; Moraes, Milton Ozorio] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil.
   [Xavier-Carvalho, Caroline; Fiestas Solorzano, Victor Edgar; Fialho, Luciana Gomes; de Azeredo, Elzinandes Leal; Kubelka, Claire Fernandes] Inst Oswaldo Cruz FIOCRUZ, Lab Imunol Viral, Rio De Janeiro, RJ, Brazil.
   [da Silva Cezar, Renata Duarte; Mola de Vasconcelos, Carla Maria; Freire de Moura, Patricia Muniz Mendes] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Freire, Naishe Matos; Silva Vasconcelos, Luydson Richardson; Baptista, Paulo] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [do Carmo, Rodrigo Feliciano] Univ Fed Vale Sao Francisco, Colegiado Ciencias Farmaceut, Petrolina, PE, Brazil.
   [Silva Vasconcelos, Luydson Richardson; Freire de Moura, Patricia Muniz Mendes] Fiocruz MS, Dept Parasitol, Lab Doencas Transmissiveis, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, CPqAM, LAVITE, Recife, PE, Brazil.
   [Pacheco, Antonio Guilherme] Programa Comp Cient PROCC FIOCRUZ, Rio De Janeiro, RJ, Brazil.
   [da Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, FM, Dept Clin Med, Campo Grande, MS, Brazil.
   [de Souza, Luiz Jose] Ctr Referencia Dengue, Campos Dos Goytacazes, RJ, Brazil.
   [de Souza, Luiz Jose] Fac Med, Campos Dos Goytacazes, RJ, Brazil.
RP Moraes, MO (corresponding author), Oswaldo Cruz Inst FIOCRUZ, Av Brasil 4365 Manguinhos, BR-21040360 Rio De Janeiro, Brazil.
EM milton.moraes@fiocruz.br
RI Carmo, Rodrigo Feliciano do/V-9795-2017; Fiestas, Victor/J-6894-2019;
   Moraes, Milton Ozorio/G-9753-2011; Pacheco, Antonio
   Guilherme/E-6378-2013; Vasconcelos, Luydson/AAC-4907-2020; Kubelka,
   Claire F/C-5558-2009
OI Carmo, Rodrigo Feliciano do/0000-0001-9601-6995; Fiestas,
   Victor/0000-0002-5554-3542; Moraes, Milton Ozorio/0000-0003-2653-0037;
   Pacheco, Antonio Guilherme/0000-0003-3095-1774; Vasconcelos,
   Luydson/0000-0002-1625-3358; Cezar, Renata/0000-0002-7278-5682; Moura,
   Patricia/0000-0003-4259-388X
FU Agency for Science Development of Pernambuco State (FACEPE); Agency for
   Research Support of Rio de Janeiro State (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Oswaldo Cruz Institute (IOC)-Oswaldo Cruz Foundation (FIOCRUZ)
FX The authors wish to thank the Agency for Science Development of
   Pernambuco State (FACEPE), the Agency for Research Support of Rio de
   Janeiro State (FAPERJ), and the Oswaldo Cruz Institute (IOC)-Oswaldo
   Cruz Foundation (FIOCRUZ). We also thank Scribendi for manuscript
   proofreading and editing.
CR Guerreiro LTA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064748
   [Anonymous], 2008, LANG ENV STAT COMP
   Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   Cheng YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32000
   Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682
   Coelho A.V.C., 2015, BRAZIL, V14, P2876
   Faria NRD, 2016, T ROY SOC TROP MED H, V110, P228, DOI 10.1093/trstmh/trw013
   Fang X, 2012, FEMS IMMUNOL MED MIC, V66, P134, DOI 10.1111/j.1574-695X.2012.00995.x
   Figueiredo GG, 2016, HUM IMMUNOL, V77, P571, DOI 10.1016/j.humimm.2016.05.006
   Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124
   Gandini M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002257
   Halstead SB, 2003, AM J TROP MED HYG, V69, P5
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Inoue S, 2010, VECTOR-BORNE ZOONOT, V10, P143, DOI 10.1089/vbz.2008.0153
   Joyce-Shaikh B, 2010, J EXP MED, V207, P579, DOI 10.1084/jem.20090516
   Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lawrence TB, 2009, INSTITUTIONAL WORK: ACTORS AND AGENCY IN INSTITUTIONAL STUDIES OF ORGANIZATIONS, P1, DOI 10.1017/CBO9780511596605.001
   Lin CC, 2010, AM J TROP MED HYG, V82, P731, DOI 10.4269/ajtmh.2010.09-0549
   Lo Y., 2016, PLOS ONE, P1
   Lo YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166474
   Musso D., 2016, LANCET, V386, P243
   Pacheco AG, 2009, DIS MARKERS, V27, P173, DOI [10.1155/2009/685618, 10.3233/DMA-2009-0654]
   Paradowska-Gorycka A, 2013, HUM IMMUNOL, V74, P730, DOI 10.1016/j.humimm.2013.02.003
   Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Stephens H.A.F., 2010, HLA OTHER GENE ASS D, P99
   Thamizhmani R., 2014, BRAZ J INFECT DIS, V8, P4, DOI DOI 10.1016/J.BJID
   Torrentes-Carvalho A, 2016, CLIN IMMUNOL, V164, P95, DOI 10.1016/j.clim.2016.01.005
   Tung YT, 2014, NANOMED-NANOTECHNOL, V10, P1335, DOI 10.1016/j.nano.2014.03.009
   Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014
   Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478
   Ward PA, 2011, J CLIN INVEST, V121, P4234, DOI 10.1172/JCI60122
   Watson AA, 2011, J BIOL CHEM, V286, P24208, DOI 10.1074/jbc.M111.226142
   World Health Organization (WHO) Regional Office for South-East Asia, 2009, SPEC PROGRAM RES TRA, V147
   Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090
   Xavier-Carvalho C, 2013, INFECT GENET EVOL, V20, P197, DOI 10.1016/j.meegid.2013.08.017
   Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693
NR 44
TC 9
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD OCT
PY 2017
VL 78
IS 10
BP 649
EP 656
DI 10.1016/j.humimm.2017.07.013
PG 8
WC Immunology
SC Immunology
GA FL6UW
UT WOS:000414382700009
PM 28764923
OA Green Published
DA 2020-12-08
ER

PT J
AU Fernandes, AIV
   Mendes, CL
   Simoes, RH
   Silva, AEVF
   Madruga, CB
   de Brito, CAA
   Castellano, LR
   Cordeiro, MT
AF Vieira Fernandes, Ana Isabel
   Mendes, Ciro Leite
   Simoes, Raissa Holmes
   Vieira Fernandes Silva, Ana Elisa
   Madruga, Clarissa Barros
   Antunes de Brito, Carlos Alexandre
   Castellano, Lucio Roberto
   Cordeiro, Marli Tenorio
TI Cardiac tamponade in a patient with severe dengue fever
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Dengue; Severe dengue; Cardiac tamponade
ID MYOCARDITIS; INFECTION
AB A 26-year-old postpartum female presented with symptoms characteristic of dengue fever on the 16th day of puerperium. On the third day of the illness, the patient presented a clinical picture consistent with shock. Tests determined primary infection with dengue virus serotype 2. Cardiac tamponade was confirmed by echocardiography. This rare manifestation is described in a patient without any associated comorbidity.
C1 [Vieira Fernandes, Ana Isabel; Simoes, Raissa Holmes; Vieira Fernandes Silva, Ana Elisa; Madruga, Clarissa Barros] Univ Fed Paraiba, Serv Doencas Infecciosas & Parasitarias, Hosp Univ Lauro Wanderley, Joao Pessoa, Paraiba, Brazil.
   [Vieira Fernandes, Ana Isabel; Castellano, Lucio Roberto] Univ Fed Paraiba, Escola Tecn Saude, Grp Estudos & Pesquisas Imunol Humana, Joao Pessoa, Paraiba, Brazil.
   [Mendes, Ciro Leite] Univ Fed Paraiba, Hosp Univ Lauro Wanderley, Unidade Terapia Intens, Joao Pessoa, Paraiba, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Med Clin, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Virol & Terapia Expt, Recife, PE, Brazil.
RP Fernandes, AIV (corresponding author), Univ Fed Paraiba, Serv Doencas Infecciosas & Parasitarias, Hosp Univ Lauro Wanderley, Joao Pessoa, Paraiba, Brazil.; Fernandes, AIV (corresponding author), Univ Fed Paraiba, Escola Tecn Saude, Grp Estudos & Pesquisas Imunol Humana, Joao Pessoa, Paraiba, Brazil.
EM anaisabelvf@gmail.com
RI Castellano, Lucio/D-8887-2015
OI Castellano, Lucio/0000-0003-0851-5298
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq) [576214/2008-6]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Brazil, grant 576214/2008-6.
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   Bendwal Suresh, 2014, J Assoc Physicians India, V62, P257
   Gupta VK, 2010, JIACM, V11, P107
   Kularatne SAM, 2007, T ROY SOC TROP MED H, V101, P804, DOI 10.1016/j.trstmh.2007.02.021
   Kumar Sunil, 2010, J Intensive Care Med, V25, P175, DOI 10.1177/0885066609358955
   Miranda CH, 2013, EUR HEART J-ACUTE CA, V2, P127, DOI 10.1177/2048872613475889
   Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403
   Motla M, 2011, PREHOSP DISASTER MED, V26, P335, DOI 10.1017/S1049023X11006637
   NAGARATNAM N, 1973, BRIT HEART J, V35, P204
   Oliveira Ricardo Villar Barbosa de, 2010, Radiol Bras, V43, P401, DOI 10.1590/S0100-39842010000600013
   Pesaro Antonio Eduardo, 2007, Arq. Bras. Cardiol., V89, pe12, DOI 10.1590/S0066-782X2007001400015
   Pothapregada S, 2016, INDIAN J PEDIATR, V83, P493, DOI 10.1007/s12098-015-1942-9
   Weerakoon Kosala Gad, 2011, BMC Res Notes, V4, P268, DOI 10.1186/1756-0500-4-268
   Wiwanitkit V, 2008, ACTA CARDIOL SIN, V24, P226
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 15
TC 2
Z9 2
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2017
VL 50
IS 5
BP 701
EP 705
DI 10.1590/0037-8682-0361-2016
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FM1JU
UT WOS:000414732300021
PM 29160522
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Castanha, PMS
   Nascimento, EJM
   Braga, C
   Cordeiro, MT
   de Carvalho, OV
   de Mendonca, LR
   Azevedo, EAN
   Franca, RFO
   Dhalia, R
   Marques, ETA
AF Castanha, Priscila M. S.
   Nascimento, Eduardo J. M.
   Braga, Cynthia
   Cordeiro, Marli T.
   de Carvalho, Otavio V.
   de Mendonca, Leila R.
   Azevedo, Elisa A. N.
   Franca, Rafael F. O.
   Dhalia, Rafael
   Marques, Ernesto T. A.
TI Enhancement of Zika Infection by Dengue-Specific Antibodies Does Not
   Alter the Production of Interleukin 6 in Fc gamma RII-Expressing K562
   Cells
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
ID DEPENDENT ENHANCEMENT; VIRUS
C1 [Castanha, Priscila M. S.; Braga, Cynthia; Cordeiro, Marli T.; de Carvalho, Otavio V.; de Mendonca, Leila R.; Azevedo, Elisa A. N.; Franca, Rafael F. O.; Dhalia, Rafael; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Inst Biol Sci, Fac Med Sci, Recife, PE, Brazil.
   [Braga, Cynthia] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Marques, ETA (corresponding author), Ctr Vaccine Res, 3501 Fifth Ave,9052 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.
EM marques@pitt.edu
RI Braga, Maria Cynthia/A-8204-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012; Marques, Ernesto T. A/L-4967-2013; Dhalia,
   Rafael/AAD-5432-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Marques, Ernesto T. A/0000-0003-3826-9358;
   Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007
FU Brazilian Federal Agency for Support and Evaluation of Graduate
   Education; Center for Vaccine Research, University of Pittsburgh;
   Fogarty Training Program [D43TW006592 Pitt GIDRTP/323 NIH]; National
   Council for Scientific and Technological DevelopmentNational Council for
   Scientific and Technological Development (CNPq) [482915/2010-2
   MCT/CNPq-321 14/2010]; Strategic Program to Support Health
   Research/PAPES VI [322 407697/2012-8]; National Institute of Allergy and
   Infectious Diseases, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19 AI56541]
FX This work was supported by the Brazilian Federal Agency for Support and
   Evaluation of Graduate Education; Center for Vaccine Research,
   University of Pittsburgh; Fogarty Training Program (grant number
   D43TW006592 Pitt GIDRTP/323 NIH to P. M. S. C.); National Council for
   Scientific and Technological Development (grant number 482915/2010-2
   MCT/CNPq-321 14/2010); Strategic Program to Support Health
   Research/PAPES VI (grant number 322 407697/2012-8); and National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health (grant number U19 AI56541).
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hueston L, 2017, J INFECT DIS, V216, P612, DOI 10.1093/infdis/jix344
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
NR 10
TC 4
Z9 4
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2017
VL 216
IS 5
BP 614
EP 615
DI 10.1093/infdis/jix346
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FG6UY
UT WOS:000410532400015
PM 28931227
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Guedes, DRD
   Paiva, MHS
   Donato, MMA
   Barbosa, PP
   Krokovsky, L
   Rocha, SWD
   La Saraiva, K
   Crespo, MM
   Rezende, TM
   Wallau, GL
   Barbosa, RMR
   Oliveira, CMF
   Melo-Santos, MAV
   Pena, L
   Cordeiro, MT
   Franca, RFD
   de Oliveira, ALS
   Peixoto, CA
   Leal, WS
   Ayres, CFJ
AF Guedes, Duschinka R. D.
   Paiva, Marcelo H. S.
   Donato, Mariana M. A.
   Barbosa, Priscilla P.
   Krokovsky, Larissa
   Rocha, Sura W. dos S.
   La Saraiva, Karina
   Crespo, Monica M.
   Rezende, Tatiana M. T.
   Wallau, Gabriel L.
   Barbosa, Rosangela M. R.
   Oliveira, Claudia M. F.
   Melo-Santos, Maria A. V.
   Pena, Lindomar
   Cordeiro, Marli T.
   Franca, Rafael F. de O.
   de Oliveira, Andre L. S.
   Peixoto, Christina A.
   Leal, Walter S.
   Ayres, Constancia F. J.
TI Zika virus replication in the mosquito Culex quinquefasciatus in Brazil
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Aedes; Culex; microcephaly; vector competence; Zika
ID AEDES-AEGYPTI MOSQUITOS; PIPIENS MOSQUITOS; FEDERATED STATES; YAP STATE;
   INFECTION; MICRONESIA; EPIDEMIC; VECTOR; SUSCEPTIBILITY; SURVEILLANCE
AB Zika virus (ZIKV) is a flavivirus that has recently been associated with an increased incidence of neonatal microcephaly and other neurological disorders. The virus is primarily transmitted by mosquito bite, although other routes of infection have been implicated in some cases. The Aedes aegypti mosquito is considered to be the main vector to humans worldwide; however, there is evidence that other mosquito species, including Culex quinquefasciatus, transmit the virus. To test the potential of Cx. quinquefasciatus to transmit ZIKV, we experimentally compared the vector competence of laboratory-reared Ae. aegypti and Cx. quinquefasciatus. Interestingly, we were able to detect the presence of ZIKV in the midgut, salivary glands and saliva of artificially fed Cx. quinquefasciatus. In addition, we collected ZIKV-infected Cx. quinquefasciatus from urban areas with high microcephaly incidence in Recife, Brazil. Corroborating our experimental data from artificially fed mosquitoes, ZIKV was isolated from field-caught Cx. quinquefasciatus, and its genome was partially sequenced. Collectively, these findings indicate that there may be a wider range of ZIKV vectors than anticipated.
C1 [Guedes, Duschinka R. D.; Paiva, Marcelo H. S.; Donato, Mariana M. A.; Barbosa, Priscilla P.; Krokovsky, Larissa; Rocha, Sura W. dos S.; La Saraiva, Karina; Crespo, Monica M.; Rezende, Tatiana M. T.; Barbosa, Rosangela M. R.; Oliveira, Claudia M. F.; Melo-Santos, Maria A. V.; Peixoto, Christina A.; Ayres, Constancia F. J.] Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Dept Entomol, BR-50760420 Recife, PE, Brazil.
   [Paiva, Marcelo H. S.] Univ Fed Pernambuco, Ctr Acad Agreste, Nucleo Ciencias Vida, BR-55002970 Caruaru, Brazil.
   [Pena, Lindomar; Cordeiro, Marli T.; Franca, Rafael F. de O.] Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Lab Virol & Terapia Expt, BR-50670420 Recife, PE, Brazil.
   [de Oliveira, Andre L. S.] Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Nucleo Estat & Geoprocessamento, BR-50670420 Recife, PE, Brazil.
   [Leal, Walter S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
RP Ayres, CFJ (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Aggeu Magalhaes, Dept Entomol, BR-50760420 Recife, PE, Brazil.
EM tans@cpqam.fiocruz.br
RI Wallau, Gabriel Luz/B-5911-2008; Barbosa, Rosangela/AAC-3339-2020;
   Rocha, Sura/R-8479-2018; PEIXOTO, CHRISTINA/AAD-9608-2019; Ayres,
   Constancia/AAQ-3448-2020
OI Wallau, Gabriel Luz/0000-0002-1419-5713; Barbosa,
   Rosangela/0000-0002-1171-598X; Rocha, Sura/0000-0003-2312-085X; 
FU Fundacao de Amparo a Pesquisa do Estado de Pernambuco (FACEPE)
   [APQ-1608-2.13/15, APQ-0085-2.13/16, APQ-345-2.13/13, APQ-0078-2.02/16];
   Brazilian National Council for Research and Development (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [441100/2016-3]; National Institute of Allergy and Infectious Diseases
   at the National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI095514,
   1R21AI128931-01]; CNPqNational Council for Scientific and Technological
   Development (CNPq); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI095514, R01AI095514, R01AI095514,
   R01AI095514, R01AI095514, R21AI128931, R21AI128931, R01AI095514,
   R01AI095514, R01AI095514] Funding Source: NIH RePORTER
FX This work was partially supported by the Fundacao de Amparo a Pesquisa
   do Estado de Pernambuco (FACEPE; APQ-1608-2.13/15 and APQ-0085-2.13/16
   to CFJA; APQ-345-2.13/13 to MAVMS and APQ-0078-2.02/16 to GLW), the
   Brazilian National Council for Research and Development (CNPq; grant
   441100/2016-3) and the National Institute of Allergy and Infectious
   Diseases at the National Institutes of Health (R01AI095514 and
   1R21AI128931-01 to WSL). CFJA and CAP were supported by productivity
   fellowships from CNPq. We thank the insectary staff at the IAM for
   technical assistance, the Program for Technological Development in Tools
   for Health (PDTIS-FIOCRUZ) for allowing us to use their facilities, the
   staff of the Pernambuco State Health Department for sharing recent data
   on microcephaly and for assisting with surveillance and the Platform of
   Statistic and Geographical Information Systems (Nucleo de Estatistica e
   Geoprocessamento, NEG) for helping us with the GIS technologies and
   statistical analyses (George Tadeu Nunes Diniz).
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amorim LB, 2013, PEST MANAG SCI, V69, P1307, DOI 10.1002/ps.3502
   Amraoui F, 2016, EURO SURVEILL, V21
   Araujo AP, 2017, BIOL CONTROL, V41, P339
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Boccolini D, 2016, EUROSURVEILLANCE, V21
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cornet M, 1979, CAH ORSTOM, V17, P7
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Chalegre KDD, 2009, APPL ENVIRON MICROB, V75, P1044, DOI 10.1128/AEM.02032-08
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Flies EJ, 2015, VECTOR-BORNE ZOONOT, V15, P397, DOI 10.1089/vbz.2014.1759
   Fontaine A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24885
   Girard YA, 2005, J MED ENTOMOL, V42, P429, DOI 10.1603/0022-2585(2005)042[0429:USOWNV]2.0.CO;2
   Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leal Walter S, 2016, F1000Res, V5, P2546
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Donato MAM, 2015, TISSUE CELL, V47, P515, DOI 10.1016/j.tice.2015.07.001
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Nasci RS, 2001, EMERG INFECT DIS, V7, P626
   Nunes AT, 2016, PROTEOMICS, V16, P2582, DOI 10.1002/pmic.201600126
   Pilotte N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004641
   REGIS L, 1995, MEM I OSWALDO CRUZ, V90, P115, DOI 10.1590/S0074-02761995000100022
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   ROSEN L, 1987, AM J TROP MED HYG, V37, pS69, DOI 10.4269/ajtmh.1987.37.69S
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   Scheuermann RH, 2016, NATURE, V531, P173, DOI 10.1038/531173a
   SUCHARIT S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P611
   Wang ZM, 2012, VECTOR-BORNE ZOONOT, V12, P605, DOI 10.1089/vbz.2011.0660
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 56
TC 86
Z9 90
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD AUG 9
PY 2017
VL 6
AR e69
DI 10.1038/emi.2017.59
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FD4BU
UT WOS:000407477100004
PM 28790458
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Freire, MCLC
   Pol-Fachin, L
   Coelho, DF
   Viana, IFT
   Magalhaes, T
   Cordeiro, MT
   Fischer, N
   Loeffler, FF
   Jaenisch, T
   Franca, RF
   Marques, ETA
   Lins, RD
AF Freire, Marjorie C. L. C.
   Pol-Fachin, Laercio
   Coelho, Danilo F.
   Viana, Isabelle F. T.
   Magalhaes, Tereza
   Cordeiro, Marli T.
   Fischer, Nico
   Loeffler, Felix F.
   Jaenisch, Thomas
   Franca, Rafael F.
   Marques, Ernesto T. A.
   Lins, Roberto D.
TI Mapping Putative B-Cell Zika Virus NS1 Epitopes Provides Molecular Basis
   for Anti-NS1 Antibody Discrimination between Zika and Dengue Viruses
SO ACS OMEGA
LA English
DT Article
ID GROMOS FORCE-FIELD; PRINTED ELECTRODE; PROTEIN NS1; DYNAMICS;
   ASSOCIATION; LOOPS; ASSAY
AB B-cell epitope sequences from Zika virus (ZIKV) NS1 protein have been identified using epitope prediction tools. Mapping these sequences onto the NS1 surface reveals two major conformational epitopes and a single linear one. Despite an overall average sequence identity of ca. 55% between the NS1 from ZIKV and the four dengue virus (DENV) serotypes, epitope sequences were found to be highly conserved. Nevertheless, nonconserved epitope-flanking residues are responsible for a dramatically divergent electrostatic surface potential on the epitope regions of ZIKV and DENV2 serotypes. These findings suggest that strategies for differential diagnostics on the basis of short linear NS1 sequences are likely to fail due to immunological cross-reactions. Overall, results provide the molecular basis of differential discrimination between Zika and DENVs by NS1 monoclonal antibodies.
C1 [Freire, Marjorie C. L. C.; Pol-Fachin, Laercio; Coelho, Danilo F.; Viana, Isabelle F. T.; Magalhaes, Tereza; Cordeiro, Marli T.; Franca, Rafael F.; Marques, Ernesto T. A.; Lins, Roberto D.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, BR-50740465 Recife, PE, Brazil.
   [Pol-Fachin, Laercio; Coelho, Danilo F.; Lins, Roberto D.] Univ Fed Pernambuco, Dept Fundamental Chem, BR-50740670 Recife, PE, Brazil.
   [Fischer, Nico; Jaenisch, Thomas] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, INF 324, D-69120 Heidelberg, Germany.
   [Loeffler, Felix F.] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Muhlenberg 1, D-14476 Potsdam, Germany.
   [Fischer, Nico; Loeffler, Felix F.; Jaenisch, Thomas] Heidelberg Univ, Karlsruhe Inst Technol KIT, HEiKA Heidelberg Karlsruhe Res Partnership, D-76131 Karlsruhe, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
RP Marques, ETA; Lins, RD (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, BR-50740465 Recife, PE, Brazil.; Lins, RD (corresponding author), Univ Fed Pernambuco, Dept Fundamental Chem, BR-50740670 Recife, PE, Brazil.; Marques, ETA (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
EM marques@pitt.edu; roberto.lins@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013; Magalhaes, Tereza/V-6632-2019;
   Loeffler, Felix F/K-6192-2016; Loeffler, Felix F/C-7920-2017; Lins,
   Roberto D/J-7511-2012; Coelho, Danilo Fernandes/AAC-9206-2020; Viana,
   Isabelle/M-4435-2017
OI Marques, Ernesto T. A/0000-0003-3826-9358; Loeffler, Felix
   F/0000-0002-8227-2522; Loeffler, Felix F/0000-0002-8227-2522; Lins,
   Roberto D/0000-0002-3983-8025; Coelho, Danilo
   Fernandes/0000-0002-1111-0825; Viana, Isabelle/0000-0003-4648-6635;
   Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007
FU FACEPE; CAPESCAPES; CNPqNational Council for Scientific and
   Technological Development (CNPq); CuraZika Foundation
FX This work was supported by grants from FACEPE, CAPES, CNPq and CuraZika
   Foundation. Computational resources were provided by the Brazilian
   National Supercomputing Center (LNCC).
CR Abraham M. J., 2015, SOFTWAREX, V1-2, P19
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   Borley DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061122
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Cavalcanti IT, 2012, BIOCHEM ENG J, V67, P225, DOI 10.1016/j.bej.2012.06.016
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dias ACMS, 2013, BIOSENS BIOELECTRON, V44, P216, DOI 10.1016/j.bios.2012.12.033
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Figueiredo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07865
   Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753
   Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362
   Flower DR, 2013, NAT CHEM BIOL, V9, P748, DOI 10.1038/nchembio.1383
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Johnson BW, 2009, CLIN VACCINE IMMUNOL, V16, P1052, DOI 10.1128/CVI.00095-09
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lover AA, 2016, LANCET INFECT DIS, V16, P1331, DOI 10.1016/S1473-3099(16)30462-5
   Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Pol-Fachin L, 2012, J CHEM THEORY COMPUT, V8, P4681, DOI 10.1021/ct300479h
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287
   Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9
   Silva MMS, 2014, TALANTA, V128, P505, DOI 10.1016/j.talanta.2014.06.009
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stadler V, 2008, ANGEW CHEM INT EDIT, V47, P7132, DOI 10.1002/anie.200801616
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumita LM, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658089, 10.1590/s1678-9946201658089]
   TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273
   Viana IFT, 2013, RSC ADV, V3, P11790, DOI 10.1039/c3ra41562g
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 55
TC 15
Z9 15
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD JUL
PY 2017
VL 2
IS 7
BP 3913
EP 3920
DI 10.1021/acsomega.7b00608
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA FG2GV
UT WOS:000409909900090
PM 30023708
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Brito, CAA
   Azevedo, F
   Cordeiro, MT
   Marques, ETA
   Franca, RFO
AF Brito, Carlos A. A.
   Azevedo, Fernanda
   Cordeiro, Marli T.
   Marques, Ernesto T. A., Jr.
   Franca, Rafael F. O.
TI Central and peripheral nervous system involvement caused by Zika and
   chikungunya coinfection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS; INFECTION; HISTORY
C1 [Brito, Carlos A. A.] Fed Univ Pernambuco UFPE, Dept Clin Med, Recife, PE, Brazil.
   [Azevedo, Fernanda] Santa Joana Hosp, Dept Neurol, Recife, PE, Brazil.
   [Cordeiro, Marli T.; Marques, Ernesto T. A., Jr.; Franca, Rafael F. O.] Fiocruz MS, Aggeu Magalhaes Inst, Oswaldo Cruz Fdn, Dept Virol & Expt Therapy, Recife, PE, Brazil.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res Pittsburgh, Pittsburgh, PA USA.
RP Franca, RFO (corresponding author), Fiocruz MS, Aggeu Magalhaes Inst, Oswaldo Cruz Fdn, Dept Virol & Expt Therapy, Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007
FU FACEPE - Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco under
   RFOF [APQ-0055.2.11/16, APQ-0044.2.11/16]
FX The research leading to these results received funding from the FACEPE -
   Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco, grant agreement
   nos. APQ-0055.2.11/16 and APQ-0044.2.11/16 under RFOF coordination and
   responsibility. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Brooks JB, 2016, J INFECT PUBLIC HLTH
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   MATHIAS CJ, 1989, J NEUROL SCI, V94, P255, DOI 10.1016/0022-510X(89)90235-9
   Mercado M, 2016, EURO SURVEILL, P21
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Omarjee R., 2014, EURO SURVEILL, V19
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Roth A, 2014, EURO SURVEILL, V19
   Solet J. L., 2007, PLOS BIOL, V77, P727
   Tandale BV, 2009, J CLIN VIROL, V46, P145, DOI 10.1016/j.jcv.2009.06.027
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   Villamil-Gomez WE, 2016, INT J INFECT DIS
   Waggoner JJ, 2016, CLIN INFECT DIS
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zambrano H, 2016, AM J TROP MED HYG
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 24
TC 9
Z9 9
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2017
VL 11
IS 7
AR e0005583
DI 10.1371/journal.pntd.0005583
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FE2PD
UT WOS:000408057300004
PM 28704365
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU van der Linden, V
   van der Linden, H
   Leal, MD
   Rolim, EL
   van der Linden, A
   Aragao, MDVV
   Brainer-Lima, AM
   Cruz, DDS
   Ventura, LO
   Florencio, TLT
   Cordeiro, MT
   Neto, SDC
   Ramos, RC
AF van der Linden, Vanessa
   van der Linden Junior, Helio
   Leal, Mariana de Carvalho
   Rolim Filho, Epitacio Leite
   van der Linden, Ana
   Viana Vasco Aragao, Maria de Faima
   Brainer-Lima, Alessandra Mertens
   Sousa Cruz, Danielle Di Cavalcanti
   Ventura, Liana O.
   Tabosa Florencio, Telma Lucia
   Cordeiro, Marli Tenorio
   Caudas Neto, Silvio da Silva
   Ramos, Regina Coeli
TI Discordant clinical outcomes of congenital Zika virus infection in twin
   pregnancies
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE Zika virus; Zika virus infection; twins; dizygotic
ID CYTOMEGALOVIRUS-INFECTION; INFANTS; HIV
AB Congenital Zika syndrome is an emergent cause of a congenital infectious disorder, resulting in severe damage to the central nervous system and microcephaly. Despite advances in understanding the pathophysiology of the disease, we still do not know all the mechanisms enrolled in the vertical transmission of the virus. As has already been reported in other types of congenital infectious disorders in dizygotic twin pregnancies, it is possible that the virus affects only one of the fetuses. In this article, we report on two cases of twin pregnancies exposed to the Zika virus, but with only one of the fetuses affected with microcephaly and brain damage. This indicates the urgent need for more studies regarding the pathophysiology of viral infection and the mechanisms involved in the natural protection against the virus.
C1 [van der Linden, Vanessa] Hosp Barao Lucena, Recife, PE, Brazil.
   [van der Linden, Vanessa; Rolim Filho, Epitacio Leite] AACD, Recife, PE, Brazil.
   [van der Linden Junior, Helio] Ctr Reabilitacao Dr Henrique Santillo, Goiania, Go, Brazil.
   [Leal, Mariana de Carvalho; Rolim Filho, Epitacio Leite; Caudas Neto, Silvio da Silva] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Leal, Mariana de Carvalho] Hosp Agamenon Magalhaes, Recife, PE, Brazil.
   [van der Linden, Ana; Sousa Cruz, Danielle Di Cavalcanti] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Viana Vasco Aragao, Maria de Faima] Ctr Diagnost Multimagem, Recife, PE, Brazil.
   [Viana Vasco Aragao, Maria de Faima] Univ Mauricio Nassau, Recife, PE, Brazil.
   [Brainer-Lima, Alessandra Mertens] Univ Pernambuco, Recife, PE, Brazil.
   [Ventura, Liana O.] Fundacao Altino Ventura, Recife, PE, Brazil.
   [Ventura, Liana O.] Hosp Olhos Pernambuco HOPE, Recife, PE, Brazil.
   [Tabosa Florencio, Telma Lucia] UniVision, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Ramos, Regina Coeli] Hosp Univ Oswaldo Cruz, Recife, PE, Brazil.
RP van der Linden, V (corresponding author), AACD Pernambuco, Ave Adv Jose Paulo Cavalcanti 155, BR-50080810 Recife, PE, Brazil.
EM vanessavdlinden@hotmail.com
RI Ventura, Liana Vieira O/N-6151-2018
OI Ventura, Liana Vieira O/0000-0001-6529-6883; VAN DER LINDEN JUNIOR,
   HELIO/0000-0002-3123-2264
CR BARLOW KM, 1993, ARCH DIS CHILD, V68, P507, DOI 10.1136/adc.68.4.507
   Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   DEMARTINO M, 1991, ARCH DIS CHILD, V66, P1235, DOI 10.1136/adc.66.10.1235
   Egana-Ugrinovic G, 2016, J MATERN-FETAL NEO M, V29, P3439, DOI 10.3109/14767058.2015.1130818
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Lazzarotto T, 2003, PEDIATRICS, V112, pE153, DOI 10.1542/peds.112.2.e153
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   SEGUIN J, 1988, JAMA-J AM MED ASSOC, V260, P3277, DOI 10.1001/jama.1988.03410220061021
   Thapa R, 2009, INDIAN J PEDIATR, V76, P1069, DOI 10.1007/s12098-009-0208-9
   Tomasik Tomasz, 2012, Med Wieku Rozwoj, V16, P252
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, 2007, WHO CHILD GROWTH STA
   Wu HY, 2011, TAIWAN J OBSTET GYNE, V50, P230, DOI 10.1016/j.tjog.2011.01.008
NR 26
TC 16
Z9 17
U1 0
U2 7
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2017
VL 75
IS 6
BP 381
EP 386
DI 10.1590/0004-282X20170066
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA EZ1MZ
UT WOS:000404476400010
PM 28658408
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Meneses, JD
   Ishigami, AC
   de Mello, LM
   de Albuquerque, LL
   de Brito, CAA
   Cordeiro, MT
   Pena, LJ
AF Meneses, Jucille do Amaral
   Ishigami, Ana Catarina
   de Mello, Luisa Medeiros
   de Albuquerque, Luciano Lira
   Antunes de Brito, Carlos Alexandre
   Cordeiro, Marli Tenorio
   Pena, Lindomar Jose
TI Lessons Learned at the Epicenter of Brazil's Congenital Zika Epidemic:
   Evidence From 87 Confirmed Cases
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE congenital Zika syndrome (CZS); microcephaly; diaphragm paralysis; Zika
   virus; immunoglobulin M
ID VIRUS-INFECTION; DIAPHRAGMATIC PARALYSIS; ASSOCIATION; ANTIBODY; INFANTS
AB Congenital Zika virus infection has stimulated great international concern. A prospective case series of 87 infants with laboratory- confirmed congenital Zika syndrome (CZS) at the epicenter of the Brazilian Zika epidemic in Pernambuco state is presented. Mothers were interviewed for symptoms of possible Zika virus (ZIKV) infection during pregnancy, and fetal ultrasounds were obtained. Infant cerebrospinal fluid (CSF) samples were tested for ZIKV-specific antibodies, and sera were screened for other congenital infections. Neuroimaging and ophthalmologic evaluations were also performed. Sixty-six mothers (76%) reported symptoms of ZIKV infection during gestation. Fetal ultrasounds were available from 90% of the mothers, and all demonstrated brain structural abnormalities. All of the CSF samples tested positive for ZIKV immunoglobulin M. The majority of infants (89%) were term; the mean birth weight was 2577 +/- 260 g, and the mean head circumference was 28.1 +/- 1.8 cm. Severe microcephaly, defined as head circumference 3 SD below the mean for sex and gestational age, was found in 72 (82%) infants. All infants had an abnormal neurological exam, and 18 (20.7%) had arthrogryposis. The main abnormalities detected in computed tomography scans were calcifications (99%), followed by ventricular enlargement (94%), cortical hypogyration (81%), and less commonly, cerebellar hypoplasia (52%). Unilateral diaphragm paralysis was identified in 3 infants. Maternal young age, term infant, small for gestational age, and the presence of ophthalmologic abnormalities were significantly associated with a smaller head circumference Z score. Our findings, based on laboratory-confirmed ZIKV infection, add valuable evidence for the understanding of CZS.
C1 [Meneses, Jucille do Amaral; Ishigami, Ana Catarina; de Mello, Luisa Medeiros; de Albuquerque, Luciano Lira] Prof Fernando Figueira Integral Med Inst, Div Neonatol, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio; Pena, Lindomar Jose] Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
RP Pena, LJ (corresponding author), Oswaldo Cruz Fdn Fiocruz, Dept Virol, Ave Prof Moraes Rego, Recife, PE, Brazil.
EM lindomar.pena@cpqam.fiocruz.br
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FACEPE (Foundation of Science and Technology of Pernambuco
   State)
FX L. J. P. is supported by grants from CNPq and FACEPE (Foundation of
   Science and Technology of Pernambuco State).
CR Ansari MK, 2010, NEUROL INDIA, V58, P596, DOI 10.4103/0028-3886.68662
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Klein Jessica L, 2016, Cerebellum Ataxias, V3, P1, DOI 10.1186/s40673-016-0039-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Pan American Health Organization/World Health Organization, 2016, ZIK SUSP CONF CAS RE
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ratnayake EC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-46
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 27
TC 50
Z9 50
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAY 15
PY 2017
VL 64
IS 10
BP 1302
EP 1308
DI 10.1093/cid/cix166
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EU3EX
UT WOS:000400912500002
PM 28329257
OA Bronze
DA 2020-12-08
ER

PT J
AU Lucena-Silva, N
   Assuncao, MELSD
   Ramos, FAP
   Azevedo, F
   Lessa, R
   Cordeiro, MT
   de Brito, CAA
AF Lucena-Silva, Norma
   Sales de Melo Assuncao, Maria Elisa Lucena
   Pereira Ramos, Frederico Antonio
   Azevedo, Fernanda
   Lessa Junior, Ronaldo
   Cordeiro, Marli Tenorio
   Antunes de Brito, Carlos Alexandre
TI Encephalitis associated with inappropriate antidiuretic hormone
   secretion due to chikungunya infection in Recife, State of Pernambuco,
   Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE CHIKV; Encephalitis; Syndrome of inappropriate antidiuretic hormone
   hypersecretion
ID VIRUS; MANIFESTATIONS
AB The symptoms of chikungunya virus (CHIKV) infection include fever, headache, muscle aches, skin rash, and polyarthralgia, characterized by intense pain, edema, and temporary functional impairment. This is the first report of encephalitis caused by CHIKV infection associated with an atypical presentation of syndrome of inappropriate antidiuretic hormone secretion, evolving to cognitive impairment and apraxia of speech.
C1 [Lucena-Silva, Norma] Fundacao Oswaldo Cruz, Dept Imunol, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Sales de Melo Assuncao, Maria Elisa Lucena] Univ Pernambuco, Pronto Socorro Cardiol Pernambuco, Recife, PE, Brazil.
   [Pereira Ramos, Frederico Antonio; Azevedo, Fernanda] Hosp Santa Joana, Recife, PE, Brazil.
   [Lessa Junior, Ronaldo] Univ Pernambuco, Dept Radiol, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Dept Virol, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Med Interna, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Med Interna, Recife, PE, Brazil.
EM cbritoc@gmail.com
RI Lucena-Silva, Norma/AAH-9437-2019
CR Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Rampal M., 2007, J ASSOC PHYSICIAN I, V55, P765
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Secretaria Executiva de Vigilancia em Saude, 24SE SECR EX VIG SAU
   Shaikh NJ, 2015, INDIAN J MED MICROBI, V33, P454, DOI 10.4103/0255-0857.158600
   Taraphdar D, 2015, INDIAN J MED MICROBI, V33, pS153, DOI 10.4103/0255-0857.150946
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
NR 12
TC 0
Z9 1
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2017
VL 50
IS 3
BP 417
EP 422
DI 10.1590/0037-8682-0434-2016
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FA4LY
UT WOS:000405416000024
PM 28700066
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU del Campo, M
   Feitosa, IML
   Ribeiro, EM
   Horovitz, DDG
   Pessoa, ALS
   Franca, GVA
   Garcia-Alix, A
   Doriqui, MJR
   Wanderley, HYC
   Sanseverino, MVT
   Neri, JICF
   Pina-Neto, JM
   Santos, ES
   Vercosa, I
   Cernach, MCSP
   Medeiros, PFV
   Kerbage, SC
   Silva, AA
   van der Linden, V
   Martelli, CMT
   Cordeiro, MT
   Dhalia, R
   Vianna, FSL
   Victora, CG
   Cavalcanti, DP
   Schuler-Faccini, L
AF del Campo, Miguel
   Feitosa, Ian M. L.
   Ribeiro, Erlane M.
   Horovitz, Dafne D. G.
   Pessoa, Andre L. S.
   Franca, Giovanny V. A.
   Garcia-Alix, Alfredo
   Doriqui, Maria J. R.
   Wanderley, Hector Y. C.
   Sanseverino, Maria V. T.
   Neri, Joao I. C. F.
   Pina-Neto, Joao M.
   Santos, Emerson S.
   Vercosa, Islane
   Cernach, Mirlene C. S. P.
   Medeiros, Paula F. V.
   Kerbage, Saile C.
   Silva, Andre A.
   van der Linden, Vanessa
   Martelli, Celina M. T.
   Cordeiro, Marli T.
   Dhalia, Rafael
   Vianna, Fernanda S. L.
   Victora, Cesar G.
   Cavalcanti, Denise P.
   Schuler-Faccini, Lavinia
CA Zika Embryopathy Task Force
TI The phenotypic spectrum of congenital Zika syndrome
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE congenital Zika infection; congenital Zika sequence; congenital Zika
   syndrome; disruption; disruptive sequence; dysmorphology; fetal brain
   disruption sequence; teratogen; teratology; Zika virus
ID BRAIN DISRUPTION SEQUENCE; VIRUS-INFECTION; HEAD CIRCUMFERENCE; LINGUAL
   FRENULA; BIRTH-DEFECTS; HUMAN PALMAR; FETAL SKULL; INFANTS; BRAZIL;
   FETUSES
AB In October 2015, Zika virus (ZIKV) outbreak the Brazilian Ministry of Health (MoH). In response, the Brazilian Society of Medical Genetics established a task force (SBGM-ZETF) to study the phenotype of infants born with microcephaly due to ZIKV congenital infection and delineate the phenotypic spectrum of this newly recognized teratogen. This study was based on the clinical evaluation and neuroimaging of 83 infants born during the period from July, 2015 to March, 2016 and registered by the SBGM-ZETF. All 83 infants had significant findings on neuroimaging consistent with ZIKV congenital infection and 12 had confirmed ZIKV IgM in CSF. A recognizable phenotype of microcephaly, anomalies of the shape of skull and redundancy of the scalp consistent with the Fetal Brain Disruption Sequence (FBDS) was present in 70% of infants, but was most often subtle. In addition, features consistent with fetal immobility, ranging from dimples (30.1%), distal hand/finger contractures (20.5%), and feet malpositions (15.7%), to generalized arthrogryposis (9.6%), were present in these infants. Some cases had milder microcephaly or even a normal head circumference (HC), and other less distinctive findings. The detailed observation of the dysmorphic and neurologic features in these infants provides insight into the mechanisms and timings of the brain disruption and the sequence of developmental anomalies that may occur after prenatal infection by the ZIKV.
C1 [del Campo, Miguel] Univ Calif San Diego, Dept Pediat, Div Dysmorphol & Teratol, San Diego, CA USA.
   [Feitosa, Ian M. L.; Silva, Andre A.; Vianna, Fernanda S. L.; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.
   [Feitosa, Ian M. L.] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Ribeiro, Erlane M.; Pessoa, Andre L. S.; Kerbage, Saile C.] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Horovitz, Dafne D. G.] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Franca, Giovanny V. A.] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Garcia-Alix, Alfredo] Univ Barcelona, Inst Recerca Pediat St Joan Deu, Barcelona, Spain.
   [Doriqui, Maria J. R.] Hosp Infantil Dr Juvencio Mattos, Sao Luis, Brazil.
   [Wanderley, Hector Y. C.] Secretaria Estado Saude Espirito Santo, Vitoria, Brazil.
   [Sanseverino, Maria V. T.; Silva, Andre A.; Vianna, Fernanda S. L.] Hosp Clin Porto Alegre, Med Genet Serv, SIAT Brazilian Teratogen Informat Serv, Porto Alegre, RS, Brazil.
   [Neri, Joao I. C. F.; Schuler-Faccini, Lavinia] Univ Potiguar, Natal, RN, Brazil.
   [Pina-Neto, Joao M.] Univ Sao Paolo, Dept Genet, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Santos, Emerson S.] Univ Fed Sergipe, Lagarto, Brazil.
   [Vercosa, Islane] Ctr Aperfeicoamento Visual Ver Esperanca Renas CA, Fortaleza, Ceara, Brazil.
   [Cernach, Mirlene C. S. P.] Univ Fed Sao Paolo UNIFESP, Dept Med Genet, Sao Paulo, Brazil.
   [Medeiros, Paula F. V.] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Silva, Andre A.] UNIVATES Univ, Porto Alegre, RS, Brazil.
   [van der Linden, Vanessa] Assoc Assistencia Crianca Deficiente AACD, Recife, PE, Brazil.
   [Martelli, Celina M. T.; Cordeiro, Marli T.; Dhalia, Rafael] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Victora, Cesar G.] Univ Fed Pelotas, Grad Program Epidemiol, Pelotas, RS, Brazil.
   [Cavalcanti, Denise P.] Univ Campinas UNICAMP, Dept Med Genet, Campinas, SP, Brazil.
RP del Campo, M (corresponding author), UCSD, Dept Pediat, 9500 Gilman Dr,MC0828, La Jolla, CA 92093 USA.; Schuler-Faccini, L (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Hosp Clin Porto Alegre, Gen Med Serv, Caixa Postal 15053-Ag,Campus Agron, BR-91501970 Porto Alegre, RS, Brazil.
EM midelcampo@ucsd.edu; lavinia.faccini@ufrgs.br
RI SCHULER-FACCINI, LAVINIA/C-8309-2013; Victora, Cesar Gomes/Y-2455-2019;
   Vianna, Fernanda Sales Luiz/O-4337-2019; Garcia-Alix,
   Alfredo/AAG-4474-2019; Dhalia, Rafael/AAD-5432-2020; SANSEVERINO, MARIA
   TERESA V/G-3884-2017; de Franca, Giovanny Vinicius Araujo/L-7385-2018
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Victora, Cesar
   Gomes/0000-0002-2465-2180; SANSEVERINO, MARIA TERESA
   V/0000-0002-7404-2911; de Franca, Giovanny Vinicius
   Araujo/0000-0002-7530-2017; Pina Neto, Joao Monteiro
   de/0000-0003-2465-3527; Doriqui, Maria/0000-0002-7370-4004; Turchi
   Martelli, Celina Maria/0000-0002-2491-0688
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [306489/2010-4]; Brazilian Society of Medical Genetics
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Grant
   number: 306489/2010-4; Brazilian Society of Medical Genetics
CR Abdel-Salam GMH, 2008, AM J MED GENET A, V146A, P2929, DOI 10.1002/ajmg.a.32549
   Abdel-Salam GMH, 2015, AM J MED GENET A, V167, P1089, DOI 10.1002/ajmg.a.37010
   Alarcon A, 2013, J PEDIATR-US, V163, P828, DOI 10.1016/j.jpeds.2013.03.014
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   ALEXANDER IE, 1995, EUR J PEDIATR, V154, P654, DOI 10.1007/BF02079071
   Anbeek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081895
   Averill LW, 2015, SEMIN ULTRASOUND CT, V36, P476, DOI 10.1053/j.sult.2015.04.001
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bonnemann C. G., 2000, J MED GENET, V27, P273
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P., 2016, NEW ENGL J MED
   Brasil P., 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Capretti MG, 2014, BRAIN DEV-JPN, V36, P203, DOI 10.1016/j.braindev.2013.04.001
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M., 2016, CLIN INFECT DIS, P1
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Felice C, 2001, LANCET, V357, P1500, DOI 10.1016/S0140-6736(00)04661-4
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Furdon Susan A, 2003, Adv Neonatal Care, V3, P286, DOI 10.1016/j.adnc.2003.09.005
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   HANSON JW, 1976, J PEDIATR-US, V89, P54, DOI 10.1016/S0022-3476(76)80926-2
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   HUGHES HE, 1986, PEDIATRICS, V78, P85
   ILLINGWORTH RS, 1965, ARCH DIS CHILD, V40, P672, DOI 10.1136/adc.40.214.672
   JONES KL, 1980, PEDIATRICS, V66, P277
   Jones KL, 2013, SMITHS RECOGNIZABLE
   KIMURA S, 1986, ANAT REC, V216, P191, DOI 10.1002/ar.1092160211
   Kumar A, 2014, INT J DERMATOL, V53, P789, DOI 10.1111/ijd.12376
   Kurjak A, 2008, J MATERN-FETAL NEO M, V21, P675, DOI 10.1080/14767050802212166
   Leal C., 2016, REPROD HLTH, V13
   Leal MDC, 2020, BRAZ J OTORHINOLAR, V86, P513, DOI 10.1016/j.bjorl.2016.06.001
   Levine D., 2016, RADIOLOGY, V281
   Li H, 2016, CELL STEM CELL, V19, P1
   Machet L, 2010, AM J CLIN DERMATOL, V11, P269, DOI 10.2165/11530090-000000000-00000
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2010, AM J HUM GENET, V87, P882, DOI 10.1016/j.ajhg.2010.10.026
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Moore CA, 2016, JAMA PEDIAT
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   NISHI M, 1992, J CHILD NEUROL, V7, P400, DOI 10.1177/088307389200700413
   Paciorkowski AR, 2013, AM J MED GENET A, V161A, P1523, DOI 10.1002/ajmg.a.35969
   PAHO, 2015, NEUR SYNDR CONG MALF, P1
   Pessoa A., 2016, MMWR MORBIDITY MORTA
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rochelson B, 2006, ULTRASOUND OBST GYN, V27, P167, DOI 10.1002/uog.2629
   Rodrigues L. C., 2016, LANCET INFECT DIS, V3099, P1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Sadler T. W., 2015, LANGMANS MED EMBRYOL
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schram A, 2004, AM J MED GENET A, V127A, P172, DOI 10.1002/ajmg.a.20645
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SMITH DW, 1973, J PEDIATR-US, V83, P374, DOI 10.1016/S0022-3476(73)80258-6
   STEVENS CA, 1988, J PEDIATR-US, V113, P128, DOI 10.1016/S0022-3476(88)80546-8
   STRATTON RF, 1984, HUM GENET, V67, P193, DOI 10.1007/BF00273000
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verloes A., 1993, GENEREVIEWS, P1993
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Villo N, 2001, ARCH DIS CHILD-FETAL, V84, pF63, DOI 10.1136/fn.84.1.F63
   Zhang F., 2016, NUCLEIC ACIDS RES, V44
NR 90
TC 81
Z9 83
U1 1
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR
PY 2017
VL 173
IS 4
BP 841
EP 857
DI 10.1002/ajmg.a.38170
PG 17
WC Genetics & Heredity
SC Genetics & Heredity
GA EQ1US
UT WOS:000397855700003
PM 28328129
OA Bronze
DA 2020-12-08
ER

PT J
AU Oliveira, RAD
   Cordeiro, MT
   de Moura, PMMF
   Baptista, PNB
   Braga-Neto, UD
   Marques, ETD
   Gil, LHVG
AF dos Santos Oliveira, Renato Antonio
   Cordeiro, Marli Tenorio
   Mendes Freire de Moura, Patricia Muniz
   Bapti Baptista Filho, Paulo Neves
   Braga-Neto, Ulisses de Mendonca
   de Azevedo Marques Junior, Ernesto Torres
   Vega Gonzales Gil, Laura Helena
TI Serum cytokine/chemokine profiles in patients with dengue fever (DF) and
   dengue hemorrhagic fever (FHD) by using protein array
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Dengue fever; Dengue hemorrhagic fever; Cytokines protein array;
   Prognostic marker
ID CD40 LIGAND; GRO-ALPHA; CHEMOKINES; PATHOGENESIS; EXPRESSION; INFECTION;
   CYTOKINE; RESPONSES; COHORT
AB Background: DENV infection can induce different clinical manifestations varying from mild forms to dengue fever (DF) or the severe hemorrhagic fever (DHF). Several factors are involved in the progression from DF to DHF. No marker is available to predict this progression. Such biomarker could allow a suitable medical care at the beginning of the infection, improving patient prognosis.
   Objectives: The aim of this study was to compare the serum expression levels of acute phase proteins in a well-established cohort of dengue fever (DF) and dengue hemorrhagic fever (DHF) patients, in order to individuate a prognostic marker of diseases severity.
   Study design: The serum levels of 36 cytokines, chemokines and acute phase proteins were determined in DF and DHF patients and compared to healthy volunteers using a multiplex protein array and near infrared (NIR) fluorescence detection. Serum levels of IL-lra, IL-23, MIF, sCD40 ligand, IP-10 and GRO-alpha were also determined by ELISA.
   Results: At the early stages of infection, GRO-alpha and IP-10 expression levels were different in DF compared to DHF patients. Besides, GRO-a was positively correlated with platelet counts and IP-10 was negatively correlated with total protein levels.
   Conclusions: These findings suggest that high levels of GRO-alpha during acute DENV infection may be associated with a good prognosis, while high levels of IP-10 may be a warning sign of infection severity. (C) 2017 Elsevier B.V. All rights reserved.
C1 [dos Santos Oliveira, Renato Antonio; Cordeiro, Marli Tenorio; de Azevedo Marques Junior, Ernesto Torres; Vega Gonzales Gil, Laura Helena] Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisas Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
   [Mendes Freire de Moura, Patricia Muniz; Braga-Neto, Ulisses de Mendonca] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.
   [de Azevedo Marques Junior, Ernesto Torres] Univ Pittsburgh, Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Mendes Freire de Moura, Patricia Muniz] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Bapti Baptista Filho, Paulo Neves] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
RP Gil, LHVG (corresponding author), Ctr Pesquisas Aggeu Magalhaes CPqAM, Ave Prof Moraes Rego S-N Campus UFPE Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM laura@cpqam.fiocruz.br
RI Oliveira, Renato/A-2863-2013; Marques, Ernesto T. A/L-4967-2013;
   Oliveira, Renato/AAN-9394-2020; Oliveira, Renato/AAN-9879-2020
OI Oliveira, Renato/0000-0002-4044-0794; Marques, Ernesto T.
   A/0000-0003-3826-9358; Oliveira, Renato/0000-0002-4044-0794; Moura,
   Patricia/0000-0003-4259-388X
FU Brazilian Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [CNPq404453/2012-0]
FX This work was supported by the Brazilian Council for Scientific and
   Technological Development (CNPq) [Grant number CNPq404453/2012-0].
CR Aloui C, 2014, INT J MOL SCI, V15, P22342, DOI 10.3390/ijms151222342
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01
   Back A.T., 2013, INFECT ECOL EPIDEMIO, V3
   Bakaysa SL, 2014, MOL HUM REPROD, V20, P701, DOI 10.1093/molehr/gau028
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Boehlen F, 2001, TRANSFUSION MED, V11, P403, DOI 10.1046/j.1365-3148.2001.00340.x
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Chintakuntlawar AV, 2009, J INTERF CYTOK RES, V29, P657, DOI 10.1089/jir.2009.0006
   Conroy AL, 2015, INT J INFECT DIS, V40, P45, DOI 10.1016/j.ijid.2015.07.027
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Danese S, 2003, GUT, V52, P1435, DOI 10.1136/gut.52.10.1435
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Freedman JE, 2003, CIRC RES, V92, P944, DOI 10.1161/01.RES.0000074030.98009.FF
   Gleissner CA, 2012, CURR VASC PHARMACOL, V10, P563
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Johansson S, 2015, ALIMENT PHARM THER, V42, P1111, DOI 10.1111/apt.13389
   Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887
   Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010
   Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001
   Malavige GN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-341
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Moreno-Altamirano MMB, 2004, SCAND J IMMUNOL, V60, P631, DOI 10.1111/j.0300-9475.2004.01519.x
   Nischalke HD, 2012, J HEPATOL, V56, P758, DOI 10.1016/j.jhep.2011.10.019
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Persson-Dajotoy T, 2003, J IMMUNOL, V170, P5309, DOI 10.4049/jimmunol.170.10.5309
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Saito M, 2004, CLIN EXP IMMUNOL, V138, P299, DOI 10.1111/j.1365-2249.2004.02626.x
   Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125
   Sanz MJ, 2012, EUR J IMMUNOL, V42, P278, DOI 10.1002/eji.201142231
   Souza L.J., 2004, BRAZ J INFECT DIS, V8, P150
   Stanaway J.D., 2016, LANCET INFECT DIS
   Sun PF, 2006, J IMMUNOL, V177, P6497, DOI 10.4049/jimmunol.177.9.6497
   Tseng YL, 2010, CYTOKINE, V51, P195, DOI 10.1016/j.cyto.2010.05.002
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Ferreira RAX, 2015, ACTA TROP, V149, P138, DOI 10.1016/j.actatropica.2015.04.023
   Yamashita K, 2005, INFLAMMATION, V29, P17, DOI 10.1007/s10753-006-8964-4
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
NR 41
TC 9
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD APR
PY 2017
VL 89
BP 39
EP 45
DI 10.1016/j.jcv.2017.02.007
PG 7
WC Virology
SC Virology
GA EO6FW
UT WOS:000396788400009
PM 28242509
DA 2020-12-08
ER

PT J
AU Castanha, PMS
   Nascimento, EJM
   Braga, C
   Cordeiro, MT
   de Carvalho, OV
   de Mendonca, LR
   Azevedo, EAN
   Franca, RFO
   Dhalia, R
   Marques, ETA
AF Castanha, Priscila M. S.
   Nascimento, Eduardo J. M.
   Braga, Cynthia
   Cordeiro, Marli T.
   de Carvalho, Otavio V.
   de Mendonca, Leila R.
   Azevedo, Elisa A. N.
   Franca, Rafael F. O.
   Dhalia, Rafael
   Marques, Ernesto T. A.
TI Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; antibody dependent enhancement; dengue antibodies
AB Anti-Flavivirus antibodies are highly cross-reactive and may facilitate Zika virus (ZIKV) infection through the antibody-dependent enhancement (ADE) mechanism. We demonstrate that dengue-specific antibodies enhance the infection of a primary Brazilian ZIKV isolate in a Fc gamma RII-expressing K562 cell line. In addition, we demonstrate that serum samples from dengue-immune pregnant women enhanced ZIKV infection. These findings highlight the need for epidemiological studies and animal models to further confirm the role of ADE in the development of congenital and neurological complications associated with ZIKV infections.
C1 [Castanha, Priscila M. S.; Braga, Cynthia; Cordeiro, Marli T.; de Carvalho, Otavio V.; de Mendonca, Leila R.; Azevedo, Elisa A. N.; Franca, Rafael F. O.; Dhalia, Rafael; Marques, Ernesto T. A.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Inst Biol Sci, Fac Med Sci, Recife, PE, Brazil.
   [Braga, Cynthia] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [de Carvalho, Otavio V.] Univ Fed Vicosa, Vicosa, MG, Brazil.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Marques, ETA (corresponding author), Ctr Vaccine Res, 3501 5th Ave,9052 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.
EM marques@pitt.edu
RI amsalu, ribka/G-8780-2019; Dhalia, Rafael/AAD-5432-2020; Marques,
   Ernesto T. A/L-4967-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012; Braga, Maria Cynthia/A-8204-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Braga, Maria Cynthia/0000-0002-7862-6455;
   Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007
FU Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES)CAPES; Center for Vaccine Research, University of
   Pittsburgh; Fogarty Training Program [D43TW006592 Pitt GIDRTP/ 323 NIH];
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [482915/2010-2 MCT/CNPq-321 14/2010]; Strategic Program to
   Support Health Research/PAPES VI [322 407697/2012-8]; National Institute
   of Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19 AI56541]
FX This work was supported by the Brazilian Federal Agency for Support and
   Evaluation of Graduate Education (CAPES); Center for Vaccine Research,
   University of Pittsburgh; Fogarty Training Program (D43TW006592 Pitt
   GIDRTP/ 323 NIH to P. M. S. C.); National Council for Scientific and
   Technological Development (CNPq) (482915/2010-2 MCT/CNPq-321 14/2010);
   Strategic Program to Support Health Research/PAPES VI (322
   407697/2012-8); and the National Institute of Allergy and Infectious
   Diseases (U19 AI56541).
CR Braga C, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00095815
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
NR 15
TC 66
Z9 68
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 1
PY 2017
VL 215
IS 5
BP 781
EP 785
DI 10.1093/infdis/jiw638
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ER2PO
UT WOS:000398636500018
PM 28039355
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Xavier-Neto, J
   Carvalho, M
   Pascoalino, BD
   Cardoso, AC
   Costa, AMS
   Pereira, AHM
   Santos, LN
   Saito, A
   Marques, RE
   Smetana, JHC
   Consonni, SR
   Bandeira, C
   Costa, VV
   Bajgelman, MC
   de Oliveira, PSL
   Cordeiro, MT
   Gil, LHVG
   Pauletti, BA
   Granato, DC
   Leme, AFP
   Freitas, L
   de Freitas, CBMH
   Teixeira, MM
   Bevilacqua, E
   Franchini, K
AF Xavier-Neto, Jose
   Carvalho, Murilo
   Pascoalino, Bruno dos Santos
   Cardoso, Alisson Campos
   Sousa Costa, Angela Maria
   Macedo Pereira, Ana Helena
   Santos, Luana Nunes
   Saito, Angela
   Marques, Rafael Elias
   Costa Smetana, Juliana Helena
   Consonni, Silvio Roberto
   Bandeira, Carla
   Costa, Vivian Vasconcelos
   Bajgelman, Marcio Chaim
   Lopes de Oliveira, Paulo Sergio
   Cordeiro, Marli Tenorio
   Vega Gonzales Gil, Laura Helena
   Pauletti, Bianca Alves
   Granato, Daniela Campos
   Paes Leme, Adriana Franco
   Freitas-Junior, Lucio
   Moraes Holanda de Freitas, Carolina Borsoi
   Teixeira, Mauro Martins
   Bevilacqua, Estela
   Franchini, Kleber
TI Hydrocephalus and arthrogryposis in an immunocompetent mouse model of
   ZIKA teratogeny: A developmental study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM;
   VIRUS-INFECTION; MICE; EXPRESSION; INTERFACE; PREGNANCY; PLACENTA;
   BRAZIL; DAMAGE
AB The teratogenic mechanisms triggered by ZIKV are still obscure due to the lack of a suitable animal model. Here we present a mouse model of developmental disruption induced by ZIKV hematogenic infection. The model utilizes immunocompetent animals from wild-type FVB/NJ and C57BL/6J strains, providing a better analogy to the human condition than approaches involving immunodeficient, genetically modified animals, or direct ZIKV injection into the brain. When injected via the jugular vein into the blood of pregnant females harboring conceptuses from early gastrulation to organogenesis stages, akin to the human second and fifth week of pregnancy, ZIKV infects maternal tissues, placentas and embryos/fetuses. Early exposure to ZIKV at developmental day 5 (second week in humans) produced complex manifestations of anterior and posterior dysraphia and hydrocephalus, as well as severe malformations and delayed development in 10.5 days post-coitum (dpc) embryos. Exposure to the virus at 7.5-9.5 dpc induces intra-amniotic hemorrhage, widespread edema, and vascular rarefaction, often prominent in the cephalic region. At these stages, most affected embryos/fetuses displayed gross malformations and/or intrauterine growth restriction (IUGR), rather than isolated microcephaly. Disrupted conceptuses failed to achieve normal developmental landmarks and died in utero. Importantly, this is the only model so far to display dysraphia and hydrocephalus, the harbinger of microcephaly in humans, as well as arthrogryposis, a set of abnormal joint postures observed in the human setting. Late exposure to ZIKV at 12.5 dpc failed to produce noticeable malformations. We have thus characterized a developmental window of opportunity for ZIKV-induced teratogenesis encompassing early gastrulation, neurulation and early organogenesis stages. This should not, however, be interpreted as evidence for any safe developmental windows for ZIKV exposure. Late developmental abnormalities correlated with damage to the placenta, particularly to the labyrinthine layer, suggesting that circulatory changes are integral to the altered phenotypes.
C1 [Xavier-Neto, Jose; Carvalho, Murilo; Pascoalino, Bruno dos Santos; Cardoso, Alisson Campos; Sousa Costa, Angela Maria; Macedo Pereira, Ana Helena; Santos, Luana Nunes; Saito, Angela; Marques, Rafael Elias; Costa Smetana, Juliana Helena; Consonni, Silvio Roberto; Bajgelman, Marcio Chaim; Lopes de Oliveira, Paulo Sergio; Pauletti, Bianca Alves; Granato, Daniela Campos; Paes Leme, Adriana Franco; Freitas-Junior, Lucio; Moraes Holanda de Freitas, Carolina Borsoi; Franchini, Kleber] Brazilian Biosci Natl Lab, LNBio, Rua Giuseppe Maximo Scolfaro 10-000, Campinas, SP, Brazil.
   [Santos, Luana Nunes; Bandeira, Carla; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Sao Paulo, SP, Brazil.
   [Costa, Vivian Vasconcelos; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Lab Imunofarmacol, Ave Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
   [Cordeiro, Marli Tenorio; Vega Gonzales Gil, Laura Helena] Univ Fed Pernambuco, FIOCRUZ, CPqAM, Ave Prof Moraes Rego S-N,Cidade Univ, Recife, PE, Brazil.
RP Xavier-Neto, J; Franchini, K (corresponding author), Brazilian Biosci Natl Lab, LNBio, Rua Giuseppe Maximo Scolfaro 10-000, Campinas, SP, Brazil.
EM xavier.neto@lnbio.cnpem.br; kleber.franchini@lnbio.cnpem.br
RI Moraes, Carolina Borsoi/I-4408-2014; Carvalho, Murilo/B-7950-2012;
   Bandeira, Carla Leticia/U-8685-2017; Saito, Angela/AAY-9404-2020;
   Consonni, Silvio Roberto/R-9281-2019; Oliveira, Paulo/K-5588-2013;
   Bevilacqua, Estela/H-3354-2011; Costa, Vivian VVC/I-2499-2018; Marques,
   Rafael Elias/R-4890-2016; Bajgelman, Marcio/A-8146-2019; Saito,
   Angela/G-6107-2019; Freitas-Junior, Lucio H/C-8677-2011; Smetana,
   Juliana/J-5354-2013; Teixeira, Mauro M/A-4587-2008
OI Moraes, Carolina Borsoi/0000-0002-0689-2770; Carvalho,
   Murilo/0000-0001-6881-5271; Bandeira, Carla Leticia/0000-0002-0796-3462;
   Saito, Angela/0000-0003-4421-9226; Bevilacqua,
   Estela/0000-0003-4178-4625; Costa, Vivian VVC/0000-0002-0175-642X;
   Marques, Rafael Elias/0000-0002-6949-0947; Bajgelman,
   Marcio/0000-0003-3371-1143; Freitas-Junior, Lucio H/0000-0002-8904-7897;
   Smetana, Juliana/0000-0001-9827-7013; Teixeira, Mauro
   M/0000-0002-6944-3008; Consonni, Silvio Roberto/0000-0003-3149-021X
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   440379/2016-4]; Fundacao de Amparo a Pesquisa do Estado de Sao
   PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [FAPESP 2013/22695-0]; individual CNPq fellowship for Productivity in
   Science [CNPq 305537/2014-8]; FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2016/07632-0]
FX This study was partially funded by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq 440379/2016-4), Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2013/22695-0) and an
   individual CNPq fellowship for Productivity in Science to JXN (CNPq
   305537/2014-8). The results in the manuscript constitute preliminary
   evidence in an application to a FAPESP grant (Project 2016/07632-0). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bevilacqua E, 2014, PLACENTA, V35, pS51, DOI 10.1016/j.placenta.2013.10.015
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Creasy RK, 2009, CREASY RESNIKS MATER, pxvii
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davis GH, 2003, CLIN PERINATOL, V30, P531, DOI 10.1016/S0095-5108(03)00053-8
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Paula Freitas B, 2016, JAMA OPHTHALMOLOGY
   Doce N, 2016, BRAZIL SCI SEEK UNRA
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   DOWNS KM, 1993, DEVELOPMENT, V118, P1255
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hannon T, 2012, OBSTET GYNECOL, V120, P1345, DOI [10.1097/AOG.0b013e3182732b53, http://10.1097/AOG.0b013e3182732b53]
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Kauffman MH., 1994, ATLAS MOUSE DEV
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kwon YJ, 2014, ANTIVIR RES, V110, P20, DOI 10.1016/j.antiviral.2014.07.006
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MCLONE DG, 1989, PEDIATR NEUROSCI, V15, P1, DOI 10.1159/000120432
   Medina F, 2012, CURRENT PROTOCOLS MI
   Menkes JH, 2006, CHILD NEUROLOGY, pxiii
   Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1016/j.ctim.2007.01.003, 10.1002/0471142735.im1501s77]
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mouillet JF, 2014, INT J DEV BIOL, V58, P281, DOI 10.1387/ijdb.130349ys
   Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013
   OEHLER E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rajan AJ, 2000, J IMMUNOL, V164, P2120, DOI 10.4049/jimmunol.164.4.2120
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sav A, 2008, SPINA BIFIDA MANAGEM, P43
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-0429-ED, 10.5858/arpa.2016-04]
   Seaman WT, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-194
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Steel CD, 2008, LAB ANIMAL, V37, P26, DOI 10.1038/laban0108-26
   Stevens DB, 1999, J IMMUNOL, V162, P7501
   Theiler K., 1989, HOUSE MOUSE ATLAS EM
   Tonra James R, 2002, Cerebellum, V1, P57, DOI 10.1080/147342202753203096
   Ueno M, 2013, DEV CELL, V27, P373, DOI 10.1016/j.devcel.2013.10.019
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   XavierNeto J, 1996, AM J PHYSIOL-HEART C, V271, pH1407
   Yadav RK, 2014, J SCI INNOVATIVE RES, V3, P258
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110620
NR 53
TC 25
Z9 25
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2017
VL 11
IS 2
AR e0005363
DI 10.1371/journal.pntd.0005363
PG 29
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EN1AD
UT WOS:000395741700032
PM 28231241
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Ferreira, MLB
   de Brito, CAA
   Moreira, AJP
   Machado, MID
   Henriques-Souza, A
   Cordeiro, MT
   Marques, ETD
   Pena, LJ
AF Brito Ferreira, Maria Lucia
   Antunes de Brito, Carlos Alexandre
   Porto Moreira, Alvaro Jose
   de Morais Machado, Maria Iris
   Henriques-Souza, Adelia
   Cordeiro, Marli Tenorio
   de Azevedo Marques, Ernesto Torres, Jr.
   Pena, Lindomar Jose
TI Guillain-Barre Syndrome, Acute Disseminated Encephalomyelitis and
   Encephalitis Associated with Zika Virus Infection in Brazil: Detection
   of Viral RNA and Isolation of Virus during Late Infection
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; TRANSMISSION
AB Zika virus (ZIKV) emerged in Brazil in 2015, which was followed by an increase of Guillain-Barre Syndrome (GBS) cases. We report the epidemiological, clinical, and laboratory findings of the first six neurological cases associated with ZIKV in Brazil seen in a reference neurology hospital in Pernambuco, Brazil. In all cases, ZIKV was detected in serum and/or cerebrospinal fluid (CSF) samples. In this case series, four cases were defined as GBS, one as acute disseminated encephalomyelitis (ADEM) and the other as encephalitis. ZIKV was detected in all cases by RT-PCR and virus isolation was successful in two patients. The time between ZIKV acute symptoms and the development of neurological manifestations varied from 3 to 13 days and ZIKV was detected between 15 and 34 days after the initial symptoms. Our results highlight the need to include ZIKV as a differential diagnosis for neurological syndromes in countries with circulation of this arbovirus. Because the viremia in these patients appears to persist longer, direct diagnostic techniques such as RT-PCR and viral isolation should be considered even if it is after the acute phase of viral infection.
C1 [Brito Ferreira, Maria Lucia; Porto Moreira, Alvaro Jose; de Morais Machado, Maria Iris] Hosp Restorat, Dept Neurol, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Fed Univ Pernambuco UFPE, Dept Med, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Henriques-Souza, Adelia] Hosp Restauracao, Dept Pediat, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio; de Azevedo Marques, Ernesto Torres, Jr.; Pena, Lindomar Jose] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, FIOCRUZ, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Fed Univ Pernambuco UFPE, Dept Med, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM lucabrito@uol.com.br; cbritoc@gmail.com; alvarojpm@yahoo.com.br;
   irismorais@terra.com.br; adelianeuro@gmail.com; marli.tenorio@gmail.com;
   marques@pitt.edu; lindomar.pena@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
FU FACEPE; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX LJP is supported by grants from FACEPE and CNPq.
CR [Anonymous], 2016, ZIK EP UPD, P1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brazilian Ministry of Health, 2015, PROT AT SAUD RESP OC
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Control ECfDPa, 2014, RAP RISK ASS ZIK VIR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marli T, 2016, J INFECT DIS, V214, P1897
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2015, 1 DEC 2015 NEUR SYND
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 24
TC 25
Z9 26
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
BP 1405
EP 1409
DI 10.4269/ajtmh.17-0106
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5VW
UT WOS:000423222300020
PM 29140242
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Carvalho, MDCG
   Miranda, DD
   van der Linden, V
   Sobral, PF
   Ramos, RCF
   Rocha, MAW
   Cordeiro, MT
   de Alencar, SP
   Nunes, ML
AF Costa Gomes Carvalho, Maria Durce
   Miranda-Filho, Democrito de Barros
   van der Linden, Vanessa
   Sobral, Paula Fabiana
   Ferreira Ramos, Regina Coeli
   Wanderley Rocha, Maria Angela
   Cordeiro, Marli Tenorio
   de Alencar, Sarah Pinheiro
   Nunes, Magda Lahorgue
TI Sleep EEG patterns in infants with congenital Zika virus syndrome
SO CLINICAL NEUROPHYSIOLOGY
LA English
DT Article
DE EEG; Zika virus; Microcephaly; Newborns
ID PROGNOSTIC VALUE; FULL-TERM; ELECTROENCEPHALOGRAM; OUTBREAK; PRETERM;
   STATES
AB Objectives: To describe sleep EEG patterns of neonates, and infants with microcephaly due to congenital Zika virus (ZikV) syndrome.
   Methods: A descriptive case series of EEGs performed in a cohort of neonates with microcephaly monitored from October 2015 to February 2016 at a University Hospital in Northeast Brazil. Infants were investigated following an established protocol that includes EEG, neuroimaging studies, PCR and specific antibodies for ZikV detection.
   Results: EEGs (n = 37) from 37 infants were reviewed. Age at investigation varied from 1 to 5 months (mean = 2.6). Diffuse low voltage (n = 7), background asymmetry (n = 6) and modified hypsarrhythmia with or without burst-suppression (n = 11), were the main background abnormalities identified. Interictal EEG abnormalities were identified in 23 recordings (62%) and localized as focal frontal (n = 8) or occipital (n = 2) spikes/sharp, multifocal spikes/sharp waves (n = 13). Electrographic seizures without clinical manifestation were identified in 4 recordings and characterized as focal pseudo rhythmic pattern. Further findings were focal high amplitude slow waves that were registered in the frontal (n = 3) or occipital (n = 1) regions.
   Conclusions: Different types of EEG abnormalities were encountered with a predominance of interictal epileptogenic activity and hypsarrhythmia.
   Significance: Sleep EEGs in congenital Zika virus syndrome are consistently abnormal even in infants who have not yet developed epilepsy. (C) 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Costa Gomes Carvalho, Maria Durce; Miranda-Filho, Democrito de Barros; Sobral, Paula Fabiana; Ferreira Ramos, Regina Coeli; Wanderley Rocha, Maria Angela; de Alencar, Sarah Pinheiro] UPE Univ Pernambuco, Recife, PE, Brazil.
   [van der Linden, Vanessa] AACD, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, Aggeu Magalhaes Res Ctr, Dept Virol, Recife, PE, Brazil.
   [Nunes, Magda Lahorgue] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil.
   [Nunes, Magda Lahorgue] Brain Inst Rio Grande do Sul Brains, Av Ipiranga 6690,Bldg 63,103, BR-90610000 Porto Alegre, RS, Brazil.
RP Nunes, ML (corresponding author), Brain Inst Rio Grande do Sul Brains, Av Ipiranga 6690,Bldg 63,103, BR-90610000 Porto Alegre, RS, Brazil.
EM nunes@pucrs.br
OI Silva, Paula/0000-0001-9475-4732
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308590/2013-9]
FX MLN is researcher level 1D from the National Advisory Board (Conselho
   Nacional de Ciencia e Tecnologia - CNPq) - Brazil. DBMF received partial
   support from CNPq (process 308590/2013-9).
CR Besnard M, 2014, EURO SURVEILL
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   De Weerd AW, 1999, RECOMMENDATIONS PRAC, P149
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FOIS A, 1957, NEUROLOGY, V7, P703, DOI 10.1212/WNL.7.10.703
   HOLMES GL, 1993, J CLIN NEUROPHYSIOL, V10, P323, DOI 10.1097/00004691-199307000-00008
   HRACHOVY RA, 1984, EPILEPSIA, V25, P317, DOI 10.1111/j.1528-1157.1984.tb04195.x
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Khan RL, 2008, J CHILD NEUROL, V23, P144, DOI 10.1177/0883073807308711
   LOMBROSO CT, 1985, PEDIATRICS, V76, P52
   Lombroso CT, 1987, ELECTROENCEPHALOGRAP, P725
   Menache CC, 2002, PEDIATR NEUROL, V27, P93, DOI 10.1016/S0887-8994(02)00396-X
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, 2015, PROT AT SAUD RESP OC
   Mizrahi Eli M., 2001, Epilepsia, V42, P102
   Mlakar J, 2016, NEJM
   MONOD N, 1972, ELECTROEN CLIN NEURO, V32, P529, DOI 10.1016/0013-4694(72)90063-6
   Nunes ML, 2014, CLIN NEUROPHYSIOL, V125, P1121, DOI 10.1016/j.clinph.2013.10.049
   Nunes ML, 2005, ARQ NEURO-PSIQUIAT, V63, P14, DOI 10.1590/S0004-282X2005000100003
   Nunes ML, 1997, ELECTROEN CLIN NEURO, V102, P186, DOI 10.1016/S0013-4694(96)95191-7
   PAHO/WHO, 2015, EP AL NEUR SYNDR CON, P1
   Scher MS, 1988, J CHILD NEUROL, V3, P175
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stockard-Pope JE, 1992, ATLAS NEONATAL ELECT, P329
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Weisman O, 2011, PEDIATRICS, V128, P706, DOI 10.1542/peds.2011-0047
NR 28
TC 28
Z9 28
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1388-2457
EI 1872-8952
J9 CLIN NEUROPHYSIOL
JI Clin. Neurophysiol.
PD JAN
PY 2017
VL 128
IS 1
BP 204
EP 214
DI 10.1016/j.clinph.2016.11.004
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EO0GW
UT WOS:000396377300022
PM 27923187
DA 2020-12-08
ER

PT J
AU Cordeiro, MT
   Brito, CAA
   Pena, LJ
   Castanha, PMS
   Gil, LHVG
   Lopes, KGS
   Dhalia, R
   Meneses, JA
   Ishigami, AC
   Mello, LM
   Alencar, LXE
   Guarines, KM
   Rodrigues, LC
   Marques, ETA
AF Cordeiro, Marli T.
   Brito, Carlos A. A.
   Pena, Lindomar J.
   Castanha, Priscila M. S.
   Gil, Laura H. V. G.
   Lopes, Kennya G. S.
   Dhalia, Rafael
   Meneses, Jucille A.
   Ishigami, Ana C.
   Mello, Luisa M.
   Alencar, Liciana X. E.
   Guarines, Klarissa M.
   Rodrigues, Laura C.
   Marques, Ernesto T. A.
TI Results of a Zika Virus (ZIKV) Immunoglobulin M-Specific Diagnostic
   Assay Are Highly Correlated With Detection of Neutralizing Anti-ZIKV
   Antibodies in Neonates With Congenital Disease
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; microcephaly; congenital Zika; anti-ZIKV IgM; ZIKV
   antibodies
ID INFECTION; DENGUE; BRAZIL
AB Background. Usually, immunoglobulin M (IgM) serologic analysis is not sufficiently specific to confirm Zika virus (ZIKV) infection. However, since IgM does not cross the placenta, it may be a good marker of infection in neonates.
   Methods. We tested blood from 42 mothers and neonates with microcephaly and collected cerebrospinal fluid (CSF) specimens from 30 neonates. Molecular assays were performed for detection of ZIKV, dengue virus, and chikungunya virus; IgM enzyme-linked immunosorbent assays and plaque-reduction neutralization tests (PRNTs) were performed to detect ZIKV and dengue virus. No control neonates without microcephaly were evaluated.
   Results. Among neonates, all 42 tested positive for ZIKV IgM: 38 of 42 serum specimens (90.5%) were positive, whereas 30 of 30 CSF specimens (100%) were positive. ZIKV IgM-specific ELISA ratios, calculated as the mean optical density (OD) of the test sample when reacted on viral antigen divided by the mean OD of the negative control when reacted with viral antigen, were higher in CSF specimens (median, 14.9 [range, 9.3-16.4]) than in serum (median, 8.9 [range, 2.1-20.6]; P =.0003). All ZIKV IgM-positive results among the neonates were confirmed by the detection of neutralizing antibodies. Mother/neonate pairs with primary ZIKV infection had neutralizing antibodies to ZIKV only, and mother/neonate pairs with ZIKV virus infection secondary to infection with another flavivirus had high titers of neutralizing antibodies to ZIKV. Among secondary infections, median titers in serum were 2072 (range, 232-12 980) for mothers and 2730 (range, 398-12 980) for neonates (P < .0001), and the median titer in CSF was 93 (range, 40-578) among neonates (P < .0001).
   Conclusions. Among neonates, detection of ZIKV IgM in serum is confirmatory of congenital ZIKV infection, and detection of ZIKV IgM in CSF is confirmatory of neurologic infection. Therefore, we recommend testing for ZIKV IgM in neonates suspected of having congenital ZIKV infection and performance of PRNTs in equivocal cases.
C1 [Cordeiro, Marli T.; Pena, Lindomar J.; Castanha, Priscila M. S.; Gil, Laura H. V. G.; Lopes, Kennya G. S.; Dhalia, Rafael; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Dept Virol, Recife, PE, Brazil.
   [Brito, Carlos A. A.] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Meneses, Jucille A.; Ishigami, Ana C.; Mello, Luisa M.] Inst Med Integral Prof Fernando Figueira, Dept Pediat, Recife, PE, Brazil.
   [Alencar, Liciana X. E.; Guarines, Klarissa M.] Secretaria Saude Estado Pernambuco, Cent Publ Hlth Lab, Recife, PE, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Marques, ETA (corresponding author), FIOCRUZ PE, Dept Virol, Ctr Pesquisas Aggeu Magalhaes CPqAM, Av Prof Moraes Rego SN,Campus UFPE,Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM marques@pitt.edu
RI Marques, Ernesto T. A/L-4967-2013; Dhalia, Rafael/AAD-5432-2020; Da
   Silva Castanha, Priscila Mayrelle/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308
FU Brazilian government "Programa de pesquisas para o SUS / Fundacao de
   amparo a ciencia e tecnologia de PE" (PPSUS/FACEPE) [APQ: 0302-4.01/13];
   Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088]
   Funding Source: researchfish
FX This study was supported by the Brazilian government "Programa de
   pesquisas para o SUS / Fundacao de amparo a ciencia e tecnologia de PE"
   (PPSUS/FACEPE - grant APQ: 0302-4.01/13).
CR Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa160241412, DOI 10.1056/NEJMOA160241412]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthlmol.2016.0267, DOI 10.1001/JAMAOPHTHLMOL.2016.0267]
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   World Health Organization, INT HLTH REG EM COMM
NR 23
TC 28
Z9 28
U1 0
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2016
VL 214
IS 12
BP 1897
EP 1904
DI 10.1093/infdis/jiw477
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EJ3RT
UT WOS:000393130000018
PM 27923950
OA Green Accepted, Bronze
DA 2020-12-08
ER

PT J
AU van der Linden, V
   Pessoa, A
   Dobyns, W
   Barkovich, AJ
   van der Linden, H
   Rolim, EL
   Ribeiro, EM
   Leal, MD
   Coimbra, PPDA
   Araglo, MDVV
   Vercosa, I
   Ventura, C
   Ramos, RC
   Cruz, DDCS
   Cordeiro, MT
   Mota, VMR
   Dott, M
   Hillard, C
   Moore, CA
AF van der Linden, Vanessa
   Pessoa, Andre
   Dobyns, William
   Barkovich, A. James
   van der Linden, Helio, Jr.
   Rolim Filho, Epitacio Leite
   Ribeiro, Erlane Marques
   Leal, Mariana de Carvalho
   de Aratijo Coimbra, Pablo Picasso
   Viana Vasco Araglo, Maria de Fatima
   Vercosa, Islane
   Ventura, Camila
   Ramos, Regina Coeli
   Sousa Cruz, Danielle Di Cavalcanti
   Cordeiro, Marli Tenorio
   Ribeiro Mota, Vivian Maria
   Dott, Mary
   Hillard, Christina
   Moore, Cynthia A.
TI Description of 13 Infants Born During October 2015-January 2016 With
   Congenital Zika Virus Infection Without Microcephaly at Birth - Brazil
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [van der Linden, Vanessa; Rolim Filho, Epitacio Leite] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [Pessoa, Andre; Ribeiro, Erlane Marques] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Dobyns, William] Univ Washington, Seattle, WA 98195 USA.
   [Dobyns, William] Seattle Childrens Res Inst, Seattle, WA USA.
   [Barkovich, A. James] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [van der Linden, Helio, Jr.] Dr Henrique Santillo Rehabil Ctr, Goiania, Go, Brazil.
   [Rolim Filho, Epitacio Leite; Leal, Mariana de Carvalho] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Leal, Mariana de Carvalho] Agamenon Magalhaes Hosp HAM, Recife, PE, Brazil.
   [de Aratijo Coimbra, Pablo Picasso] Uniclin Diagnost Imagem, Fortaleza, Ceara, Brazil.
   [Viana Vasco Araglo, Maria de Fatima] Ctr Diagnost Multimagem, Recife, PE, Brazil.
   [Viana Vasco Araglo, Maria de Fatima] Mauricio de Nassau Univ, Recife, PE, Brazil.
   [Vercosa, Islane] Caviver Clin, Fortaleza, Ceara, Brazil.
   [Ventura, Camila; Ramos, Regina Coeli] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila; Sousa Cruz, Danielle Di Cavalcanti] Pernambucos Eye Hosp, Recife, PE, Brazil.
   [Ventura, Camila; Ramos, Regina Coeli] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [Ventura, Camila; Sousa Cruz, Danielle Di Cavalcanti] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Ribeiro Mota, Vivian Maria] Univ Fortaleza, Fortaleza, Ceara, Brazil.
   [Dott, Mary] CDC, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
   [Hillard, Christina; Moore, Cynthia A.] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
RP Moore, CA (corresponding author), CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM zikamch@cdc.gov
RI Dobyns, William/AAI-2768-2020; Ventura, Camila V/N-2654-2018
OI Dobyns, William/0000-0002-7681-2844; Ventura, Camila
   V/0000-0002-2927-4684; VAN DER LINDEN JUNIOR, HELIO/0000-0002-3123-2264
CR Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   de Araujo TV, 2016, LANCET INFECT DIS
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Moore CA, 2016, JAMA PEDIAT
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Wimalasundera Neil, 2016, Pract Neurol, V16, P184, DOI 10.1136/practneurol-2015-001184
NR 10
TC 194
Z9 198
U1 2
U2 19
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD DEC 2
PY 2016
VL 65
IS 47
BP 1343
EP 1348
DI 10.15585/mmwr.mm6547e2
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EE4GX
UT WOS:000389561400004
PM 27906905
OA Bronze
DA 2020-12-08
ER

PT J
AU de Araujo, TVB
   Rodrigues, LC
   Ximenes, RADA
   Miranda-Filho, DDB
   Montarroyos, UR
   de Melo, APL
   Valongueiro, S
   de Albuquerque, MDFPM
   Souza, WV
   Braga, C
   Filho, SPB
   Cordeiro, MT
   Vazquez, E
   Cruz, DDCS
   Henriques, CMP
   Bezerra, LCA
   Castanha, PMDS
   Dhalia, R
   Marques-Junior, ETA
   Martell, CMT
AF de Araujo, Thalia Velho Barreto
   Rodrigues, Laura Cunha
   Ximenes, Ricardo Arraes de Alencar
   Miranda-Filho, Democrito de Barros
   Montarroyos, Ulisses Ramos
   de Melo, Ana Paula Lopes
   Valongueiro, Sandra
   de Albuquerque, Maria de Fcitima Pessoa Militao
   Souza, Wayner Vieira
   Braga, Cynthia
   Filho, Sinval Pinto Brandao
   Cordeiro, Marli Tenorio
   Vazquez, Enrique
   Cruz, Danielle Di Cavalcanti Souza
   Henriques, Clciudio Maierovitch Pessanha
   Bezerra, Luciana Caroline Albuquerque
   Castanha, Priscila Mayrelle da Silva
   Dhalia, Rafael
   Marques-Junior, Ernesto Torres Azevedo
   Martelli, Celina Maria Turchi
TI Association between Zika virus infection and microcephaly in Brazil,
   January to May, 2016: preliminary report of a case-control study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID AMERICA; FETAL
AB Background The microcephaly epidemic, which started in Brazil in 2015, was declared a Public Health Emergency of International Concern by WHO in 2016. We report the preliminary results of a case-control study investigating the association between microcephaly and Zika virus infection during pregnancy.
   Methods We did this case-control study in eight public hospitals in Recife, Brazil. Cases were neonates with microcephaly. Two controls (neonates without microcephaly), matched by expected date of delivery and area of residence, were selected for each case. Serum samples of cases and controls and cerebrospinal fluid samples of cases were tested for Zika virus-specific IgM and by quantitative RT-PCR. Laboratory-confirmed Zika virus infection during pregnancy was defined as detection of Zika virus-specific IgM or a positive RT-PCR result in neonates. Maternal serum samples were tested by plaque reduction neutralisation assay for Zika virus and dengue virus. We estimated crude odds ratios (ORs) and 95% CIs using a median unbiased estimator for binary data in an unconditional logistic regression model. We estimated ORs separately for cases with and without radiological evidence of brain abnormalities.
   Findings Between Jan 15, 2016, and May 2, 2016, we prospectively recruited 32 cases and 62 controls. 24 (80%) of 30 mothers of cases had Zika virus infection compared with 39 (64%) of 61 mothers of controls (p=0.12). 13 (41%) of 32 cases and none of 62 controls had laboratory-confirmed Zika virus infection; crude overall OR 55.5 (95% CI 8.6-infinity); OR 113.3 (95% CI 14.5-infinity) for seven cases with brain abnormalities; and OR 24.7 (95% CI 2.9-infinity) for four cases without brain abnormalities.
   Interpretation Our data suggest that the microcephaly epidemic is a result of congenital Zika virus infection. We await further data from this ongoing study to assess other potential risk factors and to confirm the strength of association in a larger sample size.
C1 [de Araujo, Thalia Velho Barreto; Valongueiro, Sandra] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [Ximenes, Ricardo Arraes de Alencar] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [de Melo, Ana Paula Lopes] Univ Fed Pernambuco, Dept Community Hlth, Vitoria De Santo Antao, Brazil.
   [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Ximenes, Ricardo Arraes de Alencar; Miranda-Filho, Democrito de Barros; Montarroyos, Ulisses Ramos] Univ Pernambuco, Recife, PE, Brazil.
   [de Albuquerque, Maria de Fcitima Pessoa Militao; Souza, Wayner Vieira; Braga, Cynthia; Filho, Sinval Pinto Brandao; Cordeiro, Marli Tenorio; Castanha, Priscila Mayrelle da Silva; Marques-Junior, Ernesto Torres Azevedo; Martelli, Celina Maria Turchi] Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [de Albuquerque, Maria de Fcitima Pessoa Militao; Filho, Sinval Pinto Brandao; Cordeiro, Marli Tenorio; Castanha, Priscila Mayrelle da Silva; Dhalia, Rafael; Marques-Junior, Ernesto Torres Azevedo; Martelli, Celina Maria Turchi] Oswaldo Cruz Fdn Fiocruz, Recife, PE, Brazil.
   [Vazquez, Enrique] Pan Amer Hlth Org, Brasilia, DF, Brazil.
   [Cruz, Danielle Di Cavalcanti Souza] Inst Materno Infantil Fernando Figueira, Recife, PE, Brazil.
   [Henriques, Clciudio Maierovitch Pessanha] Fiocruz Brasilia, Brasilia, DF, Brazil.
   [Bezerra, Luciana Caroline Albuquerque] Pernambuco State Hlth Dept, Recife, PE, Brazil.
   [Martelli, Celina Maria Turchi] Univ Fed Goias, Dept Community Hlth, Goiania, Go, Brazil.
RP de Araujo, TVB (corresponding author), Univ Fed Pernambuco, BR-50670901 Recife, PE, Brazil.
RI Marques, Ernesto T. A/L-4967-2013; Braga, Maria Cynthia/A-8204-2013;
   Souza, Wayner V/H-3798-2013; Brandao-Filho, Sinval Pinto/AAP-4792-2020;
   Dhalia, Rafael/AAD-5432-2020; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012; Montarroyos, Ulisses/AAJ-7527-2020
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Brandao-Filho, Sinval
   Pinto/0000-0003-3768-2810; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
FU Brazilian Ministry of Health; Pan American Health Organization;
   Enhancing Research Activity in Epidemic Situations; Medical Research
   CouncilMedical Research Council UK (MRC) [MC_PC_15088] Funding Source:
   researchfish
FX Brazilian Ministry of Health, Pan American Health Organization, and
   Enhancing Research Activity in Epidemic Situations.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Brasil Ministerio da Satide, 2016, 32 BRAS MIN SAUD
   Brasil Ministerio da Saude, 2015, 12015 BRAS MIN SAUD
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Pan American Health Organization World Health Organization, 2015, EP AL NEUR SYNDR CON
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   U.S. Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   University of Calgary, FENT PRET GROWTH CHA
   WHO, 2016, WHOZIKVMOC163REV3WHO
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, SIT REP ZIK VIR MICR, P1
   World Health Organization (WHO), 2016, SCREEN ASS MAN NEON
NR 39
TC 191
Z9 196
U1 0
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD DEC
PY 2016
VL 16
IS 12
BP 1356
EP 1363
DI 10.1016/S1473-3099(16)30318-8
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA EC3YK
UT WOS:000388062800045
PM 27641777
OA Bronze, Green Accepted
DA 2020-12-08
ER

PT J
AU Argolo, AFLDE
   Feres, VCD
   Cordeiro, MT
   da Silveira, LA
   Guilarde, AO
   Marques, ETD
   de Souza, WV
   Martelli, CMT
AF Lopes de Teive e Argolo, Angela Ferreira
   de Rezende Feres, Valeria Christina
   Cordeiro, Marli Tenorio
   da Silveira, Lucimeire Antonelli
   Guilarde, Adriana Oliveira
   de Azevedo Marques, Ernesto Torres, Jr.
   de Souza, Wayner Vieira
   Turchi Martelli, Celina Maria
TI High frequency of pre-existing neutralizing antibody responses in
   patients with dengue during an outbreak in Central Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue virus; Neutralizing antibody; Dengue fever; Brazil
ID PLAQUE-REDUCTION NEUTRALIZATION; ORIGINAL ANTIGENIC SIN;
   VIRUS-INFECTIONS; SEROTYPES; ASSAY
AB Background: This study aims to identify dengue neutralizing antibody response in patients with dengue from a well-characterized cohort during an outbreak in central Brazil, 2012-2013.
   Methods: We analyzed paired samples from 40 patients with severe dengue and 20 patients with dengue. Eligibility criteria were: IgM, NS1Ag and/or RT-PCR positivity and positive IgG result. Plaque reduction neutralization test (PRNT50) from DENV-1 to DENV-4 was performed to identify serotype-specific NAbs response. An infecting serotype was defined as >= 4-fold increase in DENV NAbs in paired samples. Monotypic response was classified as PRNT50 >= 1/20 to only one DENV serotype, and multitypic response was considered to be PRNT50 >= 1/20 to two or more serotypes simultaneously.
   Results: Patients were mainly adults. Virological dengue infection was confirmed by RT-PCR: DENV-4 (n = 14) and DENV-1 (n = 10). Forty-four out of 60 (73.3 %) patients had NAbs to DENV-4, DENV-1(68.3 %), DENV-2 (68.3 %) and DENV-3 (61.6 %) respectively. Fifteen percent of the cases presented monotypic response, whereas 85 % had multitypic response. DENV-4 infected-patients presented the greatest difference in PRNT50 titers compared with other serotypes. Pre-existing DENV NAbs was not correlated with disease severity. This was the first time that DENV-4 was implicated in an epidemic in the region.
   Conclusion: Our data indicates high exposure of multiple DENV serotypes in all age groups in the pre-dengue vaccine era and also previous to Zika virus introduction in Brazil.
C1 [Lopes de Teive e Argolo, Angela Ferreira; da Silveira, Lucimeire Antonelli; Guilarde, Adriana Oliveira; Turchi Martelli, Celina Maria] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Rua 235,St Univ, BR-74605050 Goiania, Go, Brazil.
   [Lopes de Teive e Argolo, Angela Ferreira] Secretaria Estadual Saude Goias LACEN GO, Publ Hlth Lab, Av Contorno 3-556, BR-74853120 Goiania, Go, Brazil.
   [de Rezende Feres, Valeria Christina] Univ Fed Goias, Coll Pharm, Av Univ, BR-74605220 Goiania, Go, Brazil.
   [Cordeiro, Marli Tenorio; de Azevedo Marques, Ernesto Torres, Jr.; de Souza, Wayner Vieira; Turchi Martelli, Celina Maria] Fundacao Oswaldo, Ctr Pesquisas Aggeu Magalhaes, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
   [de Azevedo Marques, Ernesto Torres, Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Argolo, AFLDE (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Rua 235,St Univ, BR-74605050 Goiania, Go, Brazil.; Argolo, AFLDE (corresponding author), Secretaria Estadual Saude Goias LACEN GO, Publ Hlth Lab, Av Contorno 3-556, BR-74853120 Goiania, Go, Brazil.
EM angelafarmaceutica@hotmail.com
RI Souza, Wayner V/H-3798-2013; Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Lopes,
   Angela/0000-0002-7261-2079; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
FU Fundacao de Amparo a Pesquisa em Goias [FAPEG]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq]National Council for
   Scientific and Technological Development (CNPq) [PRONEX-REDE DENGUE
   73/2009, 201210267000729]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [306489/2010-4, 305281/2010-0]
FX This work was supported by the Fundacao de Amparo a Pesquisa em Goias
   [FAPEG] and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico [CNPq] [PRONEX-REDE DENGUE 73/2009 # 201210267000729].
   C.M.T.M. and W.V.S. received research scholarships [CNPq numbers
   306489/2010-4, 305281/2010-0].
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brazilian Institute of Geography and Statistics (IBGE), IBGE STAT SER
   Brazilian Ministry of Health, 2014, DENG CAS BRAZ MAJ RE
   Brazilian Ministry of Health, 2011, HLTH BRAZ 2010 HLTH, P157
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   Santos Cecília Luiza Simões dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P11, DOI 10.1590/S0036-46652003000100003
   GUBLER DJ, 1985, AM J TROP MED HYG, V34, P170, DOI 10.4269/ajtmh.1985.34.170
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   LAILLE M, 1991, J MED VIROL, V34, P51, DOI 10.1002/jmv.1890340109
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Pan American Health Organization/World Health Organization, 2014, COMM DIS HLTH AN HLT
   Rainwater-Lovett K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-233
   Feres VCR, 2006, J CLIN VIROL, V37, P179, DOI 10.1016/j.jcv.2006.07.004
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Salje H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002952
   Secretariat of Health of Goias, 2013, DENG B GOIAS 2013
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   van Panhuis WG, 2010, J INFECT DIS, V202, P1002, DOI 10.1086/656141
   VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   WHO, 2007, GUID PLAQ RED NEUTR
   WHO, 1997, DENG HAEM FEV DIAGN, P1
NR 35
TC 2
Z9 2
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD OCT 7
PY 2016
VL 16
AR 546
DI 10.1186/s12879-016-1867-6
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DY9HM
UT WOS:000385444500003
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Donald, CL
   Brennan, B
   Cumberworth, SL
   Rezelj, VV
   Clark, JJ
   Cordeiro, MT
   Franca, RFD
   Pena, LJ
   Wilkie, GS
   Filipe, AD
   Davis, C
   Hughes, J
   Varjak, M
   Selinger, M
   Zuvanov, L
   Owsianka, AM
   Patel, AH
   McLauchlan, J
   Lindenbach, BD
   Fall, G
   Sall, AA
   Biek, R
   Rehwinkel, J
   Schnettler, E
   Kohl, A
AF Donald, Claire L.
   Brennan, Benjamin
   Cumberworth, Stephanie L.
   Rezelj, Veronica V.
   Clark, Jordan J.
   Cordeiro, Marli T.
   de Oliveira Franca, Rafael Freitas
   Pena, Lindomar J.
   Wilkie, Gavin S.
   Filipe, Ana Da Silva
   Davis, Christopher
   Hughes, Joseph
   Varjak, Margus
   Selinger, Martin
   Zuvanov, Luiza
   Owsianka, Ania M.
   Patel, Arvind H.
   McLauchlan, John
   Lindenbach, Brett D.
   Fall, Gamou
   Sall, Amadou A.
   Biek, Roman
   Rehwinkel, Jan
   Schnettler, Esther
   Kohl, Alain
TI Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika
   Virus from Recife, Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RNA INTERFERENCE; DENGUE; INFECTION; COINFECTION; ACTIVATION; RESPONSES;
   ALIGNMENT; HISTORY; BAHIA; STATE
AB Background
   The outbreak of Zika virus (ZIKV) in the Americas has transformed a previously obscure mosquito-transmitted arbovirus of the Flaviviridae family into a major public health concern. Little is currently known about the evolution and biology of ZIKV and the factors that contribute to the associated pathogenesis. Determining genomic sequences of clinical viral isolates and characterization of elements within these are an important prerequisite to advance our understanding of viral replicative processes and virus-host interactions.
   Methodology/Principal findings
   We obtained a ZIKV isolate from a patient who presented with classical ZIKV-associated symptoms, and used high throughput sequencing and other molecular biology approaches to determine its full genome sequence, including non-coding regions. Genome regions were characterized and compared to the sequences of other isolates where available. Furthermore, we identified a subgenomic flavivirus RNA (sfRNA) in ZIKV-infected cells that has antagonist activity against RIG-I induced type I interferon induction, with a lesser effect on MDA-5 mediated action.
   Conclusions/Significance
   The full-length genome sequence including non-coding regions of a South American ZIKV isolate from a patient with classical symptoms will support efforts to develop genetic tools for this virus. Detection of sfRNA that counteracts interferon responses is likely to be important for further understanding of pathogenesis and virus-host interactions.
C1 [Donald, Claire L.; Brennan, Benjamin; Cumberworth, Stephanie L.; Rezelj, Veronica V.; Clark, Jordan J.; Wilkie, Gavin S.; Filipe, Ana Da Silva; Davis, Christopher; Hughes, Joseph; Varjak, Margus; Zuvanov, Luiza; Owsianka, Ania M.; Patel, Arvind H.; McLauchlan, John; Schnettler, Esther; Kohl, Alain] Univ Glasgow, MRC, Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Cordeiro, Marli T.; de Oliveira Franca, Rafael Freitas; Pena, Lindomar J.] Fundacao Oswaldo Cruz PE, Ctr Pesquisas Aggeu Magalhaes, Dept Virol, Campus UFPE Cidade Univ, Recife, PE, Brazil.
   [Selinger, Martin] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.
   [Selinger, Martin] Acad Sci Czech Republ, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic.
   [Lindenbach, Brett D.] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT USA.
   [Fall, Gamou; Sall, Amadou A.] Inst Pasteur, Pole Virol, Unite Arbovirus & Virus Fievres Hemorrag, Dakar, Senegal.
   [Biek, Roman] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland.
   [Rehwinkel, Jan] Univ Oxford, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford, England.
   [Rehwinkel, Jan] Univ Oxford, Radcliffe Dept Med, Oxford, England.
   [Schnettler, Esther] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
RP Kohl, A (corresponding author), Univ Glasgow, MRC, Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland.
EM alain.kohl@glasgow.ac.uk
RI Zuvanov, Luiza/AAF-2582-2020; Hughes, Joseph/B-7711-2009; Schnettler,
   Esther/AAV-8774-2020; Biek, Roman/AAT-8109-2020; Selinger,
   Martin/U-7604-2018; Brennan, Benjamin/AAJ-9850-2020; Donald,
   Claire/AAC-7556-2019
OI Hughes, Joseph/0000-0003-2556-2563; Biek, Roman/0000-0003-3471-5357;
   Selinger, Martin/0000-0002-5420-9702; Brennan,
   Benjamin/0000-0003-4707-726X; Donald, Claire/0000-0002-4370-0707;
   Varjak, Margus/0000-0003-2608-5148; Zuvanov, Luiza/0000-0003-0132-4894;
   Clark, Jordan/0000-0003-1790-7883; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Rehwinkel, Jan/0000-0003-3841-835X; da Silva
   Filipe, Ana Cristina/0000-0002-9442-2903
FU UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014, MR/N017552/1]; FACEPE (Fundacao de Amparo a Ciencia e
   Tecnologia de Pernambuco) [APQ-0044-2.11/16]; Czech Science Foundation
   (GACR)Grant Agency of the Czech Republic [15-03044S]; Czech Research
   Infrastructure for Systems Biology (C4SYS) [LM2015055]; Biotechnology
   and Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [1518059] Funding Source:
   researchfish; Medical Research CouncilMedical Research Council UK (MRC)
   [1653420, G0801822, MC_UU_12014/8, MC_UU_12014/1, MC_UU_12010/8,
   MR/N017552/1, MC_UU_12014/12] Funding Source: researchfish; NATIONAL
   CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Advancing Translational Sciences (NCATS)
   [UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863] Funding Source: NIH
   RePORTER
FX This study was funded by the UK Medical Research Council [(MC_UU_12014)
   (AK, ES, AHP, JM) and (MR/N017552/1) (AK, ES)], and FACEPE (Fundacao de
   Amparo a Ciencia e Tecnologia de Pernambuco, APQ-0044-2.11/16) (RFdOF,
   LJP). MS is supported by the Czech Science Foundation (GACR) [15-03044S]
   and the Czech Research Infrastructure for Systems Biology (C4SYS)
   [LM2015055]. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Brennan B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003922
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Carlos TS, 2009, J GEN VIROL, V90, P2147, DOI 10.1099/vir.0.012047-0
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Melo Freire C.C., 2015, BIORXIV, DOI DOI 10.1101/032839
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   Diamond MS, 2012, TRENDS IMMUNOL, V33, P522, DOI 10.1016/j.it.2012.05.008
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Grant A, CELL HOST M IN PRESS
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2014, EURO SURVEILL, V19
   Oshiumi H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00200
   Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, SIT REP ZIK VIR MICR, P1
   Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087
   Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 65
TC 89
Z9 90
U1 1
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2016
VL 10
IS 10
AR e0005048
DI 10.1371/journal.pntd.0005048
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EA5QH
UT WOS:000386676200035
PM 27706161
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-08
ER

PT J
AU de Brito, CAA
   Cordeiro, MT
AF Antunes de Brito, Carlos Alexandre
   Cordeiro, Marli Tenorio
TI One year after the Zika virus outbreak in Brazil: from hypotheses to
   evidence
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Zika; Microcephaly; Neurological cases; Epidemiology; Review
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; UNITED-STATES; EPIDEMIOLOGY;
   INFECTIONS; HISTORY
AB Zika virusis an arbovirus of the Flaviviridae family with two major strains, an Asian and an African strain. The main vectors involved in the transmission of Zika virus are the Aedes aegypti and Aedes albopictus mosquitoes. Despite its identification, discovered in 1947 in the Zika forest in Uganda, only isolated and sporadic occurrences of human infection were reported within a largely asymptomatic proportion of individuals. The first reported outbreak occurred in 2007 in the Yap Island, which belongs to the Federated States of Micronesia in the Pacific Ocean, and in French Polynesia, where high attack rates occurred and the first cases of associated Guillain-Barre syndrome were reported. From November 2014 to early 2015, the Northeast states of Brazil reported the first outbreaks of Zika virus infection, with laboratory confirmation of Zika virus circulation in April 2015. In the second quarter of 2015, the association between Zika virus infection and neurological symptoms was confirmed in adults. Moreover, in October 2015 a novel suspicion was raised based on clinical and epidemiological observations: that an association between Zika virus infection and neonatal microcephaly may exist. A year after the first reports on Zika virus in Brazil, many hypotheses and much evidence on the patterns of involvement of the disease and its complications have been produced, both in this country and others; other hypotheses still need to be clarified. This review is a synthesis of a new chapter in the history of medicine; it outlines the main results produced.
C1 [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Dept Virol, Ctr Pesquisa Aggeu Magalhaes, Recife, PE, Brazil.
RP de Brito, CAA (corresponding author), Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
EM cbritoc@gmail.com
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   [Anonymous], 2014, REP CRIT RAW MAT EU, P1
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dick GWA, 1952, T R SOC TROP MED HYG, V46
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Control and Prevention (ECDC), 2016, RAP RISK ASS ZIK VIR, P1
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jimenez Corona ME, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053.]
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio de Saude (MS), 2015, B EPIDEMIOL, V46, P1
   Ministry of Housing Urban Poverty Alleviation Government of India, 2015, PROT AT SAUD RESP OC, P1
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Organizacion Panamericana de la Salud, 2015, EP AL NEUR SYNDR CON, P1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization/World Health Organization, 2016, ZIK EP UPD, P1
   Panel on Antiretroviral Guidelines for Adults and Adolescents, 2015, GUIDELINES USE ANTIR, P1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Polynesie Francaise, 2014, SURV DENG ZIK POL FR, P6
   Public Health England, 2016, GUID ZIK VIR TRAV AD, P1
   Rabe IB, 2016, MMWR MORB MORTAL WKL, V65
   Reuters News Agency, 2016, BRAZ REP ZIK INF BLO, P6
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Secretaria de Saude de Pernambuco, 2015, CIRC FEBR ZIK VIR PE, P1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization(WHO), 2016, SIK SIT REP
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 22
Z9 22
U1 0
U2 15
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2016
VL 49
IS 5
BP 537
EP 543
DI 10.1590/0037-8682-0328-2016
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EB8RC
UT WOS:000387657500002
PM 27812646
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU El-Bacha, T
   Struchiner, CJ
   Cordeiro, MT
   Almeida, FCL
   Marques, ET
   Da Poian, AT
AF El-Bacha, Tatiana
   Struchiner, Claudio J.
   Cordeiro, Marli Tenorio
   Almeida, Fabio C. L.
   Marques, Ernesto Torres, Jr.
   Da Poian, Andrea T.
TI H-1 Nuclear Magnetic Resonance Metabolomics of Plasma Unveils Liver
   Dysfunction in Dengue Patients
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID NMR-SPECTROSCOPY; HUMAN-BLOOD; AMINO-ACID; SERUM; INFECTION; GLUTAMINE;
   URINE
AB Dengue, due to its global burden, is the most important arthropod-borne flavivirus disease, and early detection lowers fatality rates to below 1%. Since the metabolic resources crucial for viral replication are provided by host cells, detection of changes in the metabolic profile associated with disease pathogenesis could help with the identification of markers of prognostic and diagnostic importance. We applied H-1 nuclear magnetic resonance exploratory metabolomics to study longitudinal changes in plasma metabolites in a cohort in Recife, Brazil. To gain statistical power, we used innovative paired multivariate analyses to discriminate individuals with primary and secondary infection presenting as dengue fever (DF; mild) and dengue hemorrhagic fever (DHF; severe) and subjects with a nonspecific nondengue (ND) illness (ND subjects). Our results showed that a decrease in plasma low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) discriminated dengue virus (DENV)-infected subjects from ND subjects, and also, subjects with severe infection even presented a decrease in lipoprotein concentrations compared to the concentrations in subjects with mild infection. These results add to the ongoing discussion that the manipulation of lipid metabolism is crucial for DENV replication and infection. In addition, a decrease in plasma glutamine content was characteristic of DENV infection and disease severity, and an increase in plasma acetate levels discriminated subjects with DF and DHF from ND subjects. Several other metabolites shown to be altered in DENV infection and the implications of these alterations are discussed. We hypothesize that these changes in the plasma metabolome are suggestive of liver dysfunction, could provide insights into the underlying molecular mechanisms of dengue virus pathogenesis, and could help to discriminate individuals at risk of the development of severe infection and predict disease outcome.
   IMPORTANCE
   Dengue, due to its global burden, is the most important mosquito-borne viral disease. There is no specific treatment for dengue disease, and early detection lowers fatality rates to below 1%. In this study, we observed the effects of dengue virus infection on the profile of small molecules in the blood of patients with mild and severe infection. Variations in the profiles of these small molecules reflected the replication of dengue virus in different tissues and the extent of tissue damage during infection. The results of this study showed that the molecules that changed the most were VLDL, LDL, and amino acids. We propose that these changes reflect liver dysfunction and also that they can be used to discriminate subjects with mild dengue from those with severe dengue.
C1 [El-Bacha, Tatiana; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
   [Struchiner, Claudio J.] Fundacao Oswaldo Cruz, Dept Doencas Endem Samuel Pessoa, Rio De Janeiro, RJ, Brazil.
   [Cordeiro, Marli Tenorio; Marques, Ernesto Torres, Jr.] Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, RJ, Brazil.
   [Marques, Ernesto Torres, Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [El-Bacha, Tatiana] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, RJ, Brazil.
RP El-Bacha, T; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
EM tatiana@nutricao.ufrj.br; dapoian@bioqmed.ufrj.br
RI Marques, Ernesto T. A/L-4967-2013; Da Poian, Andrea T./V-1699-2019;
   Struchiner, Claudio J/M-9360-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Struchiner, Claudio
   J/0000-0003-2114-847X; El-Bacha, Tatiana/0000-0003-0809-0218; Da Poian,
   Andrea/0000-0002-3969-704X
FU MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [306669/2013-7, 483229/2010-5]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/201.571/2014, E-26/201.167/2014, E-26/110.092/2013];
   Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS)
   [AMS-NAF2-ElBacha] Funding Source: researchfish
FX This work, including the efforts of Andrea T. Da Poian, was funded by
   MCTI vertical bar Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (306669/2013-7). This work, including the efforts of
   Tatiana El-Bacha, was funded by MCTI vertical bar Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (483229/2010-5). This
   work, including the efforts of Claudio J. Struchiner, was funded by MCTI
   vertical bar Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq). This work, including the efforts of Tatiana
   El-Bacha, was funded by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). This work, including the efforts of Tatiana
   El-Bacha, was funded by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ) (E-26/201.571/2014). This
   work, including the efforts of Andrea T. Da Poian, was funded by
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) (E-26/201.167/2014 and E-26/110.092/2013). This work,
   including the efforts of Claudio J. Struchiner, was funded by Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ).
CR Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376
   BELL JD, 1987, FEBS LETT, V215, P311, DOI 10.1016/0014-5793(87)80168-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Birungi G, 2010, J PROTEOME RES, V9, P6523, DOI 10.1021/pr100727m
   Biswas HH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003904
   Brasier AR, 2015, J CLIN VIROL, V64, P97, DOI 10.1016/j.jcv.2015.01.011
   Brazil Ministry of Health, 2015, B EPIDEMIOLOGICO, V48
   Cassol E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-203
   Chambers JW, 2010, J VIROL, V84, P1867, DOI 10.1128/JVI.02123-09
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373
   Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c
   Dona AC, 2014, ANAL CHEM, V86, P9887, DOI 10.1021/ac5025039
   DUNHAM CM, 1991, CIRC SHOCK, V35, P78
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Fontaine KA, 2014, J VIROL, V88, P4366, DOI 10.1128/JVI.03134-13
   Gonzalez I., 2011, MIXOMICS OMICS DATA
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Higa LM, 2008, BBA-PROTEINS PROTEOM, V1784, P1607, DOI 10.1016/j.bbapap.2008.06.015
   Ishida H, 2013, BIOCHEM BIOPH RES CO, V437, P127, DOI 10.1016/j.bbrc.2013.06.051
   Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515
   Lu CJ, 2012, TALANTA, V100, P51, DOI 10.1016/j.talanta.2012.07.076
   Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366
   Munshi SU, 2011, J VIRAL HEPATITIS, V18, pE591, DOI 10.1111/j.1365-2893.2011.01488.x
   Nascimento EJM, 2014, CRIT REV IMMUNOL, V34, P227, DOI 10.1615/CritRevImmunol.2014010212
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892
   Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401
   Newsholme F, 1999, J NUTR BIOCHEM, V10, P316
   Nie CY, 2014, J VIRAL HEPATITIS, V21, P53, DOI 10.1111/jvh.12122
   Pando-Robles V, 2014, J PROTEOMICS, V111, P16, DOI 10.1016/j.jprot.2014.06.029
   Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234
   Pinto J, 2015, J PROTEOME RES, V14, P1263, DOI 10.1021/pr5011982
   R Core Team, 2015, R LANG ENV STAT COMP
   Saito T, 2013, METABOLISM, V62, P1577, DOI 10.1016/j.metabol.2013.07.002
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Shahfiza N, 2015, ASIAN PAC J TROP MED, V8, P452, DOI [10.1016/S1995-7645(14)60359-X, 10.1016/j.apjtm.2015.05.012]
   Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003
   Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251
   TOLLINGER CD, 1979, CLIN CHEM, V25, P1787
   van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539
   Vastag L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002124
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Voge NV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004449
   Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z
   Wijeyesekera A, 2012, J PROTEOME RES, V11, P2224, DOI 10.1021/pr2010154
   World Health Organization, 2011, COMPR GUID PREV CONT
NR 50
TC 15
Z9 15
U1 2
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2016
VL 90
IS 16
BP 7429
EP 7443
DI 10.1128/JVI.00187-16
PG 15
WC Virology
SC Virology
GA DU6EJ
UT WOS:000382306500032
PM 27279613
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Castanha, PMS
   Braga, C
   Cordeiro, MT
   Souza, AI
   Silva, CD
   Martelli, CMT
   van Panhuis, WG
   Nascimento, EJM
   Marques, ETA
AF Castanha, Priscila M. S.
   Braga, Cynthia
   Cordeiro, Marli T.
   Souza, Ariani I.
   Silva, Claudeir D., Jr.
   Martelli, Celina M. T.
   van Panhuis, Willem G.
   Nascimento, Eduardo J. M.
   Marques, Ernesto T. A.
TI Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and
   Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE dengue; placental transfer; IgG; newborn; antibody dependent enhancement
ID TRANSPLACENTAL TRANSFER; HEMORRHAGIC-FEVER; IGG SUBCLASSES; LIFE;
   PATHOGENESIS; PREGNANCY; MEASLES; DECAY; FCRN
AB Background. Maternal-fetal transferred dengue virus ( DENV)-specific antibodies have been implicated in the immunopathogenesis of dengue during infancy. Methods. A prospective birth cohort was established in a dengue-endemic area in the Northeast Region of Brazil. DENV-specific immunoglobulin G ( IgG) and DENV-1-4 serotype-specific neutralizing antibody ( NAb) levels were assessed in 376 paired maternal and umbilical cord blood samples. The kinetics of enhancing activity by maternally acquired DENV antibodies was determined in serum samples from children enrolled in the cohort. Results. Mothers were mostly immune to DENV-3 alone ( 53.7%) or combined with DENV-4 ( 30.6%). Levels of DENV-specific IgG, DENV-3 NAbs, and DENV-4 NAbs were significantly higher in newborns than in their respective mothers. Mothers immune to a single serotype transferred greater levels of DENV-specific IgG ( P =.02) and DENV-3 NAbs ( P =.04) than mothers immune to multiple DENV serotypes. Maternally acquired DENV-3 NAbs disappeared in > 90% of the children by the age of 4 months. The peak enhancing activity was detected by the age of 2 months ( P <.0001) and rapidly declined by the age of 4 months ( P =.0035). Conclusions. Unlike Asian infants, the enhancing activity of DENV infection by maternally transferred DENV antibodies occurs at earlier ages in Brazilian children. These findings might explain the low occurrence of severe dengue among infants in our setting.
C1 [Castanha, Priscila M. S.; Braga, Cynthia; Cordeiro, Marli T.; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Braga, Cynthia; Souza, Ariani I.; Silva, Claudeir D., Jr.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Martelli, Celina M. T.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.
   [van Panhuis, Willem G.] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Nascimento, EJM (corresponding author), Ctr Vaccine Res, 3501 5th Ave,9052 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.
EM ejmn@pitt.edu
RI Souza, Ariani I/C-1568-2015; de Souza, Ariani Impieri/AAR-6884-2020;
   Braga, Maria Cynthia/A-8204-2013; Van Panhuis, Willem/S-5495-2019;
   Marques, Ernesto T. A/L-4967-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012
OI Souza, Ariani I/0000-0002-7917-5983; de Souza, Ariani
   Impieri/0000-0002-7917-5983; Braga, Maria Cynthia/0000-0002-7862-6455;
   Van Panhuis, Willem/0000-0002-7278-9982; Marques, Ernesto T.
   A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Dias da Silva Junior,
   Claudeir/0000-0002-5216-5697
FU National Council for Scientific and Technological Development of the
   Brazilian government [482915/2010-2 MCT/CNPq-14/2010]; Strategic Program
   to Support Health Research/PAPES VI [407697/2012-8]; Fogarty Training
   Program [D43TW006592 Pitt GIDRTP/NIH]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW006592, D43TW006592, D43TW006592, D43TW006592, D43TW006592,
   D43TW006592, D43TW006592, D43TW006592, D43TW006592, D43TW006592] Funding
   Source: NIH RePORTER
FX This work was supported by the National Council for Scientific and
   Technological Development of the Brazilian government (grant
   482915/2010-2 MCT/CNPq-14/2010), the Strategic Program to Support Health
   Research/PAPES VI (grant 407697/2012-8), and the Fogarty Training
   Program (grant D43TW006592 Pitt GIDRTP/NIH to P. M. S. C.).
CR Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00095815
   Brazilian Ministry of Health. Sistema de Informacao sobre Agravos de Notificacao (SINAN), 2012, SIST INF AGR NOT SIN
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845
   deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077
   Goncalves G, 1999, EPIDEMIOL INFECT, V122, P273, DOI 10.1017/S0950268899002046
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010
   Khamim K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003396
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/j.jcv.2014.02.009, 10.1016/J.JCV.2014.02.009]
   Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808
   Okoko JB, 2001, TROP MED INT HEALTH, V6, P529, DOI 10.1046/j.1365-3156.2001.00741.x
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Scott S, 2007, CLIN INFECT DIS, V45, P1417, DOI 10.1086/522989
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   THEIN S, 1993, J MED VIROL, V40, P102, DOI 10.1002/jmv.1890400205
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   van Panhuis WG, 2011, AM J TROP MED HYG, V85, P355, DOI 10.4269/ajtmh.2011.11-0125
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
NR 33
TC 19
Z9 19
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 15
PY 2016
VL 214
IS 2
BP 265
EP 272
DI 10.1093/infdis/jiw143
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DR3SM
UT WOS:000379822900014
PM 27056951
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Figueiredo, GG
   Cezar, RD
   Freire, NM
   Teixeira, VG
   Baptista, P
   Cordeiro, M
   Carmo, RF
   Vasconcelos, LRS
   Moura, P
AF Figueiredo, Gabriela G.
   Cezar, Renata D.
   Freire, Naishe M.
   Teixeira, Vanessa G.
   Baptista, Paulo
   Cordeiro, Marli
   Carmo, Rodrigo F.
   Silva Vasconcelos, Luydson Richardson
   Moura, Patricia
TI Mannose-binding lectin gene (MBL2) polymorphisms related to the
   mannose-binding lectin low levels are associated to dengue disease
   severity
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE Dengue; Mannose-Binding Lectin; Polymorphism; MBL2 gene
ID HEMORRHAGIC-FEVER; ANTIBODY-RESPONSE; VIRUS-INFECTION; PROTEIN GENE;
   COMPLEMENT; DEFICIENCY; RECOGNITION; VARIANTS; ADULTS; CELLS
AB Dengue is the main arbovirosis in the tropical and subtropical areas of the world. The majority of infected individuals present an asymptomatic outcome while others progress to dengue fever (DF) or dengue haemorrhagic fever (DHF). Dengue infection evolution to severe outcomes is in part, related to innate immunity response. The MBL2 gene encodes for a pathogen recognition pattern molecule, the mannose-binding lectin (MBL). Variant alleles at promoter and structural regions of the MBL2 are related to serum MBL levels and function. Due to the important inflammatory modulation role of MBL, MBL2 polymorphisms could influence dengue progression. Therefore, this study investigated associations of MBL2 polymorphisms and serum MBL levels in patients with dengue. Genotyping of promoter and structural regions of MBL2 was performed by real-time PCR using Taqman (R) probes in 161 patients presenting DF or DHF outcome. For the serum MBL determination a commercial ELISA kit was used. The variant OO genotype and O allele were associated with DHF (p = 0.008 and p = 0.009 respectively). Haplotypes correlated to MBL low levels were associated with DHF (p = 0.04). Our results support the hypothesis that patients carrying genotypes or haplotypes of low production of MBL would be more susceptible to DHF. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Figueiredo, Gabriela G.; Cezar, Renata D.; Teixeira, Vanessa G.; Moura, Patricia] Univ Pernambuco UPE, Inst Ciencias Biol, Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
   [Freire, Naishe M.; Baptista, Paulo] Univ Pernambuco UPE, Fac Ciencias Med, Recife, PE, Brazil.
   [Cordeiro, Marli; Silva Vasconcelos, Luydson Richardson] CPqAM FIOCRUZ PE, Recife, PE, Brazil.
   [Carmo, Rodrigo F.] Univ Fed Vale Sao Francisco UNIVASF, Colegiado Farm, Petrolina, PE, Brazil.
   [Silva Vasconcelos, Luydson Richardson] IFP, Recife, PE, Brazil.
RP Moura, P (corresponding author), Univ Pernambuco UPE, Inst Ciencias Biol, Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
EM patricia.moura@upe.br
RI Carmo, Rodrigo Feliciano do/V-9795-2017; Moura, Patricia M M
   F/H-7233-2018; Vasconcelos, Luydson/AAC-4907-2020
OI Carmo, Rodrigo Feliciano do/0000-0001-9601-6995; Vasconcelos,
   Luydson/0000-0002-1625-3358; Cezar, Renata/0000-0002-7278-5682;
   Figueiredo, Carmem Gabriela Gomes/0000-0003-2297-2305; Moura,
   Patricia/0000-0003-4259-388X
FU Founding Agency for Science of Pernambuco (FACEPE), Brazil
FX The authors wish to thank the Founding Agency for Science of Pernambuco
   (FACEPE), Brazil for providing the funds and the multidisciplinary team
   from Liver Institute of Pernambuco and Laboratory of Molecular Biology
   of Virus for their help in collection and storage of samples and for the
   support in the molecular analysis.
CR Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005
   Alagarasu K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-86
   Alipour A, 2011, ATHEROSCLEROSIS, V215, P125, DOI 10.1016/j.atherosclerosis.2010.11.041
   Avirutnan P, 2011, MBIO, V2, DOI 10.1128/mBio.00276-11
   Boldt ABW, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-38
   Dean MM, 2006, MOL IMMUNOL, V43, P950, DOI 10.1016/j.molimm.2005.06.023
   Espada-Murao Lyre Anni, 2011, Trop Med Health, V39, P53, DOI 10.2149/tmh.2011-S06
   Fang X, 2012, FEMS IMMUNOL MED MIC, V66, P134, DOI 10.1111/j.1574-695X.2012.00995.x
   Fuchs A, 2010, CELL HOST MICROBE, V8, P186, DOI 10.1016/j.chom.2010.07.007
   Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283
   Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805
   Gupta K, 2008, INDIAN J MED RES, V127, P431
   Guttormsen HK, 2009, CLIN IMMUNOL, V130, P264, DOI 10.1016/j.clim.2008.09.012
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709
   Litzman J, 2008, CLIN EXP IMMUNOL, V153, P324, DOI 10.1111/j.1365-2249.2008.03700.x
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892
   Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888
   Nauta AJ, 2003, TRENDS IMMUNOL, V24, P148, DOI 10.1016/S1471-4906(03)00030-9
   Pagh R, 2008, FEBS J, V275, P515, DOI 10.1111/j.1742-4658.2007.06218.x
   Presanis JS, 2003, BIOCHEM SOC T, V31, P748, DOI 10.1042/BST0310748
   Roos A, 2004, EUR J IMMUNOL, V34, P2589, DOI 10.1002/eji.200324401
   SASTRY K, 1989, J EXP MED, V170, P1175, DOI 10.1084/jem.170.4.1175
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stephens HAF, 2010, CURR TOP MICROBIOL, V338, P99, DOI 10.1007/978-3-642-02215-9_8
   Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014
   Takahashi K, 2011, EXPERT REV ANTI-INFE, V9, P1179, DOI [10.1586/ERI.11.136, 10.1586/eri.11.136]
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
   WHO, 1997, CLIN DIAGN
NR 33
TC 12
Z9 12
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
EI 1879-1166
J9 HUM IMMUNOL
JI Hum. Immunol.
PD JUL
PY 2016
VL 77
IS 7
BP 571
EP 575
DI 10.1016/j.humimm.2016.05.006
PG 5
WC Immunology
SC Immunology
GA DS2PR
UT WOS:000380626500007
PM 27180198
DA 2020-12-08
ER

PT J
AU Albuquerque, MDPM
   Araujo, TVB
   Barkokebas, A
   Bezerra, LCA
   Braga, C
   Brandao, SP
   Brito, CAA
   Cabral, RG
   Carneiro, AR
   Carvalho, MDCG
   Cordeiro, MT
   Costa, I
   Cunha, ASC
   Cruz, DDCS
   Dhalia, R
   Hazin, AN
   Katz, L
   Marques, ETA
   Martelli, CMT
   Miranda, DB
   Moraes, MMC
   Mota, C
   Van der Linden, V
   Ramos, RCF
   Rocha, MAW
   Silva, PFS
   Souza, WV
   Van der Linden, A
   Ximenes, RAA
   Batista, JDL
   Vazquez, E
   Coelho, GE
   Cortez-Escalante, JJ
   Duarte, E
   Henriques, CMP
   Melo, CFCA
   Oliveira, WK
   Schuler-Faccini, L
   Aldighieri, S
   Almiron, M
   Mendez-Rico, J
   Ramon-Pardo, P
   Rodrigues, LC
AF Albuquerque, Maria de Fatima P. M.
   Araujo, Thalia V. B.
   Barkokebas, Andreza
   Bezerra, Luciana Caroline A.
   Braga, Cynthia
   Brandao-Filho, Sinval P.
   Brito, Carlos Alexandre A.
   Cabral, Renata G.
   Carneiro, Adriana R.
   Carvalho, Maria Durce C. G.
   Cordeiro, Marli T.
   Costa-, Iran, Jr.
   Cunha, Adriana S. C.
   Cruz, Danielle D. C. S.
   Dhalia, Rafael
   Hazin, Adriano N.
   Katz, Leticia
   Marques, Ernesto T. A.
   Martelli, Celina Maria T.
   Miranda-Filho, Democrito B.
   Moraes, Monica Maria C.
   Mota, Cristina
   Van der Linden, Vanessa
   Ramos, Regina C. F.
   Rocha, Maria Angela W.
   Silva, Paula Fabiana S.
   Souza, Wayner V.
   Van der Linden, Ana
   Ximenes, Ricardo A. A.
   Batista, Joanna d'Arc L.
   Vazquez, Enrique
   Coelho, Giovanini E.
   Cortez-Escalante, Juan J.
   Duarte, Elisete
   Henriques, Claudio M. P.
   Melo, Carlos Frederico C. A.
   Oliveira, Wanderson K.
   Schuler-Faccini, Lavinia
   Aldighieri, Sylvain
   Almiron, Maria
   Mendez-Rico, Jairo
   Ramon-Pardo, Pilar
   Rodrigues, Laura C.
CA Microcephaly Epidemic Res Grp
TI Microcephaly in Infants, Pernambuco State, Brazil, 2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We studied the clinical characteristics for 104 infants born with microcephaly in the delivery hospitals of Pernambuco State, Brazil, during 2015. Testing is ongoing to exclude known infectious causes. However, microcephaly peaked in October and demonstrated central nervous system abnormalities with brain dysgenesis and intracranial calcifications consistent with an intrauterine infection.
C1 [Martelli, Celina Maria T.] Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes, NESC, Ave Prof Moraes Rego S-N,Campus UFPE,Cidade Univ, BR-50740465 Recife, PE, Brazil.
RP Martelli, CMT (corresponding author), Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes, NESC, Ave Prof Moraes Rego S-N,Campus UFPE,Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM turchicm@gmail.com
RI Marques, Ernesto T. A/L-4967-2013; Braga, Maria Cynthia/A-8204-2013;
   Oliveira, Wanderson/AAF-5182-2019; Batista, Joanna d'Arc L/O-9933-2014;
   SCHULER-FACCINI, LAVINIA/C-8309-2013; Folador, Adriana R.C./H-6410-2016;
   Souza, Wayner V/H-3798-2013; Dhalia, Rafael/AAD-5432-2020
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Oliveira, Wanderson/0000-0002-9662-1930;
   Batista, Joanna d'Arc L/0000-0002-3703-2845; SCHULER-FACCINI,
   LAVINIA/0000-0002-2428-0460; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Brandao Filho, Sinval/0000-0003-3768-2810;
   Souza, Wayner/0000-0002-0939-9332
FU Brazilian Ministry of Health; Pernambuco State Health Department; Pan
   American Health Organization; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [306489/2010-4, 308311/2009-4,
   308590/2013-9, 301779/2009-0, 304174/2014-9, 306222/2013-2]; Medical
   Research CouncilMedical Research Council UK (MRC) [MC_PC_15088] Funding
   Source: researchfish
FX We are thankful for the support of the Brazilian Ministry of Health,
   Pernambuco State Health Department and Pan American Health Organization
   for their support.r The authors received partial support from the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (scholarship 306489/2010-4 to C.M.T.M., 308311/2009-4 to RAAX,
   308590/2013-9 to D.B.M.F., 301779/2009-0 to M.F.P.M.A., 304174/2014-9 to
   C.B., and 306222/2013-2 to W.V.S.).
CR Brazilian Ministry of Health, 2015, EP B ZIK VIR DAT
   Brazilian Ministry of Health, 2015, EPIDEMIOLOGICAL B
   Brazilian Ministry of Health, 2015, MIN HLTH CONF REL ZI
   Brazilian Ministry of Health, 2015, PROT MON RESP MICR O
   Pereira APE, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00160313
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Pan American Health Organization, 2015, NEUR SYNDR CONG MALF
   Trimm F, 2004, PEDIAT MOD, V2, P1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 52
Z9 53
U1 0
U2 9
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2016
VL 22
IS 6
BP 1090
EP 1093
DI 10.32032/eid2206.160062
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DN0YY
UT WOS:000376794200022
PM 27071041
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Oliveira, RAD
   da Silva, MMC
   Calzavara-Silva, CE
   Silva, AM
   Cordeiro, MT
   de Moura, PMMF
   Baptista, PN
   Marques, ETD
   Gil, LHVG
AF dos Santos Oliveira, Renato Antonio
   Carneiro da Silva, Mayara Marques
   Calzavara-Silva, Carlos Eduardo
   Silva, Ana Maria
   Cordeiro, Marli Tenorio
   Mendes Freire de Moura, Patricia Muniz
   Baptista Filho, Paulo Neves
   de Azevedo Marques Junior, Ernesto Torres
   Vega Gonzales Gil, Laura Helena
TI Primary dengue haemorrhagic fever in patients from northeast of Brazil
   is associated with high levels of interferon-beta during acute phase
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue fever; dengue haemorrhagic fever; type I interferon; innate
   immunity
ID VIRUS-INFECTION; DISEASE SEVERITY; ANTIBODY-RESPONSE; ALPHA PRODUCTION;
   CELL-LINES; IN-VITRO; EXPRESSION; CYTOKINES; VIREMIA; GAMMA
AB Dengue is an acute febrile disease caused by the mosquito-borne dengue virus (DENV) that according to clinical manifestations can be classified as asymptomatic, mild or severe dengue. Severe dengue cases have been associated with an unbalanced immune response characterised by an over secretion of inflammatory cytokines. In the present study we measured type I interferon (IFN-I) transcript and circulating levels in primary and secondary DENV infected patients. We observed that dengue fever (DF) and dengue haemorrhagic fever (DHF) patients express IFN-I differently. While DF and DHF patients express interferon-a similarly (52,71 +/- 7,40 and 49,05 +/- 7,70, respectively), high levels of circulating IFN-beta were associated with primary DHF patients. On the other hand, secondary DHF patients were not able to secrete large amounts of IFN-beta which in turn may have influenced the high-level of viraemia. Our results suggest that, in patients from our cohort, infection by DENV serotype 3 elicits an innate response characterised by higher levels of IFN-beta in the DHF patients with primary infection, which could contribute to control infection evidenced by the low-level of viraemia in these patients. The present findings may contribute to shed light in the role of innate immune response in dengue pathogenesis.
C1 [dos Santos Oliveira, Renato Antonio; Carneiro da Silva, Mayara Marques; Silva, Ana Maria; Cordeiro, Marli Tenorio; de Azevedo Marques Junior, Ernesto Torres; Vega Gonzales Gil, Laura Helena] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
   [Calzavara-Silva, Carlos Eduardo] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Dept Imunol, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil.
   [de Azevedo Marques Junior, Ernesto Torres] Univ Pittsburgh, Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Mendes Freire de Moura, Patricia Muniz] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Baptista Filho, Paulo Neves] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
RP Gil, LHVG (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Virol, Recife, PE, Brazil.
EM laura@cpqam.fiocruz.br
RI Oliveira, Renato/AAN-9879-2020; Oliveira, Renato/A-2863-2013; Oliveira,
   Renato/AAN-9394-2020; Marques, Ernesto T. A/L-4967-2013
OI Oliveira, Renato/0000-0002-4044-0794; Oliveira,
   Renato/0000-0002-4044-0794; Marques, Ernesto T. A/0000-0003-3826-9358;
   CALZAVARA-SILVA, CARLOS/0000-0002-1406-6401
FU NIAID/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI56541, N01 AI 40085]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [CNPq-550140/2010-7, CNPq-404453/2012-0]; FACEPE [APQ-1516-4.01/10];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI040085, U19AI056541, R01AI040085, U19AI056541, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, R01AI040085, R01AI040085,
   R01AI040085, R01AI040085, U19AI056541, R21AI040085, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, U19AI056541, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, R01AI040085, U19AI056541,
   R01AI040085] Funding Source: NIH RePORTER
FX NIAID/NIH (grants U19 AI56541 and N01 AI 40085), CNPq (grants
   CNPq-550140/2010-7 and CNPq-404453/2012-0 (RASO's visiting research
   fellowship)), FACEPE (grant APQ-1516-4.01/10 (MTC's research
   fellowship)). RASO and MMCS contributed equally to this work.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Alonzo MTG, 2012, J INFECT DIS, V205, P1321, DOI 10.1093/infdis/jis180
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Applied Biosystems, 2010, APPL BIOS US B
   Applied Biosystems, 2012, AMPL EFF TAQMANR GEN
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799
   Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Hernandez SID, 2014, J CLIN VIROL, V60, P196, DOI 10.1016/j.jcv.2014.04.002
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   Dong T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001192
   Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086
   Gandini M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002257
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 1988, J CHALL MOL BIO, V239, P476, DOI DOI 10.1126/SCIENCE.3277268
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010
   Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0
   Li YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055108
   Liang ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023346
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Reis SRNI, 2007, MEM I OSWALDO CRUZ, V102, P983, DOI 10.1590/S0074-02762007000800014
   Torres REP, 2016, J MED VIROL, V88, P395, DOI 10.1002/jmv.24343
   Pozner FG, 2010, PLOS PATHOG, V6, P1
   Pozo-Aguilar JO, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0590-7
   Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Ross TM, 2010, CLIN LAB MED, V30, P149, DOI 10.1016/j.cll.2009.10.007
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001
   Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255
   Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835
   Tang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012644
   Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Wu SY, 2013, J INFECTION, V67, P329, DOI 10.1016/j.jinf.2013.05.003
   Ferreira RAX, 2015, ACTA TROP, V149, P138, DOI 10.1016/j.actatropica.2015.04.023
NR 51
TC 11
Z9 10
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2016
VL 111
IS 6
BP 378
EP 384
DI 10.1590/0074-02760150453
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ0LC
UT WOS:000378889800004
PM 27223651
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Barbosa, PP
   Guedes, DRD
   Melo-Santos, MAV
   Cordeiro, MT
   Acioli, RV
   Batista, CAV
   Goncalves, LSM
   Souza, MFM
   Araujo, YV
   Magalhaes, FJR
   Regis, L
   Ayres, CFJ
AF Barbosa, P. P.
   Guedes, D. R. D.
   Melo-Santos, M. A. V.
   Cordeiro, M. T.
   Acioli, R. V.
   Batista, C. A. V.
   Goncalves, L. S. M.
   Souza, M. F. M.
   Araujo, Y. V.
   Magalhaes, F. J. R.
   Regis, L.
   Ayres, C. F. J.
TI Vector Surveillance for Dengue Virus Detection in the Archipelago of
   Fernando de Noronha, Brazil
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE arbovirus; diagnostic; RT-PCR; NS1; Fernando de Noronha
ID POLYMERASE-CHAIN-REACTION; AEDES-AEGYPTI DIPTERA; NS1 ANTIGEN;
   CO-CIRCULATION; DIAGNOSIS; STATE; POPULATION; CULICIDAE; INFECTION;
   MOSQUITOS
AB Aedes aegypti (L.) has become an efficient vector of important arboviruses due to its anthropophilic and domiciliary behaviors. Since the 1980s, dengue affects thousands of people every year in Brazil; in Fernando de Noronha (FN), a touristic archipelago, dengue cases have occurred since 2001. Once Ae. aegypti populations are well established in the inhabited areas of FN, the threat of dengue or another arbovirus epidemic is continuously imminent. This study aimed to monitor the DENV serotypes in mosquito samples collected in FN, where at least one resident was clinically diagnosed as dengue patient. Entomological surveillance was conducted in 2011 and 2012. Mosquitoes were sorted by sex and location and were stored in pools. DENV detection was performed using polymerase chain reaction with reverse transcription (RT-PCR) and the Platelia Dengue NS1 Ag. RNA integrity was checked by RT-PCR using rpL8 primers, and the minimum infection rate (MIR) was calculated. In total, 339 pools were analyzed, and only one was positive (DENV-1) by Multiplex RT-PCR (MIR = 1.53). When considering only pools with RNA integrity, the MIR was 2.92. Using the Platelia kit, the MIR was 9.18 (considering all the pools) and 17.54 (only 140 pools with RNA integrity). Our results showed the importance of a constant entomological surveillance in that area, the need to improve storage and transportation protocols, and an endogenous control in the RT-PCR to avoid false-negative results. Finally, our study indicated that the NS1-Ag detection was the most sensitive method and should be used routinely for DENV surveillance in mosquitoes if the serotype identification is not required.
C1 [Barbosa, P. P.; Guedes, D. R. D.; Melo-Santos, M. A. V.; Regis, L.; Ayres, C. F. J.] FIOCRUZ PE, CPqAM, Dept Entomol, Av Prof Moraes Rego S-N,Cidade Univ, Recife, PE, Brazil.
   [Cordeiro, M. T.] FIOCRUZ PE, CPqAM, Dept Virol, LaViTE, Av Prof Moraes Rego S-N,Cidade Univ, Recife, PE, Brazil.
   [Acioli, R. V.; Batista, C. A. V.; Goncalves, L. S. M.; Souza, M. F. M.; Araujo, Y. V.; Magalhaes, F. J. R.] Secretaria Saude Estado Pernambuco Fernando Noron, Recife, PE, Brazil.
RP Ayres, CFJ (corresponding author), FIOCRUZ PE, CPqAM, Dept Entomol, Av Prof Moraes Rego S-N,Cidade Univ, Recife, PE, Brazil.
EM priscillapaschoal@hotmail.com; duschinka@gmail.com; mavarjal@gmail.com;
   marli@cpqam.fiocruz.br; ridelane.veiga@hotmail.com;
   carlosvbatista@ig.com.br; liliane.melo@hotmail.com;
   fatimamsouza@hotmail.com; yedalima@hotmail.com;
   fernando.rodrigues@noronha.pe.gov; regis.leda@gmail.com;
   tans@cpqam.fiocruz.br
RI Ayres, Constancia/AAQ-3448-2020
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [479214/2010-7, 590154/2011-7]; Fundacao de Amparo a Ciencia e
   Tecnologia do Estado de Pernambuco (FACEPE) [APQ-0225-2.13/12,
   APQ-0375-4.06/12, BFT-0072-2.13/12]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior/Associacao das Universidades de Lingua
   Portuguesa (CAPES/AULP) [2501/2013]
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, grants 479214/2010-7 and 590154/2011-7),
   Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE, grants APQ-0225-2.13/12, APQ-0375-4.06/12 and BFT-0072-2.13/12)
   and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior/Associacao das Universidades de Lingua Portuguesa (CAPES/AULP,
   grant 2501/2013). We thank the Platform of Statistic and Geographical
   Information System (Nucleo de Estatistica e Geoprocessamento, NEG) for
   statistical analysis
CR Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Castro-Jorge LA, 2010, J MED VIROL, V82, P1400, DOI 10.1002/jmv.21814
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Cordeiro M. T., 2008, VINTE ANOS EVOLUCAO
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   da Costa CA, 2009, REV SOC BRAS MED TRO, V42, P677, DOI 10.1590/S0037-86822009000600013
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   De Paula Sérgio Oliveira, 2004, Braz J Infect Dis, V8, P390, DOI 10.1590/S1413-86702004000600002
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   da Moura AJF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0706-8
   Fouque F, 2004, TROP MED INT HEALTH, V9, P41, DOI 10.1046/j.1365-3156.2003.01166.x
   de Figueiredo MLG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-60
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guedes DRD, 2010, J VECTOR DIS, V47, P67
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   (IBGE) Instituto Brasileiro de geografia e Estataistica, 2015, ESTIMATIVA DA POPULA
   Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mishra B, 2011, J CLIN LAB ANAL, V25, P76, DOI 10.1002/jcla.20434
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   NOGUEIRA R M R, 1988, Memorias do Instituto Oswaldo Cruz, V83, P219, DOI 10.1590/S0074-02761988000200012
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Pinheiro VCS, 2005, MEM I OSWALDO CRUZ, V100, P833, DOI 10.1590/S0074-02762005000800003
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Regis LN, 2014, ACTA TROP, V137, P80, DOI 10.1016/j.actatropica.2014.04.010
   Roth A, 2014, EURO SURVEILL, V19
   Samuel PP, 2006, INDIAN J MED RES, V123, P615
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030
   Sylvestre G, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-155
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
   Teerasut C, 2012, SE ASIAN J TROP MED, V43, P641
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Tewari SC, 2004, TROP MED INT HEALTH, V9, P499, DOI 10.1111/j.1365-3156.2004.01103.x
   Thenmozhi V, 2000, T ROY SOC TROP MED H, V94, P507, DOI 10.1016/S0035-9203(00)90067-1
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477
   Wilder-Smith A, 2012, GLOBAL HLTH ACTION, V5
NR 42
TC 3
Z9 3
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAY
PY 2016
VL 53
IS 3
BP 613
EP 619
DI 10.1093/jme/tjw034
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DM6II
UT WOS:000376454800018
PM 27067800
DA 2020-12-08
ER

PT J
AU Cordeiro, MT
   Pena, LJ
   Brito, CA
   Gil, LH
   Marques, ET
AF Cordeiro, Marli Tenorio
   Pena, Lindomar J.
   Brito, Carlos A.
   Gil, Laura H.
   Marques, Ernesto T.
TI Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates
   with microcephaly in Brazil
SO LANCET
LA English
DT Letter
C1 [Cordeiro, Marli Tenorio; Pena, Lindomar J.; Gil, Laura H.; Marques, Ernesto T.] Fiocruz MS, Dept Virol, Ctr Pesquisas Aggeu Magalhaes CPqAM, BR-50670420 Recife, PE, Brazil.
   [Brito, Carlos A.] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Marques, Ernesto T.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Cordeiro, MT (corresponding author), Fiocruz MS, Dept Virol, Ctr Pesquisas Aggeu Magalhaes CPqAM, BR-50670420 Recife, PE, Brazil.
EM marli@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
CR Carrolla ID, 2007, TRAVEL MED INFECT DI, V5, P3183
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 4
TC 83
Z9 83
U1 0
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 30
PY 2016
VL 387
IS 10030
BP 1811
EP 1812
DI 10.1016/S0140-6736(16)30253-7
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6SS
UT WOS:000375056100017
PM 27103126
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Braga, C
   de Albuquerque, MFPM
   Cordeiro, MT
   Castanha, PMS
   Ramesh, A
   Alexander, N
   de Mello, MJG
   Marques, ETA
   Martelli, CMT
AF Braga, Cynthia
   Pessoa Militao de Albuquerque, Maria de Fatima
   Cordeiro, Marli Tenorio
   Castanha, Priscila M. S.
   Ramesh, Anita
   Alexander, Neal
   de Mello, Maria Julia G.
   Marques, Ernesto T. A., Jr.
   Turchi Martelli, Celina M.
TI Prospective birth cohort in a hyperendemic dengue area in Northeast
   Brazil: methods and preliminary results
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Passive Immunization; Dengue; Cohort Studies
ID VIRUS-INFECTIONS; HEMORRHAGIC-FEVER; FOLLOW-UP; ANTIBODIES; INFANTS;
   SEROTYPES; RESPONSES
AB Dengue cases have increased in younger age groups in Brazil. Maternal anti-dengue antibodies can have a protective effect in the first months of life, but their decline can increase the risk of severe dengue. A prospective birth cohort was established in 2011-2012 in the city of Recife, Pernambuco State, Brazil, to determine the incidence of serotype-specific dengue infection and the kinetics of transferred maternal anti-dengue antibodies in the first years of life. This article describes the design, methods and preliminary results of this cohort study. 354 children underwent clinical and laboratory monitoring for two years, with 15% losses to follow-up. The overall rate of new infections was approximately 10% in the first year of follow-up. Information on the force of serotype-specific dengue infection and the evaluation of transferred maternal antibodies can contribute to understanding dengue etiopathogenesis.
C1 [Braga, Cynthia; Pessoa Militao de Albuquerque, Maria de Fatima; Cordeiro, Marli Tenorio; Castanha, Priscila M. S.; Marques, Ernesto T. A., Jr.; Turchi Martelli, Celina M.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Av Moraes Rego S-N, Recife, PE, Brazil.
   [Braga, Cynthia; de Mello, Maria Julia G.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Ramesh, Anita; Alexander, Neal] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Turchi Martelli, Celina M.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
RP Braga, C (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Av Moraes Rego S-N, Recife, PE, Brazil.
EM braga@cpqam.fiocruz.br
RI Braga, Maria Cynthia/A-8204-2013; Marques, Ernesto T. A/L-4967-2013; Da
   Silva Castanha, Priscila Mayrelle/G-1785-2012
OI Braga, Maria Cynthia/0000-0002-7862-6455; Marques, Ernesto T.
   A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [304174/2014-9,
   308491/2013-0, 306489/2010-4]; United Kingdom Medical Research Council
   (MRC)Medical Research Council UK (MRC); Department for International
   Development (DFID) [MR/K012126/1]; Medical Research CouncilMedical
   Research Council UK (MRC) [MR/K012126/1] Funding Source: researchfish
FX The authors of this study would like to thank Dr. Clarence Tam and Dr.
   Lyda Osorio for their methodological input during the inception of this
   cohort. We would also like to thank the Brazilian National Research
   Council (CNPq), which provided financial support to C. Braga
   (304174/2014-9), M. F. P. M. Albuquerque (308491/2013-0), and C. M. T.
   Martelli (306489/2010-4). N. Alexander receives salary support from the
   United Kingdom Medical Research Council (MRC) and the Department for
   International Development (DFID) (MR/K012126/1).
CR [Anonymous], 2013, DENG DIAGN MAN CLIN
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Endy TP, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00183
   Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Kassanjee R, 2014, AIDS RES HUM RETROV, V30, P45, DOI [10.1089/aid.2013.0113, 10.1089/AID.2013.0113]
   Kirkwood B. R., 2003, ESSENTIAL MED STAT
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/j.jcv.2014.02.009, 10.1016/J.JCV.2014.02.009]
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V7, pe2126
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2009, DIAGN EV SER, V3
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Woods CR, 2013, J PEDIATR INFECT DIS, V2, P87, DOI 10.1093/jpids/pis133
   World Health Organization, 2012, GLOB STRAT DENG PREV
   Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357
NR 31
TC 5
Z9 5
U1 0
U2 1
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JAN
PY 2016
VL 32
IS 1
AR e00095815
DI 10.1590/0102-311X00095815
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF7WY
UT WOS:000371569700005
PM 26886185
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Luna, DMN
   Avelino, KYPS
   Cordeiro, MT
   Andrade, CAS
   Oliveira, MDL
AF Luna, Debora M. N.
   Avelino, Karen Y. P. S.
   Cordeiro, Marli T.
   Andrade, Cesar A. S.
   Oliveira, Maria D. L.
TI Electrochemical immunosensor for dengue virus serotypes based on
   4-mercaptobenzoic acid modified gold nanoparticles on self-assembled
   cysteine monolayers
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Dengue; Immunosensor; Label-free biosensor; Gold nanoparticles;
   Self-assembled monolayers
ID ANTIBODY-DEPENDENT ENHANCEMENT; BIOSENSOR; GLYCOPROTEINS; LECTIN
AB Currently, Dengue is a worldwide health problem and no effective vaccine or specific medication. Thus, the development of new diagnostic methods has been the focus of efforts to combat the disease. Immunosensor based on gold nanoparticles (AuNPs) and self-assembled monolayers of cysteine was developed for dengue virus (DENV-1, DENV-2, DENV-3 and DENV-4) detection. Electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) were used to monitor the signal response of the each dengue serotype in different dilutions. Scanning electron microscopy was used to characterize the surface of the immunosensor before and after exposure to DENV. In this work, four different immunosensors with specificity for DENV1-4 were obtained. EIS and CV measurements demonstrate the ability of the immunosensor to recognize all four studied DENV serotypes showing sensitivity and selectivity. The real part of the impedance was higher for Cys-MBA-AuNPs-anti-DENV antibody sensor system after interaction to different concentrations of DENV (1-4) compared to the sensor system without immunoreaction on their surface, revealing an increased blockage of the electron transfer. In addition, the surface coverage values indicate a good recognition of DENV by anti-DENV antibody. The new sensor platform consists of a single method, more affordable than conventional immunoassays and creates expectation on future production of new real-time devices for diagnosis of pathologies caused by virus. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Luna, Debora M. N.; Andrade, Cesar A. S.] Univ Fed Pernambuco, Programa Posgrad Inovacao Terapeut, BR-50670901 Recife, PE, Brazil.
   [Avelino, Karen Y. P. S.; Andrade, Cesar A. S.; Oliveira, Maria D. L.] Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
   [Cordeiro, Marli T.] Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Virol & Terapia Expt, BR-50670901 Recife, PE, Brazil.
RP Oliveira, MDL (corresponding author), Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
EM m_danielly@yahoo.com.br
RI Oliveira, Maria/AAM-4055-2020
OI Avelino, Karen/0000-0003-3002-0291; Oliveira, Maria/0000-0002-8572-4846;
   Souza de Andrade, Cesar Augusto/0000-0002-3271-2817
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Rede ELINOR de Nanobiotecnologia/CAPESCAPES; MCT/FINEPCiencia
   Tecnologia e Inovacao (FINEP); Department of Chemistry of the Federal
   University of Pernambuco, SEM images; Fundacao de Amparo a Ciencia e
   Tecnologia do Estado de Pernambuco (FACEPE)
FX The authors are grateful for the support provided by the Brazilian
   National Council for Scientific and Technological Development (CNPq),
   Rede ELINOR de Nanobiotecnologia/CAPES, MCT/FINEP and Department of
   Chemistry of the Federal University of Pernambuco by the SEM images.
   Luna would like to thank Fundacao de Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco (FACEPE) for a PhD scholarship.
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   Avelino KYPS, 2014, SYNTHETIC MET, V194, P102, DOI 10.1016/j.synthmet.2014.05.001
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Cao XD, 2011, ANAL BIOCHEM, V417, P1, DOI 10.1016/j.ab.2011.05.027
   Caygill RL, 2010, ANAL CHIM ACTA, V681, P8, DOI 10.1016/j.aca.2010.09.038
   Costa MP, 2014, J COLLOID INTERF SCI, V433, P141, DOI 10.1016/j.jcis.2014.07.014
   de Melo AB, 2011, AM J TROP MED HYG, V85, P739, DOI 10.4269/ajtmh.2011.10-0496
   Doria G, 2012, SENSORS-BASEL, V12, P1657, DOI 10.3390/s120201657
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Luna DMN, 2014, CHEM PHYS LIPIDS, V180, P7, DOI 10.1016/j.chemphyslip.2014.02.008
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415
   Oliveira MDL, 2011, COLLOID SURFACE B, V82, P365, DOI 10.1016/j.colsurfb.2010.09.019
   Owino JHO, 2008, SENSORS-BASEL, V8, P8262, DOI 10.3390/s8128262
   Teles FSRR, 2011, ANAL CHIM ACTA, V687, P28, DOI 10.1016/j.aca.2010.12.011
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI200421512
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wang HH, 2011, PHYSCS PROC, V14, DOI 10.1016/j.phpro.2011.05.003
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Zhou Y, 2008, ANGEW CHEM INT EDIT, V47, P7454, DOI 10.1002/anie.200802317
NR 27
TC 32
Z9 33
U1 4
U2 85
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
EI 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD DEC 1
PY 2015
VL 220
BP 565
EP 572
DI 10.1016/j.snb.2015.05.067
PG 8
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA CR3QX
UT WOS:000361249100075
DA 2020-12-08
ER

PT J
AU Castanha, PMD
   Nascimento, EJ
   Cordeiro, MT
   Souza, AI
   Silva, CD
   Panhuis, WG
   Martelli, CT
   Marques, ET
   Braga, C
AF Da Silva Castanha, Priscila M.
   Nascimento, Eduardo J.
   Cordeiro, Marli T.
   Souza, Ariani I.
   Silva, Claudeir D., Jr.
   Panhuis, Willem G.
   Martelli, Celina T.
   Marques, Ernesto T., Jr.
   Braga, Cynthia
TI INFLUENCE OF MATERNAL IGG PROFILE ON PLACENTAL TRANSFER OF DENGUE
   VIRUS-SPECIFIC ANTIBODIES TO NEONATES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Da Silva Castanha, Priscila M.; Cordeiro, Marli T.; Braga, Cynthia] Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Nascimento, Eduardo J.; Marques, Ernesto T., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Souza, Ariani I.; Silva, Claudeir D., Jr.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Panhuis, Willem G.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.
   [Martelli, Celina T.] Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
RI de Souza, Ariani Impieri/AAR-6884-2020; Braga, Maria
   Cynthia/A-8204-2013; Marques, Ernesto T. A/L-4967-2013
OI de Souza, Ariani Impieri/0000-0002-7917-5983; Braga, Maria
   Cynthia/0000-0002-7862-6455; Marques, Ernesto T. A/0000-0003-3826-9358
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2015
VL 93
IS 4
SU S
MA 150
BP 45
EP 46
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA VB0ZJ
UT WOS:000412844101150
DA 2020-12-08
ER

PT J
AU Santos, JJD
   Magalhaes, T
   Silva, JVJ
   da Silva, ANMR
   Cordeiro, MT
   Gil, LHVG
AF da Silva Santos, Jefferson Jose
   Magalhaes, Tereza
   Joaquim Silva Junior, Jose Valter
   Jonteiro Rangel da Silva, Andrea Nazare
   Cordeiro, Marli Tenorio
   Vega Gonzales Gil, Laura Helena
TI Full-length infectious clone of a low passage dengue virus serotype 2
   from Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE infectious clone; yeast homologous recombination; flavivirus
ID CDNA-CLONES; RAPID DETECTION; AEDES-AEGYPTI; CONSTRUCTION; TYPE-2;
   VACCINE; STRAIN; IDENTIFICATION; MUTATIONS; EVOLUTION
AB Full-length dengue virus (DENV) cDNA clones are an invaluable tool for many studies, including those on the development of attenuated or chimeric vaccines and on host-virus interactions. Furthermore, the importance of low passage DENV infectious clones should be highlighted, as these may harbour critical and unique strain-specific viral components from field-circulating isolates. The successful construction of a functional Brazilian low passage DENV serotype 2 full-length clone through homologous recombination reported here supports the use of a strategy that has been shown to be highly useful by our group for the development of flavivirus infectious clones and replicons.
C1 [da Silva Santos, Jefferson Jose; Magalhaes, Tereza; Joaquim Silva Junior, Jose Valter; Jonteiro Rangel da Silva, Andrea Nazare; Cordeiro, Marli Tenorio; Vega Gonzales Gil, Laura Helena] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Virol & Terapia Expt, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Lab Cent Saude Publ, Dept Saude Estado Pernambuco, Recife, PE, Brazil.
RP Gil, LHVG (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Virol & Terapia Expt, Recife, PE, Brazil.
EM laura@cpqam.fiocruz.br
RI Magalhaes, Tereza/V-6632-2019; Santos, Jefferson/W-9610-2019
OI Santos, Jefferson/0000-0001-5895-4163
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [CNPq-470892/2007-2]; FIOCRUZ (PAPES V)
FX FIOCRUZ (PAPES V), CNPq (CNPq-470892/2007-2)
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blaney JE, 2004, AM J TROP MED HYG, V71, P811, DOI 10.4269/ajtmh.2004.71.811
   Blaney JE, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-39
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Carvalho-Leandro D, 2012, ACTA TROP, V124, P113, DOI 10.1016/j.actatropica.2012.07.006
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Santos JJD, 2013, MEM I OSWALDO CRUZ, V108, P983, DOI 10.1590/0074-0276130298
   Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687
   GRUENBERG A, 1988, J GEN VIROL, V69, P1391, DOI 10.1099/0022-1317-69-6-1391
   Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437
   Horstick O, 2015, PATHOG GLOB HEALTH, V109, P19, DOI 10.1179/2047773215Y.0000000003
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Kelly EP, 2011, VIRUS GENES, V43, P18, DOI 10.1007/s11262-011-0602-z
   Kelly EP, 2010, VACCINE, V28, P3030, DOI 10.1016/j.vaccine.2009.10.084
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003
   LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Pierro DJ, 2006, J GEN VIROL, V87, P2263, DOI 10.1099/vir.0.81958-0
   Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Puri B, 2000, VIRUS GENES, V20, P57, DOI 10.1023/A:1008160123754
   Queiroz SRA, 2013, AN ACAD BRAS CIENC, V85, P159, DOI 10.1590/S0001-37652013005000008
   Rico-Hesse R, 2007, CLIN INFECT DIS, V44, P1462, DOI 10.1086/517587
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Sriburi R, 2001, J VIROL METHODS, V92, P71, DOI 10.1016/S0166-0934(00)00277-9
   Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026
   Tajima S, 2006, VIRUS RES, V116, P38, DOI 10.1016/j.virusres.2005.08.015
   Usme-Ciro JA, 2014, VIRUS RES, V180, P12, DOI 10.1016/j.virusres.2013.12.001
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Zhu W, 2007, VIRUS RES, V126, P226, DOI 10.1016/j.virusres.2007.03.004
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 35
TC 0
Z9 0
U1 0
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2015
VL 110
IS 5
BP 677
EP 683
DI 10.1590/0074-02760150053
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CQ3LQ
UT WOS:000360504200015
PM 26200712
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Oliveira, N
   Souza, E
   Ferreira, D
   Zanforlin, D
   Bezerra, W
   Borba, MA
   Arruda, M
   Lopes, K
   Nascimento, G
   Martins, D
   Cordeiro, M
   Lima, J
AF Oliveira, Natalia
   Souza, Elaine
   Ferreira, Danielly
   Zanforlin, Deborah
   Bezerra, Wessulla
   Borba, Maria Amelia
   Arruda, Mariana
   Lopes, Kennya
   Nascimento, Gustavo
   Martins, Danyelly
   Cordeiro, Marli
   Lima-Filho, Jose
TI A Sensitive and Selective Label-Free Electrochemical DNA Biosensor for
   the Detection of Specific Dengue Virus Serotype 3 Sequences
SO SENSORS
LA English
DT Article
DE dengue fever; DNA biosensors; differential pulse voltammetry;
   electrochemical detection; guanine oxidation
ID POLYMERASE-CHAIN-REACTION; HYBRIDIZATION; FEVER; DIAGNOSIS; TRAVELERS;
   DESIGN; PROBES; TYPE-3; IMPACT; ASSAY
AB Dengue fever is the most prevalent vector-borne disease in the world, with nearly 100 million people infected every year. Early diagnosis and identification of the pathogen are crucial steps for the treatment and for prevention of the disease, mainly in areas where the co-circulation of different serotypes is common, increasing the outcome of dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Due to the lack of fast and inexpensive methods available for the identification of dengue serotypes, herein we report the development of an electrochemical DNA biosensor for the detection of sequences of dengue virus serotype 3 (DENV-3). DENV-3 probe was designed using bioinformatics software and differential pulse voltammetry (DPV) was used for electrochemical analysis. The results showed that a 22-m sequence was the best DNA probe for the identification of DENV-3. The optimum concentration of the DNA probe immobilized onto the electrode surface is 500 nM and a low detection limit of the system (3.09 nM). Moreover, this system allows selective detection of DENV-3 sequences in buffer and human serum solutions. Therefore, the application of DNA biosensors for diagnostics at the molecular level may contribute to future advances in the implementation of specific, effective and rapid detection methods for the diagnosis dengue viruses.
C1 [Oliveira, Natalia; Ferreira, Danielly; Zanforlin, Deborah; Bezerra, Wessulla; Borba, Maria Amelia; Arruda, Mariana; Nascimento, Gustavo; Martins, Danyelly; Lima-Filho, Jose] Univ Fed Pernambuco UFPE, LIKA, BR-50670901 Recife, PE, Brazil.
   [Souza, Elaine] Univ Fed Alagoas UFAL, BR-57309005 Arapiraca, AL, Brazil.
   [Lopes, Kennya] Fundacao Oswaldo Cruz Fiocruz Pernambuco, Ctr Pesquisas Aggeu Magalhaes CPqAM, Dept Virol & Terapia Expt LAVITE, BR-50670420 Recife, PE, Brazil.
   [Martins, Danyelly; Cordeiro, Marli; Lima-Filho, Jose] Univ Fed Pernambuco UFPE, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
RP Oliveira, N (corresponding author), Univ Fed Pernambuco UFPE, LIKA, Av Prof Moraes Rego S-N,Campus UFPE, BR-50670901 Recife, PE, Brazil.
EM nataliacybelle.89@gmail.com; elainevms@yahoo.com.br;
   daniellylsantos@hotmail.com; deborahzanforin@gmail.com;
   wessullas@yahoo.com.br; mariameliaborba@gmail.com;
   mariana.s.arruda@gmail.com; kennya.genne@bol.com.br;
   galvesn23@gmail.com; bruneska@prospecmol.org; Marli@cpqam.fiocruz.br;
   joseluiz60@mac.com
RI Filho, Jose Luiz Lima/M-8076-2019; Souza, Elaine/AAK-7955-2020
OI Campos Ferreira, Danielly Santos/0000-0003-4918-6080
FU Fundacao de Amparo a Pesquisa do Estado de Pernambuco (FACEPE); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); Laboratorio
   de Imunopatologia Keizo Asami (LIKA)
FX The authors would like to thank Centro de Pesquisas Aggeu Magalhaes
   (CPqAM) that kindly provided biological samples for this project. In
   addition, they would like to thank Fundacao de Amparo a Pesquisa do
   Estado de Pernambuco (FACEPE), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Laboratorio de Imunopatologia Keizo
   Asami (LIKA) for providing financial support and Graziella El Khoury for
   reviewing of the manuscript for English language.
CR Arora P, 2011, BIOSENS BIOELECTRON, V28, P1, DOI 10.1016/j.bios.2011.06.002
   Ashley EA, 2011, TRENDS ANAESTH CRIT, V1, P39, DOI 10.1016/j.tacc.2010.10.002
   Auer S, 2011, ANAL BIOANAL CHEM, V400, P1387, DOI 10.1007/s00216-011-4871-0
   Aydogdu G, 2014, SENSOR ACTUAT B-CHEM, V197, P211, DOI 10.1016/j.snb.2014.02.083
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Campos-Ferreira D. S., 2014, J CHEM, DOI [10.1016/j.arabjc.2014.05.023, DOI 10.1016/J.ARABJC.2014.05.023]
   Campos-Ferreira DS, 2013, ANAL CHIM ACTA, V804, P258, DOI 10.1016/j.aca.2013.10.038
   Cedillo-Barron L, 2014, MICROBES INFECT, V16, P711, DOI 10.1016/j.micinf.2014.07.011
   Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007
   Chien LC, 2014, ENVIRON INT, V73, P46, DOI 10.1016/j.envint.2014.06.018
   Conde J, 2015, ADV DRUG DELIVER REV, V81, P169, DOI 10.1016/j.addr.2014.09.003
   Corrigan DK, 2014, J ELECTROANAL CHEM, V732, P25, DOI 10.1016/j.jelechem.2014.08.026
   Ensafi AA, 2012, BIOSENS BIOELECTRON, V31, P376, DOI 10.1016/j.bios.2011.10.050
   Erdem A, 2012, COLLOID SURFACE B, V95, P222, DOI 10.1016/j.colsurfb.2012.02.042
   Ermini ML, 2011, BIOSENS BIOELECTRON, V26, P4785, DOI 10.1016/j.bios.2011.06.004
   Ferraz FO, 2013, J CLIN VIROL, V58, P41, DOI 10.1016/j.jcv.2013.06.015
   Gao Z, 2013, ELECTROCHIM ACTA, V91, P185, DOI 10.1016/j.electacta.2012.12.119
   Gong P, 2006, ANAL CHEM, V78, P3326, DOI 10.1021/ac052138b
   Gumustas M., 2011, OPEN ANAL CHEM J, V5, P1, DOI DOI 10.2174/1874065001005010001
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hapugoda MD, 2010, T ROY SOC TROP MED H, V104, P279, DOI 10.1016/j.trstmh.2009.11.001
   Hejazi MS, 2007, TALANTA, V71, P1734, DOI 10.1016/j.talanta.2006.08.010
   Huang J, 2014, TRAC-TREND ANAL CHEM, V53, P11, DOI 10.1016/j.trac.2013.08.007
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Liu XF, 2011, BIOSENS BIOELECTRON, V26, P2154, DOI 10.1016/j.bios.2010.09.025
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   Lucarelli F, 2002, ANAL CHIM ACTA, V469, P93, DOI 10.1016/S0003-2670(02)00605-0
   Lucarelli F, 2008, ANAL CHIM ACTA, V609, P139, DOI 10.1016/j.aca.2007.12.035
   Mohamadi M, 2015, BIOELECTROCHEMISTRY, V101, P52, DOI 10.1016/j.bioelechem.2014.07.003
   Nascimento GA, 2012, BIOSENS BIOELECTRON, V38, P61, DOI 10.1016/j.bios.2012.04.052
   O'Brien B, 2013, J HISTOCHEM CYTOCHEM, V61, P134, DOI 10.1369/0022155412470955
   Ozcan A, 2011, ANAL CHIM ACTA, V685, P9, DOI 10.1016/j.aca.2010.11.004
   Palecek E, 1998, BIOSENS BIOELECTRON, V13, P621, DOI 10.1016/S0956-5663(98)00017-7
   Pechansky F, 2012, REV BRAS PSIQUIATR, V34, P277, DOI 10.1016/j.rbp.2012.06.002
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Peyrefitte CN, 2003, J CLIN MICROBIOL, V41, P5195, DOI 10.1128/JCM.41.11.5195-5198.2003
   Pournaghi-Azar MH, 2008, BIOSENS BIOELECTRON, V24, P524, DOI 10.1016/j.bios.2008.05.008
   Qing X, 2014, EXP MOL PATHOL, V97, P208, DOI 10.1016/j.yexmp.2014.07.004
   Ren YQ, 2013, ANAL CHEM, V85, P4784, DOI 10.1021/ac400583e
   Teles FSRR, 2011, ANAL CHIM ACTA, V687, P28, DOI 10.1016/j.aca.2010.12.011
   Rovida F, 2011, J CLIN VIROL, V50, P76, DOI 10.1016/j.jcv.2010.09.015
   Sadik OA, 2009, BIOSENS BIOELECTRON, V24, P2749, DOI 10.1016/j.bios.2008.10.003
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   Sehatnia B, 2011, J IRAN CHEM SOC, V8, P115, DOI 10.1007/BF03246208
   Shenoy B., 2014, PEDIAT INFECT DIS, V6, P110, DOI DOI 10.1016/J.PID.2014.08.002
   Siddiquee S., 2014, SENS BIOSENS RES, V2, P16, DOI [10.1016/j.sbsr.2014.06.002, DOI 10.1016/j.sbsr.2014.06.002]
   Soares ROS, 2013, BBA-PROTEINS PROTEOM, V1834, P221, DOI 10.1016/j.bbapap.2012.09.007
   Souada M, 2015, BIOSENS BIOELECTRON, V68, P49, DOI 10.1016/j.bios.2014.12.033
   Souza E, 2014, BIOSENS J, V3, P3
   Souza E, 2011, SENSORS-BASEL, V11, P5616, DOI 10.3390/s110605616
   Teles FRR, 2008, TALANTA, V77, P606, DOI 10.1016/j.talanta.2008.07.024
   Tichoniuk M, 2008, SENSORS-BASEL, V8, P2118, DOI 10.3390/s8042118
   Tosar JP, 2009, BIOSENS BIOELECTRON, V24, P3036, DOI 10.1016/j.bios.2009.03.016
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wang J, 2006, BIOSENS BIOELECTRON, V21, P1887, DOI 10.1016/j.bios.2005.10.027
   Wang J, 2001, ANAL CHIM ACTA, V431, P219, DOI 10.1016/S0003-2670(00)01318-0
   Wang QX, 2013, ANAL CHIM ACTA, V788, P158, DOI 10.1016/j.aca.2013.06.018
   Wattal C, 2012, MED CLIN N AM, V96, P1225, DOI 10.1016/j.mcna.2012.08.004
   Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   WHO DengueGuidelines for Diagnosis, 2009, DENG GUID DIAGN TREA, P147
   Zhang LQ, 2014, BIOSENS BIOELECTRON, V60, P259, DOI 10.1016/j.bios.2014.04.037
NR 65
TC 36
Z9 36
U1 0
U2 22
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD JUL
PY 2015
VL 15
IS 7
BP 15562
EP 15577
DI 10.3390/s150715562
PG 16
WC Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments
   & Instrumentation
SC Chemistry; Engineering; Instruments & Instrumentation
GA CS0YN
UT WOS:000361788200036
PM 26140346
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Maciel, M
   Cruz, FDP
   Cordeiro, MT
   da Motta, MA
   Cassemiro, KMSD
   Maia, RDC
   de Figueiredo, RCBQ
   Galler, R
   Freire, MD
   August, JT
   Marques, ETA
   Dhalia, R
AF Maciel, Milton, Jr.
   Pereira Cruz, Fabia da Silva
   Cordeiro, Marli Tenorio
   da Motta, Marcia Archer
   Soares de Melo Cassemiro, Klecia Marilia
   Carvalho Maia, Rita de Cassia
   Bressan Queiroz de Figueiredo, Regina Celia
   Galler, Ricardo
   Freire, Marcos da Silva
   August, Joseph Thomas
   Marques, Ernesto T. A.
   Dhalia, Rafael
TI A DNA Vaccine against Yellow Fever Virus: Development and Evaluation
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID NEUTRALIZING ANTIBODY-RESPONSE; CLASS-II COMPARTMENT; MEMBRANE-PROTEIN;
   T-CELL; JAPANESE ENCEPHALITIS; MONOCLONAL-ANTIBODIES; PROTECTIVE
   IMMUNITY; ENVELOPE GENES; B-CELLS; MICE
AB Attenuated yellow fever (YF) virus 17D/17DD vaccines are the only available protection from YF infection, which remains a significant source of morbidity and mortality in the tropical areas of the world. The attenuated YF virus vaccine, which is used worldwide, generates both long-lasting neutralizing antibodies and strong T-cell responses. However, on rare occasions, this vaccine has toxic side effects that can be fatal. This study presents the design of two non-viral DNA-based antigen formulations and the characterization of their expression and immunological properties. The two antigen formulations consist of DNA encoding the full-length envelope protein (p/YFE) or the full-length envelope protein fused to the lysosomal-associated membrane protein signal, LAMP-1 (pL/YFE), aimed at diverting antigen processing/presentation through the major histocompatibility complex II precursor compartments. The immune responses triggered by these formulations were evaluated in H2b and H2d backgrounds, corresponding to the C57Bl/6 and BALB/c mice strains, respectively. Both DNA constructs were able to induce very strong T-cell responses of similar magnitude against almost all epitopes that are also generated by the YF 17DD vaccine. The pL/YFE formulation performed best overall. In addition to the T-cell response, it was also able to stimulate high titers of anti-YF neutralizing antibodies comparable to the levels elicited by the 17DD vaccine. More importantly, the pL/YFE vaccine conferred 100% protection against the YF virus in intracerebrally challenged mice. These results indicate that pL/YFE DNA is an excellent vaccine candidate and should be considered for further developmental studies.
C1 [Maciel, Milton, Jr.; August, Joseph Thomas; Marques, Ernesto T. A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.
   [Pereira Cruz, Fabia da Silva; Cordeiro, Marli Tenorio; Soares de Melo Cassemiro, Klecia Marilia; Bressan Queiroz de Figueiredo, Regina Celia; Marques, Ernesto T. A.; Dhalia, Rafael] Univ Fed Pernambuco UFPE, Oswaldo Cruz Fdn FIOCRUZ, Lab Virol & Terapia Expt LAVITE, Aggeu Magalhaes Res Ctr,Dept Virol, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Hlth Secretariat State Pernambuco, Cent Publ Hlth Lab LACEN, Recife, PE, Brazil.
   [da Motta, Marcia Archer; Galler, Ricardo; Freire, Marcos da Silva] Oswaldo Cruz Fdn FIOCRUZ, Inst Oswaldo Cruz, Biomanguinhos, Lab Tecnol Virol LATEV, Rio De Janeiro, Brazil.
   [Carvalho Maia, Rita de Cassia] Univ Fed Rural Pernambuco, Dept Vet Med, Recife, PE, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Maciel, M (corresponding author), Naval Med Res Ctr, ETEC Vaccine Program, Silver Spring, MD 20910 USA.
EM emarques@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013; FIGUEIREDO, REGINA CBQ/N-2800-2013;
   Dhalia, Rafael/AAD-5432-2020; FIGUEIREDO, REGINA/T-7230-2019; de Cassia
   Carvalho Maia, Rita/AAH-8741-2020
OI Marques, Ernesto T. A/0000-0003-3826-9358; de Cassia Carvalho Maia,
   Rita/0000-0001-6765-6686; FIGUEIREDO, REGINA/0000-0001-5806-0944
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services, USAUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19 AI56541, HHSN2662-00400085C, PDTIS RVR09-FIOCRUZ];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI040085, R01AI040085, R01AI040085, R01AI040085, R01AI040085,
   U19AI056541, R01AI040085, U19AI056541, R01AI040085, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, R21AI040085, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, R01AI040085, U19AI056541,
   R01AI040085, R01AI040085, R01AI040085, R01AI040085, U19AI056541,
   U19AI056541] Funding Source: NIH RePORTER
FX This work was supported in part with Federal Funds from the National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health, Department of Health and Human Services, USA under Grant No. U19
   AI56541, Contract No. HHSN2662-00400085C and PDTIS RVR09-FIOCRUZ. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anwar A, 2005, VIROLOGY, V332, P66, DOI 10.1016/j.virol.2004.11.022
   Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265
   BARRETT ADT, 1986, J GEN VIROL, V67, P631, DOI 10.1099/0022-1317-67-4-631
   BRANDRISS MW, 1986, J GEN VIROL, V67, P229, DOI 10.1099/0022-1317-67-2-229
   Breugelmans JG, 2013, VACCINE, V31, P1819, DOI 10.1016/j.vaccine.2013.01.054
   Cetron Martin S, 2002, MMWR Recomm Rep, V51, P1
   Chikhlikar P, 2004, VIROLOGY, V323, P220, DOI 10.1016/j.virol.2004.02.025
   De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x
   DESPRES P, 1991, J GEN VIROL, V72, P2811, DOI 10.1099/0022-1317-72-11-2811
   Disis ML, 1996, J IMMUNOL, V156, P3151
   Drake JR, 1999, J IMMUNOL, V162, P1150
   Julander JG, 2013, ANTIVIR RES, V97, P169, DOI 10.1016/j.antiviral.2012.12.002
   Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639
   Konishi E, 2003, VACCINE, V21, P3713, DOI 10.1016/S0264-410X(03)00376-1
   Konishi E, 1998, J VIROL, V72, P4925, DOI 10.1128/JVI.72.6.4925-4930.1998
   Konishi E, 2000, VACCINE, V18, P1133, DOI 10.1016/S0264-410X(99)00376-X
   Lefeuvre Anabelle, 2004, Curr Infect Dis Rep, V6, P96, DOI 10.1007/s11908-996-0005-9
   Lewis PJ, 1999, ADV VIRUS RES, V54, P129, DOI 10.1016/S0065-3527(08)60367-X
   Li L, 2012, J BIOTECHNOL, V162, P171, DOI 10.1016/j.jbiotec.2012.08.012
   LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593
   Lu Y, 2003, VACCINE, V21, P2178, DOI 10.1016/S0264-410X(03)00009-4
   Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043
   Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200
   Miyaji KT, 2013, HUM VACCIN IMMUNOTHE, V9
   Monath TP, 2005, HUM VACCINES, V1, P207, DOI 10.4161/hv.1.5.2221
   Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533
   PINCUS S, 1992, VIROLOGY, V187, P290, DOI 10.1016/0042-6822(92)90317-I
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   PUTNAK JR, 1990, J GEN VIROL, V71, P1697, DOI 10.1099/0022-1317-71-8-1697
   Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8
   Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   Robinson HL, 1999, INT J MOL MED, V4, P549
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   Schultz J, 2000, INTERVIROLOGY, V43, P197, DOI 10.1159/000053988
   SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729
   Sidibe M, 2012, T ROY SOC TROP MED H, V106, P437, DOI 10.1016/j.trstmh.2012.04.002
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Thomas RE, 2011, CURR DRUG SAF, V6, P145, DOI 10.2174/157488611797579258
   Van Der Most RG, 2000, J VIROL, V74, P8094, DOI 10.1128/JVI.74.17.8094-8101.2000
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   *WHO, 1992, GLOB HLTH SIT PROJ E
   *WHO, 1998, WHO TECHN REP SER, V872
   Wu CJ, 2006, MICROBES INFECT, V8, P2578, DOI 10.1016/j.micinf.2006.06.010
NR 44
TC 20
Z9 20
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2015
VL 9
IS 4
AR e0003693
DI 10.1371/journal.pntd.0003693
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CI7VF
UT WOS:000354972200043
PM 25875109
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-08
ER

PT J
AU Brasier, AR
   Zhao, YX
   Wiktorowicz, JE
   Spratt, HM
   Nascimento, EJM
   Cordeiro, MT
   Soman, KV
   Ju, H
   Recinos, A
   Stafford, S
   Wu, Z
   Marques, ETA
   Vasilakis, N
AF Brasier, Allan R.
   Zhao, Yingxin
   Wiktorowicz, John E.
   Spratt, Heidi M.
   Nascimento, Eduardo J. M.
   Cordeiro, Marli T.
   Soman, Kizhake V.
   Ju, Hyunsu
   Recinos, Adrian, III
   Stafford, Susan
   Wu, Zheng
   Marques, Ernesto T. A., Jr.
   Vasilakis, Nikos
TI Molecular classification of outcomes from dengue virus-3 infections
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Dengue; Biomarker pipeline; Selected reaction monitoring; Acute phase
   reaction
ID HEMORRHAGIC-FEVER; DISEASE SEVERITY; BIOMARKER PANEL; PATHOGENESIS;
   PREDICTION; ASSOCIATIONS; COMPLEMENT; CORRELATE; PROTEINS; PROTEOME
AB Objectives: Dengue virus (DENV) infection is a significant risk to over a third of the human population that causes a wide spectrum of illness, ranging from sub-clinical disease to intermediate syndrome of vascular complications called dengue fever complicated (DFC) and severe, dengue hemorrhagic fever (DHF). Methods for discriminating outcomes will impact clinical trials and understanding disease pathophysiology.
   Study design: We integrated a proteomics discovery pipeline with a heuristics approach to develop a molecular classifier to identify an intermediate phenotype of DENV-3 infectious outcome.
   Results: 121 differentially expressed proteins were identified in plasma from DHF vs dengue fever (DF), and informative candidates were selected using nonparametric statistics. These were combined with markers that measure complement activation, acute phase response, cellular leak, granulocyte differentiation and viral load. From this, we applied quantitative proteomics to select a 15 member panel of proteins that accurately predicted DF, DHF, and DFC using a random forest classifier. The classifier primarily relied on acute phase (A2M), complement (CFD), platelet counts and cellular leak (TPM4) to produce an 86% accuracy of prediction with an area under the receiver operating curve of >0.9 for DHF and DFC vs DF.
   Conclusions: Integrating discovery and heuristic approaches to sample distinct pathophysiological processes is a powerful approach in infectious disease. Early detection of intermediate outcomes of DENV-3 will speed clinical trials evaluating vaccines or drug interventions. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Brasier, Allan R.; Zhao, Yingxin; Wiktorowicz, John E.; Recinos, Adrian, III] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.
   [Brasier, Allan R.; Zhao, Yingxin; Wiktorowicz, John E.; Spratt, Heidi M.; Soman, Kizhake V.] UTMB, Sealy Ctr Mol Med, Galveston, TX 77555 USA.
   [Brasier, Allan R.; Zhao, Yingxin; Wiktorowicz, John E.; Spratt, Heidi M.] UTMB, Inst Translat Sci, Galveston, TX 77555 USA.
   [Wiktorowicz, John E.; Soman, Kizhake V.] UTMB, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Cordeiro, Marli T.; Marques, Ernesto T. A., Jr.] Fiocruz MS, Lab Virol & Terapie Expt, Ctr Pesquisas Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [Stafford, Susan; Wu, Zheng] UTMB, Biomol Resource Facil, Galveston, TX 77555 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol & Immunol, Pittsburgh, PA 15260 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Brasier, AR (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.
EM arbrasie@utmb.edu
RI Vasilakis, Nikos/ABE-7318-2020; Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Brasier,
   Allan/0000-0002-5012-4090
FU NIAID Clinical Proteomics Center [HHSN272200800048C]; National Center
   for Advancing Translational Science [UL1TR000071 UTMB CTSA, NIEHSP30
   ES006676]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
   [HHSN272201000040I/HHSN27200004/D04]; CNPqPRONEXNational Council for
   Scientific and Technological Development (CNPq) [DENGUE550140/2010-7];
   FACEPE project [APQ-1516-4.01/10];  [NIAIDAI56541AI049820]; NATIONAL
   CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Advancing Translational Sciences (NCATS)
   [UL1TR000071, UL1TR000071, UL1TR000071, UL1TR000071, UL1TR000071,
   UL1TR000071, UL1TR000071, UL1TR000071, UL1TR000071, UL1TR000071] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32AI049820, T32AI049820, T32AI049820,
   T32AI049820, T32AI049820, T32AI049820, T32AI049820, T32AI049820,
   T32AI049820, T32AI049820, T32AI049820, T32AI049820, T32AI049820,
   T32AI049820, T32AI049820] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Environmental Health Sciences (NIEHS)
   [P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676] Funding Source: NIH RePORTER
FX Research support was provided by the NIAID Clinical Proteomics Center,
   HHSN272200800048C (ARB), National Center for Advancing Translational
   Science UL1TR000071 UTMB CTSA (ARB), NIEHSP30 ES006676 (ARB) and NIH
   contract HHSN272201000040I/HHSN27200004/D04 (NV). NIAIDAI56541AI049820,
   CNPqPRONEX-DENGUE550140/2010-7 - FACEPE project APQ-1516-4.01/10.
CR Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546
   Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f
   Anantapreecha S, 2005, EPIDEMIOL INFECT, V133, P503, DOI 10.1017/S0950268804003541
   Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Brasier AR, 2012, CTS-CLIN TRANSL SCI, V5, P8, DOI 10.1111/j.1752-8062.2011.00377.x
   Brasier AR, 2012, AM J TROP MED HYG, V86, P341, DOI 10.4269/ajtmh.2012.11-0469
   Brasier AR, 2010, CTS-CLIN TRANSL SCI, V3, P147, DOI 10.1111/j.1752-8062.2010.00204.x
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090
   Fragnoud R, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-60
   Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350
   Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276
   Guzman M G, 1984, Bull Pan Am Health Organ, V18, P213
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24
   Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180
   Jamaluddin M, 2010, J VIROL, V84, P9533, DOI 10.1128/JVI.01005-10
   Ju Hyunsu, 2013, BMC Res Notes, V6, P365, DOI 10.1186/1756-0500-6-365
   Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887
   KUSHNER I, 1988, METHOD ENZYMOL, V163, P373
   Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304
   Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314
   Malheiros S M, 1993, Arq Neuropsiquiatr, V51, P159
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nascimento EJM, 2014, CRIT REV IMMUNOL, V34, P227, DOI 10.1615/CritRevImmunol.2014010212
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x
   Potts JA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000769
   Pretzer E, 2008, ANAL BIOCHEM, V374, P250, DOI 10.1016/j.ab.2007.12.014
   Spratt H, 2013, METHODS IN PRESS
   Stephens HAF, 2010, CURR TOP MICROBIOL, V338, P99, DOI 10.1007/978-3-642-02215-9_8
   Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x
   Thayan R, 2009, T ROY SOC TROP MED H, V103, P413, DOI 10.1016/j.trstmh.2008.12.018
   Villar-Centeno LA, 2008, AM J TROP MED HYG, V78, P370, DOI 10.4269/ajtmh.2008.78.370
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Yacoub S, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0147-9
   Zhao Y., 2013, METHODS
   Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959
NR 47
TC 7
Z9 7
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD MAR
PY 2015
VL 64
BP 97
EP 106
DI 10.1016/j.jcv.2015.01.011
PG 10
WC Virology
SC Virology
GA CF0ZP
UT WOS:000352273600018
PM 25728087
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Santos, JJS
   Cordeiro, MT
   Bertani, GR
   Marques, ETA
   Gil, LHVG
AF Santos, Jefferson J. S.
   Cordeiro, Marli T.
   Bertani, Giovani R.
   Marques, Ernesto T. A.
   Gil, Laura H. V. G.
TI A two-plasmid strategy for engineering a dengue virus type 3 infectious
   clone from primary Brazilian isolate
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE reverse genetics; dengue virus; molecular cloning; infectious clone
ID REVERSE GENETICS SYSTEM; CDNA-CLONES; SUBGENOMIC REPLICONS;
   CONSTRUCTION; RNA; PROTEIN; STRAIN; EXPRESSION; YEAST
AB Dengue infections represent one of the most prevalent arthropod-borne diseases worldwide, causing a wide spectrum of clinical outcomes. Engineered infectious clone is an important tool to study Dengue virus (DENV) biology. Functional full-length cDNA clones have been constructed for many positive-strand RNA viruses and have provided valuable tools for studying the molecular mechanisms involved in viral genome replication, virion assembly, virus pathogenesis and vaccine development. We report herein the successful development of an infectious clone from a primary Brazilian isolate of dengue virus 3 (DENV3) of the genotype III. Using a two-plasmid strategy, DENV3 genome was divided in two parts and cloned separately into a yeast-bacteria shuttle vector. All plasmids were assembled in yeast by homologous recombination technique and a full-length template for transcription was obtained by in vitro ligation of the two parts of the genome. Transcript-derived DENV3 is infectious upon transfection into BHK-21 cells and in vitro characterization confirmed its identity. Growth kinetics of transcript-derived DENV3 was indistinguishable from wild type DENV3. This system is a powerful tool that will help shed light on molecular features of DENV biology, as the relationship of specific mutations and DENV pathogenesis.
C1 [Santos, Jefferson J. S.; Cordeiro, Marli T.; Marques, Ernesto T. A.; Gil, Laura H. V. G.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Virol & Terapia Expt, BR-50670420 Recife, PE, Brazil.
   [Cordeiro, Marli T.] Secretaria Saude Estado Pernambuco, Lab Cent Saude Publ, BR-50050210 Recife, PE, Brazil.
   [Bertani, Giovani R.] Univ Fed Pernambuco, Dept Bioquim, BR-50760420 Recife, PE, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
RP Gil, LHVG (corresponding author), Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Virol & Terapia Expt, Av Prof Moraes Rego S-N,Campus UFPE, BR-50670420 Recife, PE, Brazil.
EM laura@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013; Santos, Jefferson/W-9610-2019
OI Marques, Ernesto T. A/0000-0003-3826-9358; Santos,
   Jefferson/0000-0001-5895-4163
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Oswaldo Cruz - FIOCRUZ (Papes V); Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)
   [APQ-0519-2.12/06]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [470892/2007-2]; National Institute of
   Allergy and Infectious Diseases (NIAID/NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [U19
   AI56541]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI040085, R01AI040085, R01AI040085, R01AI040085,
   R01AI040085, R01AI040085, R21AI040085, U19AI082632, U19AI056541,
   R01AI040085, R01AI040085, U19AI056541, R01AI040085, U19AI056541,
   U19AI082632, R01AI040085, R01AI040085, R01AI040085, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, U19AI056541, U19AI056541,
   R01AI040085, R01AI040085, R01AI040085, R01AI040085] Funding Source: NIH
   RePORTER
FX The authors thank the Program for Technological Development in Tools for
   Health-PDTISFIOCRUZ for the use of its facilities, Dr. Pedro Vasconcelos
   at the Evandro Chagas Institute (Belem, Para, Brazil) for kindly
   supplying the polyclonal hyperimmune ascitic fluid used in this paper
   and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq) for supporting J.J.S.S. through a graduate scholarship. This work
   is supported by research grants from Fundacao Oswaldo Cruz - FIOCRUZ
   (Papes V), Fundacao de Amparo a Ciencia e Tecnologia do Estado de
   Pernambuco (FACEPE) (APQ-0519-2.12/06), the CNPq (470892/2007-2), and
   the National Institute of Allergy and Infectious Diseases (NIAID/NIH) -
   Grant U19 AI56541.
CR Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   Ansari IH, 2004, J VIROL, V78, P9612, DOI 10.1128/JVI.78.18.9612-9623.2004
   Blaney JE, 2004, AM J TROP MED HYG, V71, P811, DOI 10.4269/ajtmh.2004.71.811
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Santos JJD, 2013, MEM I OSWALDO CRUZ, V108, P983, DOI 10.1590/0074-0276130298
   Das Suchismita, 2007, J Vis Exp, P220, DOI 10.3791/220
   FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980
   Galler R, 2011, MEM I OSWALDO CRUZ, V106, P905, DOI 10.1590/S0074-02762011000800001
   Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687
   Gil LHVG, 2006, VIRUS RES, V116, P69, DOI 10.1016/j.virusres.2005.08.011
   Gil LHVG, 2006, J VIROL, V80, P900, DOI 10.1128/JVI.80.2.900-911.2006
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hershkovitz O, 2008, J VIROL, V82, P7666, DOI 10.1128/JVI.02274-07
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   KAPOOR M, 1995, GENE, V162, P175, DOI 10.1016/0378-1119(95)00332-Z
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1102
   McElroy KL, 2006, J GEN VIROL, V87, P2993, DOI 10.1099/vir.0.82023-0
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Puri B, 2000, VIRUS GENES, V20, P57, DOI 10.1023/A:1008160123754
   Queiroz SRA, 2013, AN ACAD BRAS CIENC, V85, P159, DOI 10.1590/S0001-37652013005000008
   RICE C M, 1989, New Biologist, V1, P285
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Sambrook J., 2001, MOL CLONING LAB MANU
   Shanks RMQ, 2009, PLASMID, V62, P88, DOI 10.1016/j.plasmid.2009.05.002
   Sriburi R, 2001, J VIROL METHODS, V92, P71, DOI 10.1016/S0166-0934(00)00277-9
   SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992
   Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004
   Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026
   Yamshchikov VF, 2001, VIROLOGY, V281, P294, DOI 10.1006/viro.2000.0795
   Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003
NR 42
TC 6
Z9 8
U1 0
U2 12
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PD DEC
PY 2014
VL 86
IS 4
BP 1749
EP 1759
DI 10.1590/0001-3765201420130332
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AY4CQ
UT WOS:000347526200017
PM 25590713
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Silva, MMS
   Dias, ACMS
   Cordeiro, MT
   Marques, E
   Goulart, MOF
   Dutra, RF
AF Silva, M. M. S.
   Dias, A. C. M. S.
   Cordeiro, M. T.
   Marques, E., Jr.
   Goulart, M. O. F.
   Dutra, R. F.
TI A thiophene-modified screen printed electrode for detection of dengue
   virus NS1 protein
SO TALANTA
LA English
DT Article
DE Screen printed electrode; Thiophene; Dengue virus; Immunosensor
ID RAPID DETECTION; ANTIGEN; TOOL; IMMUNOSENSOR; SENSITIVITY; DIAGNOSIS;
   ASSAYS; TESTS; ELISA
AB A thiophene-modified screen printed electrode (SPE) for detection of the Dengue virus non-structural protein 1 (NS1), an important marker for acute phase diagnosis, is described. A sulfur-containing heterocyclic compound, the thiophene was incorporated to a carbon ink to prepare reproducible screen printed electrodes. After cured, the thiophene SPE was coated by gold nanoparticles conjugated to Protein A to form a nanostrutured surface. The Anti-NS1 antibodies immobilized via their Fc portions via Protein A, leaving their antigen specific sites free circumventing the problem of a random antibodies immobilization. Amperometric responses to the NS1 protein of dengue virus were obtained by cyclic voltammetries performed in presence of ferrocyanide/ferricyanide as redox probe. The calibration curve of immunosensor showed a linear response from 0.04 mu g mL(-1) to 0.6 mu g mL(-1) of NS1 with a good linear correlation (r=0.991, p<0.05). The detection limit (0.015 mu g mL(-1) NS1) was lower than conventional analytical methods. In this work, thiophene monomers incorporated in the carbon ink enhanced the electroanalytical properties of the SPEs, increasing their reproducibility and sensitivity. This point-of-care testing represents a great potential for use in epidemic situations, facilitating the early diagnosis in acute phase of dengue virus. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Silva, M. M. S.; Dias, A. C. M. S.; Dutra, R. F.] Univ Fed Pernambuco, Biomed Engn Lab, BR-50670901 Recife, PE, Brazil.
   [Cordeiro, M. T.; Marques, E., Jr.] FIOCRUZ PE, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Marques, E., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Goulart, M. O. F.] Univ Fed Alagoas, Inst Chem & Biotechnol, Maceio, Brazil.
RP Dutra, RF (corresponding author), Univ Fed Pernambuco, Biomed Engn Lab, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM rosa.dutra@ufpe.br
RI Goulart, Marilia/A-1199-2013; Marques, Ernesto T. A/L-4967-2013; Dutra,
   Rosa F/O-5550-2018; Dutra, Rosa Fireman/Q-1380-2019
OI Goulart, Marilia/0000-0001-9860-3667; Marques, Ernesto T.
   A/0000-0003-3826-9358; Dutra, Rosa F/0000-0001-8314-4218; Dutra, Rosa
   Fireman/0000-0001-8314-4218
FU National Council of Scientific and Technological Development (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Pernambuco Research Foundation (FACEPE, PE, Brazil)
FX The authors thank the National Council of Scientific and Technological
   Development (CNPq, Brazil) and the Pernambuco Research Foundation
   (FACEPE, PE, Brazil) for financial support.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Alonso-Lomillo MA, 2010, BIOSENS BIOELECTRON, V25, P1333, DOI 10.1016/j.bios.2009.10.024
   Babacan S, 2000, BIOSENS BIOELECTRON, V15, P615, DOI 10.1016/S0956-5663(00)00115-9
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Cavalcanti IT, 2012, BIOCHEM ENG J, V67, P225, DOI 10.1016/j.bej.2012.06.016
   Datta S, 2010, INDIAN J MED MICROBI, V28, P107, DOI 10.4103/0255-0857.62484
   Dias ACMS, 2013, BIOSENS BIOELECTRON, V44, P216, DOI 10.1016/j.bios.2012.12.033
   Dolatabadi JEN, 2014, ANAL METHODS-UK, V6, P3891, DOI 10.1039/c3ay41749b
   Renedo OD, 2007, TALANTA, V73, P202, DOI 10.1016/j.talanta.2007.03.050
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gomes SLR, 2013, MICROCHEM J, V109, P10, DOI 10.1016/j.microc.2012.05.033
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Koncki R, 1997, ANAL CHIM ACTA, V351, P143, DOI 10.1016/S0003-2670(97)00367-X
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Mairuhu ATA, 2004, EUR J CLIN MICROBIOL, V23, P425, DOI 10.1007/s10096-004-1145-1
   Metters JP, 2011, ANALYST, V136, P1067, DOI 10.1039/c0an00894j
   Moi ML, 2013, J TRAVEL MED, V20, P185, DOI 10.1111/jtm.12018
   O'Reilly J. M., 1981, CARBON N Y, V21, P47
   Pei ZC, 2010, ANAL BIOCHEM, V398, P161, DOI 10.1016/j.ab.2009.11.038
   Ricci F, 2012, ELECTROCHIM ACTA, V84, P74, DOI 10.1016/j.electacta.2012.06.033
   SISSON TH, 1990, J IMMUNOL METHODS, V127, P215, DOI 10.1016/0022-1759(90)90071-3
   Somerset V, 2010, ELECTROCHIM ACTA, V55, P4240, DOI 10.1016/j.electacta.2009.01.029
   Stradiotto NR, 2003, J BRAZIL CHEM SOC, V14, P159, DOI 10.1590/S0103-50532003000200003
   Huy TQ, 2011, TALANTA, V86, P271, DOI 10.1016/j.talanta.2011.09.012
   Wu ZL, 2002, J PHYS CHEM B, V106, P979, DOI 10.1021/jp011577l
   Yoshioka Y, 2006, SYNTHETIC MET, V156, P779, DOI 10.1016/j.synthmet.2006.03.013
   Zhang GJ, 2010, SENSOR ACTUAT B-CHEM, V146, P138, DOI 10.1016/j.snb.2010.02.021
NR 33
TC 30
Z9 30
U1 0
U2 45
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD OCT 1
PY 2014
VL 128
BP 505
EP 510
DI 10.1016/j.talanta.2014.06.009
PG 6
WC Chemistry, Analytical
SC Chemistry
GA AN6FE
UT WOS:000340689500072
PM 25059193
DA 2020-12-08
ER

PT J
AU Laroque, PO
   Valenca-Montenegro, MM
   Ferreira, DRA
   Chiang, JO
   Cordeiro, MT
   Vasconcelos, PFC
   Silva, JCR
AF Laroque, Plautino O.
   Valenca-Montenegro, Monica M.
   Ferreira, Debora R. A.
   Chiang, Jannifer O.
   Cordeiro, Marli T.
   Vasconcelos, Pedro F. C.
   Silva, Jean C. R.
TI Epidemiologic survey for arbovirus in Galician capuchin monkeys (Cebus
   flavius) free living in Paraiba and captive capuchin monkey (Cebus
   libidinosus) from Northeast Brazil
SO PESQUISA VETERINARIA BRASILEIRA
LA Portuguese
DT Article
DE Arbovirus; monkeys; Cebus flavius; Cebus libidinosus; non-human
   primates; arboviruses serology; Brazil
ID ARTHROPOD-BORNE VIRUSES; PRIMATES
AB This paper describes the first investigation of arbovirus antibodies on New World non-human primates from Northeast Brazil, From March 2008 to September 2010 blood serum samples were collected from 31 wild blond capuchin monkeys (Cebus flavius) from Paraiba and 100 captive capuchin monkeys from Alagoas, Paraiba, Pernambuco, Piaui and Rio Grande do Norte. The haemagglutination-inhibition test (HI) was employed for 19 arbovirus of the Flavivirus, Alphavirus and Bunyavirus genus. Serum samples were tested from 1:20 to 1:1280 dilutions. Among the primates tested all C.flavius were negative and 46% C. libidinosus presented antibodies to arbovirus. Antibodies were detected for nine arbovirus (9/19). Seventeen heterotypic reactions were observed for at least two Or Flavirus and 15 for Alphavirus, at titers varying between 1:20 to 1:1280. Fifteen samples presented monotypic reaction for ILHV (n=4), MAYV (n=6), SLEV (n=1), ROCV (n=2), OROV (n=1) and MUCV (n=1). These results suggest that there was an intense arbovirus circulation in the studied population of captive capuchin monkeys.
C1 [Laroque, Plautino O.; Ferreira, Debora R. A.; Silva, Jean C. R.] Univ Fed Rural Pernambuco UFRPE, Programa Posgrad Ciencia Vet, BR-52171900 Recife, PE, Brazil.
   [Laroque, Plautino O.; Valenca-Montenegro, Monica M.] Inst Chico Mendes Conservacao Biodiversidade, Ctr Nacl Pesquisa & Conservacao Primetas Brasilei, Minist Meio Ambiente, BR-58010480 Joao Pessoa, PB, Brazil.
   [Chiang, Jannifer O.; Vasconcelos, Pedro F. C.] Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrgg, Secretaria Vigilancia Saude, Ananindeua, PA, Brazil.
   [Cordeiro, Marli T.] Fiocruz MS, Ctr Pesquisa aggeu Magalhaes, BR-50670420 Recife, PE, Brazil.
   [Silva, Jean C. R.] Inst Brasileiro Para Med Conservacao, BR-52061030 Recife, PE, Brazil.
   [Silva, Jean C. R.] Univ Sao Paulo, Fac Med Vet Zootecnia, Dept Med Vet Prevent & Saude Anim VSP, BR-05580270 Sao Paulo, Brazil.
RP Laroque, PO (corresponding author), Univ Fed Rural Pernambuco UFRPE, Programa Posgrad Ciencia Vet, Rua Dom Manoel Medeiros S-N, BR-52171900 Recife, PE, Brazil.
EM plautino@terra.com.br
RI Vasconcelos, Pedro/AAH-3142-2019
CR Aranjo F.A.A, 2011, THESIS U FEDERAL GOI
   Azevedo RSS, 2007, INFECT PEDIAT, P533
   Batista WC, 2007, THESIS U FEDERAL AMA
   Catao-Dias J. L., 2003, CIENCIA CULTURA, V55, P32
   CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Contigiani MS, 2000, MEDICINA-BUENOS AIRE, V60, P348
   Cruz A.C.R., 2008, BIOLOGICO SAO PAULO, V70, P45
   de Thoisy B, 2001, AM J PRIMATOL, V54, P1, DOI 10.1002/ajp.1008
   DEGALLIER N, 1986, REV FUND SESP, V31, P127
   Diniz LSM, 1997, PRIMATAS CATIVEIRO M
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Malanski L.S., 2006, AN 42 C SOC BRAS MED
   Mattews L.H., 1967, ZOONOSIS PRIMATES EP
   Medeiros AS, 2008, THESIS U FEDERAL RIO
   Moreira G. V., 2000, Revista Brasileira de Medicina Veterinaria, V22, P252
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   Pereira LE, 2001, REV SAUDE PUBL, V35, P119, DOI 10.1590/S0034-89102001000200003
   PEREIRA W. L. A., 2010, REV PAN AMAZONICA SA, V1, P57, DOI DOI 10.5123/S2176-
   Pinheiro FP, 1997, DOENCAS INFECCIOSAS, P285
   Rodrigues SG, 2010, REV PAN AMAZ SAUDE, V1, P81
   Santos A.L., 2011, PAR 2009 AN 47 C SOC
   Shope R.E., 1986, DIAGNOSTIC PROCEDURE, P797
   SHOPE ROBERT E., 1963, AN MICROBIOL, V11, P167
   Svoboda WK, 2007, THESIS U ESTADUAL LO
   Travassos da Rosa APA, 1996, REVTA SOC BRAS MED T, V29, P537
   Valenca-Montenegro M.M., 2009, AN 13 C BRAS PRIM BL
   Valenca-Montenegro M.M., 2011, THESIS U SAO PAULO P
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
NR 30
TC 4
Z9 4
U1 0
U2 13
PU REVISTA PESQUISA VETERINARIA BRASILEIRA
PI RIO JANEIRO
PA EMBRAPA-SAUDE ANIMAL, KM47 SEROPEDICA, 23851-970 RIO JANEIRO, BRAZIL
SN 0100-736X
EI 1678-5150
J9 PESQUI VET BRASIL
JI Pesqui. Vet. Bras.
PD MAY
PY 2014
VL 34
IS 5
BP 462
EP 468
DI 10.1590/S0100-736X2014000500013
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA AM8HX
UT WOS:000340115300013
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Leite, RC
   Souza, AI
   Castanha, PMS
   Cordeiro, MT
   Martelli, CT
   Ferreira, ALG
   Katz, L
   Braga, C
AF Leite, Rachel C.
   Souza, Ariani I.
   Castanha, Priscila M. S.
   Cordeiro, Marli T.
   Martelli, Celina T.
   Ferreira, Ana Laura G.
   Katz, Leila
   Braga, Cynthia
TI Dengue infection in pregnancy and transplacental transfer of anti-dengue
   antibodies in Northeast, Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Dengue virus; Epidemiology; Pregnancy; Prevalence; Vertical infectious
ID HEMORRHAGIC-FEVER; MATERNAL DENGUE; RISK-FACTORS; VIRUS; REEMERGENCE;
   PREVALENCE; EPIDEMIC; DYNAMICS; OUTCOMES
AB Background: Dengue affects nearly 400 million people annually worldwide and considered one of the most serious health threats in tropical and subtropical countries.
   Objective: To analyze the occurrence of dengue infection among the parturient who have formed the baseline of an ongoing birth cohort study in the city of Recife, Northeast of Brazil. Study design: From March 2011 to May 2012, we recruited 417 parturients with low-risk pregnancies at maternity ward who agreed to a follow-up of their babies. Dengue infection was accessed through DENVRT-PCR and anti-dengue antibodies (IgM and IgG). The prevalence of IgG antibodies in the parturients and their concepts were determined. The concordance among the pairs was tested using Kappa. The association of recent infection (IgM and/or DENV RT-PCR positive) with the maternal characteristics and clinical features of the neonates was analyzed through logistic regression.
   Results: The prevalence of IgG antibodies in the maternal and cord blood samples was 95.1% (95% CI: 92.6-96.9%) and 95.8% (95% CI: 93.4-97.5%), respectively, with high agreement between maternal-cord pairs (Kappa = 0.93). The prevalence of recent infection was 10.6% (95% CI: 7.9-14.2%) in the parturients. Reported fever during pregnancy was associated to recent infection (p =0.023).
   Conclusion: The data draw attention for the high frequency of anti-dengue antibodies in the women studied and for the high occurrence of infection during pregnancy in this region of Brazil. There is a need for further studies to better characterize dengue infection in pregnant women. (c) 2014 Elsevier B.V. All rights reserved.
C1 [Leite, Rachel C.; Souza, Ariani I.; Ferreira, Ana Laura G.; Katz, Leila; Braga, Cynthia] Inst Med Integral Prof Fernando Figueira IMIP, BR-50070550 Recife, PE, Brazil.
   [Martelli, Celina T.] Ctr Pesquisas Aggeu Magalhaes FIOCRUZ, BR-50670420 Recife, PE, Brazil.
   [Castanha, Priscila M. S.; Cordeiro, Marli T.; Braga, Cynthia] Inst Patol Trop & Saude Publ UFGO, Setor Univ, BR-74605050 Goiania, Go, Brazil.
RP Souza, AI (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM rachelcaroline@hotmail.com; ariani@imip.org.br;
   castanha.priscila@gmail.com; marli@cpqam.fiocruz.br; celina@pq.cnpq.br;
   analaura@imip.org.br; katzleila@gmail.com; braga@cpqam.fiocruz.br
RI Braga, Maria Cynthia/A-8204-2013; Souza, Ariani I/C-1568-2015; de Souza,
   Ariani Impieri/AAR-6884-2020; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012; amsalu, ribka/G-8780-2019; Katz,
   Leila/M-5291-2013; Marques, Ernesto T. A/L-4967-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Souza, Ariani
   I/0000-0002-7917-5983; de Souza, Ariani Impieri/0000-0002-7917-5983; Da
   Silva Castanha, Priscila Mayrelle/0000-0002-1220-5308; Katz,
   Leila/0000-0001-9854-7917; Marques, Ernesto T. A/0000-0003-3826-9358;
   Turchi Martelli, Celina Maria/0000-0002-2491-0688
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq
   (National Council for Scientific and Technological Development)National
   Council for Scientific and Technological Development (CNPq) [MCT/CNPq -
   14/2010, 482915/2010-2]; PAPES VINational Council for Scientific and
   Technological Development (CNPq) [407697/2012-8]
FX This research is funded by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico-CNPq (National Council for Scientific and
   Technological Development), grants MCT/CNPq - 14/2010, number
   482915/2010-2 and PAPES VI, number 407697/2012-8.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brazilian Ministry of Health, 2011, SIST INF NASC VIV SI
   Brazilian Ministry of Health. Sistema de Informacao sobre Agravos de Notificacao (SINAN), 2012, SIST INF AGR NOT SIN
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Gershman MD, 2013, INFECT DIS RELATED T
   Gubler D J, 1989, Bull Pan Am Health Organ, V23, P397
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2013, EST POP REC
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Maroun SLC, 2008, J PEDIAT-BRAZIL, V84, P556, DOI 10.1590/S0021-75572008000700014
   PAHO, 2013, NUMB REP CAS DENG SE
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Prince HE, 2008, CLIN VACCINE IMMUNOL, V15, P1304, DOI 10.1128/CVI.00157-08
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tan PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001637
   Tang KF, 2012, EXPERT REV ANTI-INFE, V10, P895, DOI [10.1586/eri.12.76, 10.1586/ERI.12.76]
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
NR 38
TC 18
Z9 22
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD MAY
PY 2014
VL 60
IS 1
BP 16
EP 21
DI 10.1016/J.JCV.2014.02.009
PG 6
WC Virology
SC Virology
GA AF1YW
UT WOS:000334510800004
PM 24657101
DA 2020-12-08
ER

PT J
AU Santos, JJD
   Cordeiro, MT
   Bertani, GR
   Marques, ETD
   Gil, LHVG
AF da Silva Santos, Jefferson Jose
   Cordeiro, Marli Tenorio
   Bertani, Giovani Rota
   de Azevedo Marques, Ernesto Torres
   Vega Gonzales Gil, Laura Helena
TI Construction and characterisation of a complete reverse genetics system
   of dengue virus type 3
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE reverse genetics; dengue virus; molecular cloning
ID CDNA-CLONES; HEMORRHAGIC-FEVER; INFECTIOUS CLONE; VACCINE; YEAST;
   PATHOGENESIS; REPLICON; PROTEIN; STRAIN; DNA
AB Dengue virulence and fitness are important factors that determine disease outcome. However, dengue virus (DENV) molecular biology and pathogenesis are not completely elucidated. New insights on those mechanisms have been facilitated by the development of reverse genetic systems in the past decades. Unfortunately, instability of flavivirus genomes cloned in Escherichia coli has been a major problem in these systems. Here, we describe the development of a complete reverse genetics system, based on the construction of an infectious clone and replicon for a low passage DENV-3 genotype III of a clinical isolate. Both constructs were assembled into a newly designed yeast-E. coli shuttle vector by homologous recombination technique and propagated in yeast to prevent any possible genome instability in E. coli. RNA transcripts derived from the infectious clone are infectious upon transfection into BHK-21 cells even after repeated passages of the plasmid in yeast. Transcript-derived DENV-3 exhibited growth kinetics, focus formation size comparable to original DENV-3 in mosquito C6/36 cell culture. In vitro characterisation of DENV-3 replicon confirmed its identity and ability to replicate transiently in BHK-21 cells. The reverse genetics system reported here is a valuable tool that will facilitate further molecular studies in DENV replication, virus attenuation and pathogenesis.
C1 [da Silva Santos, Jefferson Jose; Cordeiro, Marli Tenorio; de Azevedo Marques, Ernesto Torres; Vega Gonzales Gil, Laura Helena] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Virol & Terapia Expt, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Dept Saude Estado Pernambuco, Lab Cent Saude Publ, Recife, PE, Brazil.
   [Bertani, Giovani Rota] Univ Fed Pernambuco, Dept Bioquim, Recife, PE, Brazil.
   [de Azevedo Marques, Ernesto Torres] Univ Pittsburgh, Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
RP Gil, LHVG (corresponding author), Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Virol & Terapia Expt, Recife, PE, Brazil.
EM laura@cpqam.fiocruz.br
RI Marques, Ernesto T. A/L-4967-2013; Santos, Jefferson/W-9610-2019
OI Marques, Ernesto T. A/0000-0003-3826-9358; Santos,
   Jefferson/0000-0001-5895-4163
FU FIOCRUZ (Papes V); FACEPE [APQ-0519-2.12/06]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [470892/2007-2];
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX Financial support: FIOCRUZ (Papes V), FACEPE (APQ-0519-2.12/06), CNPq
   (470892/2007-2); JJSS receives a graduate scholarship from the CNPq.
CR Alcaraz-Estrada SL, 2010, J GEN VIROL, V91, P2713, DOI 10.1099/vir.0.024083-0
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Ansari IH, 2004, J VIROL, V78, P9612, DOI 10.1128/JVI.78.18.9612-9623.2004
   Blaney JE, 2004, AM J TROP MED HYG, V71, P811, DOI 10.4269/ajtmh.2004.71.811
   Bouloy M, 2009, ANTIVIR RES, V84, P101, DOI 10.1016/j.antiviral.2009.08.002
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Das S, 2007, J VIS EXP, V2007, P220
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980
   Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687
   Gil LHVG, 2006, J VIROL, V80, P900, DOI 10.1128/JVI.80.2.900-911.2006
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Hurrelbrink RJ, 1999, J GEN VIROL, V80, P3115, DOI 10.1099/0022-1317-80-12-3115
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   KAPOOR M, 1995, GENE, V162, P175, DOI 10.1016/0378-1119(95)00332-Z
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Kurosu T, 2010, BIOCHEM BIOPH RES CO, V394, P398, DOI 10.1016/j.bbrc.2010.02.181
   LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139
   Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1102
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   MEILHOC E, 1990, BIO-TECHNOL, V8, P223, DOI 10.1038/nbt0390-223
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Pang X, 2001, BMC Microbiol, V1, P18, DOI 10.1186/1471-2180-1-18
   Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Puri B, 2000, VIRUS GENES, V20, P57, DOI 10.1023/A:1008160123754
   RICE C M, 1989, New Biologist, V1, P285
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Sambrook J., 2001, MOL CLONING LAB MANU
   Shanks RMQ, 2009, PLASMID, V62, P88, DOI 10.1016/j.plasmid.2009.05.002
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Sriburi R, 2001, J VIROL METHODS, V92, P71, DOI 10.1016/S0166-0934(00)00277-9
   Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026
   Tuiskunen A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-398
   Ubol S, 2008, VIROLOGY, V376, P290, DOI 10.1016/j.virol.2008.03.030
   Widman DG, 2008, VACCINE, V26, P2762, DOI 10.1016/j.vaccine.2008.03.009
   Yamshchikov VF, 2001, VIROLOGY, V281, P294, DOI 10.1006/viro.2000.0795
NR 43
TC 9
Z9 11
U1 0
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD DEC
PY 2013
VL 108
IS 8
BP 983
EP 991
DI 10.1590/0074-0276130298
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 294HY
UT WOS:000330037300005
PM 24402142
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Gouveia, FL
   de Oliveira, RMB
   Lucena, AED
   Cordeiro, MT
   Leite, ACL
AF Gouveia, Frederico Leite
   Batista de Oliveira, Renata Mendes
   de Souza Lucena, Antnio Edson
   Cordeiro, Marli Tenorio
   Lima Leite, Ana Cristina
TI Production of intravenous human dengue immunoglobulin from
   Brazilian-blood donors
SO BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Viral infections; Dengue/treatment; Dengue/virus/neutralization;
   Immunoglobulins/preparation; Plasma fractionation; Virus neutralization
ID VIRUS INACTIVATION; PEPSIN TREATMENT; PH; NEUTRALIZATION; ENHANCEMENT;
   PROPHYLAXIS; VALIDATION; PREVENTION; REDUCTION; INFECTION
AB Dengue represents an important health problem in Brazil and therefore there is a great need to develop a vaccine or treatment. The neutralization of the dengue virus by a specific antibody can potentially be applied to therapy. The present paper describes, for the first time, the preparation of Immunoglobulin specific for the dengue virus (anti-DENV IgG), collected from screened Brazilian blood-donations. Production was performed using the classic Cohn-Oncley process with minor modifications. The anti-DENV IgG was biochemically and biophysically characterized and fulfilled the requirements defined by the European Pharmacopoeia. The finished product was able to neutralize different virus serotypes (DENV-1, DENV-2, and DENV-3), while a commercial IgG collected from American blood donations was found to have low anti-dengue antibody titers. Overall, this anti-DENV IgG represents an important step in the study of the therapeutic potential and safety of a specific antibody that neutralizes the dengue virus in humans.
C1 [Gouveia, Frederico Leite; Batista de Oliveira, Renata Mendes; Lima Leite, Ana Cristina] Univ Fed Pernambuco, Dept Ciencias Farmaceut, BR-50670901 Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Res Ctr Aggeu Magalhaes, Dept Virol & Expt Therapy, Rio De Janeiro, Brazil.
RP Cordeiro, MT (corresponding author), Univ Fed Pernambuco, Dept Ciencias Farmaceut, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM fredgouveia@outlook.com
RI Lima Leite, Ana/C-5430-2013
OI Lima Leite, Ana/0000-0002-9346-2292
FU FACEPE (PPSUS Program) [APQ-1380-4.00/08]; Instituto Nacional de
   Pesquisas em Dengue (INCT em Dengue, CNPq) [573876/2008-8]; FACEPE; INCT
   em Dengue; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This study received funding from FACEPE (PPSUS Program, grant number
   APQ-1380-4.00/08) and the Instituto Nacional de Pesquisas em Dengue
   (INCT em Dengue, CNPq, grant number 573876/2008-8). The authors are
   deeply grateful to all the HEMOPE employees for their help during the
   study. F. L. G. is receiving a FACEPE scholarship for doctoral studies,
   while R.M.B.O. is receiving a scholarship from INCT em Dengue. A. C. L.
   L. receives a senior scholarship awarded by CNPq (research productivity
   grant program).
CR Achiron A, 2000, J AUTOIMMUN, V15, P323, DOI 10.1006/jaut.2000.0433
   Achiron A, 1998, NEUROLOGY, V50, P398, DOI 10.1212/WNL.50.2.398
   Atkins JT, 2000, PEDIATR INFECT DIS J, V19, P138, DOI 10.1097/00006454-200002000-00012
   Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870
   Biesert L, 1996, CLIN EXP RHEUMATOL, V14, pS47
   BJORKANDER J, 1987, J CLIN IMMUNOL, V7, P8, DOI 10.1007/BF00915419
   Bos OJM, 1998, BIOLOGICALS, V26, P267, DOI 10.1006/biol.1998.0148
   BRASIL. Secretaria de Vigilancia em Saude, 2011, NOT TECN IS SOR DENV
   BRASIL. Secretaria de Vigilancia em Saude, 2011, NOT TECN IS SOR DENV
   BRASIL. Secretaria de Vigilancia em Saude, 2010, NOT TECN IS VIR DENV
   Brennan DC, 2001, TRANSPLANT P, V33, P1002, DOI 10.1016/S0041-1345(00)02304-6
   Chang CE, 2000, PREP BIOCHEM BIOTECH, V30, P177, DOI 10.1080/10826060008544957
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139
   DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704
   Lucena AED, 2010, BRAZ J PHARM SCI, V46, P777, DOI 10.1590/S1984-82502010000400020
   Elluru S, 2006, IMMUNOL LETT, V107, P58, DOI 10.1016/j.imlet.2006.07.009
   Figueiredo L. T. M., 2010, Dengue Bulletin, V34, P6
   Gelfand EW, 2006, INT IMMUNOPHARMACOL, V6, P592, DOI 10.1016/j.intimp.2005.11.003
   Gelfand EW, 2001, J ALLERGY CLIN IMMUN, V108, pS111, DOI 10.1067/mai.2001.117824
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Gurcan HM, 2010, AUTOIMMUN REV, V9, P553, DOI 10.1016/j.autrev.2010.03.003
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Hahn AF, 1996, BRAIN, V119, P1067, DOI 10.1093/brain/119.4.1067
   Haley M, 2003, CLIN INFECT DIS, V37, pE88, DOI 10.1086/377172
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HOROWITZ B, 1985, TRANSFUSION, V25, P516, DOI 10.1046/j.1537-2995.1985.25686071422.x
   Kroez M, 2003, BIOLOGICALS, V31, P277, DOI 10.1016/j.biologicals.2003.09.001
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   Lories RJU, 2000, ACTA CLIN BELG, V55, P163, DOI 10.1080/17843286.2000.11754288
   Mohammed H, 2008, TRANSFUSION, V48, P1348, DOI 10.1111/j.1537-2995.2008.01771.x
   MORELL A, 1972, J IMMUNOL, V108, P195
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   NOGUEIRA R M R, 1988, Memorias do Instituto Oswaldo Cruz, V83, P219, DOI 10.1590/S0074-02761988000200012
   OHLSSON A., 2001, COCHRANE DB SYST REV
   Okwundu CI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007885.pub2
   Omar A, 1996, TRANSFUSION, V36, P866, DOI 10.1046/j.1537-2995.1996.361097017171.x
   ONCLEY JL, 1949, J AM CHEM SOC, V71, P541, DOI 10.1021/ja01170a048
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   REID KG, 1988, VOX SANG, V55, P75, DOI 10.1111/j.1423-0410.1988.tb05140.x
   Ross TM, 2010, CLIN LAB MED, V30, P149, DOI 10.1016/j.cll.2009.10.007
   Saquib R, 2008, AM J KIDNEY DIS, V52, pE19, DOI 10.1053/j.ajkd.2008.03.042
   Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   UEMURA Y, 1994, VOX SANG, V67, P246, DOI 10.1111/j.1423-0410.1994.tb01246.x
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   VYAS GN, 1968, LANCET, V2, P312
   Wadei H, 2004, CLIN TRANSPLANT, V18, P753, DOI 10.1111/j.1399-0012.2004.00283.x
   Werdan K, 2001, Curr Opin Crit Care, V7, P354, DOI 10.1097/00075198-200110000-00007
   Wilder-Smith A, 2005, EPIDEMIOL INFECT, V133, P667, DOI 10.1017/S0950268805003821
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
NR 60
TC 1
Z9 1
U1 0
U2 2
PU UNIV SAO PAULO, CONJUNTO QUIMICAS
PI SAO PAULO
PA SERVICO PUBLICACOES E CIRCULACAO, CAIXA POSTAL 66083, SAO PAULO, 00000,
   BRAZIL
SN 1984-8250
EI 2175-9790
J9 BRAZ J PHARM SCI
JI Braz. J. Pharm. Sci.
PD OCT-DEC
PY 2013
VL 49
IS 4
BP 821
EP 829
DI 10.1590/S1984-82502013000400022
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AD2EW
UT WOS:000333047500022
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Nascimento, EJM
   Mailliard, RB
   Khan, AM
   Sidney, J
   Sette, A
   Guzman, N
   Paulaitis, M
   de Melo, AB
   Cordeiro, MT
   Gil, LVG
   Lemonnier, F
   Rinaldo, C
   August, JT
   Marques, ETA
AF Nascimento, Eduardo J. M.
   Mailliard, Robbie B.
   Khan, Asif M.
   Sidney, John
   Sette, Alessandro
   Guzman, Nicole
   Paulaitis, Michael
   de Melo, Andrea Barbosa
   Cordeiro, Marli T.
   Gil, Laura V. G.
   Lemonnier, Francoir
   Rinaldo, Charles
   August, J. Thomas
   Marques, Ernesto T. A., Jr.
TI Identification of Conserved and HLA Promiscuous DENV3 T-Cell Epitopes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE HEMORRHAGIC-FEVER; ORIGINAL ANTIGENIC SIN; LYMPHOCYTE CLONES;
   VARIANT PEPTIDES; SUBTYPE-III; VIRUS; RESPONSES; VACCINE; BINDING; MICE
AB Anti-dengue T-cell responses have been implicated in both protection and immunopathology. However, most of the T-cell studies for dengue include few epitopes, with limited knowledge of their inter-serotype variation and the breadth of their human leukocyte antigen (HLA) affinity. In order to expand our knowledge of HLA-restricted dengue epitopes, we screened T-cell responses against 477 overlapping peptides derived from structural and non-structural proteins of the dengue virus serotype 3 (DENV3) by use of HLA class I and II transgenic mice (TgM): A2, A24, B7, DR2, DR3 and DR4. TgM were inoculated with peptides pools and the T-cell immunogenic peptides were identified by ELISPOT. Nine HLA class I and 97 HLA class II novel DENV3 epitopes were identified based on immunogenicity in TgM and their HLA affinity was further confirmed by binding assays analysis. A subset of these epitopes activated memory T-cells from DENV3 immune volunteers and was also capable of priming naive T-cells, ex vivo, from dengue IgG negative individuals. Analysis of inter-and intra-serotype variation of such an epitope (A02-restricted) allowed us to identify altered peptide ligands not only in DENV3 but also in other DENV serotypes. These studies also characterized the HLA promiscuity of 23 HLA class II epitopes bearing highly conserved sequences, six of which could bind to more than 10 different HLA molecules representing a large percentage of the global population. These epitope data are invaluable to investigate the role of T-cells in dengue immunity/pathogenesis and vaccine design.
C1 [Nascimento, Eduardo J. M.; Mailliard, Robbie B.; Rinaldo, Charles; Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15213 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Khan, Asif M.; August, J. Thomas] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD USA.
   [Khan, Asif M.] Perdana Univ, Grad Sch Med, Serdang, Selangor Darul, Malaysia.
   [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA.
   [Guzman, Nicole; Paulaitis, Michael] Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
   [de Melo, Andrea Barbosa; Cordeiro, Marli T.; Gil, Laura V. G.; Marques, Ernesto T. A., Jr.] Fiocruz MS, Dept Virol & Expt Therapy, CPqAM, Recife, PE, Brazil.
   [Lemonnier, Francoir] Inst Pasteur, Unite Immunite Cellulaire Antivirale, Paris, France.
RP Nascimento, EJM (corresponding author), Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15213 USA.
EM ejmn@pitt.edu; marques@pitt.edu
RI Nascimento, Eduardo/J-4590-2014; Khan, Mohammad Asif/F-4663-2010;
   Marques, Ernesto T. A/L-4967-2013; Mailiiard, Robbie/M-9723-2015
OI Nascimento, Eduardo/0000-0002-9851-2332; Khan, Mohammad
   Asif/0000-0001-9202-279X; Marques, Ernesto T. A/0000-0003-3826-9358;
   Mailliard, Robbie/0000-0001-5501-503X
FU NIH/NAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [HHSN272200900042C, U19 AI56541]
FX This work was supported by NIH/NAID contracts HHSN272200900042C (AS) and
   U19 AI56541. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817
   Buchli R, 2004, BIOCHEMISTRY-US, V43, P14852, DOI 10.1021/bi048580q
   Capeding RZ, 2010, AM J TROP MED HYG, V82, P330, DOI 10.4269/ajtmh.2010.09-0542
   Chaturvedi UC, 2005, INDIAN J MED RES, V121, P639
   Chotiyarnwong P, 2007, ACTA CRYSTALLOGR F, V63, P386, DOI 10.1107/S1744309107013693
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Melo AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001938
   de Melo AB, 2011, AM J TROP MED HYG, V85, P739, DOI 10.4269/ajtmh.2011.10-0496
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   de Alencar LXE, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/648475
   Fruci D, 2003, J IMMUNOL, V170, P2977, DOI 10.4049/jimmunol.170.6.2977
   Green S, 1997, VIROLOGY, V234, P383, DOI 10.1006/viro.1997.8648
   Green SL, 1997, VET CLIN N AM-EQUINE, V13, P1
   Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Gwinn W, 2003, AM J TROP MED HYG, V69, P39, DOI 10.4269/ajtmh.2003.69.39
   Harenberg A, 2013, HUM VACC IMMUNOTHER, V9, P2317, DOI 10.4161/hv.25562
   Hertz T, 2011, J VIROL, V85, P1310, DOI 10.1128/JVI.01966-10
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635
   Jung KO, 2012, J VIROL, V86, P7616, DOI 10.1128/JVI.00166-12
   Kanakaratne N, 2009, EMERG INFECT DIS, V15, P192, DOI 10.3201/eid1502.080926
   Khan AM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S4
   Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272
   KURANE I, 1993, J VIROL, V67, P6285, DOI 10.1128/JVI.67.10.6285-6288.1993
   Kurane I, 1998, VIROLOGY, V240, P169, DOI 10.1006/viro.1997.8925
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Li SF, 2011, VACCINE, V29, P3695, DOI 10.1016/j.vaccine.2011.03.002
   Lund O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026494
   Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043
   Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338
   Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261
   Mailliard RB, 2013, J IMMUNOL, V191, P2570, DOI 10.4049/jimmunol.1300373
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mathew A, 1998, J VIROL, V72, P3999, DOI 10.1128/JVI.72.5.3999-4004.1998
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238
   Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296
   Okamoto Y, 1998, J GEN VIROL, V79, P697, DOI 10.1099/0022-1317-79-4-697
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Paramasivan R, 2010, INDIAN J MED RES, V132, P339
   Pascolo S, 2005, EXPERT OPIN BIOL TH, V5, P919, DOI 10.1517/14712598.5.7.919
   Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09
   Roederer M, 2003, J IMMUNOL METHODS, V274, P221, DOI 10.1016/S0022-1759(02)00423-4
   Rohrlich PS, 2003, INT IMMUNOL, V15, P765, DOI 10.1093/intimm/dxg073
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sanchez V, 2006, VACCINE, V24, P4914, DOI 10.1016/j.vaccine.2006.03.066
   Scharnagl NC, 2007, EXPERT REV VACCINES, V6, P605, DOI 10.1586/14760584.6.4.605
   Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017
   Sidney J, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1803s31
   Sidney J, 2010, J IMMUNOL, V185, P4189, DOI 10.4049/jimmunol.1001006
   Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655
   Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Simon GG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008574
   STRAUSS G, 1994, IMMUNOGENETICS, V40, P104
   Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555
   Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396
   Tan PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008754
   Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361
   Toma A, 2009, DIABETES, V58, P394, DOI 10.2337/db08-0599
   Vandenbark AA, 2003, J IMMUNOL, V171, P127, DOI 10.4049/jimmunol.171.1.127
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zeng LL, 1996, J VIROL, V70, P3108, DOI 10.1128/JVI.70.5.3108-3117.1996
   Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959
   ZIVNY J, 1995, J EXP MED, V182, P853, DOI 10.1084/jem.182.3.853
NR 77
TC 23
Z9 23
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2013
VL 7
IS 10
AR e2497
DI 10.1371/journal.pntd.0002497
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 299DW
UT WOS:000330376500034
PM 24130917
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-08
ER

PT J
AU Pastor, AF
   Moura, LR
   Neto, JWD
   Nascimento, EJM
   Calzavara-Silva, CE
   Gomes, ALV
   da Silva, AM
   Cordeiro, MT
   Braga-Neto, U
   Crovella, S
   Gil, LHVG
   Marques, ETA
   Acioli-Santos, B
AF Pastor, Andre F.
   Moura, Lais Rodrigues
   Neto, Jose W. D.
   Nascimento, Eduardo J. M.
   Calzavara-Silva, Carlos E.
   Gomes, Ana Lisa V.
   da Silva, Ana Maria
   Cordeiro, Marli T.
   Braga-Neto, Ulisses
   Crovella, Sergio
   Gil, Laura H. V. G.
   Marques, Ernesto T. A., Jr.
   Acioli-Santos, Bartolomeu
TI Complement factor H gene (CFH) polymorphisms C-257T, G257A and
   haplotypes are associated with protection against severe dengue
   phenotype, possible related with high CFH expression
SO HUMAN IMMUNOLOGY
LA English
DT Article
ID HEMOLYTIC-UREMIC SYNDROME; HEMORRHAGIC-FEVER; VIRUS-INFECTIONS;
   INTERFERON-GAMMA; DISEASE SEVERITY; PROTEIN NS1; RISK-FACTOR; VIRAL
   LOAD; ACTIVATION; SURVEILLANCE
AB Four genetic polymorphisms located at the promoter (C-257T) and coding regions of CFH gene (exon 2 G257A, exon 14 A2089G and exon 19 G2881T) were investigated in 121 dengue patients (DENV-3) in order to assess the relationship between allele/haplotypes variants and clinical outcomes. A statistical value was found between the CFH-257T allele (TT/TC genotypes) and reduced susceptibility to severe dengue (SD). Statistical associations indicate that individuals bearing a T allele presented significantly higher protein levels in plasma. The -257T variant is located within a NF-kappa B binding site, suggesting that this variant might have effect on the ability of the CFH gene to respond to signals via the NF-kappa B pathway. The G257A allelic variant showed significant protection against severe dengue. When CFH haplotypes effect was considered, the ancestral CG/CG promoter-exon 2 SNP genotype showed significant risk to SD either in a general comparison (ancestral x all variant genotypes), as well as in individual genotypes comparison (ancestral x each variant genotype), where the most prevalent effect was observed in the CG/CG x CA/TG comparison. These findings support the involvement of -257T, 257A allele variants and haplotypes on severe dengue phenotype protection, related with high basal CFH expression. (C) 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
C1 [Pastor, Andre F.; Moura, Lais Rodrigues; Neto, Jose W. D.; Calzavara-Silva, Carlos E.; Gomes, Ana Lisa V.; da Silva, Ana Maria; Cordeiro, Marli T.; Gil, Laura H. V. G.; Marques, Ernesto T. A., Jr.; Acioli-Santos, Bartolomeu] FIOCRUZ PE, Virol & Expt Therapy Lab, Recife, PE, Brazil.
   [Braga-Neto, Ulisses] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA.
   [Pastor, Andre F.; Crovella, Sergio] Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Acioli-Santos, B (corresponding author), FIOCRUZ PE, Virol & Expt Therapy Lab, Av Prof Moraes Rego S-N Campus UFPE Cidade Univ, Recife, PE, Brazil.
EM bartacioli@yahoo.com
RI Nascimento, Eduardo/J-4590-2014; Neto, Jose Manoel Duarte/AAH-6963-2020;
   Marques, Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013;
   Crovella, Sergio/K-5050-2016
OI Nascimento, Eduardo/0000-0002-9851-2332; Neto, Jose Manoel
   Duarte/0000-0002-3588-2934; Marques, Ernesto T. A/0000-0003-3826-9358;
   Marques, Ernesto/0000-0003-3826-9358; Crovella,
   Sergio/0000-0001-8493-1168; CALZAVARA-SILVA, CARLOS/0000-0002-1406-6401
FU National Institute of Allergy and Infectious Diseases (NIAID/NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19 AI56541, N01 AI 40085]; Brazilian National
   Research Council (CNPq)National Council for Scientific and Technological
   Development (CNPq) [DCR 35.0382/2004.2]; FACEPE (Fundacao de Amparo
   Ciencia e Tecnologia do Estado de Pernambuco, Brazil); NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI056541, U19AI056541, U19AI056541, U19AI056541, U19AI056541]
   Funding Source: NIH RePORTER; Division of Computing and Communication
   FoundationsNational Science Foundation (NSF)NSF - Directorate for
   Computer & Information Science & Engineering (CISE) [0845407] Funding
   Source: National Science Foundation
FX The author also acknowledge the support of the National Institute of
   Allergy and Infectious Diseases (NIAID/NIH), under Grants U19 AI56541
   and N01 AI 40085, the Brazilian National Research Council (CNPq), under
   Grant DCR 35.0382/2004.2 (to Dr. Braga-Neto), and the FACEPE (Fundacao
   de Amparo Ciencia e Tecnologia do Estado de Pernambuco, Brazil) for A.
   Pastor's fellowship.
CR Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005
   Alencar LXE, 2013, J TROPICAL MED, V2013, DOI DOI 10.1155/2013/648475
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Bokisch V A, 1973, Trans Assoc Am Physicians, V86, P102
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Caprioli J, 2003, HUM MOL GENET, V12, P3385, DOI 10.1093/hmg/ddg363
   CHIEWSILP P, 1981, AM J TROP MED HYG, V30, P1100, DOI 10.4269/ajtmh.1981.30.1100
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Fang X, 2012, FEMS IMMUNOL MED MIC, P1
   Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x
   Friese MA, 1999, MOL IMMUNOL, V36, P809, DOI 10.1016/S0161-5890(99)00101-7
   Furlan M, 2000, NEPHROL DIAL TRANSPL, V15, P1112, DOI 10.1093/ndt/15.8.1112
   Gubler D, 1997, DENGUE DENGUE HEMORR
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Halme J, 2009, MOL IMMUNOL, V46, P2284, DOI 10.1016/j.molimm.2009.04.005
   Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102
   Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320
   Luo W, 1999, SCAND J IMMUNOL, V49, P487
   Marques ETA, 2008, CAD SAUDE PUBLICA, V24, P547, DOI 10.1590/S0102-311X2008000300008
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Nishioka K, 1974, Allerg Immunol (Leipz), V20-21, P385
   Organization WH, 2004, DENGUE GUIDELINES DI
   PEREZ MLP, 1987, HAEMATOLOGIA, V20, P83
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Shresta S, 2012, MBIO, V3, DOI 10.1128/mBio.00003-12
   Soundravally R, 2007, HUM IMMUNOL, V68, P973, DOI 10.1016/j.humimm.2007.09.007
   Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x
   Tan GK, 2009, CURR OPIN INFECT DIS, V22, P302, DOI 10.1097/QCO.0b013e328329ae32
   Timar KK, 2006, MOL IMMUNOL, V43, P317, DOI 10.1016/j.molimm.2005.02.009
   Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   Warwicker P, 1997, IMMUNOGENETICS, V46, P437, DOI 10.1007/s002510050300
   Williams SA, 1997, SCAND J IMMUNOL, V45, P7, DOI 10.1046/j.1365-3083.1997.d01-364.x
NR 43
TC 12
Z9 12
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0198-8859
J9 HUM IMMUNOL
JI Hum. Immunol.
PD SEP
PY 2013
VL 74
IS 9
BP 1225
EP 1230
DI 10.1016/j.humimm.2013.05.005
PG 6
WC Immunology
SC Immunology
GA 198RG
UT WOS:000322939400026
PM 23747994
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Castanha, PMS
   Cordeiro, MT
   Martelli, CMT
   Souza, WV
   Marques, ETA
   Braga, C
AF Castanha, P. M. S.
   Cordeiro, M. T.
   Martelli, C. M. T.
   Souza, W. V.
   Marques, E. T. A., Jr.
   Braga, C.
TI Force of infection of dengue serotypes in a population-based study in
   the northeast of Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Dengue; neutralizing antibody; prevalence
ID PLAQUE-REDUCTION NEUTRALIZATION; VIRUS SEROTYPES; HEMORRHAGIC-FEVER;
   CHILDREN; TRANSMISSION; EPIDEMIOLOGY; DETERMINANTS; ADOLESCENTS;
   REEMERGENCE; PREVALENCE
AB This study investigated anti-dengue serotype-specific neutralizing antibodies in a random sample of dengue IgG-positive individuals identified in a survey performed in a hyperendemic setting in northeastern Brazil in 2005. Of 323 individuals, 174 (53.8%) had antibodies to dengue virus serotype 1 (DENV-1), 104 (32.2%) to DENV-2 and 301 (93.2%) to DENV-3. Monotypic infections by DENV-3 were the most frequent infection (35.6%). Of 109 individuals aged < 15 years, 61.5% presented multitypic infections. The force of infection estimated by a catalytic model was 0.9%, 0.4% and 2.5% person-years for DENV-1, DENV-2 and DENV-3, respectively. By the age of 5 years, about 70%, 30% and 40% of participants were immune to DENV-3, DENV-2 and DENV-1, respectively. The data suggest that infection with DENV-1, -2 and -3 is intense at early ages, demonstrating the need for research efforts to investigate dengue infection in representative population samples of Brazilian children during early infancy.
C1 [Castanha, P. M. S.; Braga, C.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Doencas Transmissiveis, Dept Parasitol, BR-50670420 Recife, PE, Brazil.
   [Cordeiro, M. T.; Marques, E. T. A., Jr.] Fundacao Oswaldo Cruz, Lab Virol & Terapia Expt, Ctr Pesquisas Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil.
   [Cordeiro, M. T.] Secretaria Saude Pernambuco, Lab Cent Saude Publ, Recife, PE, Brazil.
   [Martelli, C. M. T.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
   [Martelli, C. M. T.] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [Souza, W. V.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Saude Colet, BR-50670420 Recife, PE, Brazil.
   [Marques, E. T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Castanha, PMS (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Ave Prof Moraes Rego S-N,Cidade Univ, BR-50670420 Recife, PE, Brazil.
EM castanha.priscila@gmail.com
RI Souza, Wayner V/H-3798-2013; Publica, Inct Saude/J-9544-2013; Iats,
   Inct/K-2300-2013; Da Silva Castanha, Priscila Mayrelle/G-1785-2012;
   Marques, Ernesto T. A/L-4967-2013; Braga, Maria Cynthia/A-8204-2013;
   Marques, Ernesto/L-4514-2013
OI Da Silva Castanha, Priscila Mayrelle/0000-0002-1220-5308; Marques,
   Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Marques, Ernesto/0000-0003-3826-9358;
   Turchi Martelli, Celina Maria/0000-0002-2491-0688; Souza,
   Wayner/0000-0002-0939-9332
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   [BFT-0190-4.06/10]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [306489/2010-4, 305281/2010-0];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI056541, U19AI082632, U19AI056541, U19AI082632, U19AI056541,
   U19AI056541, U19AI056541] Funding Source: NIH RePORTER
FX The authors acknowledge the partial support of the P. M. S. Castanha by
   Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (Grant
   BFT-0190-4.06/10). C. M. T. Martelli and W. V. Souza received research
   scholarships (CNPq numbers 306489/2010-4, 305281/2010-0) and are
   research members from the National Institute of Science and Technology
   for Health Technology Assessment.
CR Anderson R, 1991, INFECT DIS HUMANS DY, P63
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057
   Cavalcanti LP, 2011, EMERG INFECT DIS, V17, P132, DOI 10.3201/eid1701.100321
   Chang SF, 2008, J MICROBIOL IMMUNOL, V41, P377
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Ximenes RAD, 2008, INT J EPIDEMIOL, V37, P852, DOI 10.1093/ije/dyn114
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   Sanchez-Burgos GG, 2008, SALUD PUBLICA MEXICO, V50, P362, DOI 10.1590/s0036-36342008000500008
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Pessanha JEM, 2010, REV PANAM SALUD PUBL, V27, P252, DOI 10.1590/S1020-49892010000400003
   Montenegro D, 2006, REV SOC BRAS MED TRO, V39, P9, DOI 10.1590/S0037-86822006000100002
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Reiskind MH, 2001, TROP MED INT HEALTH, V6, P212, DOI 10.1046/j.1365-3156.2001.00703.x
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Scheaffer RL, 1979, ELEMENTARY SURVEY SA, P48
   Simasathien S, 2008, AM J TROP MED HYG, V78, P426, DOI 10.4269/ajtmh.2008.78.426
   Siqueira JC, 2002, FLORA FANEROGAMICA E, P11
   Swaminathan S, 2010, EXPERT OPIN THER PAT, V20, P819, DOI 10.1517/13543771003767476
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Wilder-Smith A, 2005, EPIDEMIOL INFECT, V133, P667, DOI 10.1017/S0950268805003821
NR 33
TC 25
Z9 26
U1 0
U2 17
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD MAY
PY 2013
VL 141
IS 5
BP 1080
EP 1088
DI 10.1017/S0950268812001367
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 118YZ
UT WOS:000317064800023
PM 22800513
DA 2020-12-08
ER

PT J
AU Garcia-Bates, TM
   Cordeiro, MT
   Nascimento, EJM
   Smith, AP
   de Melo, KMS
   McBurney, SP
   Evans, JD
   Marques, ETA
   Barratt-Boyes, SM
AF Garcia-Bates, Tatiana M.
   Cordeiro, Marli T.
   Nascimento, Eduardo J. M.
   Smith, Amanda P.
   de Melo, Klecia M. Soares
   McBurney, Sean P.
   Evans, Jared D.
   Marques, Ernesto T. A., Jr.
   Barratt-Boyes, Simon M.
TI Association between Magnitude of the Virus-Specific Plasmablast Response
   and Disease Severity in Dengue Patients
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID ORIGINAL ANTIGENIC SIN; ANTIBODY-DEPENDENT ENHANCEMENT; CROSS-REACTIVE
   B; HEMORRHAGIC-FEVER; PERIPHERAL-BLOOD; IMMUNE ACTIVATION; CELL
   RESPONSES; INFECTION; CHILDREN; HUMANS
AB Dengue is a globally expanding disease caused by infection with dengue virus (DENV) that ranges from febrile illness to acute disease with serious complications. Secondary infection predisposes individuals to more severe disease, and B lymphocytes may play a role in this phenomenon through production of Ab that enhance infection. To better define the acute B cell response during dengue, we analyzed peripheral B cells from an adult Brazilian hospital cohort with primary and secondary DENV infections of varying clinical severity. Circulating B cells in dengue patients were proliferating, activated, and apoptotic relative to individuals with other febrile illnesses. Severe secondary DENV infection was associated with extraordinary peak plasmablast frequencies between 4 and 7 d of illness, averaging 46% and reaching 87% of B cells, significantly greater than those seen in mild illness or primary infections. On average >70% of IgG-secreting cells in individuals with severe secondary DENV infection were DENV specific. Plasmablasts produced Ab that cross-reacted with heterotypic DENV serotypes, but with a 3-fold greater reactivity to DENV-3, the infecting serotype. Plasmablast frequency did not correlate with acute serum-neutralizing Ab titers to any DENV serotype regardless of severity of disease. These findings indicate that massive expansion of DENV-specific and serotype cross-reactive plasmablasts occurs in acute secondary DENV infection of adults in Brazil, which is associated with increasing disease severity. The Journal of Immunology, 2013, 190: 80-87.
C1 [Garcia-Bates, Tatiana M.; Nascimento, Eduardo J. M.; Smith, Amanda P.; de Melo, Klecia M. Soares; McBurney, Sean P.; Evans, Jared D.; Marques, Ernesto T. A., Jr.; Barratt-Boyes, Simon M.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
   [Garcia-Bates, Tatiana M.; Nascimento, Eduardo J. M.; Smith, Amanda P.; Marques, Ernesto T. A., Jr.; Barratt-Boyes, Simon M.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.
   [Cordeiro, Marli T.; de Melo, Klecia M. Soares; Marques, Ernesto T. A., Jr.] Fiocruz MS, Virol & Expt Therapy Lab, Aggeu Magalhaes Res Ctr, BR-50670420 Recife, PE, Brazil.
   [McBurney, Sean P.; Evans, Jared D.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA.
   [Barratt-Boyes, Simon M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA.
RP Barratt-Boyes, SM (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, 9046 Biomed Sci Tower 3,3501 5th Ave, Pittsburgh, PA 15261 USA.
EM smbb@pitt.edu
RI Publica, Inct Saude/J-9544-2013; Marques, Ernesto T. A/L-4967-2013;
   Marques, Ernesto/L-4514-2013; Nascimento, Eduardo/J-4590-2014
OI Marques, Ernesto T. A/0000-0003-3826-9358; Marques,
   Ernesto/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332;
   Barratt Boyes, Simon/0000-0002-8869-4945; Garcia-Bates,
   Tatiana/0000-0001-7579-5272
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI049820, AI118297];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI049820, T32AI049820, T32AI049820, T32AI049820, T32AI049820,
   T32AI049820, T32AI049820, T32AI049820, U19AI082632, T32AI049820,
   U19AI082632, T32AI049820, T32AI049820, T32AI049820, T32AI049820,
   T32AI049820, T32AI049820] Funding Source: NIH RePORTER
FX This work was supported by National Institutes of Health Training Grant
   AI049820 (to T.M.G.-B.) and National Institutes of Health Research Grant
   AI118297.
CR Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Brazil Ministry of Health, 2005, DENG DIAGN MAN CLIN
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cordeiro MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004945
   Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991
   Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969
   de Melo AB, 2011, AM J TROP MED HYG, V85, P739, DOI 10.4269/ajtmh.2011.10-0496
   Devignot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011671
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Gawoski JM, 2003, ARCH PATHOL LAB MED, V127, P1026
   Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412
   Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680
   Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P804, DOI 10.1093/aje/152.9.804
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457
   Kyu SY, 2009, J IMMUNOL METHODS, V340, P42, DOI 10.1016/j.jim.2008.09.025
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Myint KS, 2006, J INFECT DIS, V194, P600, DOI 10.1086/506451
   Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28
   Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Siqueira JB, 2011, SAUDE BRASIL 2010 AN, P157
   Thai KTD, 2011, CLIN MICROBIOL INFEC, V17, P1823, DOI 10.1111/j.1469-0691.2010.03434.x
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959
   Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 58
TC 43
Z9 45
U1 0
U2 5
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD JAN 1
PY 2013
VL 190
IS 1
BP 80
EP 87
DI 10.4049/jimmunol.1103350
PG 8
WC Immunology
SC Immunology
GA 061FB
UT WOS:000312832500010
PM 23203929
OA Green Accepted, Bronze
DA 2020-12-08
ER

PT J
AU Carvalho-Leandro, D
   Ayres, CFJ
   Guedes, DRD
   Suesdek, L
   Melo-Santos, MAV
   Oliveira, CF
   Cordeiro, MT
   Regis, LN
   Marques, ET
   Gil, LH
   Magalhaes, T
AF Carvalho-Leandro, D.
   Ayres, C. F. J.
   Guedes, D. R. D.
   Suesdek, L.
   Melo-Santos, M. A. V.
   Oliveira, C. F.
   Cordeiro, M. T.
   Regis, L. N.
   Marques, E. T.
   Gil, L. H.
   Magalhaes, T.
TI Immune transcript variations among Aedes aegypti populations with
   distinct susceptibility to dengue virus serotype 2
SO ACTA TROPICA
LA English
DT Article
DE Mosquito; Dengue virus; Immune response; Toll; JAK-STAT; RNAi
ID ORAL INFECTION; VECTOR COMPETENCE; SINDBIS VIRUS; PATHWAY; EXPRESSION;
   MIDGUT; RNAI; QUANTITATION; SUPPRESSORS; STRAINS
AB The innate immune response of insects is one of the factors that may dictate their susceptibility to viral infection. Two immune signaling pathways, Toll and JAK-STAT, and the RNA interference (RNAi) pathway are involved in Aedes aegypti responses against dengue virus (DENV), however natural differences in these antiviral defenses among mosquito populations have not been studied. Here, two field Ae. aegypti populations from distinct ecological environments, one from Recife and the other from Petrolina (Brazil), and a laboratory strain were studied for their ability to replicate a primary isolate of dengue virus serotype 2 (DENV-2). Virus infectivity and replication were determined in insect tissues collected after viral exposure through reverse-transcription real time PCR (RT-PCR). The expression of a transcript representing these defense mechanisms (Toll, JAK-STAT and RNAi) in the midgut and fat body was studied with RTPCR to evaluate variations in innate immune mechanisms possibly employed against DENV. Analyses of infection rates indicated that the field populations were more susceptible to DENV-2 infection than the lab strain. There were distinct expression patterns among mosquito populations, in both control and infected insects. Moreover, lower expression of immune molecules in DENV-2-infected insects compared to controls was observed in the two field populations. These results suggest that natural variations in vector competence against DENV may be partly due to differences in mosquito defense mechanisms, and that the down-regulation of immune transcripts after viral infection depends on the insect strain. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Carvalho-Leandro, D.; Ayres, C. F. J.; Guedes, D. R. D.; Melo-Santos, M. A. V.; Oliveira, C. F.; Regis, L. N.; Magalhaes, T.] Fiocruz Pernambuco, Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes CPqAM, Dept Entomol, Recife, PE, Brazil.
   [Ayres, C. F. J.; Guedes, D. R. D.; Melo-Santos, M. A. V.; Oliveira, C. F.; Regis, L. N.; Marques, E. T.; Gil, L. H.] Fiocruz Pernambuco, CPqAM, Programa Posgrad Saude Publ, Recife, PE, Brazil.
   [Carvalho-Leandro, D.; Ayres, C. F. J.] Univ Fed Pernambuco UFPE, Ctr Ciencias Biol, Dept Zool, Programa Posgrad Biol Anim, Recife, PE, Brazil.
   [Suesdek, L.] Inst Butantan Sao Paulo, Parasitol Lab, Sao Paulo, Brazil.
   [Suesdek, L.] Univ Sao Paulo, Inst Ciencias Biomed, Programa Posgrad Biol Relacao Patogeno Hospedeiro, BR-09500900 Sao Paulo, Brazil.
   [Cordeiro, M. T.; Marques, E. T.; Gil, L. H.] Fiocruz Pernambuco, CPqAM, Lab Virol & Terapia Expt LaViTE, Recife, PE, Brazil.
   [Cordeiro, M. T.] Secretaria Saude Pernambuco, Recife, PE, Brazil.
   [Marques, E. T.] Univ Pittsburg, Ctr Vaccine Res, Pittsburg, KS USA.
RP Magalhaes, T (corresponding author), Fiocruz Pernambuco, CPqAM, LaViTE, Recife, PE, Brazil.
EM danilo@cpqam.fiocruz.br; tans@cpqam.fiocruz.br;
   dguedes@cpqam.fiocruz.br; linrocha@butantan.gov.br;
   mavarjal@cpqam.fiocruz.br; claudia@cpqam.fiocruz.br;
   marli@cpqam.fiocruz.br; leda@cpqam.fiocruz.br; marques@pitt.edu;
   laura@cpqam.fiocruz.br; tecamagalhaes@hotmail.com
RI Suesdek, Lincoln/C-7943-2013; Ayres, Constancia/AAQ-3448-2020;
   Magalhaes, Tereza/V-6632-2019; Publica, Inct Saude/J-9544-2013; Marques,
   Ernesto/L-4514-2013; Marques, Ernesto T. A/L-4967-2013
OI Suesdek, Lincoln/0000-0001-6829-738X; Marques,
   Ernesto/0000-0003-3826-9358; Marques, Ernesto T. A/0000-0003-3826-9358
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [Universal 479029/2010-5, Pronex Rede Dengue 550140/2010-7]; FACEPE
   [PPSUS/APQ-1361-4.00/08]; FIOCRUZ; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI056541, U19AI056541,
   U19AI056541, U19AI056541, U19AI056541] Funding Source: NIH RePORTER
FX We thank Dr. Brian D. Foy (CSU, USA) for providing the opportunity for
   the one-month training in the techniques used in this study, and Dr.
   Marcos H. F. Sorgine (UFRJ, Brazil) for his helpful comments on an early
   version of the manuscript. We also thank the staff of Recife and
   Petrolina City Halls for collaborating with mosquito egg collection, and
   the PDTIS program at FIOCRUZ for supplying reagents for real-time PCRs
   and for technical support with these assays. Financial support for this
   work was obtained from CNPq (Grants Universal 479029/2010-5 and Pronex
   Rede Dengue 550140/2010-7), FACEPE (Grant PPSUS/APQ-1361-4.00/08) and
   FIOCRUZ.
CR Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Bonizzoni M, 2012, G3-GENES GENOM GENET, V2, P103, DOI 10.1534/g3.111.001107
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Diallo M, 2008, T ROY SOC TROP MED H, V102, P493, DOI 10.1016/j.trstmh.2008.02.010
   Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423
   Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   IBGE - Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012
   Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130
   Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lan Q., 1992, Insect Molecular Biology, V1, P71, DOI 10.1111/j.1365-2583.1993.tb00107.x
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Magalhaes T, 2008, ARCH INSECT BIOCHEM, V68, P134, DOI 10.1002/arch.20238
   Magalhaes T, 2008, EXP PARASITOL, V120, P364, DOI 10.1016/j.exppara.2008.09.003
   [Ministerio da Sande Secretaria de Vigilancia em Sande], 2008, RED NAC MON RES AED
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006
   Schneider JR, 2011, INFECT GENET EVOL, V11, P11, DOI 10.1016/j.meegid.2010.10.019
   Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   TARDIEUX I, 1990, AM J TROP MED HYG, V43, P308, DOI 10.4269/ajtmh.1990.43.308
   van Cleef KWR, 2011, METHODS MOL BIOL, V721, P201, DOI 10.1007/978-1-61779-037-9_12
   Vargas REM, 2010, INFECT GENET EVOL, V10, P580, DOI 10.1016/j.meegid.2010.01.004
   de Melo-Santos MAV, 2009, BIOL CONTROL, V49, P186, DOI 10.1016/j.biocontrol.2009.01.011
   Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292
   Vidal P.O., 2011, INFECT GENETICS EVOL
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 49
TC 16
Z9 16
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2012
VL 124
IS 2
BP 113
EP 119
DI 10.1016/j.actatropica.2012.07.006
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 014JT
UT WOS:000309372600002
PM 22877626
DA 2020-12-08
ER

PT J
AU Cordeiro, MT
AF Cordeiro, Marli Tenorio
TI LABORATORY DIAGNOSIS FOR DENGUE
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
ID PLAQUE-REDUCTION NEUTRALIZATION; ANTIBODIES; VIRUSES; ASSAY; NS1
C1 Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Virol & Expt Therapy, Recife, PE, Brazil.
RP Cordeiro, MT (corresponding author), Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Virol & Expt Therapy, Recife, PE, Brazil.
CR CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   McBride WJH, 2009, DIAGN MICR INFEC DIS, V64, P31, DOI 10.1016/j.diagmicrobio.2009.01.002
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Vorndam Vance, 1997, P313
   WHO, 2007, GUID PLAQ RED NEUTR
   World Health Organization, 1997, DENG HEM FEV DIAGN T
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 15
TC 3
Z9 3
U1 0
U2 3
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PD OCT
PY 2012
VL 54
SU 18
BP S10
EP S12
DI 10.1590/S0036-46652012000700005
PG 3
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 012NI
UT WOS:000309242600005
PM 23011452
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Melo, AB
   da Silva, MDC
   Magalhaes, MCF
   Gil, LHVG
   de Carvalho, EMF
   Braga-Neto, UM
   Bertani, GR
   Marques, ETA
   Cordeiro, MT
AF de Melo, Andrea Barbosa
   da Silva, Maria da Paz C.
   Magalhaes, Maria Cecilia F.
   Vega Gonzales Gil, Laura Helena
   Freese de Carvalho, Eduardo M.
   Braga-Neto, Ulisses M.
   Bertani, Giovani Rota
   Marques, Ernesto T. A., Jr.
   Cordeiro, Marli Tenorio
TI Description of a Prospective 17DD Yellow Fever Vaccine Cohort in Recife,
   Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID SERIOUS ADVERSE EVENTS; HEMAGGLUTINATION-INHIBITION; IMMUNOFLUORESCENCE
   ASSAY; IGG ANTIBODIES; CLINICAL-TRIAL; UNITED-STATES; MAC-ELISA; VIRUS;
   DENGUE; NEUTRALIZATION
AB From September 2005 to March 2007, 238 individuals being vaccinated for the first time with the yellow fever (YF) -17DD vaccine were enrolled in a cohort established in Recife, Brazil. A prospective study indicated that, after immunization, anti-YF immunoglobulin M (IgM) and anti-YF IgG were present in 70.6% (IgM) and 98.3% (IgG) of the vaccinated subjects. All vaccinees developed protective immunity, which was detected by the plaque reduction neutralization test (PRNT) with a geometric mean titer of 892. Of the 238 individuals, 86.6% had IgG antibodies to dengue virus; however, the presence of anti-dengue IgG did not interfere significantly with the development of anti-YF neutralizing antibodies. In a separate retrospective study of individuals immunized with the 17DD vaccine, the PRNT values at 5 and 10 years post-vaccination remained positive but showed a significant decrease in neutralization titer (25% with PRNT titers < 100 after 5 years and 35% after 10 years).
C1 [de Melo, Andrea Barbosa; Magalhaes, Maria Cecilia F.; Vega Gonzales Gil, Laura Helena; Marques, Ernesto T. A., Jr.; Cordeiro, Marli Tenorio] Fiocruz MS, Virol & Expt Therapy Lab, Aggeu Magalhaes Res Ctr, BR-50670420 Recife, PE, Brazil.
   [da Silva, Maria da Paz C.; Bertani, Giovani Rota] Univ Fed Pernambuco, Dept Bioquim, Recife, PE, Brazil.
   [Braga-Neto, Ulisses M.] Texas A&M Univ, Dept Elect Engn, College Stn, TX 77843 USA.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   Secretaria Saude Estado Pernambuco, Cent Publ Hlth Lab, Recife, PE, Brazil.
   [Freese de Carvalho, Eduardo M.] Aggeu Magalhaes Res Ctr, Dept Saude Colet, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Secretaria Saude Estado Pernambuco, Telephone & Cent Lab Publ Hlth, Recife, PE, Brazil.
RP Marques, ETA (corresponding author), Fiocruz MS, Virol & Expt Therapy Lab, Aggeu Magalhaes Res Ctr, Av Moraes Rego S-N,Campus Univ Fed Pernambuco,Cid, BR-50670420 Recife, PE, Brazil.
EM abm@cpqam.fiocruz.br; mariadapazc@gmail.com; cecimag@cpqam.fiocruz.br;
   laura@cpqam.fiocruz.br; freese@cpqam.fiocruz.br; ulisses@ece.tamu.edu;
   gbertani@gmail.com; marques@pitt.edu; marli@cpqam.fiocruz.br
RI Marques, Ernesto/L-4514-2013; Publica, Inct Saude/J-9544-2013; Marques,
   Ernesto T. A/L-4967-2013
OI Marques, Ernesto/0000-0003-3826-9358; Marques, Ernesto T.
   A/0000-0003-3826-9358
FU National Institute of Allergy and Infectious Diseases (NIAID/NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [N01-AI-40085]; Oswald Cruz Foundation [PDTIS-RVR9];
   National Science FoundationNational Science Foundation (NSF)
   [CCF-0845407]; Brazilian National Research Council (CAPES)National
   Council for Scientific and Technological Development (CNPq)CAPES;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI040085, R01AI040085, R01AI040085, R01AI040085, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, R01AI040085, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, R01AI040085, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, R21AI040085, R01AI040085,
   R01AI040085] Funding Source: NIH RePORTER
FX The authors would like to acknowledge the support of National Institute
   of Allergy and Infectious Diseases (NIAID/NIH) Grant N01-AI-40085,
   Oswald Cruz Foundation Grant PDTIS-RVR9, National Science Foundation
   Award CCF-0845407, and the Brazilian National Research Council (CAPES;
   doctoral scholarship for Andrea Melo).
CR Arya SC, 1999, EMERG INFECT DIS, V5, P487, DOI 10.3201/eid0503.990333
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2009, GUIA VIG EP
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Codeco CT, 2004, T ROY SOC TROP MED H, V98, P702, DOI 10.1016/j.trstmh.2003.12.019
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105
   DOSSANTOS CND, 1995, VIRUS RES, V35, P35
   Galler R, 1998, VACCINE, V16, P1024, DOI 10.1016/S0264-410X(97)00278-8
   Galler R, 2001, VIROLOGY, V290, P309, DOI 10.1006/viro.2001.1168
   Gómez Sergio Y, 2008, Rev. salud pública, V10, P796
   Guimard T, 2009, AM J TROP MED HYG, V81, P1141, DOI 10.4269/ajtmh.2009.09-0295
   Houghton-Triviño Natalia, 2008, Rev. salud pública, V10, P299
   Izurieta RO, 2009, J GLOB INFECT DIS, V1, P111, DOI 10.4103/0974-777X.56257
   KUNO G, 1991, J VIROL METHODS, V33, P101, DOI 10.1016/0166-0934(91)90011-N
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   LHUILLIER M, 1986, B WORLD HEALTH ORGAN, V64, P415
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Makela A, 2002, PEDIATRICS, V110, P957, DOI 10.1542/peds.110.5.957
   Marchevsky RS, 2006, BIOLOGICALS, V34, P191, DOI 10.1016/j.biologicals.2005.09.005
   Marques ETA, 2008, CAD SAUDE PUBLICA, V24, P547, DOI 10.1590/S0102-311X2008000300008
   Martin M, 2001, EMERG INFECT DIS, V7, P945, DOI 10.3201/eid0706.010605
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533
   MONATH TPC, 1971, AM J EPIDEMIOL, V93, P122, DOI 10.1093/oxfordjournals.aje.a121232
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Niedrig M, 2007, J VIROL METHODS, V139, P103, DOI 10.1016/j.jviromet.2006.09.009
   Niedrig M, 1999, TROP MED INT HEALTH, V4, P867, DOI 10.1046/j.1365-3156.1999.00496.x
   Niedrig M, 2008, CLIN VACCINE IMMUNOL, V15, P177, DOI 10.1128/CVI.00078-07
   NOGUEIRA RMR, 1992, REV I MED TROP, V34, P447, DOI 10.1590/S0036-46651992000500012
   Pfister M, 2005, AM J TROP MED HYG, V72, P339, DOI 10.4269/ajtmh.2005.72.339
   Pugachev KV, 2005, CURR OPIN INFECT DIS, V18, P387, DOI 10.1097/01.qco.0000178823.28585.ad
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   Silva ML, 2010, CLIN VACCINE IMMUNOL, V17, P118, DOI 10.1128/CVI.00369-09
   STREBEL PM, 1992, CLIN INFECT DIS, V14, P568, DOI 10.1093/clinids/14.2.568
   Suzano CES, 2006, VACCINE, V24, P1421, DOI 10.1016/j.vaccine.2005.09.033
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0
   Vazquez S, 2003, J VIROL METHODS, V110, P179, DOI 10.1016/S0166-0934(03)00128-9
NR 45
TC 26
Z9 26
U1 0
U2 6
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2011
VL 85
IS 4
BP 739
EP 747
DI 10.4269/ajtmh.2011.10-0496
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 833QB
UT WOS:000295898900029
PM 21976581
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Nascimento, HPO
   Oliveira, MDL
   de Melo, CP
   Silva, GJL
   Cordeiro, MT
   Andrade, CAS
AF Nascimento, Helena P. O.
   Oliveira, Maria D. L.
   de Melo, Celso P.
   Silva, Gilcelia J. L.
   Cordeiro, Marli T.
   Andrade, Cesar A. S.
TI An impedimetric biosensor for detection of dengue serotype at picomolar
   concentration based on gold nanoparticles-polyaniline hybrid composites
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Dengue; DNA; Cyclic voltammetry; Electrochemical impedance spectroscopy
ID COMPLETE NUCLEOTIDE-SEQUENCE; DNA; NANOCOMPOSITES; OXIDATION; ELECTRODE;
   POLYMER
AB In this work, we describe the preparation and characterization of a novel gold nanoparticles-polyaniline hybrid composite (AuNpPANI) with SH-terminal groups that, due to its ability of immobilizing dengue serotype-specific primers 1,2 and 3 (ST1, ST2 and ST3), can be used for the development of biosensors. Electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) were performed. CV and EIS results demonstrated that the AuNpPANI can immobilize ST1, ST2 and ST3, forming AuNpPANI-ST complexes. Well-defined cyclic voltammograms characteristic of a diffusion-limited redox process were observed both for the bare gold electrode and after these electrodes have been modified by the adsorption of AuNpPANI or AuNpPANI-ST. The AuNpPANI-ST(1-3) systems were able to recognize the dengue serotype of different patients at picomolar concentrations. Even when small volumes and low concentrations of the analyte were used, the CV and EIS results showed unequivocal evidence of an existing interaction between dengue serotype-specific primers and their complementary genomic DNA targets. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Silva, Gilcelia J. L.; Andrade, Cesar A. S.] UFPE, Ctr Acad Vitoria, BR-55608680 Vitoria De Santo Antao, PE, Brazil.
   [Oliveira, Maria D. L.] Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
   [de Melo, Celso P.] Univ Fed Pernambuco, Dept Fis, BR-50670901 Recife, PE, Brazil.
   [Cordeiro, Marli T.] Fiocruz MS, Lab Cent Saude Publ PE, Recife, PE, Brazil.
RP Andrade, CAS (corresponding author), UFPE, Ctr Acad Vitoria, BR-55608680 Vitoria De Santo Antao, PE, Brazil.
EM csrandrade@gmail.com
RI de Melo, Celso P/I-3418-2015
OI de Melo, Celso P/0000-0002-2715-2448; Oliveira,
   Maria/0000-0002-8572-4846; Souza de Andrade, Cesar
   Augusto/0000-0002-3271-2817
FU Rede ELINOR de Nanobiotecnologia/CAPESCAPES; FACEPE; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX The authors are grateful for the support from the Rede ELINOR de
   Nanobiotecnologia/CAPES, FACEPE and CNPq. H.P.O. Nascimento would like
   to thank CNPq for an M.Sc. scholarship.
CR Bock G., 2006, NEW TREATMENT STRATE
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Melo CP, 2008, US Patent, Patent No. [PCT/BR2009/000117, 2009000117]
   de Oliveira HP, 2008, J COLLOID INTERF SCI, V319, P441, DOI 10.1016/j.jcis.2007.11.011
   Doleman L, 2007, ANAL CHEM, V79, P4149, DOI 10.1021/ac0702847
   dos Santos FB, 2002, MEM I OSWALDO CRUZ, V97, P991, DOI 10.1590/S0074-02762002000700011
   Fang FF, 2008, J NANOSCI NANOTECHNO, V8, P1559, DOI 10.1166/jnn.2008.036
   Grant S, 2005, ANAL CHIM ACTA, V537, P163, DOI 10.1016/j.aca.2005.01.003
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   HUANG WS, 1986, J CHEM SOC FARAD T 1, V82, P2385, DOI 10.1039/f19868202385
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Mallick K, 2008, GOLD BULL, V41, P246, DOI 10.1007/BF03214877
   Mallick K, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/9/095409
   Oliveira MDL, 2011, COLLOID SURFACE B, V82, P365, DOI 10.1016/j.colsurfb.2010.09.019
   Oliveira MDL, 2009, BIOSENS BIOELECTRON, V25, P728, DOI 10.1016/j.bios.2009.08.009
   OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R
   Schmidt G, 2003, CURR OPIN COLLOID IN, V8, P103, DOI 10.1016/S1359-0294(03)00008-6
   Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283
   Xue D, 2007, J AM CHEM SOC, V129, P1854, DOI 10.1021/ja067339r
   Yan W, 2008, BIOELECTROCHEMISTRY, V72, P21, DOI 10.1016/j.bioelechem.2007.07.003
   Zhang J, 2006, J AM CHEM SOC, V128, P8575, DOI 10.1021/ja061521a
   Zhang SX, 2005, SENSOR ACTUAT B-CHEM, V109, P367, DOI 10.1016/j.snb.2005.01.003
NR 22
TC 35
Z9 36
U1 3
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD SEP 1
PY 2011
VL 86
IS 2
BP 414
EP 419
DI 10.1016/j.colsurfb.2011.04.028
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 785KB
UT WOS:000292226800024
PM 21592745
DA 2020-12-08
ER

PT J
AU Rodriguez-Barraquer, I
   Cordeiro, MT
   Braga, C
   de Souza, WV
   Marques, ET
   Cummings, DAT
AF Rodriguez-Barraquer, Isabel
   Cordeiro, Marli T.
   Braga, Cynthia
   de Souza, Wayner V.
   Marques, Ernesto T.
   Cummings, Derek A. T.
TI From Re-Emergence to Hyperendemicity: The Natural History of the Dengue
   Epidemic in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HEMORRHAGIC-FEVER; INFECTION; VIRUS; TRANSMISSION; NICARAGUA; THAILAND;
   DYNAMICS; AMERICA; BANGKOK; DISEASE
AB Background: Dengue virus (DENV) was reintroduced into Brazil in 1986 and by 1995 it had spread throughout the country. In 2007 the number of dengue hemorrhagic fever (DHF) cases more than doubled and a shift in the age distribution was reported. While previously the majority of DHF cases occurred among adults, in 2007 53% of cases occurred in children under 15 years old. The reasons for this shift have not been determined.
   Methods and Findings: Age stratified cross-sectional seroepidemiologic survey conducted in Recife, Brazil in 2006. Serostatus was determined by ELISA based detection of Dengue IgG. We estimated time-constant and time-varying forces of infection of DENV between 1986 and 2006. We used discrete-time simulation to estimate the accumulation of monotypic and multitypic immunity over time in a population previously completely susceptible to DENV. We projected the age distribution of population immunity to dengue assuming similar hazards of infection in future years. The overall prevalence of DENV IgG was 0.80 (n = 1427). The time-constant force of infection for the period was estimated to be 0.052 (95% CI 0.041, 0.063), corresponding to 5.2% of susceptible individuals becoming infected each year by each serotype. Simulations show that as time since re-emergence of dengue goes by, multitypic immunity accumulates in adults while an increasing proportion of susceptible individuals and those with monotypic immunity are among young age groups. The median age of those monotypically immune can be expected to shift from 24 years, 10 years after introduction, to 13 years, 50 years after introduction. Of those monotypically immune, the proportion under 15 years old shifts from 27% to 58%. These results are consistent with the dengue notification records from the same region since 1995.
   Interpretation: Assuming that persons who have been monotypically exposed are at highest risk for severe dengue, the shift towards younger patient ages observed in Brazil can be partially explained by the accumulation of multitypic immunity against DENV-1, 2, and 3 in older age groups, 22 years after the re-introduction of these viruses. Serotype specific seroepidemiologic studies are necessary to accurately estimate the serotype specific forces of infection.
C1 [Rodriguez-Barraquer, Isabel; Cummings, Derek A. T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.
   [Cordeiro, Marli T.; Braga, Cynthia; de Souza, Wayner V.; Marques, Ernesto T.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Cordeiro, Marli T.] Cent Publ Hlth Lab, Secretaria Saude Estado Pernambuco, Recife, PE, Brazil.
   [Marques, Ernesto T.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Rodriguez-Barraquer, I (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.
EM irodrigu@jhsph.edu
RI Iats, Inct/K-2300-2013; Braga, Maria Cynthia/A-8204-2013; Marques,
   Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013; Publica, Inct
   Saude/J-9544-2013; Souza, Wayner V/H-3798-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Marques, Ernesto T.
   A/0000-0003-3826-9358; Marques, Ernesto/0000-0003-3826-9358;
   Rodriguez-Barraquer, Isabel/0000-0001-6784-1021; Souza,
   Wayner/0000-0002-0939-9332
FU Gates FoundationBill & Melinda Gates Foundation; National Institute of
   General Medical SciencesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [1U54GM088491-01]; National
   Institute of Allergy and Infectious Diseases (NIAID/NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19 AI56541]; PDTIS [RVR09-FIOCRUZ]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico -CNPqNational Council for
   Scientific and Technological Development (CNPq) [305947/2006-0];
   Burroughs Wellcome FundBurroughs Wellcome Fund; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19AI056541,
   U19AI056541, U19AI056541, U19AI056541, U19AI056541] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491] Funding Source: NIH RePORTER
FX The authors acknowledge the support of the Gates Foundation through the
   Vaccine Modeling Initiative (I. R. B., D. A. T. C.), the National
   Institute of General Medical Sciences MIDAS grant 1U54GM088491-01 (I. R.
   B., D. A. T. C.), the National Institute of Allergy and Infectious
   Diseases (NIAID/NIH), Grant U19 AI56541 and PDTIS RVR09-FIOCRUZ (E. M.).
   W. V. de Souza was partially supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico -CNPq (305947/2006-0). Derek
   Cummings holds a Career Award at the Scientific Interface from the
   Burroughs Wellcome Fund. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   FISCHER DB, 1970, YALE J BIOL MED, V42, P329
   GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859
   Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997
   Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   *IBGE, 2000, DEM CENS 2000 CHAR P
   KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mendez Angela, 2003, Biomedica, V23, P180
   *MIN SAUD, 2010, SIST INF HOSP SIH SU
   Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS4, DOI 10.1590/S0102-311X2009001300001
   WHO/TDR, 2009, DENG GUID DIAGN TREA
NR 28
TC 89
Z9 91
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1935-2727
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2011
VL 5
IS 1
AR e935
DI 10.1371/journal.pntd.0000935
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 711MP
UT WOS:000286596000013
PM 21245922
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-08
ER

PT J
AU Guedes, DRD
   Cordeiro, MT
   Melo-Santos, MAV
   Magalhaes, T
   Marques, E
   Regis, L
   Furtado, AF
   Ayres, CFJ
AF Guedes, D. R. D.
   Cordeiro, M. T.
   Melo-Santos, M. A. V.
   Magalhaes, T.
   Marques, E.
   Regis, L.
   Furtado, A. F.
   Ayres, C. F. J.
TI Patient-based dengue virus surveillance in Aedes aegypti from Recife,
   Brazil
SO JOURNAL OF VECTOR BORNE DISEASES
LA English
DT Article
DE Arbovirus; entomological surveillance; mosquito; RT-PCR; vertical
   transmission
ID NATURAL VERTICAL TRANSMISSION; POLYMERASE-CHAIN-REACTION; STATE;
   CULICIDAE; DIPTERA; VECTOR
AB Background & objectives: Dengue is currently one of the most important arthropod-borne diseases and may be caused by four different dengue virus serotypes (DENV-1 to DENV-4), transmitted mainly by Aedes aegypti (Diptera: Culicidae) mosquitoes. With the lack of a dengue vaccine, vector control strategies constitute a crucial mode to prevent or reduce disease transmission. In this context, DENV detection in natural Ae. aegypti populations may serve as a potential additional tool for early prediction systems of dengue outbreaks, leading to an intensification of vector control measures, aimed at reducing disease transmission. In Brazil, this type of surveillance has been performed sporadically by a few groups and has not been incorporated as a routine activity in control programs. This study aimed at detecting DENV in natural Ae. aegypti from Recife, Pernambuco, to check the circulating serotypes and the occurrence of transovarial transmission in local mosquito populations.
   Methods: From January 2005 to June 2006, mosquitoes (adults and eggs) were collected in houses where people with clinical suspicion of dengue infection lived at. RNA was extracted from pooled mosquitoes and RT-PCR was performed in these samples for detection of the four DENV serotypes.
   Results & conclusion: Out of 83 pools of adult mosquitoes collected in the field, nine were positive for DENV: five for DENV-1, two for DENV-2 and two for DENV-3. From 139 pools of adult mosquitoes reared from collected eggs, there were 17 positive pools: three for DENV-1, 10 for DENV-2, and four for DENV-3. These results are discussed in the paper in regard to the local dengue epidemiological data. The conclusions clearly point to the informative power and sensitivity of DENV entomological surveillance and to the importance of including mosquito immature forms in this strategy.
C1 [Guedes, D. R. D.; Melo-Santos, M. A. V.; Magalhaes, T.; Regis, L.; Ayres, C. F. J.] Fiocruz MS, CPqAM, Dept Entomol, Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Cordeiro, M. T.; Marques, E.; Furtado, A. F.] Fiocruz MS, CPqAM, Lab Virol & Terapia Expt, Recife, PE, Brazil.
   [Cordeiro, M. T.] Secretaria Saude Estado Pernambuco, Cent Lab, Recife, PE, Brazil.
RP Ayres, CFJ (corresponding author), Fiocruz MS, CPqAM, Dept Entomol, Fundacao Oswaldo Cruz, Av Moraes Rego S-N, Recife, PE, Brazil.
EM tans@cpqam.fiocruz.br
RI Magalhaes, Tereza/V-6632-2019; Ayres, Constancia/AAQ-3448-2020; Marques,
   Ernesto/L-4514-2013; Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto/0000-0003-3826-9358; Marques, Ernesto T.
   A/0000-0003-3826-9358
FU FIOCRUZ [Papes 0250.250. 110/2003, PDTSP-Rede Dengue RDVE-03]
FX The authors are thankful to the insectary and field teams from the
   Department of Entomology at CPqAM/FIOCRUZ. This work received financial
   support from FIOCRUZ (grants Papes 0250.250. 110/2003 and PDTSP-Rede
   Dengue RDVE-03).
CR Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56
   Arunachalam N, 2008, INDIAN J MED RES, V127, P395
   Barbosa da Silva Jarbas Jr, 2002, Epidemiol Bull, V23, P3
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Cecilio AB, 2009, BRAZ J BIOL, V69, P123, DOI 10.1590/S1519-69842009000100015
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   CORDEIRO MT, 2008, VINTE ANOS EVOLUCAO, P225
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   Fouque F, 2004, TROP MED INT HEALTH, V9, P41, DOI 10.1046/j.1365-3156.2003.01166.x
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940
   Gu W, 2004, MED VET ENTOMOL, V18, P200, DOI 10.1111/j.0269-283X.2004.00482.x
   GUBLER DJ, 1994, AM J TROP MED HYG, V50, P50, DOI 10.4269/ajtmh.1994.50.50
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272
   KHIN MM, 1983, AM J TROP MED HYG, V32, P590, DOI 10.4269/ajtmh.1983.32.590
   Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475
   Lam S K, 1993, Malays J Pathol, V15, P9
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P799, DOI 10.1590/S0074-02762002000600009
   *MIN SAUD BRAS SEC, 2008, INF EP DENG, V1
   Pinheiro VCS, 2005, MEM I OSWALDO CRUZ, V100, P833, DOI 10.1590/S0074-02762005000800003
   *PREF REC, 2009, INF EP SEM DENG
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Regis L, 2009, AN ACAD BRAS CIENC, V81, P655, DOI 10.1590/S0001-37652009000400004
   ROSEN L, 1987, AM J TROP MED HYG, V37, P398
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   WHO, 2000, STRENGTH IMPL GLOB S
   Zeidler Julianna Dias, 2008, Rev. Saúde Pública, V42, P986, DOI 10.1590/s0034-89102008000600002
NR 30
TC 33
Z9 35
U1 0
U2 10
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-9062
J9 J VECTOR DIS
JI J. Vector Borne Dis.
PD JUN
PY 2010
VL 47
IS 2
BP 67
EP 75
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 606CI
UT WOS:000278398100001
PM 20539043
DA 2020-12-08
ER

PT J
AU Braga, C
   Luna, CF
   Martelli, CM
   de Souza, WV
   Cordeiro, MT
   Alexander, N
   de Albuquerque, MDPM
   Silveira, JC
   Marques, ET
AF Braga, Cynthia
   Luna, Carlos Feitosa
   Martelli, Celina MariaTurchi
   de Souza, Wayner Vieira
   Cordeiro, Marli Tenorio
   Alexander, Neal
   Pessoa Militao de Albuquerque, Maria de Fatima
   Silveira Junior, Jose Constantino
   Marques, Ernesto T.
TI Seroprevalence and risk factors for dengue infection in
   socio-economically distinct areas of Recife, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Dengue; Seroprevalence; Risk factors; Spatial analysis
ID VIRUS-INFECTION; TRANSMISSION; EPIDEMIC; SURVEILLANCE; CIRCULATION;
   PREVENTION; SINGAPORE; DYNAMICS; CHILDREN; FEVER
AB Brazil currently accounts for the majority of dengue cases reported in the Americas, with co-circulation of DENV 1-3. Striking variation in the epidemiological pattern of infection within cities has been observed. Therefore, investigation of dengue transmission in small areas is important to formulate control strategies. A population-based household survey was performed in three diverse socio-economic and environmental areas of Recife, a large urban center of Brazil, between 2005 and 2006. Dengue serostatus and individual- and household-level risk factors for infection were collected in residents aged between 5 and 64 years. A total of 2833 individuals were examined, and their residences were geo-referenced. Anti-dengue IgG antibodies were measured using commercial ELISA. The dengue seroprevalence and the force of infection were estimated in each area. Individual and household variables associated with seropositivity were assessed by multilevel models for each area. A spatial analysis was conducted to identify risk gradients of dengue seropositivity using Generalized Additive Models (GAM). The dengue seroprevalence was 91.1%,87.4% 74.3%, respectively, in the deprived, intermediate and high socio-economic areas, inversely related to their socio-economic status. In the deprived area, 59% of children had already been exposed to dengue virus by the age of 5 years and the estimated force of infection was three times higher than that in the privileged area. The risk of infection increased with age in the three areas. Not commuting away from the area was a risk factor for seropositivity in the deprived area (OR = 2.26; 95% CI: 1.18-4.30). Number of persons per room was a risk factor for seropositivity in the intermediate (OR = 3.00; 95% CI: 3.21-7.37) and privileged areas (OR = 1.81; 95% Cl: 1.07-3.04). Living in a house, as opposed to an apartment, was a risk factor for seropositivity in the privileged area (OR = 3.62; 95% Cl: 2.43-5.41). The main difference between the privileged and other areas could be attributed to the much larger proportion of apartment dwellers. Intensive vector control, surveillance and community education should be considered in deprived urban areas where a high proportion of children are infected by an early age. (C) 2009 Published by Elsevier B.V.
C1 [Braga, Cynthia; Luna, Carlos Feitosa; de Souza, Wayner Vieira; Cordeiro, Marli Tenorio; Pessoa Militao de Albuquerque, Maria de Fatima; Silveira Junior, Jose Constantino; Marques, Ernesto T.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil.
   [Braga, Cynthia] Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
   [Martelli, Celina MariaTurchi] Univ Fed Goias, Inst Patol Trop & Saude Publ, Dept Saude Colet, Setor Univ, BR-74605050 Goiania, Go, Brazil.
   [Cordeiro, Marli Tenorio] Secretaria Saude Estado Pernambuco, Lab Cent Saude Publ, BR-50050210 Recife, PE, Brazil.
   [Alexander, Neal] Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England.
   [Pessoa Militao de Albuquerque, Maria de Fatima] Univ Fed Pernambuco, Dept Trop Med, Hosp Clin, BR-50670420 Recife, PE, Brazil.
   [Marques, Ernesto T.] Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.
RP Braga, C (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Av Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM braga@cpqam.fiocruz.br
RI Souza, Wayner V/H-3798-2013; Iats, Inct/K-2300-2013; Marques, Ernesto T.
   A/L-4967-2013; Publica, Inct Saude/J-9544-2013; Marques,
   Ernesto/L-4514-2013; Braga, Maria Cynthia/A-8204-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Marques,
   Ernesto/0000-0003-3826-9358; Braga, Maria Cynthia/0000-0002-7862-6455;
   Souza, Wayner/0000-0002-0939-9332; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU National Institute of Allergy and Infectious Diseases (NIAID/NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19 AI56541, PDTIS RVR09-FIOCRUZ]; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico -CNPqNational Council for
   Scientific and Technological Development (CNPq) [307963/2004-7,
   305947/2006-0]; Medical Research CouncilMedical Research Council UK
   (MRC) [G0700837] Funding Source: researchfish; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19AI056541,
   U19AI056541, U19AI056541, U19AI056541, U19AI056541] Funding Source: NIH
   RePORTER
FX The authors acknowledge the support of the National Institute of Allergy
   and Infectious Diseases (NIAID/NIH), Grant U19 AI56541 and PDTIS
   RVR09-FIOCRUZ. Martelli CMT, Albuquerque MFP and Souza WV were partially
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico -CNPq (scholarships 307963/2004-7, 305947/2006-0,
   respectively)
CR Barrera R, 2000, Rev Panam Salud Publica, V8, P225, DOI 10.1590/S1020-49892000000900001
   Collett D., 2002, MODELLING BINARY DAT
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P485, DOI 10.4269/ajtmh.2008.79.485
   Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   *IBGE, 2000, DEM CENS 2000 CHAR P
   *IBGE, 2009, IBGE CIT
   *ITEP, 2009, CLIM
   Kelsall JE, 1998, J ROY STAT SOC C-APP, V47, P559, DOI 10.1111/1467-9876.00128
   KO YC, 1992, AM J EPIDEMIOL, V136, P214, DOI 10.1093/oxfordjournals.aje.a116487
   Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lian CW, 2006, TROP BIOMED, V23, P85
   Almeida MCD, 2008, CAD SAUDE PUBLICA, V24, P2385, DOI 10.1590/S0102-311X2008001000019
   *PAHO, 2008, EID UPD EM REEM INF
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Torralba JM, 2007, ADV MATER RES-SWITZ, V23, P1, DOI 10.4028/www.scientific.net/AMR.23.1
   Vallee J, 2009, TROP MED INT HEALTH, V14, P1134, DOI 10.1111/j.1365-3156.2009.02319.x
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5
   Vasconcelos PFC, 1998, REV SAUDE PUBL, V32, P447, DOI 10.1590/S0034-89101998000500007
   WHO, 2007, GUID PLAQ RED NEUTR
   *WHO, 2009, 117 WHO
   Wood S., 2006, GEN ADDITIVE MODELS
   Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
NR 38
TC 111
Z9 114
U1 0
U2 30
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAR
PY 2010
VL 113
IS 3
BP 234
EP 240
DI 10.1016/j.actatropica.2009.10.021
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 570KZ
UT WOS:000275677700005
PM 19896921
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Nascimento, EJM
   Braga-Neto, U
   Calzavara-Silva, CE
   Gomes, ALV
   Abath, FGC
   Brito, CAA
   Cordeiro, MT
   Silva, AM
   Magalhaes, C
   Andrade, R
   Gil, LHVG
   Marques, ETA
AF Nascimento, Eduardo J. M.
   Braga-Neto, Ulisses
   Calzavara-Silva, Carlos E.
   Gomes, Ana L. V.
   Abath, Frederico G. C.
   Brito, Carlos A. A.
   Cordeiro, Marli T.
   Silva, Ana M.
   Magalhaes, Cecilia
   Andrade, Raoni
   Gil, Laura H. V. G.
   Marques, Ernesto T. A., Jr.
TI Gene Expression Profiling during Early Acute Febrile Stage of Dengue
   Infection Can Predict the Disease Outcome
SO PLOS ONE
LA English
DT Article
ID BOLSTERED ERROR ESTIMATION; T-CELL RESPONSES; HEMORRHAGIC-FEVER;
   PERIPHERAL-BLOOD; VIRUS-INFECTIONS; SHOCK-SYNDROME; ELEVATED LEVELS;
   SEVERITY; ACTIVATION; APOPTOSIS
AB Background: We report the detailed development of biomarkers to predict the clinical outcome under dengue infection. Transcriptional signatures from purified peripheral blood mononuclear cells were derived from whole-genome gene-expression microarray data, validated by quantitative PCR and tested in independent samples.
   Methodology/Principal Findings: The study was performed on patients of a well-characterized dengue cohort from Recife, Brazil. The samples analyzed were collected prospectively from acute febrile dengue patients who evolved with different degrees of disease severity: classic dengue fever or dengue hemorrhagic fever (DHF) samples were compared with similar samples from other non-dengue febrile illnesses. The DHF samples were collected 2-3 days before the presentation of the plasma leakage symptoms. Differentially-expressed genes were selected by univariate statistical tests as well as multivariate classification techniques. The results showed that at early stages of dengue infection, the genes involved in effector mechanisms of innate immune response presented a weaker activation on patients who later developed hemorrhagic fever, whereas the genes involved in apoptosis were expressed in higher levels.
   Conclusions/Significance: Some of the gene expression signatures displayed estimated accuracy rates of more than 95%, indicating that expression profiling with these signatures may provide a useful means of DHF prognosis at early stages of infection.
RP Nascimento, EJM (corresponding author), Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes CPqAM, Dept Virol & Terapia Expt, Recife, PE, Brazil.
EM marques@pitt.edu
RI Nascimento, Eduardo/J-4590-2014; Publica, Inct Saude/J-9544-2013;
   Marques, Ernesto/L-4514-2013; Marques, Ernesto T. A/L-4967-2013
OI Nascimento, Eduardo/0000-0002-9851-2332; Marques,
   Ernesto/0000-0003-3826-9358; Marques, Ernesto T. A/0000-0003-3826-9358;
   CALZAVARA-SILVA, CARLOS/0000-0002-1406-6401
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI056541, U19AI056541, U19AI056541, U19AI056541, U19AI056541]
   Funding Source: NIH RePORTER; Direct For Computer & Info Scie &
   EnginrNational Science Foundation (NSF)NSF - Directorate for Computer &
   Information Science & Engineering (CISE) [0845407] Funding Source:
   National Science Foundation; NIAID NIH HHSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [U19
   AI056541, U19 AI56541] Funding Source: Medline
CR Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x
   Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x
   BRAGA UMD, 2005, EURASIP BOOK SERIES
   Braga-Neto U, 2004, PATTERN RECOGN, V37, P1267, DOI 10.1016/j.patcog.2003.08.017
   Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021
   Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096
   Clementi M, 2006, REPROD TOXICOL, V21, P345, DOI 10.1016/j.reprotox.2005.08.006
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072
   Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.1080/10618600.1996.10474713
   Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x
   Myint KS, 2006, J INFECT DIS, V194, P600, DOI 10.1086/506451
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   *OPAS, 1995, DENG DENG HEM AM GUI
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Pettiford JN, 2002, CLIN EXP IMMUNOL, V128, P110, DOI 10.1046/j.1365-2249.2002.01813.x
   Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   SCHERER CA, 2007, VACCINE
   Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001
   Sima C, 2005, PATTERN RECOGN, V38, P2472, DOI 10.1016/j.patcog.2005.03.026
   Sima C, 2005, BIOINFORMATICS, V21, P1046, DOI 10.1093/bioinformatics/bti081
   Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162
   Soundravally R, 2007, HUM IMMUNOL, V68, P973, DOI 10.1016/j.humimm.2007.09.007
   Suharti C, 2002, THROMB HAEMOSTASIS, V87, P42
   Tan GK, 2009, CURR OPIN INFECT DIS, V22, P302, DOI 10.1097/QCO.0b013e328329ae32
   Tseng CS, 2005, FEMS IMMUNOL MED MIC, V43, P99, DOI 10.1016/j.femsim.2004.10.004
   Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699
   van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967
   *WHO, 1999, TREATM DENG FEV DENG
   Yunta M, 2003, ONCOGENE, V22, P1219, DOI 10.1038/sj.onc.1206183
NR 49
TC 48
Z9 48
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 19
PY 2009
VL 4
IS 11
AR e7892
DI 10.1371/journal.pone.0007892
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 522NJ
UT WOS:000272004600001
PM 19936257
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-08
ER

PT J
AU da Silva, ANMR
   Nascimento, EJM
   Cordeiro, MT
   Gil, LHVG
   Abath, FGC
   Montenegro, SML
   Marques, ETA
AF Rangel da Silva, Andrea N. M.
   Nascimento, Eduardo J. M.
   Cordeiro, Marli Tenorio
   Gil, Laura H. V. G.
   Abath, Frederico G. C.
   Montenegro, Silvia M. L.
   Marques, Ernesto T. A., Jr.
TI Identification of Continuous Human B-Cell Epitopes in the Envelope
   Glycoprotein of Dengue Virus Type 3 (DENV-3)
SO PLOS ONE
LA English
DT Article
ID MONOCLONAL-ANTIBODIES; SYNTHETIC PEPTIDE; NEUTRALIZING ANTIBODY;
   REACTIVE EPITOPES; SWISS-MODEL; DOMAIN-III; PROTEIN; DETERMINANTS;
   RECOGNITION; PREDICTION
AB Background: Dengue virus infection is a growing global public health concern in tropical and subtropical regions of the world. Dengue vaccine development has been hampered by concerns that cross-reactive immunological memory elicited by a candidate vaccine could increase the risk of development of more severe clinical forms. One possible strategy to reduce risks associated with a dengue vaccine is the development of a vaccine composed of selected critical epitopes of each of the serotypes.
   Methodology/Principal Findings: Synthetic peptides were used to identify B-cell epitopes in the envelope (E) glycoprotein of dengue virus type 3 (DENV-3). Eleven linear, immunodominant epitopes distributed in five regions at amino acid (aa) positions: 51-65, 71-90, 131-170, 196-210 and 246-260 were identified by employing an enzyme-linked immunosorbent assay (ELISA), using a pool of human sera from dengue type 3 infected individuals. Peptides 11 (aa51-65), 27 and 28 (aa131-150) also reacted with dengue 1 (DENV-1) and dengue 2 (DENV-2) patient sera as analyzed through the ROC curves generated for each peptide by ELISA and might have serotype specific diagnostic potential. Mice immunized against each one of the five immunogenic regions showed epitopes 51-65, 131-170, 196-210 and 246-260 elicited the highest antibody response and epitopes 131-170, 196-210 and 246-260, elicited IFN-gamma production and T CD4+ cell response, as evaluated by ELISA and ELISPOT assays respectively.
   Conclusions/Significance: Our study identified several useful immunodominant IgG-specific epitopes on the envelope of DENV-3. They are important tools for understanding the mechanisms involved in antibody dependent enhancement and immunity. If proven protective and safe, in conjunction with others well-documented epitopes, they might be included into a candidate epitope-based vaccine.
RP da Silva, ANMR (corresponding author), Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil.
EM marques@pitt.edu
RI Marques, Ernesto T. A/L-4967-2013; montenegro, silvia/AAD-9090-2020;
   Publica, Inct Saude/J-9544-2013; Marques, Ernesto/L-4514-2013;
   Nascimento, Eduardo/J-4590-2014
OI Marques, Ernesto T. A/0000-0003-3826-9358; Marques,
   Ernesto/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI05641] Funding Source: Medline
CR AnandaRao R, 2005, VIRUS RES, V112, P60, DOI 10.1016/j.virusres.2005.03.022
   Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100
   Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   HECHAVARRIA A, 2002, MANUAL PROCEDIMIENTO
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Huang JH, 1999, J MED VIROL, V57, P1, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;1::AID-JMV1&gt;3.0.CO;2-T
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   MATHEWS JH, 1991, J VIROL, V65, P5141, DOI 10.1128/JVI.65.10.5141-5148.1991
   Matsui K, 2009, VIROLOGY, V384, P16, DOI 10.1016/j.virol.2008.11.013
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Reynolds J, 2009, CLIN EXP IMMUNOL, V155, P311, DOI 10.1111/j.1365-2249.2008.03833.x
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   ROEHRIG JT, 1992, J VIROL, V66, P3385, DOI 10.1128/JVI.66.6.3385-3390.1992
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Serafin IL, 2001, ARCH VIROL, V146, P2469, DOI 10.1007/s007050170017
   SINGH B, 1980, J IMMUNOL, V124, P1336
   Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885
   Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0
   Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001
   Yamada KI, 2002, J CLIN VIROL, V24, P203, DOI 10.1016/S1386-6532(01)00250-5
   Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
NR 37
TC 20
Z9 21
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 13
PY 2009
VL 4
IS 10
AR e7425
DI 10.1371/journal.pone.0007425
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 506WQ
UT WOS:000270808300008
PM 19826631
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Nascimento, EJM
   Silva, AM
   Cordeiro, MT
   Brito, CA
   Gil, LHVG
   Braga-Neto, U
   Marques, ETA
AF Nascimento, Eduardo J. M.
   Silva, Ana M.
   Cordeiro, Marli T.
   Brito, Carlos A.
   Gil, Laura H. V. G.
   Braga-Neto, Ulisses
   Marques, Ernesto T. A.
TI Alternative Complement Pathway Deregulation Is Correlated with Dengue
   Severity
SO PLOS ONE
LA English
DT Article
AB Background: The complement system, a key component that links the innate and adaptive immune responses, has three pathways: the classical, lectin, and alternative pathways. In the present study, we have analyzed the levels of various complement components in blood samples from dengue fever (DF) and dengue hemorrhagic fever (DHF) patients and found that the level of complement activation is associated with disease severity.
   Methods and Results: Patients with DHF had lower levels of complement factor 3 (C3; p = 0.002) and increased levels of C3a, C4a and C5a (p<0.0001) when compared to those with the less severe form, DF. There were no significant differences between DF and DHF patients in the levels of C1q, immunocomplexes (CIC-CIq) and CRP. However, small but statistically significant differences were detected in the levels of MBL. In contrast, the levels of two regulatory proteins of the alternative pathway varied widely between DF and DHF patients: DHF patients had higher levels of factor D (p = 0.01), which cleaves factor B to yield the active (C3bBb) C3 convertase, and lower levels of factor H (p = 0.03), which inactivates the (C3bBb) C3 convertase, than did DF patients. When we considered the levels of factors D and H together as an indicator of (C3bBb) C3 convertase regulation, we found that the plasma levels of these regulatory proteins in DHF patients favored the formation of the (C3bBb) C3 convertase, whereas its formation was inhibited in DF patients (p<0.0001).
   Conclusion: The data suggest that an imbalance in the levels of regulatory factors D and H is associated with an abnormal regulation of complement activity in DHF patients.
RP Nascimento, EJM (corresponding author), Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21218 USA.
EM emarques@jhmi.edu
RI Publica, Inct Saude/J-9544-2013; Marques, Ernesto/L-4514-2013; Marques,
   Ernesto T. A/L-4967-2013; Nascimento, Eduardo/J-4590-2014
OI Marques, Ernesto/0000-0003-3826-9358; Marques, Ernesto T.
   A/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI056541, U19 AI56541] Funding Source:
   Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI056541, U19AI056541, U19AI056541, U19AI056541,
   U19AI056541] Funding Source: NIH RePORTER; Division of Computing and
   Communication FoundationsNational Science Foundation (NSF)NSF -
   Directorate for Computer & Information Science & Engineering (CISE)
   [0845407] Funding Source: National Science Foundation
CR Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005
   ACIOLISANTOS B, PNAS UNPUB
   Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x
   Bokisch V A, 1973, Trans Assoc Am Physicians, V86, P102
   BOONPUCKNAVIG S, 1979, AM J TROP MED HYG, V28, P881, DOI 10.4269/ajtmh.1979.28.881
   Chen LJ, 2006, MOL VIS, V12, P1536
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396
   Coppo Paul, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P36
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cordeiro MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004945
   Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102
   de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215
   Fakhouri F, 2008, BLOOD, V112, P4542, DOI 10.1182/blood-2008-03-144691
   Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023
   HARBOE M, 2008, J CELL MOL MED
   Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Karpman D, 2006, SEMIN THROMB HEMOST, V32, P128, DOI 10.1055/s-2006-939769
   Kavanagh D, 2008, ANNU REV MED, V59, P293, DOI 10.1146/annurev.med.59.060106.185110
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LARUSSA VF, 1995, BAILLIERE CLIN HAEM, V8, P249, DOI 10.1016/S0950-3536(05)80240-9
   Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L
   Lin CF, 2006, VIRAL IMMUNOL, V19, P127, DOI 10.1089/vim.2006.19.127
   Lutz HU, 2007, MOL IMMUNOL, V44, P3862, DOI 10.1016/j.molimm.2007.06.146
   Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015
   Meri S, 2007, ANN NY ACAD SCI, V1109, P93, DOI 10.1196/annals.1398.011
   MITRAKUL C, 1977, AM J TROP MED HYG, V26, P975, DOI 10.4269/ajtmh.1977.26.975
   Morrison TE, 2008, CURR DRUG TARGETS, V9, P165
   NASCIMENTO EJM, J CLIN INVESTI UNPUB
   Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007
   Nishioka K, 1974, Allerg Immunol (Leipz), V20-21, P385
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Saito M, 2004, CLIN EXP IMMUNOL, V138, P299, DOI 10.1111/j.1365-2249.2004.02626.x
   SOBEL AT, 1975, J EXP MED, V142, P139, DOI 10.1084/jem.142.1.139
   Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073
   Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153
   Su DHW, 2007, OPHTHALMOLOGY, V114, P1743, DOI 10.1016/j.ophtha.2007.03.054
   Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008
   Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699
   Villar-Centeno LA, 2008, AM J TROP MED HYG, V78, P370, DOI 10.4269/ajtmh.2008.78.370
   Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406
   Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635
   Wiersinga WJ, 2006, CLIN INFECT DIS, V43, P800, DOI 10.1086/507111
   Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07
NR 51
TC 80
Z9 80
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 26
PY 2009
VL 4
IS 8
AR e6782
DI 10.1371/journal.pone.0006782
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 488FQ
UT WOS:000269335000025
PM 19707565
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Gadelha, DNB
   Ventura, BV
   Ventura, LMVD
   Miller, MT
   Cordeiro, MT
   de Castro, CMMB
AF Benevides Gadelha, Diego Nery
   Ventura, Bruna Vieira
   Vieira de Oliveira Ventura, Liana Maria
   Miller, Marilyn T.
   Cordeiro, Marli Tenorio
   Machado Barbosa de Castro, Celia Maria
TI Humoral immune response to dengue virus in mothers/children: relation
   with Mobius sequence
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA Portuguese
DT Article
DE Mobius syndrome/etiology; Antibody formation; Dengue; Dengue virus
ID MOEBIUS-SYNDROME; FEVER
AB Purpose: To investigate the humoral immune response to dengue virus in patients with Mobius sequence and their mothers, assessing the relation between this infection during pregnancy and Mobius sequence. Methods: The medical records were reviewed, and a questionnaire was answered by each mother. IgG ELISA was performed in 35 patients and their mothers. A plaque reduction neutralization test was further done in the mothers who reported a viral infection during pregnancy and in their children for determining which dengue serotype virus had caused the infection. Results: Fever, headache and/or retrobulbar pain during pregnancy was referred by eighteen (51.4%) mothers. Three (8.6%) reported dengue during the first or second quarteers of pregnancy. When cross analyzing the mothers and their respective children serological results, 57.1% of them matched. Of the three mothers with clinical diagnosis of viral infection during pregnancy, one and its respective children had a positive plaque reduction neutralization test for dengue serotype three (DENV-3), this serotype reached Pernambuco in 2002, which excludes the possibility of a vertical transmission to the children. Conclusion: The serology of the cases that had clinical diagnosis of dengue during pregnancy proved to be incompatible with the hypothesis of the disease vertical transmission. Therefore, in the present serie, the dengue virus infection can not be considered as a factor involved in the genesis of Mobius sequence.
C1 [Benevides Gadelha, Diego Nery; Ventura, Bruna Vieira; Vieira de Oliveira Ventura, Liana Maria; Miller, Marilyn T.; Cordeiro, Marli Tenorio; Machado Barbosa de Castro, Celia Maria] FAV, BR-50070170 Recife, PE, Brazil.
RP Gadelha, DNB (corresponding author), FAV, Rua Soledade 170, BR-50070170 Recife, PE, Brazil.
EM fav@fundacaoaltinoventura.org.br
RI Ventura, Bruna/N-2724-2018; Ventura, Liana Vieira O/N-6151-2018
OI Ventura, Bruna/0000-0003-4333-3932; Ventura, Liana Vieira
   O/0000-0001-6529-6883
CR AMAYA LG, 1990, BINOCULAR VISION Q, V5, P119
   Barata EAMD, 2001, REV SAUDE PUBL, V35, P237, DOI 10.1590/S0034-89102001000300004
   BAVINCK JNB, 1986, AM J MED GENET, V23, P903, DOI 10.1002/ajmg.1320230405
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, GUIA VIG EP
   Carles G, 2000, J Gynecol Obstet Biol Reprod (Paris), V29, P758
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   CORDEIRO MT, 2002, 13 ENCONTRO NACL VIR, V7, P54
   COURTENS W, 1992, J PEDIATR-US, V121, P833, DOI 10.1016/S0022-3476(05)81934-1
   da Costa AIP, 1998, REV SAUDE PUBL, V32, P232, DOI 10.1590/S0034-89101998000300005
   DCRUZ OF, 1993, J CHILD NEUROL, V8, P260, DOI 10.1177/088307389300800310
   Fontenelle L, 2001, ARQ NEURO-PSIQUIAT, V59, P812, DOI 10.1590/S0004-282X2001000500031
   Henderson JL, 1939, BRAIN, V62, P381, DOI 10.1093/brain/62.4.381
   HINRICHSEN SL, 2005, DOENCAS INFECCIOSAS, P115
   ISMAIL NA, 2007, ASIAN J TROP MED PUB, V38, P195
   Ismail Nor Azlin Mohamed, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P681
   KUMAR D, 1990, J MED GENET, V27, P122, DOI 10.1136/jmg.27.2.122
   MILLER E, 1982, LANCET, V2, P781
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Phupong Vorapong, 2001, BMC Pregnancy Childbirth, V1, P7, DOI 10.1186/1471-2393-1-7
   Restrepo Berta N, 2003, Biomedica, V23, P416
   SHARMA JB, 1992, INT J GYNECOL OBSTET, V39, P291, DOI 10.1016/0020-7292(92)90260-P
   Shashikiran N D, 2004, J Indian Soc Pedod Prev Dent, V22, P96
   Stromland Kerstin, 2002, Eur J Paediatr Neurol, V6, P35, DOI 10.1053/ejpn.2001.0540
   VENTURA LMV, 2001, THESIS U FEDERAL MIN
   VOIRIN J, 1991, ARCH FR PEDIATR, V48, P35
   Waduge R, 2006, J CLIN VIROL, V37, P27, DOI 10.1016/j.jcv.2006.06.002
NR 26
TC 1
Z9 1
U1 0
U2 1
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAY-JUN
PY 2009
VL 72
IS 3
BP 327
EP 331
DI 10.1590/S0004-27492009000300009
PG 5
WC Ophthalmology
SC Ophthalmology
GA 558OO
UT WOS:000274754000009
PM 19668961
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Cordeiro, MT
   Braga-Neto, U
   Nogueira, RMR
   Marques, ETA
AF Cordeiro, Marli Tenorio
   Braga-Neto, Ulisses
   Ribeiro Nogueira, Rita Maria
   Marques, Ernesto T. A., Jr.
TI Reliable Classifier to Differentiate Primary and Secondary Acute Dengue
   Infection Based on IgG ELISA
SO PLOS ONE
LA English
DT Article
AB Background: Dengue virus infection causes a wide spectrum of illness, ranging from sub-clinical to severe disease. Severe dengue is associated with sequential viral infections. A strict definition of primary versus secondary dengue infections requires a combination of several tests performed at different stages of the disease, which is not practical.
   Methods and Findings: We developed a simple method to classify dengue infections as primary or secondary based on the levels of dengue-specific IgG. A group of 109 dengue infection patients were classified as having primary or secondary dengue infection on the basis of a strict combination of results from assays of antigen-specific IgM and IgG, isolation of virus and detection of the viral genome by PCR tests performed on multiple samples, collected from each patient over a period of 30 days. The dengue-specific IgG levels of all samples from 59 of the patients were analyzed by linear discriminant analysis (LDA), and one-and two-dimensional classifiers were designed. The one-dimensional classifier was estimated by bolstered resubstitution error estimation to have 75.1% sensitivity and 92.5% specificity. The two-dimensional classifier was designed by taking also into consideration the number of days after the onset of symptoms, with an estimated sensitivity and specificity of 91.64% and 92.46%. The performance of the two-dimensional classifier was validated using an independent test set of standard samples from the remaining 50 patients. The classifications of the independent set of samples determined by the two-dimensional classifiers were further validated by comparing with two other dengue classification methods: hemagglutination inhibition (HI) assay and an in-house anti-dengue IgG-capture ELISA method. The decisions made with the two-dimensional classifier were in 100% accordance with the HI assay and 96% with the in-house ELISA.
   Conclusions: Once acute dengue infection has been determined, a 2-D classifier based on common dengue virus IgG kits can reliably distinguish primary and secondary dengue infections. Software for calculation and validation of the 2-D classifier is made available for download.
C1 [Cordeiro, Marli Tenorio; Braga-Neto, Ulisses; Marques, Ernesto T. A., Jr.] Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Cent Lab Publ Hlth, Secretar Saude Estado Pernambuco, Recife, PE, Brazil.
   [Ribeiro Nogueira, Rita Maria] Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Braga-Neto, Ulisses] Texas A&M Univ, Dept Electr & Comp Engn, College Stn, TX USA.
   [Marques, Ernesto T. A., Jr.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA.
   [Marques, Ernesto T. A., Jr.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA.
RP Cordeiro, MT (corresponding author), Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil.
EM emarques@jhmi.edu
RI Publica, Inct Saude/J-9544-2013; Marques, Ernesto/L-4514-2013; Marques,
   Ernesto T. A/L-4967-2013
OI Marques, Ernesto/0000-0003-3826-9358; Marques, Ernesto T.
   A/0000-0003-3826-9358
FU National Institute of Allergy and Infectious Diseases (NIAID/NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19 AI56541, N01 AI 40085]; Brazilian National
   Research Council (CNPq)National Council for Scientific and Technological
   Development (CNPq) [DCR 35.0382/2004.2]; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI040085, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, U19AI056541, R01AI040085,
   U19AI056541, R01AI040085, R01AI040085, R01AI040085, U19AI056541,
   R01AI040085, R01AI040085, R01AI040085, R01AI040085, U19AI056541,
   R01AI040085, R01AI040085, R21AI040085, U19AI056541, R01AI040085,
   R01AI040085, R01AI040085, R01AI040085, R01AI040085] Funding Source: NIH
   RePORTER; Division of Computing and Communication FoundationsNational
   Science Foundation (NSF)NSF - Directorate for Computer & Information
   Science & Engineering (CISE) [0845407] Funding Source: National Science
   Foundation
FX The authors would like to acknowledge the support of the National
   Institute of Allergy and Infectious Diseases (NIAID/NIH), under Grants
   U19 AI56541 and N01 AI 40085. Dr. Braga-Neto would like to acknowledge
   the support of the Brazilian National Research Council (CNPq), under
   Grant DCR 35.0382/2004.2. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR BRAGA UM, 2005, GENOMIC SIGNAL PROCE
   Braga-Neto U, 2004, PATTERN RECOGN, V37, P1267, DOI 10.1016/j.patcog.2003.08.017
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   CHUNGUE E, 1989, T ROY SOC TROP MED H, V83, P708, DOI 10.1016/0035-9203(89)90404-5
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead Scott B., 1997, P23
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   RDevelopmentCoreTeam, 2005, R LANG ENV STAT COMP
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Schilling S, 2004, J CLIN VIROL, V31, P179, DOI 10.1016/j.jcv.2004.03.020
   Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693
   Vorndam AV, 1997, DENGUE DENGUE HEMORR
   *WORLD ORG VOLC OB, 1997, DIR VOLC OBS 1996 19, P1
NR 23
TC 29
Z9 29
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 2
PY 2009
VL 4
IS 4
AR e4945
DI 10.1371/journal.pone.0004945
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 437PZ
UT WOS:000265500700003
PM 19340301
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Oliveira, MJC
   Cordeiro, MT
   Costa, FM
   Murakami, G
   da Silva, AMS
   Travassos, RC
   Magalhaes, V
AF Couto Oliveira, Maria Jose
   Cordeiro, Marli Tenorio
   Costa, Fabianni Menezes
   Murakami, Gabriela
   Sinicio da Silva, Ana Maria
   Travassos, Risalva Correia
   Magalhaes, Vera
TI Frequency of measles, rubella, dengue and erythema infectiosum among
   suspected cases of measles and rubella in the State of Pernambuco
   between 2001 and 2004
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article
DE Measles; Rubella; Dengue; Erythema infectiosum; Parvovirus B19
ID RIO-DE-JANEIRO; PARVOVIRUS B19; BRAZIL; RASH; ILLNESSES; ETIOLOGY
AB This study had the aim of investigating the frequency of measles, rubella, dengue and erythema infectiosum among suspected cases of measles and/or rubella in the State of Pernambuco, Brazil. A total of 1,161 serum samples collected between 2001 and 2004 were tested for these four viral diseases, using enzyme immunoassays to detect IgM antibodies. Out of this total, 276 (23.8%) samples were positive for one of the four viral diseases analyzed. There were 196 positive cases (16.9%) for dengue, 38 (3.3%) for erythema infectiosum (parvovirus B19), 32 (2.8%) for rubella and 10 (0.9%) for measles. Among the suspected cases of measles and rubella, dengue infection was the most frequent, followed by parvovirus B19. The similarity of the clinical manifestations among rash diseases contributes towards making it difficult to diagnose measles, rubella, dengue and erythema infectiosum on clinical grounds alone. It must be emphasized that the four tests used were insufficient for diagnosing 76.2% of the febrile and rash diseases notified. This is the first study bringing evidence of human parvovirus B19 circulation in Pernambuco.
C1 [Couto Oliveira, Maria Jose; Cordeiro, Marli Tenorio; Sinicio da Silva, Ana Maria; Travassos, Risalva Correia] Secretaria Saude Estado Pernambuco, Lab Cent Saude Publ, Recife, PE, Brazil.
   [Couto Oliveira, Maria Jose] Univ Fed Pernambuco, Setor Virol, Lab Cent Saude Publ Pernambuco, Programa Posgrad Med Trop, BR-50050210 Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Ctr Pesquisas Ageu Magalhaes, Lab Virol & Terapia Expt, Recife, PE, Brazil.
   [Magalhaes, Vera] Univ Fed Pernambuco, Dept Trop Med, BR-50050210 Recife, PE, Brazil.
RP Oliveira, MJC (corresponding author), Univ Fed Pernambuco, Setor Virol, Lab Cent Saude Publ Pernambuco, Programa Posgrad Med Trop, Praca Oswaldo Cruz S-N, BR-50050210 Recife, PE, Brazil.
EM mariajosecouto@hotmail.com
CR ANDERSON LJ, 1986, J CLIN MICROBIOL, V24, P522, DOI 10.1128/JCM.24.4.522-526.1986
   Aratijo T. P., 2002, REV SOC BRAS MED TRO, V35, P579
   de Oliveira SA, 2006, REV SAUDE PUBL, V40, P450, DOI 10.1590/S0034-89102006000300013
   BROWN KE, 2005, PRINCIPLES PRACTICE, P1891
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   CUBEL RC, 1996, REV SOC BRAS MED TRO, V30, P15
   Davidkin I, 1998, J INFECT DIS, V178, P1567, DOI 10.1086/314513
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   de Figueiredo RMP, 2005, REV SOC BRAS MED TRO, V38, P396, DOI 10.1590/S0037-86822005000500006
   Dietz V, 2004, B WORLD HEALTH ORGAN, V82, P852
   *FUND NAC SAUD, 2002, GUIA VIG EP
   Gonçalves Neto Vicente Silva, 2004, Cad. Saúde Pública, V20, P1427, DOI 10.1590/S0102-311X2004000500039
   Kerr JR, 1996, EUR J CLIN MICROBIOL, V15, P10, DOI 10.1007/BF01586181
   LINHARES MIS, 1991, MICROBIOL IMMUNOL, V35, P1023, DOI 10.1111/j.1348-0421.1991.tb01624.x
   *MIN SAUD, 2003, MAN VIG EP DOENC EX
   *MIN SAUD, 2007, COORD GER LAB SAUD P
   Oliveira MI, 2002, REV SAUDE PUBL, V36, P155, DOI [10.1590/S0034-89102002000200006, 10.1590/s0034-89102002000200006]
   Oliveira SA, 2001, EPIDEMIOL INFECT, V127, P509, DOI 10.1017/S0950268801005908
   OLIVEIRA SA, 2006, PAN AM J PUBLIC HLTH, V19, P229
   Prevots DR, 2003, J INFECT DIS, V187, pS111, DOI 10.1086/368030
   Ramsay M, 2002, ARCH DIS CHILD, V87, P202, DOI 10.1136/adc.87.3.202
   Scott Lycia A, 2003, Dermatol Online J, V9, P4
   Seve P, 2004, REV MED INTERNE, V25, P740, DOI 10.1016/j.revmed.2004.02.026
   SHIRLEY JA, 1987, J MED VIROL, V21, P369, DOI 10.1002/jmv.1890210409
   Vieira MGS, 2002, MEM I OSWALDO CRUZ, V97, P979, DOI 10.1590/S0074-02762002000700009
   Wermelinger MCD, 2002, J CLIN VIROL, V25, P223, DOI 10.1016/S1386-6532(02)00014-8
   Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840
NR 27
TC 4
Z9 4
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2008
VL 41
IS 4
BP 338
EP 344
DI 10.1590/S0037-86822008000400004
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 369DS
UT WOS:000260675100004
PM 18853004
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Cordeiro, MT
   Silva, AM
   Brito, CAA
   Nascimento, EJM
   Magalhaes, MCF
   Guimaraes, GF
   Lucena-Silva, N
   de Carvalho, EMF
   Marques, ETA
AF Cordeiro, Marli Tenorio
   Silva, Ana Maria
   Brito, Carlos A. A.
   Nascimento, Eduardo J. M.
   Magalhaes, Maria Cecilia F.
   Guimaraes, Georgia F.
   Lucena-Silva, Norma
   Freese de Carvalho, Eduardo M.
   Marques, Ernesto T. A., Jr.
TI Characterization of a dengiie patient cohort in Recife, Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DENGUE HEMORRHAGIC-FEVER; RIO-DE-JANEIRO; PRIMARY-SCHOOL CHILDREN; VIRUS
   TYPE-3; VIROLOGICAL FEATURES; KAMPHAENG PHET; CO-CIRCULATION;
   EPIDEMIOLOGY; SURVEILLANCE; STATE
AB From 2004 to 2006, 658 patients with suspected dengue virus infections were enrolled in a clinical dengue cohort established in Recife, Pernambuco, located at the northeastern region of Brazil. A total of 2,364 blood samples were collected, and serum, plasma, and cells were cryopreserved. Among the suspected cases, 354 (54%) were confirmed as acute DENV-3 infection based on reverse transcription-polymerase chain reaction, virus isolation, and ELISA-IgM. According to WHO criteria, 29.4% of the positive acute cases were classified as dengue fever (DF) and 8.2% of the cases as dengue hemorrhagic fever (DHF), grade 1 or 2. The DHF cases represent 100% of those confirmed in Recife during the period of the study. The dengue cases that did not fulfill the definition of either DHF or DF were classified as DF complicated and accounted for 44.0% of the cases. All the acute cases were classified as either primary or secondary acute dengue virus infections. Secondary infection was predominant in patients with DF; however, there was no predominance of either primary or secondary infections in patients with DHF.
C1 [Cordeiro, Marli Tenorio; Silva, Ana Maria; Brito, Carlos A. A.; Nascimento, Eduardo J. M.; Magalhaes, Maria Cecilia F.; Guimaraes, Georgia F.] CPqAM, Lab Virol & Terapia Expt, BR-50670420 Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Estado Pernambuco, Secretaria Saude, Lab Cent Saude Publ, BR-50050210 Recife, PE, Brazil.
   [Nascimento, Eduardo J. M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.
   Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD USA.
   [Brito, Carlos A. A.] Univ Fed Pernambuco, Hosp Esperanca, Dept Clin Med, Recife, PE, Brazil.
   [Lucena-Silva, Norma] Ctr Pesquisas Aggeu Magalhaes, Dept Imunol, BR-50670420 Recife, PE, Brazil.
   [Freese de Carvalho, Eduardo M.] Ctr Pesquisas Aggeu Magalhaes, Dept Saude Coletiva, BR-50670420 Recife, PE, Brazil.
RP Marques, ETA (corresponding author), 725 Wolf St,Biophys Build Room 307A, Baltimore, MD 21205 USA.
EM marli@cpqam.fiocruz.br; anasilva@cpqam.fiocruz.br;
   cbrito@cpqam.fiocruz.br; enacimento@cpqam.fiocruz.br;
   cecimag@cpqam.fiocruz.br; georgia@cpqam.fiocruz.br;
   nlucena@cpqam.fiocruz.br; freese@cpqam.fiocruz.br; emarques@jhmi.edu
RI Lucena-Silva, Norma/AAH-9437-2019; Marques, Ernesto T. A/L-4967-2013;
   Nascimento, Eduardo/J-4590-2014; Marques, Ernesto/L-4514-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Nascimento,
   Eduardo/0000-0002-9851-2332; Marques, Ernesto/0000-0003-3826-9358
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI56541] Funding Source: Medline;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI056541, U19AI056541, U19AI056541, U19AI056541, U19AI056541]
   Funding Source: NIH RePORTER
CR Anantapreecha S, 2005, EPIDEMIOL INFECT, V133, P503, DOI 10.1017/S0950268804003541
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Campagna Delmina de S., 2006, J. Pediatr. (Rio J.), V82, P354, DOI [10.1590/S0021-75572006000600008, 10.2223/JPED.1522]
   Chadee DD, 2007, ANN TROP MED PARASIT, V101, P69, DOI 10.1179/136485907X157059
   Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   da Costa AIP, 1998, REV SAUDE PUBL, V32, P232, DOI 10.1590/S0034-89101998000300005
   Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017
   de Castro JAF, 2003, MEM I OSWALDO CRUZ, V98, P1021, DOI 10.1590/S0074-02762003000800007
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   Duarte HHP, 2006, REV SAUDE PUBL, V40, P134, DOI 10.1590/S0034-89102006000100021
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412
   Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Kochel TJ, 2005, J INFECT DIS, V191, P1000, DOI 10.1086/427511
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   MARQUES ETA, IN PRESS CAD SAUDE P
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   *MIN SAUD BRAZ SEC, 2005, DENG DIAGN MAN CLIN
   Montenegro D, 2006, REV SOC BRAS MED TRO, V39, P9, DOI 10.1590/S0037-86822006000100002
   MYINT KS, 2006, CELLULAR IMMUNE ACTI, V194, P600
   Neto RJP, 2005, BRAZ J MED BIOL RES, V38, P843, DOI 10.1590/S0100-879X2005000600005
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Nunes-Araujo FRF, 2003, ANN TROP MED PARASIT, V97, P415, DOI 10.1179/000349803235002263
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rodriguez-Roche R, 2005, EMERG INFECT DIS, V11, P773
   Santos S. R. A., 2003, Dengue Bulletin, V27, P156
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   Uzcategui NY, 2003, J GEN VIROL, V84, P1569, DOI 10.1099/vir.0.18807-0
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 54
TC 56
Z9 57
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2007
VL 77
IS 6
BP 1128
EP 1134
DI 10.4269/ajtmh.2007.77.1128
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 248AH
UT WOS:000252123200026
PM 18165535
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Cordeiro, MT
   Schatzmayr, HG
   Nogueira, RMR
   de Oliveira, VF
   de Melo, WT
   de Carvalho, EF
AF Cordeiro, Marli Tenorio
   Schatzmayr, Hermann Goncalves
   Nogueira, Rita Maria Ribeiro
   de Oliveira, Valdete Felix
   de Melo, Wellinton Tavares
   de Carvalho, Eduardo Freese
TI Dengue and dengue hemorrhagic fever in the State of Pernambuco,
   1995-2006
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE dengue; dengue virus; dengue hemorrhagic fever; epidemiology
ID RIO-DE-JANEIRO; CO-CIRCULATION; VIRUS TYPE-3; BRAZIL; EPIDEMIC;
   SURVEILLANCE; INFECTIONS
AB In Pernambuco, the first dengue cases occurred in 1987. After a seven-year interval without autochthonous cases, anew epidemic occurred in 1995. Important aspects of the dengue epidemics during the period 1995-2006 have been analyzed here, using epidemiological, clinical and laboratory data. A total 0078,374 cases were notified, with 612 confirmed cases of dengue hemorrhagic fever and 33 deaths. The mortality rate was 5.4%. The incidence rate increased from 134 to 1,438/100,000 inhabitants, corresponding to the epidemics due to serotypes 2 and 3, in 1995 and 2002, respectively. Dengue mainly affected adults (20-49 years); 40.7% were male and 59.3% were female. From 2003 onwards, the number of cases among individuals younger than 15 years old increased. Out of 225 dengue hemorrhagic fever cases, 42.7% primary and 57.3% secondary infections were identified (p = 0.0279). Neurological manifestations were also observed. From 2002 onwards, serotypes 1, 2 and 3 were circulating, serotype 3 was predominant.
C1 [Cordeiro, Marli Tenorio] Fiocruz MS, Lab Virol & Terapia Expt CPqAM, BR-50670420 Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio; de Oliveira, Valdete Felix] Lab Cent Saude Publ Secretaria Saude Estado Perna, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Virol & Terapia Expt, Recife, PE, Brazil.
   [Schatzmayr, Hermann Goncalves; Nogueira, Rita Maria Ribeiro] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Virol, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [de Melo, Wellinton Tavares] Gerencia Geral Vigilancia Saude Secretaria Saude, Recife, PE, Brazil.
   [de Carvalho, Eduardo Freese] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Saude Coletiva, Recife, PE, Brazil.
RP Cordeiro, MT (corresponding author), Fiocruz MS, Lab Virol & Terapia Expt CPqAM, Av Moraes Rego,S-N,Campus UFPE,Cidade Univ, BR-50670420 Recife, PE, Brazil.
EM marli@cpqam.fiocruz.br
CR CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   CORDEIRO MT, 2002, ANAIS VIRUS REV RES, V7, P54
   da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   Gonzalez D, 2005, INT J INFECT DIS, V9, P280, DOI 10.1016/j.ijid.2004.07.012
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   GUBLER DJ, 1983, ANN INT C DENG DENG, P290
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Leão Raimundo N.Q., 2002, Rev. Soc. Bras. Med. Trop., V35, P401, DOI 10.1590/S0037-86822002000400018
   Marzochi K B, 1991, Cad Saude Publica, V7, P409, DOI 10.1590/S0102-311X1991000300009
   Marzochi Keyla Belizia Feldman, 2004, Rev. Soc. Bras. Med. Trop., V37, P413, DOI 10.1590/S0037-86822004000500009
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   *MIN SAUD DATASUS, 2007, CENS DEM CONT POP AN
   *MIN SAUD SECR VIG, 2005, DENG DIAGN MAN CLIN
   Nogueira R. M. R., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P68
   NOGUEIRA R M R, 1988, Memorias do Instituto Oswaldo Cruz, V83, P219, DOI 10.1590/S0074-02761988000200012
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Nogueira RMR, 1999, T ROY SOC TROP MED H, V93, P418, DOI 10.1016/S0035-9203(99)90142-6
   NOGUEIRA SA, 1999, JORNAL PEDIAT, V75, P9
   Nogueira Susie Andries, 2005, J. Pediatr. (Rio J.), V81, P191, DOI 10.1590/S0021-75572005000400003
   Nunes-Araujo FRF, 2003, ANN TROP MED PARASIT, V97, P415, DOI 10.1179/000349803235002263
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   Rigau-Perez J G, 1999, P R Health Sci J, V18, P347
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   ZAGNE SMO, 1994, T ROY SOC TROP MED H, V88, P677, DOI 10.1016/0035-9203(94)90225-9
NR 39
TC 39
Z9 42
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2007
VL 40
IS 6
BP 605
EP 611
DI 10.1590/S0037-86822007000600001
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 249HY
UT WOS:000252220100001
PM 18200409
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Gomes, ALV
   Silva, AM
   Cordeiro, MT
   Guimaraes, GF
   Marques, ETA
   Abath, FGC
AF Gomes, A. L. V.
   Silva, A. M.
   Cordeiro, M. T.
   Guimaraes, G. F.
   Marques, E. T. A., Jr.
   Abath, F. G. C.
TI Single-tube nested PCR using immobilized internal primers for the
   identification of dengue virus serotypes
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE nested PCR; diagnosis; dengue; single-tube
ID RAPID DETECTION; REVERSE
AB Molecular techniques based on the detection of genomic sequences by reverse transcription (RT)-PCR, nested PCR, or real-time PCR have made possible the rapid diagnosis of dengue virus (DENV) infections, and these approaches have been accepted by clinical laboratories as the new standard method for the detection of dengue virus in acute-phase serum samples. One of these PCR-based assays, the two-step RT nested PCR (RT-NPCR) technique is used routinely in laboratories worldwide. In the present study, the two-step RT-NPCR as described by Lanciotti et al. [Lanciotti, R.S., Calisher, C.H., Gabler, D.J., Chang, G.J., Vorndam, AX, 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30, 545-55 1] was adapted to a novel single-tube nested PCR (STNPCR) format, which is less prone to cross-contamination and reduces reaction cost and time. When standards for each dengue serotype were tested, the detection limit of the STNPCR was at least 10 copies for DENV-1 and 100 copies for DENV-2 and DENV-3, whereas the detection limit for the two-step RT-NPCR was 100 copies for each serotype. Sera from 22 patients with confirmed DENV-3 infections and from 14 healthy individuals were then tested in the STNPCR format using the system described by Lanciotti et al. as the reference standard. The results indicated a sensitivity of 75.9% (CI 95%, 60.3-91.4) and a specificity of 100% for the RT-STNPCR. Although RT-STNPCR was less sensitive than the conventional two-step RT-NPCR for the detection of virus in serum samples, it was still adequately sensitive, and the advantages associated with a single-tube format may outweigh the somewhat lower assay sensitivity, making it useful for diagnosis in the field. (c) 2007 Elsevier B.V. All rights reserved.
C1 Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Lab Virol & Terapia Expt, BR-50670420 Recife, PE, Brazil.
   Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Immunol, BR-50670420 Recife, PE, Brazil.
   Johns Hopkins Univ, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA.
RP Marques, ETA (corresponding author), Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Lab Virol & Terapia Expt, Av Moraes Rego S-N,Cidade Univ, BR-50670420 Recife, PE, Brazil.
EM emarques@cpqam.fiocruz.br
RI Marques, Ernesto/L-4514-2013; Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto/0000-0003-3826-9358; Marques, Ernesto T.
   A/0000-0003-3826-9358
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI056541, U19 AI056541-01, U19
   AI056541-04, U19 AI056541-02, U19 AI56541, U19 AI056541-05, U19
   AI056541-03, U19 AI056541-010004] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI056541, U19AI056541, U19AI056541, U19AI056541, U19AI056541]
   Funding Source: NIH RePORTER
CR Abath FGC, 2002, BIOTECHNIQUES, V33, P1210, DOI 10.2144/02336bm05
   Anwar A, 2006, ANAL BIOCHEM, V352, P120, DOI 10.1016/j.ab.2006.01.046
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Guha P, 2005, INT J GEOM METHODS M, V2, P1, DOI 10.1142/S0219887805000429
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Harris E, 1998, J CLIN MICROBIOL, V36, P2634, DOI 10.1128/JCM.36.9.2634-2639.1998
   Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003
   Kumaria R, 2005, DIAGN MICR INFEC DIS, V52, P311, DOI 10.1016/j.diagmicrobio.2005.04.013
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Melo FL, 2006, T ROY SOC TROP MED H, V100, P1049, DOI 10.1016/j.trstmh.2005.12.008
   Montenegro LML, 2004, T ROY SOC TROP MED H, V98, P619, DOI 10.1016/j.trstmh.2003.11.011
   Picken MM, 1996, EUR J CLIN MICROBIOL, V15, P489, DOI 10.1007/BF01691317
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI200421512
NR 14
TC 17
Z9 17
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD OCT
PY 2007
VL 145
IS 1
BP 76
EP 79
DI 10.1016/j.jviromet.2007.05.003
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 211FG
UT WOS:000249509100011
PM 17573132
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Brito, CAA
   Sobreira, S
   Cordeiro, MT
   Lucena-Silva, N
AF Brito, Carlos A. A.
   Sobreira, Silvana
   Cordeiro, Marli Tenorio
   Lucena-Silva, Norma
TI Acute disseminated encephalomyelitis in classic dengue
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE acute disseminated encephalomyelitis; dengue; neurological symptoms
ID NEUROLOGICAL MANIFESTATIONS; INFECTION; VIRUS
AB Neurological manifestation is uncommon in dengue infection. The pathogenesis of central nervous system involvement is controversial. We report a rare case of acute disseminated encephalomyelitis in classic dengue, with isolation of serotype 3 in liquor This condition was associated with significant structural damage detected by magnetic resonance.
C1 Fiocruz MS, Ctr Pesquisa Aggeu Magalhaes, Oswaldo Cruz Fdn, BR-50670420 Recife, PE, Brazil.
   Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   Hosp Mem Sao Jose, Recife, PE, Brazil.
   Dr Milton Bezerra Lab, Cent Lab, Recife, PE, Brazil.
   Inst Materno Infantil Pernambuco Prof Fernando Fi, Recife, PE, Brazil.
RP Lucena-Silva, N (corresponding author), Fiocruz MS, Ctr Pesquisa Aggeu Magalhaes, Oswaldo Cruz Fdn, Av Moraes Rego S-N,Campus UFPE,Cidade Univ, BR-50670420 Recife, PE, Brazil.
EM nlucena@cpqam.fiocruz.br
RI Lucena-Silva, Norma/AAH-9437-2019
CR CARN BV, 2001, AM J TROP MED HYG, V66, P848
   CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157
   Ferreira MLB, 2005, ARQ NEURO-PSIQUIAT, V63, P488, DOI 10.1590/S0004-282X2005000300023
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Kankirawatana P, 2000, J CHILD NEUROL, V15, P544, DOI 10.1177/088307380001500809
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Misra UK, 2006, J NEUROL SCI, V244, P117, DOI 10.1016/j.jns.2006.01.011
   NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P398
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Santos NQ, 2004, ARQ NEURO-PSIQUIAT, V62, P144, DOI 10.1590/S0004-282X2004000100025
   Yamamoto Yuuji, 2002, Journal of Infection and Chemotherapy, V8, P175, DOI 10.1007/s101560200030
NR 12
TC 22
Z9 24
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAR-APR
PY 2007
VL 40
IS 2
BP 236
EP 238
DI 10.1590/S0037-86822007000200019
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 174KG
UT WOS:000246940200019
PM 17568897
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Cordeiro, MT
   Silva, AM
   Nascimento, E
   Brito, CA
   Magalhaes, MCF
   Guimaraes, GF
   Marquess, ET
AF Cordeiro, Marli T.
   Silva, Ana M.
   Nascimento, Eduardo
   Brito, Carlos A.
   Magalhaes, Maria Cecilia F.
   Guimaraes, Georgia F.
   Marquess, Ernesto T.
TI Clinical and molecular characterization of dengue patients cohort in
   Recife, Brazil for epitope mapping and immuno pathogenesis studies
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
RI Nascimento, Eduardo/J-4590-2014; Marques, Ernesto T. A/L-4967-2013
OI Nascimento, Eduardo/0000-0002-9851-2332; Marques, Ernesto T.
   A/0000-0003-3826-9358
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2006
VL 75
IS 5
SU S
MA 796
BP 230
EP 230
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 109XW
UT WOS:000242343901231
DA 2020-12-08
ER

PT J
AU La Braga, E
   Moura, P
   Pinto, LM
   Ignacio, SR
   Oliveira, MJC
   Cordeiro, MT
   Kubelka, CF
AF La Braga, E
   Moura, P
   Pinto, LM
   Ignacio, SR
   Oliveira, MJC
   Cordeiro, MT
   Kubelka, CF
TI Detection of circulant tumor necrosis factor-alpha, soluble tumor
   necrosis factor p75 and interferon-gamma in Brazilian patients with
   dengue fever and dengue hemorrhagic fever
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; cytokines; dengue hemorrhagic fever
ID INFECTED PATIENTS; TNF-ALPHA; VIRUS; CYTOKINE; ANTIBODIES; MONOCYTES;
   LEVEL
AB Pro-inflammatory cytokines are believed to play an important role in the pathogenesis of dengue infection. This study reports cytokine levels in a total of 54 patients examined in Recife, State of Pernambuco, Brazil. Five out of eight patients who had hemorrhagic manifestations presented tumor necrosis factor-alpha (TNF-alpha) levels in sera which were statistically higher than those recorded for controls. In contrast, only one out of 16 patients with mild manifestations had elevated TNF-alpha levels. The levels of interleukin-6 (IL), IL-1 beta tested in 24 samples and IL-12 in 30 samples were not significantly increased. Interferon-gamma was present in 10 out of 30 patients with dengue. The data support the concept that the increased level of TNF-alpha is related to the severity of the disease. Soluble TNF receptor p75 was found in most patients but it is unlikely to be related to severity since it was found with an equivalent frequency and levels in 15 patients with dengue fever and another 15 with dengue hemorrhagic fever.
C1 FIOCRUZ, Inst Oswaldo Cruz, Dept Virol, BR-21045900 Rio De Janeiro, Brazil.
   Univ Fed Pernambuco, Inst Ciencias Biol, Dept Patol, Recife, PE, Brazil.
   Fusam, Cent Lab, Dept Virol, Recife, PE, Brazil.
RP Kubelka, CF (corresponding author), FIOCRUZ, Inst Oswaldo Cruz, Dept Virol, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
RI Moura, Patricia M M F/H-7233-2018; Kubelka, Claire F/C-5558-2009
CR Anderson R, 1997, J VIROL, V71, P4226, DOI 10.1128/JVI.71.6.4226-4232.1997
   Bethell DB, 1998, J INFECT DIS, V177, P778, DOI 10.1086/517807
   DINARELLO CA, 1996, PATHOLOGY SEPTIC SHO, P134
   Eigler A, 1997, IMMUNOL TODAY, V18, P487, DOI 10.1016/S0167-5699(97)01118-3
   Halstead S., 1980, TOGAVIRUSES BIOL STR, P107
   HALSTEAD SB, 1990, CURR OPIN INFECT DIS, V3, P434, DOI 10.1097/00001432-199006000-00020
   Hober D, 1996, MICROBIOL IMMUNOL, V40, P569, DOI 10.1111/j.1348-0421.1996.tb01110.x
   HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324
   Hober D, 1998, J MED VIROL, V54, P210, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;210::AID-JMV12&gt;3.0.CO;2-L
   Iyngkaran N., 1995, Singapore Medical Journal, V36, P218
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Kubelka CF, 1995, MEM I OSWALDO CRUZ, V90, P741, DOI 10.1590/S0074-02761995000600015
   KUNO G, 1994, MEM I OSWALDO CRUZ, V89, P179, DOI 10.1590/S0074-02761994000200010
   LEUWENBERG JFM, 1994, J IMMUNOL, V152, P5070
   Mantovani A, 1997, IMMUNOL TODAY, V18, P231, DOI 10.1016/S0167-5699(97)81662-3
   NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6
   *PAHO PAN AM HLTH, 1994, PAHO WHO SCI PUBLICA, V548
   PANG T, 1987, BIOESSAYS, V6, P141, DOI 10.1002/bies.950060311
   PINTO LMO, 1999, MEM I O CRUZ, V94, P1
   VANZEE KJ, 1992, P NATL ACAD SCI USA, V89, P4845, DOI 10.1073/pnas.89.11.4845
   VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211
   YANG KD, 1995, ACTA VIROL, V39, P19
NR 22
TC 77
Z9 80
U1 1
U2 4
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD FEB
PY 2001
VL 96
IS 2
BP 229
EP 232
DI 10.1590/S0074-02762001000200015
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 402PA
UT WOS:000166996300015
PM 11285501
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU PATRIARCA, PA
   PALMEIRA, G
   LIMA, J
   CORDEIRO, MT
   ORENSTEIN, WA
   LAENDER, F
   OLIVEIRA, MJC
   DANTES, MCD
   RISI, JB
AF PATRIARCA, PA
   PALMEIRA, G
   LIMA, J
   CORDEIRO, MT
   ORENSTEIN, WA
   LAENDER, F
   OLIVEIRA, MJC
   DANTES, MCD
   RISI, JB
TI RANDOMIZED TRIAL OF ALTERNATIVE FORMULATIONS OF ORAL POLIOVACCINE IN
   BRAZIL
SO LANCET
LA English
DT Article
C1 NATL SCI PUBL HLTH, RIO DE JANEIRO, BRAZIL.
   REG VIROL LAB, RECIFE, PE, BRAZIL.
   DEPT HLTH, PERNAMBUCO, BRAZIL.
   MINIST HLTH, BRASILIA, BRAZIL.
RP PATRIARCA, PA (corresponding author), CTR DIS CONTROL, DIV IMMUNISAT, ATLANTA, GA 30333 USA.
CR BASTOS N. C. B., 1974, Bulletin of the Pan American Health Organization, V8, P54
   BELCOURT RJP, 1967, C J PUBLIC HEALTH, V58, P152
   BULPITT CJ, 1987, LANCET, V1, P494
   CHANDRA RK, 1975, BRIT MED J, V2, P583, DOI 10.1136/bmj.2.5971.583
   DOMOK I, 1973, B WORLD HEALTH ORGAN, V51, P333
   HANLON P, 1987, LANCET, V1, P800
   IDRIS MZ, 1980, INDIAN J MED RES, V71, P671
   JOHN TJ, 1984, REV INFECT DIS, V6, pS438
   KIMFARLEY RJ, 1984, LANCET, V2, P1322
   Lamy M E, 1979, Dev Biol Stand, V43, P207
   LASCH EE, 1984, REV INFECT DIS, V6, pS467
   MONTEFIORE DG, 1971, INT C APPLICATION VA, P182
   ODUNTAN SO, 1978, ANN TROP MED PARASIT, V72, P111, DOI 10.1080/00034983.1978.11719290
   RISI JB, 1984, REV INFECT DIS, V6, pS400
   ROBERTSON H. E., 1962, CANADIAN JOUR PUBL HEALTH, V53, P179
   SABIN AB, 1960, JAMA-J AM MED ASSOC, V173, P1521, DOI 10.1001/jama.1960.03020320001001
   Sangkawibha N, 1974, Southeast Asian J Trop Med Public Health, V5, P171
   SCHATZMAYR HG, 1986, VACCINE, V4, P111, DOI 10.1016/0264-410X(86)90048-4
   WHITE PMB, 1986, BRIT MED J, V293, P1153, DOI 10.1136/bmj.293.6555.1153
   1961, 5TH INT POL C
   1960, PAHO SCI PUBL, V50
   1959, PAHO SCI PUBL, V44
   1987, MMWR, V36, P387
   1986, EPI NEWSL, V8, P3
   1986, EPI NEWSL, V8, P4
NR 25
TC 62
Z9 62
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 27
PY 1988
VL 1
IS 8583
BP 429
EP 433
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA M2547
UT WOS:A1988M254700001
PM 2893864
DA 2020-12-08
ER

PT J
AU CORDEIRO, M
   ABECASIS, M
AF CORDEIRO, M
   ABECASIS, M
TI PURPURA WITH HYPOGAMMAGLOBULINAEMIA
SO LANCET
LA English
DT Letter
CR Cordeiro M, 1966, Rev Port Pediatr Pueric, V29, P5
NR 1
TC 1
Z9 1
U1 0
U2 0
PU LANCET LTD
PI LONDON
PA 42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND
SN 0140-6736
J9 LANCET
JI Lancet
PY 1968
VL 1
IS 7541
BP 534
EP &
PG 0
WC Medicine, General & Internal
SC General & Internal Medicine
GA A7697
UT WOS:A1968A769700043
DA 2020-12-08
ER

EF